index	sentence	label
0	The absorption spectrum of the @PROTEIN$ enzyme showed an absorption peak at 425nm indicating that the enzyme had iron-@COMPOUND$ clusters.	1
1	The @PROTEIN$ was purified to homogeneity using ammonium @COMPOUND$ precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.	0
2	The @PROTEIN$ was purified to homogeneity using @COMPOUND$ sulfate precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.	0
3	In addition, we demonstrated that Hsp20, @PROTEIN$ and HspB8 induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0
4	In addition, we demonstrated that Hsp20, HspB2 and HspB8 induced @PROTEIN$ production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	1
5	In addition, we demonstrated that Hsp20, HspB2 and @PROTEIN$ induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0
6	Furthermore, @COMPOUND$ was found to be capable of significantly preventing the inhibitory effect of @PROTEIN$ on Abeta oligomer formation.	1
7	The scavenger receptor, class B, type I (@PROTEIN$) is critical in maintaining the homeostasis of cholesterol and @COMPOUND$.	1
8	The scavenger receptor, class B, type I (@PROTEIN$) is critical in maintaining the homeostasis of @COMPOUND$ and alpha-tocopherol.	1
9	SR-BI binds @PROTEIN$ (HDL) and mediates the selective transfer of cholesteryl esters and @COMPOUND$ from circulating HDL to cells.	0
10	@PROTEIN$ binds high-density lipoproteins (HDL) and mediates the selective transfer of cholesteryl esters and @COMPOUND$ from circulating HDL to cells.	1
11	Thus, @PROTEIN$ influences neural and cognitive processes, a finding that highlights the contribution of @COMPOUND$ and alpha-tocopherol homeostasis in proper cognitive function.	0
12	Thus, @PROTEIN$ influences neural and cognitive processes, a finding that highlights the contribution of cholesterol and @COMPOUND$ homeostasis in proper cognitive function.	0
13	@COMPOUND$ supplementation prevents the exercise-induced reduction of serum paraoxonase 1/@PROTEIN$ activities in healthy individuals.	1
14	Although @PROTEIN$4 has been repeatedly associated with altered sphingomyelin and @COMPOUND$ levels in tissue culture and rodent models, there has not been a direct quantification of sphingomyelin or sterol levels in the brains of patients with different forms of ApoE.	1
15	The mood stabilizers @COMPOUND$ and valproate selectively activate the promoter IV of @PROTEIN$ in neurons.	1
16	The mood stabilizers lithium and @COMPOUND$ selectively activate the promoter IV of @PROTEIN$ in neurons.	1
17	Treatment of cultured rat cortical neurons with therapeutic concentrations of @COMPOUND$ or VPA selectively increased the levels of exon IV (formerly rat exon III)-containing @PROTEIN$ mRNA, and the activity of BDNF promoter IV.	1
18	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of @PROTEIN$ or GSK-3beta isoforms.	1
19	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or @PROTEIN$ isoforms.	1
20	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of @PROTEIN$ or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or GSK-3beta isoforms.	1
21	Furthermore, treatment with other HDAC inhibitors, @COMPOUND$ and trichostatin A, or transfection with an HDAC1-specific siRNA also activated @PROTEIN$ promoter IV.	1
22	Furthermore, treatment with other HDAC inhibitors, sodium butyrate and @COMPOUND$, or transfection with an HDAC1-specific siRNA also activated @PROTEIN$ promoter IV.	1
23	Our study demonstrates for the first time that @PROTEIN$ and HDAC are respective initial targets for @COMPOUND$ and VPA to activate BDNF promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.	1
24	Our study demonstrates for the first time that GSK-3 and HDAC are respective initial targets for @COMPOUND$ and VPA to activate @PROTEIN$ promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.	0
25	Addition of biphasic @PROTEIN$ aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0
26	Addition of biphasic @PROTEIN$ aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0
27	Addition of biphasic insulin aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0
28	Addition of biphasic insulin aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0
29	Efficacy and safety of biphasic @PROTEIN$ aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting insulin aspart) added to an optimized treatment of metformin and @COMPOUND$ (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.	0
30	Efficacy and safety of biphasic @PROTEIN$ aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting insulin aspart) added to an optimized treatment of @COMPOUND$ and pioglitazone (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.	0
31	Other potential treatments discussed for possible use with long-acting @PROTEIN$ overdoses include incision and drainage of the injection site, glucagon, and @COMPOUND$.	0
32	@COMPOUND$ inhalation induced: (1) a transient bronchial inflammation, dominated by neutrophils; (2) a neutrophilia of the blood that persisted for up to 4 weeks; (3) a transient increased bronchial reactivity, and (4) a significant increase in @PROTEIN$ activity in the BALF.	1
33	To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, @PROTEIN$ and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
34	To assess whether follicle-stimulating hormone (FSH) and @PROTEIN$ (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
35	To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of @PROTEIN$, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
36	In conclusion, our results show that FSH and bFGF increase @COMPOUND$ levels in Sertoli cells through stimulation of the de novo synthesis and recycling by upregulating @PROTEIN$ and GR expression respectively.	0
37	@PROTEIN$ mutation impairs cholinergic modulation of synaptic plasticity and suppresses @COMPOUND$ currents in hippocampus slices.	1
38	Similarly, mutant @PROTEIN$ impairs the ability of the cholinesterase inhibitor @COMPOUND$ to enhance LTP.	1
39	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1
40	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1
41	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1
42	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1
43	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1
44	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1
45	In the present study, we investigated the effects of @COMPOUND$ on memory impairment and pathological changes in an amyloid precursor protein (APP)/@PROTEIN$ (PS-1) double transgenic mouse model of Alzheimer's disease (AD).	0
46	In the present study, we investigated the effects of @COMPOUND$ on memory impairment and pathological changes in an amyloid precursor protein (APP)/presenilin-1 (@PROTEIN$) double transgenic mouse model of Alzheimer's disease (AD).	0
47	In the present study, we investigated the effects of @COMPOUND$ on memory impairment and pathological changes in an amyloid precursor protein (@PROTEIN$)/presenilin-1 (PS-1) double transgenic mouse model of Alzheimer's disease (AD).	0
48	@COMPOUND$ also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of @PROTEIN$ (an APP C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.	1
49	@COMPOUND$ also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of C99 (an @PROTEIN$ C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.	1
50	Furthermore, @COMPOUND$ attenuated anxiety-like behavior, up-regulated cerebral @PROTEIN$ protein, and decreased cerebral nitrotyrosine in the transgenic mice.	1
51	@COMPOUND$ rapidly phosphorylated Akt and endothelial @PROTEIN$ (eNOS) in human endothelial cells.	1
52	@COMPOUND$ rapidly phosphorylated Akt and endothelial nitric oxide synthase (@PROTEIN$) in human endothelial cells.	1
53	@COMPOUND$ rapidly phosphorylated @PROTEIN$ and endothelial nitric oxide synthase (eNOS) in human endothelial cells.	1
54	Our findings indicate that @COMPOUND$ protects endothelial cells from death with phosphorylation of Akt and @PROTEIN$.	1
55	Our findings indicate that @COMPOUND$ protects endothelial cells from death with phosphorylation of @PROTEIN$ and eNOS.	1
56	@COMPOUND$ is an endogenous vasodilator gas produced by the enzyme @PROTEIN$ (HO).	1
57	The @PROTEIN$ gene product forms part of a complex with the glucocorticoid receptor and can modulate @COMPOUND$-binding affinity.	1
58	The FKBP5 gene product forms part of a complex with the @PROTEIN$ and can modulate @COMPOUND$-binding affinity.	1
59	Several studies have shown that epsilon 2 carriers have lower low-density lipoprotein and apo B levels and higher @PROTEIN$ @COMPOUND$ and apo A-I levels than epsilon 3 carriers.	1
60	Several studies have shown that @PROTEIN$ 2 carriers have lower low-density lipoprotein and apo B levels and higher high-density lipoprotein @COMPOUND$ and apo A-I levels than epsilon 3 carriers.	1
61	We examined the association of @PROTEIN$ C677T and A1298C, and changes in plasma @COMPOUND$ in 352 Tunisian patients with angiographically-demonstrated CAD, and 390 age and gender-matched healthy subjects.	0
62	Expression of senescence-associated beta-galactosidase (SA-beta-@PROTEIN$) by human skin fibroblasts, effect of advanced glycation end-products and @COMPOUND$ or rhamnose-rich polysaccharides.	0
63	Expression of senescence-associated @PROTEIN$ (SA-beta-Gal) by human skin fibroblasts, effect of advanced glycation end-products and @COMPOUND$ or rhamnose-rich polysaccharides.	0
64	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
65	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
66	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
67	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
68	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
69	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
70	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
71	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
72	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
73	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
74	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
75	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
76	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @COMPOUND$ peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
77	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
78	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
79	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
80	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
81	Abnormally high CSF 3-OMD occurs frequently for RLS patients indicating either increased @COMPOUND$ synthesis, limitations in l-dopa decarboxylation or increased @PROTEIN$/COMT activity, or some combination of these.	0
82	Abnormally high CSF 3-OMD occurs frequently for RLS patients indicating either increased @COMPOUND$ synthesis, limitations in l-dopa decarboxylation or increased MAT/@PROTEIN$ activity, or some combination of these.	0
83	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
84	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
85	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
86	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
87	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
88	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
89	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
90	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
91	The mood stabilizers @COMPOUND$ and valproate activate the @PROTEIN$ pathway in prefrontal cortex and hippocampus and potentiate ERK pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.	1
92	The mood stabilizers lithium and @COMPOUND$ activate the @PROTEIN$ pathway in prefrontal cortex and hippocampus and potentiate ERK pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.	1
93	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, P53 and @PROTEIN$ D1.	1
94	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, @PROTEIN$ and Cyclin D1.	1
95	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: @PROTEIN$, Bcl2, P53 and Cyclin D1.	1
96	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, @PROTEIN$, P53 and Cyclin D1.	1
97	The array and western blotting showed that Bcl2 and @PROTEIN$ D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
98	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; P53 expression was not affected while @PROTEIN$ was over expressed by combination of @COMPOUND$ with Dox.	1
99	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; @PROTEIN$ expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	0
100	The array and western blotting showed that @PROTEIN$ and Cyclin D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
101	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of Bcl2 and @PROTEIN$ D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
102	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of @PROTEIN$ and Cyclin D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
103	Randomised trials have demonstrated that the efficacy of anti-tumour necrosis factor (@PROTEIN$) agents is significantly increased by concomitant @COMPOUND$ (MTX) in rheumatoid arthritis (RA).	1
104	Neither @PROTEIN$ nor ATP altered production of reactive oxygen intermediates (ROI) or reactive @COMPOUND$ intermediates (RNI) by bovine monocytes.	0
105	Neither @PROTEIN$ nor ATP altered production of reactive @COMPOUND$ intermediates (ROI) or reactive nitrogen intermediates (RNI) by bovine monocytes.	0
106	Neither @PROTEIN$ nor @COMPOUND$ altered production of reactive oxygen intermediates (ROI) or reactive nitrogen intermediates (RNI) by bovine monocytes.	0
107	In this systematic review, we have analyzed the results of 52 clinical trials, including 72 intervention groups and 6290 patients, on @COMPOUND$ supplementation in order to evaluate the experimental evidence and the effects of age and chronic immobility on responses of parathyroid hormone (@PROTEIN$).	1
108	The @COMPOUND$ supplementation of the chronically immobile patients resulted in a smaller decrease in @PROTEIN$ 0.001).	1
109	Our results also suggest that @PROTEIN$ decreases quite linearly during @COMPOUND$ supplementation at any given 25-OHD level.	1
110	@PROTEIN$ did not show any effect in long photoperiod but decreased proliferation by stimulating @COMPOUND$ in short photoperiod.	1
111	To compare the changes in body composition and in @PROTEIN$ levels in postmenopausal women receiving hormone therapy (HT) or @COMPOUND$.	1
112	Common 677C--&gt;T mutation of the @PROTEIN$ gene affects follicular @COMPOUND$ synthesis.	1
113	Surprisingly, a deletion of the @PROTEIN$ gene affected not only insoluble @COMPOUND$) reduction, which requires pili, but also soluble Fe(III) reduction, which, in contrast, does not require pili.	1
114	Furthermore, the suppressive effects of P on @PROTEIN$ release and caspase-9 and caspase-3 activation in serum-deprived MC3T3-E1 cells were also reversed by @COMPOUND$.	1
115	Therapeutic @COMPOUND$/@PROTEIN$ activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.	1
116	However, when ERalpha negative MDA-MB-435 cells were treated with @COMPOUND$, they demonstrated increased expression of vascular endothelial growth factor (VEGF) in an @PROTEIN$ dependent manner; while the ERalpha positive MCF-7 cells did not.	1
117	However, when ERalpha negative MDA-MB-435 cells were treated with @COMPOUND$, they demonstrated increased expression of vascular endothelial growth factor (@PROTEIN$) in an AMPK dependent manner; while the ERalpha positive MCF-7 cells did not.	1
118	The @COMPOUND$-treated group showed increased @PROTEIN$ expression, intratumoral microvascular density and reduced necrosis.	1
119	@COMPOUND$ treatment was sufficient, however, to reduce systemic @PROTEIN$ and the proliferation rate of tumor cells in vascularized regions.	1
120	Systemic administration of @PROTEIN$ vesicle elevates tumor tissue @COMPOUND$ tension and modifies tumor response to irradiation.	1
121	At the time, @PROTEIN$ activity was significantly inhibited and gamma-glutamyl @COMPOUND$ increased by ACA exposure.	0
122	The effect of the polymorphism is non-conservative and results in a glutamine to @COMPOUND$ change (Gln460Arg), which is likely to affect @PROTEIN$ dimerization and protein-protein interactions.	1
123	The effect of the polymorphism is non-conservative and results in a @COMPOUND$ to arginine change (Gln460Arg), which is likely to affect @PROTEIN$ dimerization and protein-protein interactions.	1
124	Increased @COMPOUND$ tone and decreased @PROTEIN$ concentrations may also contribute to reduced GH levels.	0
125	A novel oligodeoxynuleotides containing 11 @COMPOUND$ motifs was synthesized and inserted into the VR1020 plasmid containing pig @PROTEIN$ (IL-6) gene (VPIL6) to construct recombinant plasmid, VPIL6C.	0
126	A novel oligodeoxynuleotides containing 11 @COMPOUND$ motifs was synthesized and inserted into the VR1020 plasmid containing pig interleukin-6 (@PROTEIN$) gene (VPIL6) to construct recombinant plasmid, VPIL6C.	0
127	Furthermore, it has also been reported that @COMPOUND$-treated pigs significantly increase mean arterial blood pressure compared with controls and that the decrease in @PROTEIN$ synthesis and release contributes to the elevated blood pressure.	1
128	Mitochondrial dysfunction was associated with higher levels of reactive @COMPOUND$ species, an altered Bcl-xL/Bax ratio and reduction of @PROTEIN$ IV activity.	0
129	Mitochondrial dysfunction was associated with higher levels of reactive @COMPOUND$ species, an altered Bcl-xL/@PROTEIN$ ratio and reduction of COX IV activity.	0
130	Peripheral venous levels of @COMPOUND$, @PROTEIN$, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), malondialdehyde and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects.	0
131	Peripheral venous levels of testosterone, @PROTEIN$, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), @COMPOUND$ and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects.	0
132	Intranasal and intravenous administration of live Cpn and Aa, respectively induced an accumulation of activated mast cells in the aortic sinus of apolipoprotein E-deficient mice, however, with varying responses in the systemic levels of @COMPOUND$ (LPS) and @PROTEIN$.	0
133	@PROTEIN$ and two additional catalase isozymes were induced by @COMPOUND$ or bensulfuron-methyl in S. maltophilia WZ2, but not in E. coli K12.	1
134	MnSOD and two additional @PROTEIN$ isozymes were induced by @COMPOUND$ or bensulfuron-methyl in S. maltophilia WZ2, but not in E. coli K12.	1
135	@PROTEIN$ and two additional catalase isozymes were induced by quinclorac or @COMPOUND$ in S. maltophilia WZ2, but not in E. coli K12.	1
136	MnSOD and two additional @PROTEIN$ isozymes were induced by quinclorac or @COMPOUND$ in S. maltophilia WZ2, but not in E. coli K12.	1
137	Results indicate that @PROTEIN$ has a much weakly role in the defense against @COMPOUND$ or bensulfuron-methyl induced oxidative stress, whereas SOD could be critical.	1
138	Results indicate that catalase has a much weakly role in the defense against quinclorac or @COMPOUND$ induced oxidative stress, whereas @PROTEIN$ could be critical.	1
139	Results indicate that @PROTEIN$ has a much weakly role in the defense against quinclorac or @COMPOUND$ induced oxidative stress, whereas SOD could be critical.	1
140	Results indicate that catalase has a much weakly role in the defense against @COMPOUND$ or bensulfuron-methyl induced oxidative stress, whereas @PROTEIN$ could be critical.	1
141	Depletion of @COMPOUND$ levels was accompanied by the induction of @PROTEIN$ (GR) after 24h exposure with each of the four carbamates to CHO-K1 cells.	1
142	@COMPOUND$ and wortmannin inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1
143	Chloroquine and @COMPOUND$ inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1
144	Moreover, PD98059 and SP600125 inhibited only amino acid deprivation-induced upregulation and @COMPOUND$ inhibited only @PROTEIN$-induced upregulation.	1
145	Moreover, PD98059 and @COMPOUND$ inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0
146	Moreover, @COMPOUND$ and SP600125 inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0
147	The role of phosphorylated @PROTEIN$ (p-Akt) in oral carcinogenesis induced by @COMPOUND$ and alkaline environments was investigated.	0
148	Sera from a population sample of infants with cryptorchidism (n = 43), hypospadias (n = 41) and controls (n = 113) were analyzed for inhibin B, anti-Müllerian hormone (@PROTEIN$), @COMPOUND$, luteinizing hormone (LH), follicle stimulating hormone (FSH) and sex hormone binding globulin (SHBG).	0
149	Sera from a population sample of infants with cryptorchidism (n = 43), hypospadias (n = 41) and controls (n = 113) were analyzed for inhibin B, anti-Müllerian hormone (AMH), @COMPOUND$, luteinizing hormone (LH), follicle stimulating hormone (FSH) and sex hormone binding globulin (@PROTEIN$).	0
150	Myeloperoxidase (@PROTEIN$) is an endogenous oxidant enzyme that generates reactive @COMPOUND$ species (ROS).	1
151	In present study, we investigated the combined effect of @COMPOUND$ and baicalin on pancreatic damage and pancreatitis associated lung injury, as well as tissue @PROTEIN$ expression in the setting of AP.	0
152	In present study, we investigated the combined effect of emodin and @COMPOUND$ on pancreatic damage and pancreatitis associated lung injury, as well as tissue @PROTEIN$ expression in the setting of AP.	0
153	The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, tumor necrosis factor-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed @PROTEIN$ expression in pancreas and lung.	1
154	The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, tumor necrosis factor-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed @PROTEIN$ expression in pancreas and lung.	1
155	The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, @PROTEIN$-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
156	The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, tumor necrosis factor-alpha and @PROTEIN$, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
157	The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, tumor necrosis factor-alpha and @PROTEIN$, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
158	The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, @PROTEIN$-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
159	@COMPOUND$ accumulated cells in S phase of the cell cycle and reduced @PROTEIN$ expression.	1
160	Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
161	Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
162	Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
163	Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
164	Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
165	Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
166	Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml @PROTEIN$ for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (iNOS), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0
167	Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml IFN-gamma for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (@PROTEIN$), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0
168	@COMPOUND$) promotes cytoprotection by activating @PROTEIN$-mediated up-regulation of antioxidant defence.	1
169	Here, we addressed this issue and found that @COMPOUND$) triggered nuclear accumulation of @PROTEIN$ (Nrf2), a transcription factor that up-regulates antioxidant-/electrophile-responsive element (ARE-EpRE)-related genes, in PC12 cells.	1
170	Here, we addressed this issue and found that @COMPOUND$) triggered nuclear accumulation of NF-E2-related factor-2 (@PROTEIN$), a transcription factor that up-regulates antioxidant-/electrophile-responsive element (ARE-EpRE)-related genes, in PC12 cells.	1
171	In women, @PROTEIN$ levels were higher in individuals with diagnosed ischemic heart disease (IHD) and increased with triglycerides (TG) and @COMPOUND$ level.	0
172	To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (@PROTEIN$) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
173	To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (IL6) and tumour necrosis factor alpha (@PROTEIN$) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
174	To investigate overnight variations in absolute values and patterns of cytokines including @PROTEIN$ (IL6) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
175	Intracellular oxidative status was assessed by analysis of @COMPOUND$/GSSG levels and time course of ROS production and @PROTEIN$ (GR) activity.	0
176	Intracellular oxidative status was assessed by analysis of GSH/@COMPOUND$ levels and time course of ROS production and @PROTEIN$ (GR) activity.	0
177	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), @PROTEIN$ (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
178	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of @PROTEIN$ interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
179	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (@PROTEIN$) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
180	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and @PROTEIN$ (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
181	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (@PROTEIN$), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
182	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (@PROTEIN$), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
183	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), @PROTEIN$ (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
184	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (@PROTEIN$), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
185	Significant elevation of numbers of GM-CFC evoked by the combinations of @COMPOUND$ with IL-3, @PROTEIN$, or GM-CSF as compared with these growth factors alone has been noted.	0
186	Significant elevation of numbers of GM-CFC evoked by the combinations of @COMPOUND$ with @PROTEIN$, SCF, or GM-CSF as compared with these growth factors alone has been noted.	0
187	Combination of @COMPOUND$ with @PROTEIN$ did not induce significantly higher numbers of GM-CFC in comparison with G-CSF alone.	0
188	Joint action of three drugs, namely of @COMPOUND$+ IL-3+ @PROTEIN$, produced significantly higher numbers of GM-CFC in comparison with the combinations of IB-MECA+ IL-3, IB-MECA+ GM-CSF, or IL-3+ GM-CSF.	0
189	Joint action of three drugs, namely of @COMPOUND$+ @PROTEIN$+ GM-CSF, produced significantly higher numbers of GM-CFC in comparison with the combinations of IB-MECA+ IL-3, IB-MECA+ GM-CSF, or IL-3+ GM-CSF.	0
190	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (IGF-1), transforming growth factor-beta1 (@PROTEIN$), or a combination of both growth factors were mixed with OPF, a poly(ethylene glycol)-diacrylate crosslinker and the radical initiators ammonium persulfate and @COMPOUND$, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
191	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (@PROTEIN$), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a poly(ethylene glycol)-diacrylate crosslinker and the radical initiators ammonium persulfate and @COMPOUND$, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
192	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (IGF-1), transforming growth factor-beta1 (@PROTEIN$), or a combination of both growth factors were mixed with OPF, a @COMPOUND$ crosslinker and the radical initiators ammonium persulfate and N,N,N',N'-tetramethylethylenediamine, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
193	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with @PROTEIN$-like growth factor-1 (IGF-1), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a poly(ethylene glycol)-diacrylate crosslinker and the radical initiators ammonium persulfate and @COMPOUND$, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
194	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (@PROTEIN$), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a @COMPOUND$ crosslinker and the radical initiators ammonium persulfate and N,N,N',N'-tetramethylethylenediamine, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
195	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with @PROTEIN$-like growth factor-1 (IGF-1), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a @COMPOUND$ crosslinker and the radical initiators ammonium persulfate and N,N,N',N'-tetramethylethylenediamine, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
196	Real-time RT-PCR showed that the expression of osteoblast marker genes such as CBFalpha1 and @PROTEIN$ was increased in hyaluronic acid-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, @COMPOUND$, and BMP-2.	1
197	Real-time RT-PCR showed that the expression of osteoblast marker genes such as CBFalpha1 and alkaline phosphatase was increased in hyaluronic acid-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, @COMPOUND$, and @PROTEIN$.	0
198	Real-time RT-PCR showed that the expression of osteoblast marker genes such as CBFalpha1 and @PROTEIN$ was increased in @COMPOUND$-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, RGD peptide, and BMP-2.	1
199	Real-time RT-PCR showed that the expression of osteoblast marker genes such as @PROTEIN$ and alkaline phosphatase was increased in hyaluronic acid-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, @COMPOUND$, and BMP-2.	1
200	Real-time RT-PCR showed that the expression of osteoblast marker genes such as CBFalpha1 and alkaline phosphatase was increased in @COMPOUND$-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, RGD peptide, and @PROTEIN$.	0
201	Real-time RT-PCR showed that the expression of osteoblast marker genes such as @PROTEIN$ and alkaline phosphatase was increased in @COMPOUND$-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, RGD peptide, and BMP-2.	1
202	We monitored bcr-@PROTEIN$ transcript levels by quantitative real time PCR in 50 tunisian patients treated with @COMPOUND$ for chronic myeloid leukemia in chronic phase for a median of 29 months (3-60) after they started imatinib.	0
203	We monitored @PROTEIN$-abl transcript levels by quantitative real time PCR in 50 tunisian patients treated with @COMPOUND$ for chronic myeloid leukemia in chronic phase for a median of 29 months (3-60) after they started imatinib.	0
204	Recent studies suggest that crystals of monosodium urate (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, @COMPOUND$-rich repeat and @PROTEIN$ domain-containing protein (NALP)3 inflammasome.	0
205	Recent studies suggest that crystals of @COMPOUND$ (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, leucine-rich repeat and @PROTEIN$ domain-containing protein (NALP)3 inflammasome.	1
206	Nicotine, @COMPOUND$, and chlorpyrifos induced the phosphorylation of @PROTEIN$ and 2.	1
207	Nicotine, muscarine, and @COMPOUND$ induced the phosphorylation of @PROTEIN$ and 2.	1
208	@COMPOUND$, muscarine, and chlorpyrifos induced the phosphorylation of @PROTEIN$ and 2.	1
209	Adult bone marrow (BM)-derived @PROTEIN$-producing cells (IPCs) are capable of regulating blood @COMPOUND$ levels in chemically induced hyperglycemic mice.	1
210	Treatment with @COMPOUND$ activated glucose metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	1
211	Treatment with benfotiamine activated @COMPOUND$ metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	0
212	Benfotiamine was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to @COMPOUND$.	1
213	Benfotiamine was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to @COMPOUND$.	0
214	@COMPOUND$ was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	1
215	@COMPOUND$ was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	0
216	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, insulin, and @PROTEIN$.	1
217	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, @PROTEIN$, insulin, and GAPDH.	1
218	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, @PROTEIN$, and GAPDH.	1
219	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of @PROTEIN$, glucokinase, insulin, and GAPDH.	1
220	) and two @COMPOUND$ tensions (5 and 20%) were compared for their ability to sustain blastocyst survival and @PROTEIN$ production from days 8 to 11 post-insemination.	0
221	In conclusion, culturing blastocysts of cattle in a 5% @COMPOUND$ environment with M199 containing serum sustains embryo viability and permits constitutive and inducible @PROTEIN$ production.	1
222	Incubation in 20% @COMPOUND$ increases @PROTEIN$ production.	1
223	Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite A771726 (@COMPOUND$).	1
224	Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as @COMPOUND$ and its metabolite A771726 (teriflunomide).	1
225	Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite @COMPOUND$ (teriflunomide).	1
226	Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as @COMPOUND$ and its metabolite A771726 (teriflunomide).	1
227	Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite A771726 (@COMPOUND$).	1
228	Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite @COMPOUND$ (teriflunomide).	1
229	Inhibition of @PROTEIN$ by zebularine enhances the antineoplastic action of @COMPOUND$.	0
230	Inhibition of @PROTEIN$ by @COMPOUND$ enhances the antineoplastic action of 5-aza-2'-deoxycytidine.	1
231	An individual's response to @COMPOUND$ may be influenced by the amount of @PROTEIN$ (+) and CD8(+) T-lymphocyte suppression.	1
232	mRNA expressions of matrix metallopeptidase-9, inducible @PROTEIN$ and pro-inflammatory cytokines interleukin-1 beta and tumour necrosis factor-alpha in EAN sciatic nerves were greatly decreased by administration of @COMPOUND$ as well.	1
233	Then the review evaluates the involvement of @PROTEIN$ activated by the endogenous agonist @COMPOUND$ in the generation and propagation of epileptiform activity.	1
234	Glutamate @COMPOUND$ ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
235	Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (@COMPOUND$) biosynthesis.	1
236	@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from @COMPOUND$ and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
237	Glutamate cysteine ligase (@PROTEIN$), synthesizing @COMPOUND$ from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
238	@PROTEIN$ (GCL), synthesizing @COMPOUND$ from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
239	Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from @COMPOUND$ and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
240	@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in @COMPOUND$ (GSH) biosynthesis.	1
241	Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in @COMPOUND$ (GSH) biosynthesis.	1
242	@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (@COMPOUND$) biosynthesis.	1
243	Serine and cysteine @PROTEIN$ proved to be suitable tools for the production of amino acids and peptides conjugated to @COMPOUND$, whereas metalloproteases do not seem to be very qualified for accepting this nucleophile.	0
244	Role of serotonin @PROTEIN$ receptors in the antidepressant-like effect and the antinociceptive effect of @COMPOUND$ in mice.	1
245	The present study was undertaken to evaluate the potential role of @PROTEIN$ receptors in the antidepressant-like effect and antinociceptive effect of @COMPOUND$.	0
246	These findings show that @PROTEIN$ receptors play differing roles in modulating the antidepressant-like and antinociceptive effects of @COMPOUND$ in the models investigated.	1
247	In contrast, the antinociceptive effect of @COMPOUND$ is probably potentiated due to the blockade of somatodendritic @PROTEIN$ receptors in the same raphe nuclei, facilitating the descending monoaminergic pain control system.	1
248	Moreover, @PROTEIN$ hydrolysis of baicalin sequentially yielded glucuronic acid and @COMPOUND$ as confirmed by co-TLC with authentic samples.	1
249	Moreover, @PROTEIN$ hydrolysis of @COMPOUND$ sequentially yielded glucuronic acid and baicalein as confirmed by co-TLC with authentic samples.	1
250	@COMPOUND$ inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of @PROTEIN$ and paxillin in a dose-dependent manner in a Calu-6 xenograft model.	1
251	@COMPOUND$ inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of FAK and @PROTEIN$ in a dose-dependent manner in a Calu-6 xenograft model.	1
252	Here, we report that the citrus bioflavonoid @COMPOUND$ reduces amyloid-beta (Abeta) peptide generation in both human 'Swedish' mutant @PROTEIN$ transgene-bearing neuron-like cells and primary neurons.	1
253	Here, we report that the citrus @COMPOUND$ luteolin reduces amyloid-beta (Abeta) peptide generation in both human 'Swedish' mutant @PROTEIN$ transgene-bearing neuron-like cells and primary neurons.	1
254	We also find that @COMPOUND$ induces changes consistent with GSK-3 inhibition that (i) decrease amyloidogenic gamma-secretase @PROTEIN$ processing, and (ii) promote presenilin-1 (PS1) carboxyl-terminal fragment (CTF) phosphorylation.	1
255	We also find that @COMPOUND$ induces changes consistent with GSK-3 inhibition that (i) decrease amyloidogenic gamma-secretase APP processing, and (ii) promote @PROTEIN$ (PS1) carboxyl-terminal fragment (CTF) phosphorylation.	1
256	We also find that @COMPOUND$ induces changes consistent with GSK-3 inhibition that (i) decrease amyloidogenic gamma-secretase APP processing, and (ii) promote presenilin-1 (@PROTEIN$) carboxyl-terminal fragment (CTF) phosphorylation.	1
257	We also find that @COMPOUND$ induces changes consistent with @PROTEIN$ inhibition that (i) decrease amyloidogenic gamma-secretase APP processing, and (ii) promote presenilin-1 (PS1) carboxyl-terminal fragment (CTF) phosphorylation.	1
258	As validation of these findings in vivo, we find that @COMPOUND$, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces GSK-3 activity, and disrupts PS1-@PROTEIN$ association.	1
259	As validation of these findings in vivo, we find that @COMPOUND$, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces GSK-3 activity, and disrupts @PROTEIN$-APP association.	1
260	As validation of these findings in vivo, we find that @COMPOUND$, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces @PROTEIN$ activity, and disrupts PS1-APP association.	1
261	Since biliverdin and @COMPOUND$ are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1
262	Since biliverdin and bilirubin are downstream products of @COMPOUND$ degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	0
263	Since @COMPOUND$ and bilirubin are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1
264	Here, we examine the effect of resistin on @COMPOUND$ uptake in human trophoblast cells and we demonstrate that transplacental glucose transport is mediated by @PROTEIN$ (GLUT)-1.	1
265	ERK1 and 2 activation stimulated @PROTEIN$ synthesis and resulted in increase of placental @COMPOUND$ uptake.	1
266	@PROTEIN$ and 2 activation stimulated GLUT-1 synthesis and resulted in increase of placental @COMPOUND$ uptake.	1
267	High resistin levels (50-100 ng/ml) seem able to affect @COMPOUND$-uptake, presumably by decreasing the cell surface @PROTEIN$.	1
268	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
269	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
270	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	1
271	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	0
272	The homomeric @PROTEIN$ (7) receptor is extraordinary in that in addition to distinctive localization and biological functions it exhibits several hallmark properties, for example, the receptor is potently inhibited by divalent cations such as calcium, magnesium, zinc and @COMPOUND$.	1
273	The homomeric @PROTEIN$ (7) receptor is extraordinary in that in addition to distinctive localization and biological functions it exhibits several hallmark properties, for example, the receptor is potently inhibited by divalent cations such as calcium, @COMPOUND$, zinc and copper.	1
274	Replacement doses of hydrocortisone (HC) (10 mg/m2/day) failed to produce a feedback inhibition of @PROTEIN$ (ACTH), and @COMPOUND$ levels remained high.	0
275	Replacement doses of @COMPOUND$ (HC) (10 mg/m2/day) failed to produce a feedback inhibition of adrenocorticotropic hormone (@PROTEIN$), and testosterone levels remained high.	0
276	Replacement doses of hydrocortisone (HC) (10 mg/m2/day) failed to produce a feedback inhibition of adrenocorticotropic hormone (@PROTEIN$), and @COMPOUND$ levels remained high.	0
277	Replacement doses of @COMPOUND$ (HC) (10 mg/m2/day) failed to produce a feedback inhibition of @PROTEIN$ (ACTH), and testosterone levels remained high.	0
278	The discovery of the PLN/@PROTEIN$ interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0
279	The discovery of the @PROTEIN$/HAX-1 interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0
280	@COMPOUND$ alone evoked effects similar to low N/@PROTEIN$ doses, suggesting tonic inhibitory control over forelimb movement by endogenous N/OFQ.	0
281	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single whey acidic protein (@PROTEIN$) domain at the C-terminus.	0
282	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single @PROTEIN$ (WAP) domain at the C-terminus.	0
283	Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl ammonium bromide (@COMPOUND$) to avoid the problem of enzyme extraction.	1
284	Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl @COMPOUND$ (CTAB) to avoid the problem of enzyme extraction.	1
285	Although the levels of IL-4, IL-13, IL-10, and @PROTEIN$/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
286	Although the levels of @PROTEIN$, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
287	Although the levels of IL-4, @PROTEIN$, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
288	Although the levels of IL-4, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and @PROTEIN$ were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
289	Although the levels of IL-4, IL-13, @PROTEIN$, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
290	Although the levels of IL-4, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, @PROTEIN$ and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	1
291	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (@COMPOUND$, 5050) and a blend of PLGA and PHBV.	0
292	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, @COMPOUND$) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
293	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (@COMPOUND$, 5050) and a blend of PLGA and PHBV.	0
294	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), @COMPOUND$) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
295	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, @COMPOUND$) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
296	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), @COMPOUND$) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
297	It is suggested that @COMPOUND$ acting through the GABA(A) receptor mechanism on the expression of GnRH gene and @PROTEIN$ gene in the hypothalamus may be involved in two processes: the biosynthesis of GnRH and the release of this neurohormone in the hypothalamus.	1
298	It is suggested that @COMPOUND$ acting through the GABA(A) receptor mechanism on the expression of @PROTEIN$ gene and GnRH-R gene in the hypothalamus may be involved in two processes: the biosynthesis of GnRH and the release of this neurohormone in the hypothalamus.	1
299	It is suggested that @COMPOUND$ acting through the @PROTEIN$ mechanism on the expression of GnRH gene and GnRH-R gene in the hypothalamus may be involved in two processes: the biosynthesis of GnRH and the release of this neurohormone in the hypothalamus.	1
300	TT-induced increases in @COMPOUND$, adrenocorticotropic hormone and prolactin were reduced only after 3-h @PROTEIN$.	0
301	TT-induced increases in @COMPOUND$, @PROTEIN$ and prolactin were reduced only after 3-h REC.	0
302	TT-induced increases in @COMPOUND$, adrenocorticotropic hormone and @PROTEIN$ were reduced only after 3-h REC.	0
303	@COMPOUND$ inhibits vascular superoxide production induced by endothelin-1 : Role of NADPH oxidase, uncoupled eNOS and @PROTEIN$.	0
304	@COMPOUND$ inhibits vascular superoxide production induced by endothelin-1 : Role of NADPH oxidase, uncoupled @PROTEIN$ and PKC.	0
305	Quercetin inhibits vascular @COMPOUND$ production induced by endothelin-1 : Role of NADPH oxidase, uncoupled eNOS and @PROTEIN$.	0
306	Quercetin inhibits vascular @COMPOUND$ production induced by endothelin-1 : Role of NADPH oxidase, uncoupled @PROTEIN$ and PKC.	0
307	Quercetin inhibits vascular @COMPOUND$ production induced by @PROTEIN$ : Role of NADPH oxidase, uncoupled eNOS and PKC.	1
308	@COMPOUND$ inhibits vascular superoxide production induced by @PROTEIN$ : Role of NADPH oxidase, uncoupled eNOS and PKC.	1
309	Furthermore, ET-1 increased intracellular O(2*)(-) production in all layers of the vessel, protein expression of NADPH oxidase subunit @PROTEIN$ (phox) without affecting p22 (phox) expression and lucigenin-enhanced chemiluminescence signal stimulated by @COMPOUND$.	0
310	Furthermore, ET-1 increased intracellular O(2*)(-) production in all layers of the vessel, protein expression of NADPH oxidase subunit p47 (phox) without affecting @PROTEIN$ (phox) expression and lucigenin-enhanced chemiluminescence signal stimulated by @COMPOUND$.	0
311	Moreover, quercetin but not @COMPOUND$, inhibited the increased @PROTEIN$ activity induced by ET-1.	0
312	Moreover, @COMPOUND$ but not isorhamnetin, inhibited the increased @PROTEIN$ activity induced by ET-1.	1
313	Taken together these results indicate that ET-1-induced NADPH oxidase up-regulation and @PROTEIN$ uncoupling via PKC leading to endothelial dysfunction and these effects were prevented by quercetin and @COMPOUND$.	1
314	Taken together these results indicate that ET-1-induced NADPH oxidase up-regulation and eNOS uncoupling via @PROTEIN$ leading to endothelial dysfunction and these effects were prevented by quercetin and @COMPOUND$.	1
315	Taken together these results indicate that ET-1-induced NADPH oxidase up-regulation and @PROTEIN$ uncoupling via PKC leading to endothelial dysfunction and these effects were prevented by @COMPOUND$ and isorhamnetin.	1
316	Taken together these results indicate that ET-1-induced NADPH oxidase up-regulation and eNOS uncoupling via @PROTEIN$ leading to endothelial dysfunction and these effects were prevented by @COMPOUND$ and isorhamnetin.	1
317	We hypothesized that variants in @PROTEIN$ that lower LDL @COMPOUND$ levels are associated with reduced prevalence and incidence of peripheral artery disease (PAD).	1
318	A series of 2-aryl-naphtho(1,2-d) @COMPOUND$ derivatives have been synthesized and evaluated for @PROTEIN$ inhibitory activity.	0
319	A new series of @COMPOUND$ and aurone derivatives have been synthesized and tested for in vitro @PROTEIN$ inhibitory activity by modified Ellman method.	0
320	@COMPOUND$ differentially alter @PROTEIN$ (2alpha) and PGE (2) release from bovine trophoblast and endometrial tissues during short-term culture.	1
321	@COMPOUND$ differentially alter PGF (2alpha) and @PROTEIN$ (2) release from bovine trophoblast and endometrial tissues during short-term culture.	1
322	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or linoleic acid (C18 :2omega6; @COMPOUND$) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
323	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or linoleic acid (C18 :2omega6; @COMPOUND$) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
324	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), @COMPOUND$ (22:6omega3; DHA) or linoleic acid (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
325	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or @COMPOUND$ (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
326	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or @COMPOUND$ (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
327	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), @COMPOUND$ (22:6omega3; DHA) or linoleic acid (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
328	To get insight into the underlying mechanisms, we compared the ability of recombinant wild type and variant (D327N) @PROTEIN$ to influence @COMPOUND$ effects in MCF-7 breast cancer cells.	1
329	D327N @PROTEIN$ was more effective than wild type protein in inhibiting @COMPOUND$-induced cell proliferation and anti-apoptosis.	1
330	Our results suggest that @COMPOUND$)-induced changes in cytokine secretion by monocytes are diverse and may be influenced by Nrf2 but are not likely influenced by changes in whole-cell @PROTEIN$ levels.	1
331	Our results suggest that @COMPOUND$)-induced changes in cytokine secretion by monocytes are diverse and may be influenced by @PROTEIN$ but are not likely influenced by changes in whole-cell Trx1 levels.	1
332	To test the hypothesis that increasing @COMPOUND$ levels is associated with improved @PROTEIN$ resistance in patients with polycystic ovary syndrome (PCOS).	1
333	Melatonin altered PHZ-induced responses significantly to a greater degree than @COMPOUND$ as evidenced by LPO status, @PROTEIN$ activity, and ABTS radical cation scavenging activity of antioxidants.	0
334	@COMPOUND$ altered PHZ-induced responses significantly to a greater degree than vitamin E as evidenced by LPO status, @PROTEIN$ activity, and ABTS radical cation scavenging activity of antioxidants.	1
335	@COMPOUND$ altered PHZ-induced responses significantly to a greater degree than vitamin E as evidenced by @PROTEIN$ status, SOD activity, and ABTS radical cation scavenging activity of antioxidants.	1
336	Melatonin altered @COMPOUND$-induced responses significantly to a greater degree than vitamin E as evidenced by LPO status, @PROTEIN$ activity, and ABTS radical cation scavenging activity of antioxidants.	0
337	Melatonin altered PHZ-induced responses significantly to a greater degree than vitamin E as evidenced by @PROTEIN$ status, SOD activity, and @COMPOUND$ scavenging activity of antioxidants.	0
338	Melatonin altered PHZ-induced responses significantly to a greater degree than vitamin E as evidenced by LPO status, @PROTEIN$ activity, and @COMPOUND$ scavenging activity of antioxidants.	0
339	Melatonin altered @COMPOUND$-induced responses significantly to a greater degree than vitamin E as evidenced by @PROTEIN$ status, SOD activity, and ABTS radical cation scavenging activity of antioxidants.	0
340	Melatonin altered PHZ-induced responses significantly to a greater degree than @COMPOUND$ as evidenced by @PROTEIN$ status, SOD activity, and ABTS radical cation scavenging activity of antioxidants.	0
341	The hydrolysis reaction of @COMPOUND$ catalyzed by @PROTEIN$ was followed with in situ UV/vis diode array spectrophotometry.	1
342	Five enzymes-Candida antarctica @PROTEIN$ B and Fusarium solani pisi cutinase wild-type and three single-mutation variants-were tested as catalysts in homogeneous conditions and immobilized on zeolite NaY, on a @COMPOUND$ support and as cross-linked aggregates.	0
343	Five enzymes-Candida antarctica @PROTEIN$ B and Fusarium solani pisi cutinase wild-type and three single-mutation variants-were tested as catalysts in homogeneous conditions and immobilized on zeolite @COMPOUND$, on a polyacrylate support and as cross-linked aggregates.	0
344	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (@PROTEIN$), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
345	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (@PROTEIN$), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
346	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), @PROTEIN$, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
347	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of @PROTEIN$ (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
348	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated @PROTEIN$ (GHb) in blood.	0
349	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (@PROTEIN$), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
350	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (@PROTEIN$) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
351	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (@PROTEIN$), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
352	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), @PROTEIN$ (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
353	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and @PROTEIN$ (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
354	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (@PROTEIN$), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
355	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of @PROTEIN$ (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
356	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @PROTEIN$ (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
357	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), @PROTEIN$, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
358	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and @PROTEIN$ (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
359	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated @PROTEIN$ (GHb) in blood.	0
360	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @PROTEIN$ (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
361	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (@PROTEIN$), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
362	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (@PROTEIN$) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
363	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), @PROTEIN$ (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
364	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of @PROTEIN$ (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
365	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (@PROTEIN$), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
366	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (@PROTEIN$), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
367	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and @PROTEIN$ (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
368	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (@PROTEIN$) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
369	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), @PROTEIN$ (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
370	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated @PROTEIN$ (GHb) in blood.	0
371	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), @PROTEIN$, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
372	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (@PROTEIN$), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
373	@PROTEIN$ was decreased with @COMPOUND$ and the coexposure, but not with arsenic, whereas GSH was decreased with arsenic and endosulfan, but not with the coexposure.	1
374	@PROTEIN$ was decreased with endosulfan and the coexposure, but not with arsenic, whereas @COMPOUND$ was decreased with arsenic and endosulfan, but not with the coexposure.	0
375	@PROTEIN$ activity was decreased in the @COMPOUND$-treated and the coexposed birds.	1
376	@COMPOUND$ is known to bind @PROTEIN$, beta1 integrin and focal adhesion kinase, members of focal contacts, multi-protein complexes that mediate cell adhesion to the extracellular matrix.	1
377	Furthermore, free radical overproduction and oxidative stress were associated with a significant decrease in hepatic @COMPOUND$ levels in septic mice, and with an excessive NO production attributed to the induction of the inducible isoform of NO synthase (@PROTEIN$).	0
378	In fact, hepatic @COMPOUND$ levels were significantly increased in the group of mice receiving the probiotic, and the increased @PROTEIN$ expression both in the colon and lungs was down-regulated in those mice treated with L. fermentum.	1
379	Furthermore, supplementation of specific inhibitors of @PROTEIN$, C4H and 4CL in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
380	Furthermore, supplementation of specific inhibitors of PAL, C4H and @PROTEIN$ in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
381	Furthermore, supplementation of specific inhibitors of PAL, @PROTEIN$ and 4CL in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
382	@COMPOUND$-induced growth inhibition was associated with induction of Cdk inhibitor p21, inhibition of @PROTEIN$ D1 and activation of caspase-3.	1
383	Three proteins, porcine somatotropin, bovine @PROTEIN$, and immunoglobulin, as well as materials with a strong calorimetric glass transition (T(g)), that is, @COMPOUND$ and poly(vinypyrrolidone) (PVP), were studied by both TSC and differential scanning calorimetry (DSC).	0
384	Three proteins, porcine @PROTEIN$, bovine serum albumin, and immunoglobulin, as well as materials with a strong calorimetric glass transition (T(g)), that is, @COMPOUND$ and poly(vinypyrrolidone) (PVP), were studied by both TSC and differential scanning calorimetry (DSC).	0
385	Only the @PROTEIN$ of pI 5.4 and superior to 7.6 hydrolyze the @COMPOUND$.	1
386	Functional polymorphisms in the @PROTEIN$ and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and @COMPOUND$ treatment.	1
387	There was a significant increase in @PROTEIN$ oxidase activity at 2.5 mg/L, which might indicate @COMPOUND$'s disruption of the mitochondrial membrane and subsequently ATP synthesis.	1
388	There was a significant increase in @PROTEIN$ oxidase activity at 2.5 mg/L, which might indicate irgarol's disruption of the mitochondrial membrane and subsequently @COMPOUND$ synthesis.	1
389	Treatment of A549, which express wild-type @PROTEIN$, and H1299, which are p53-deficient, human lung cancer cells with @COMPOUND$ resulted in inhibition of cell proliferation and an increase in apoptotic cell death ; however, A549 cells were more sensitive to the berberine-induced cytotoxic effects than H1299 cells.	1
390	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine @PROTEIN$.	1
391	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and @PROTEIN$, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
392	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, @PROTEIN$ and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
393	Furthermore @COMPOUND$ treatment markedly decreased the levels of @PROTEIN$, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
394	Our study suggests that the modulation of the balance between pro- and anti-inflammatory cytokines towards the anti-inflammatory cytokine @PROTEIN$ is one salutary mechanism underlying how @COMPOUND$ influences post-MI remodelling and thus improves LV function.	1
395	In addition, @COMPOUND$ treatment attenuated macrophage infiltration and inhibited urinary excretion of @PROTEIN$ (monocyte chemoattractant protein-1) and kidney cortex MCP-1 gene expression.	1
396	In addition, @COMPOUND$ treatment attenuated macrophage infiltration and inhibited urinary excretion of MCP-1 (@PROTEIN$) and kidney cortex MCP-1 gene expression.	1
397	Exogenous spermidine, arsenic and @COMPOUND$ modulate tobacco resistance to tobacco mosaic virus, and affect local and systemic glucosylsalicylic acid levels and @PROTEIN$ gene expression in tobacco leaves.	1
398	Exogenous @COMPOUND$, arsenic and beta-aminobutyric acid modulate tobacco resistance to tobacco mosaic virus, and affect local and systemic glucosylsalicylic acid levels and @PROTEIN$ gene expression in tobacco leaves.	1
399	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and PR-2 and @PROTEIN$ (ADC)).	1
400	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (@PROTEIN$ PR-1a and PR-2 and arginine decarboxylase (ADC)).	1
401	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and PR-2 and arginine decarboxylase (@PROTEIN$)).	1
402	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and @PROTEIN$ and arginine decarboxylase (ADC)).	1
403	She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of Alanine to @COMPOUND$ in exon 5 (A382V).	1
404	She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of @COMPOUND$ to Valine in exon 5 (A382V).	1
405	Decreased hepatic @PROTEIN$ secretion is correlated with reduced hepatic @COMPOUND$ production but is not associated with insulin resistance in patients with liver cirrhosis.	1
406	Decreased hepatic RBP4 secretion is correlated with reduced hepatic @COMPOUND$ production but is not associated with @PROTEIN$ resistance in patients with liver cirrhosis.	0
407	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (@PROTEIN$/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
408	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of @PROTEIN$ (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
409	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in @PROTEIN$ expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
410	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), @PROTEIN$-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
411	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and @PROTEIN$.	1
412	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/@PROTEIN$), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
413	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of @PROTEIN$ (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
414	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, @PROTEIN$ B1 and c-Myc.	1
415	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of @PROTEIN$, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
416	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming @PROTEIN$ (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1
417	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming peroxidase (@PROTEIN$) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
418	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming @PROTEIN$ (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
419	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (@PROTEIN$) and lignin-forming peroxidase (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
420	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (@PROTEIN$) and lignin-forming peroxidase (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1
421	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) @PROTEIN$ (CAT) and lignin-forming peroxidase (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
422	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) @PROTEIN$ (CAT) and lignin-forming peroxidase (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1
423	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming peroxidase (@PROTEIN$) were found to be increased by proline and @COMPOUND$ under salt stress.	1
424	Significant @PROTEIN$ activity changes, sensitivity of isozyme patterns (Mr of 60, 64, and 85kDa) and increased variation in ALP plasticity during acute exposure to @COMPOUND$ point to its possible aplication as an exposure biomarker.	1
425	To decrease the level of androgen @COMPOUND$ in the prostate, we are interested in developing inhibitors of 17beta-hydroxysteroid dehydrogenase type 5 (@PROTEIN$).	0
426	To decrease the level of androgen @COMPOUND$ in the prostate, we are interested in developing inhibitors of @PROTEIN$ (17beta-HSD5).	0
427	@PROTEIN$ (EC 3.2.1.52) are lysosomal enzymes that remove terminal beta-glycosidically bound N-acetylglucosamine and @COMPOUND$ residues from a number of glycoconjugates.	1
428	@PROTEIN$ (EC 3.2.1.52) are lysosomal enzymes that remove terminal beta-glycosidically bound @COMPOUND$ and N-acetylgalactosamine residues from a number of glycoconjugates.	1
429	Distribution of the @PROTEIN$ in the diencephalon and the pituitary gland in goats: Co-localisation with corticotrophin releasing hormone, @COMPOUND$ and corticotrophs.	0
430	A differential regulation of the two @COMPOUND$ synthesizing enzymes (GAD65 and @PROTEIN$) parallels GABAergic neuron differentiation.	1
431	A differential regulation of the two @COMPOUND$ synthesizing enzymes (@PROTEIN$ and GAD67) parallels GABAergic neuron differentiation.	1
432	The production of rhG-@PROTEIN$ was induced by switching from growth on @COMPOUND$ to growth on methanol.	0
433	The production of rhG-@PROTEIN$ was induced by switching from growth on glycerol to growth on @COMPOUND$.	1
434	In the induction phase, the @COMPOUND$ feed rate had a significant effect on the specific expression rate of rhG-@PROTEIN$.	1
435	Under this condition, a maximum concentration of 300 mg/l of rhG-@PROTEIN$ and the expression yield of 0.6 mg of rhG-CSF/g of @COMPOUND$ were attained.	1
436	Among seven additives tested, @COMPOUND$, Tween 80 and betaine exhibited the best results in respect of preventing the formation of rhG-@PROTEIN$ protein aggregates.	1
437	Among seven additives tested, Tween 20, Tween 80 and @COMPOUND$ exhibited the best results in respect of preventing the formation of rhG-@PROTEIN$ protein aggregates.	1
438	@COMPOUND$ induces apoptosis in colorectal carcinoma cells by modulating the @PROTEIN$ and p38 MAPK pathways.	1
439	@COMPOUND$ induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and @PROTEIN$ pathways.	1
440	The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and @COMPOUND$ (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
441	The protein inhibitors wortmannin (@COMPOUND$ 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
442	The protein inhibitors @COMPOUND$ (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
443	The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), @COMPOUND$ (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
444	Feeding long-chain n-3 polyunsaturated fatty acids during gestation increases intestinal @COMPOUND$ absorption potentially via the acute activation of @PROTEIN$.	0
445	Feeding long-chain n-3 @COMPOUND$ during gestation increases intestinal glucose absorption potentially via the acute activation of @PROTEIN$.	1
446	Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated protein kinase (@PROTEIN$.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
447	Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated @PROTEIN$ (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
448	Furthermore, adding @COMPOUND$ (DHA) or an @PROTEIN$-activated protein kinase (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
449	Hepatocyte growth factor, keratinocyte growth factor or @PROTEIN$ prevented the effect of @COMPOUND$ on cell permeability, but not on PGE (2) release.	1
450	Hepatocyte growth factor, keratinocyte growth factor or insulin prevented the effect of @COMPOUND$ on cell permeability, but not on @PROTEIN$ (2) release.	0
451	@PROTEIN$ stimulated PGE (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1
452	Cyclooxygenase-2 stimulated @PROTEIN$ (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1
453	In all final products, @COMPOUND$ used to prepare the @PROTEIN$/lipid mixture was below 20 ppm.	1
454	Our results showed 2a, 2d and 2g as the most active compounds that inhibited the HIV-1 reverse @PROTEIN$ catalytic activity with cytotoxicity lower than @COMPOUND$ and SI higher than DDC and DDI.	1
455	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (COX-1), @PROTEIN$ (COX-2) and the transcription factor NF-kappaB.	1
456	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits @PROTEIN$ (COX-1), cyclooxygenase-2 (COX-2) and the transcription factor NF-kappaB.	1
457	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (@PROTEIN$), cyclooxygenase-2 (COX-2) and the transcription factor NF-kappaB.	1
458	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (COX-1), cyclooxygenase-2 (@PROTEIN$) and the transcription factor NF-kappaB.	1
459	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (@PROTEIN$).	0
460	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and @PROTEIN$ (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
461	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by @PROTEIN$-alpha (TNFalpha).	0
462	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (@PROTEIN$) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
463	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (@PROTEIN$) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
464	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (@PROTEIN$), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
465	@COMPOUND$ was able to reduce @PROTEIN$-induced upregulation of VCAM-1, ICAM-1 and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
466	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of VCAM-1, @PROTEIN$ and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
467	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of VCAM-1, ICAM-1 and @PROTEIN$ at both the protein and transcript (mRNA) level in HUASMC.	1
468	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of @PROTEIN$, ICAM-1 and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
469	However the quercetin metabolites, @COMPOUND$, quercetin 3-glucuronide and 3'-methylquercetin 3-glucuronide, had no effect on @PROTEIN$-induced up regulation of adhesion molecule or chemokine expression, at either concentration tested.	0
470	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and @PROTEIN$ (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
471	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of @PROTEIN$ ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
472	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (@PROTEIN$) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
473	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of @PROTEIN$ ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
474	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(@PROTEIN$-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
475	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, @PROTEIN$ release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
476	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of @PROTEIN$ and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
477	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of @PROTEIN$ and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
478	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and @PROTEIN$ (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
479	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(@PROTEIN$-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
480	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, @PROTEIN$ (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
481	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, @PROTEIN$ release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
482	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (@PROTEIN$) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
483	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, @PROTEIN$ (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
484	@COMPOUND$ attenuates CD40-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced @PROTEIN$ activation.	1
485	@COMPOUND$ attenuates @PROTEIN$-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced MAPK activation.	1
486	Treatment of ECs with anthocyanins cyanidin-3-O-beta-glucoside (Cy-3-g) and @COMPOUND$ (Pn-3-g) prevents @PROTEIN$-induced endothelial activation by inhibiting production of proinflammatory cytokines and matrix metalloproteinases (MMPs).	1
487	Collectively, our findings suggested that the inhibition of JNK and @PROTEIN$ activation interrupts CD40 induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1
488	Collectively, our findings suggested that the inhibition of @PROTEIN$ and p38 activation interrupts CD40 induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1
489	Collectively, our findings suggested that the inhibition of JNK and p38 activation interrupts @PROTEIN$ induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1
490	Postsynaptic action of @COMPOUND$ is mediated through metabotropic P2Y and ionotropic @PROTEIN$ receptors abundantly expressed in neural cells.	1
491	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (PKC)-alpha (30 min to 18 h), in concert with unaltered c-@PROTEIN$ N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
492	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (@PROTEIN$)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
493	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (PKC)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like @PROTEIN$ (5 min to 18 h).	1
494	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as @PROTEIN$ (PKC)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
495	Phospholipidosis and down-regulation of the @PROTEIN$-K/PDK-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
496	Phospholipidosis and down-regulation of the PI3-K/PDK-1/@PROTEIN$ signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
497	Phospholipidosis and down-regulation of the PI3-K/@PROTEIN$-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
498	@PROTEIN$ antagonism augments @COMPOUND$-induced downregulation of the 5-HT transporter.	1
499	In contrast, chronic @COMPOUND$ markedly decreased 5-@PROTEIN$ levels in all regions.	1
500	This downregulation of 5-@PROTEIN$ by @COMPOUND$ and its enhancement by Org 34850 can explain our recent observation that GR antagonists augment the SSRI-induced increase in extracellular 5-HT.	1
501	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
502	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
503	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
504	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
505	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
506	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
507	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
508	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
509	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
510	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
511	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
512	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
513	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
514	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
515	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
516	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
517	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
518	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
519	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
520	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
521	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
522	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
523	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
524	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
525	Using in vitro binding assays we have demonstrated that transcription factors Sp3, ZBP-89 and NF-Y are capable of binding to the @PROTEIN$ promoter region spanning the sequence-200 to-162 relative to ATG and that formation of complexes could be efficiently reduced by @COMPOUND$.	1
526	Using in vitro binding assays we have demonstrated that @PROTEIN$, ZBP-89 and NF-Y are capable of binding to the SOX18 promoter region spanning the sequence-200 to-162 relative to ATG and that formation of complexes could be efficiently reduced by @COMPOUND$.	1
527	Treatment with @PROTEIN$ indicates that the dimensions of the small fibrils may be dependent upon the presence of @COMPOUND$ within the matrix.	1
528	@COMPOUND$ coatings reduce @PROTEIN$ and von Willebrand factor adsorption and platelet adhesion under both static and flow conditions.	1
529	@COMPOUND$ coatings reduce fibrinogen and @PROTEIN$ adsorption and platelet adhesion under both static and flow conditions.	1
530	Previous studies have showed that radio-frequency plasma deposited @COMPOUND$ coatings greatly reduced @PROTEIN$ adsorption (Gamma(Fg)) from highly diluted plasmas (0.1 and 1%) and subsequent platelet adhesion under static conditions.	1
531	Differential gene expression of @PROTEIN$ and interleukin-1 receptor associated kinase-M in peripheral blood mononuclear cells of young and aged rats following preconditioning with @COMPOUND$.	1
532	The IL-1 receptor-associated kinase 1 (IRAK-1) and @PROTEIN$ are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1
533	The IL-1 receptor-associated kinase 1 (IRAK-1) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (@PROTEIN$).	1
534	The IL-1 receptor-associated kinase 1 (@PROTEIN$) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1
535	The aim of this study was to evaluate the effect of age on the modulation of TLRs and IRAK-1 and @PROTEIN$ in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
536	The aim of this study was to evaluate the effect of age on the modulation of TLRs and @PROTEIN$ and IRAK-M in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
537	The aim of this study was to evaluate the effect of age on the modulation of @PROTEIN$ and IRAK-1 and IRAK-M in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
538	We also previously demonstrated that @COMPOUND$ (GLN) significantly induced @PROTEIN$ in the lower intestinal tract.	0
539	@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of @PROTEIN$ and Bcl-2.	1
540	@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of @PROTEIN$, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	1
541	Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of @PROTEIN$ and Bcl-2.	0
542	@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, @PROTEIN$, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	1
543	Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, @PROTEIN$, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	0
544	@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and @PROTEIN$.	1
545	Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and @PROTEIN$.	0
546	Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of @PROTEIN$, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	0
547	@COMPOUND$ treatment may thus protect mucosal cells from HS-induced oxidative damage via the anti-inflammatory and antiapoptotic properties of @PROTEIN$.	1
548	In this work, we identified a high affinity and potency metallocene-containing @COMPOUND$ peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its @PROTEIN$ and co-receptor binding sites.	1
549	In this work, we identified a high affinity and potency metallocene-containing @COMPOUND$ peptide conjugate that suppresses the interactions of HIV-1 envelope @PROTEIN$ at both its CD4 and co-receptor binding sites.	1
550	Surface plasmon resonance interaction analysis revealed that, compared to a previously reported phenyl-containing triazole conjugate @COMPOUND$ (105), peptide 156 had a higher direct binding affinity for several subtypes of HIV-1 @PROTEIN$ due mainly to the decreased dissociation rate of the conjugate-gp120 complex.	1
551	Surface plasmon resonance interaction analysis revealed that, compared to a previously reported phenyl-containing @COMPOUND$ conjugate HNG-105 (105), peptide 156 had a higher direct binding affinity for several subtypes of HIV-1 @PROTEIN$ due mainly to the decreased dissociation rate of the conjugate-gp120 complex.	1
552	The ferrocene @COMPOUND$ conjugate bound to gp120 of both clade A (92UG037-08) and clade B (YU-2 and SF162) virus subtypes with nanomolar KD in direct binding and inhibited the binding of gp120 to soluble @PROTEIN$ and to antibodies that bind to HIV-1YU-2 gp120 at both the CD4 binding site and CD4-induced binding sites.	1
553	The ferrocene @COMPOUND$ conjugate bound to @PROTEIN$ of both clade A (92UG037-08) and clade B (YU-2 and SF162) virus subtypes with nanomolar KD in direct binding and inhibited the binding of gp120 to soluble CD4 and to antibodies that bind to HIV-1YU-2 gp120 at both the CD4 binding site and CD4-induced binding sites.	1
554	Screening of risk factors for thromboembolism revealed that all patients carried a @PROTEIN$ 677C--&gt;T (MTHFR) mutation in a gene involved in folate metabolism, and either borderline or elevated @COMPOUND$ levels.	0
555	Screening of risk factors for thromboembolism revealed that all patients carried a methylenetetrahydrofolate reductase 677C--&gt;T (@PROTEIN$) mutation in a gene involved in folate metabolism, and either borderline or elevated @COMPOUND$ levels.	0
556	Circulating leptin was negatively correlated with mRNA expression of adiponectin, LEPR and @PROTEIN$, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0
557	Circulating @PROTEIN$ was negatively correlated with mRNA expression of adiponectin, LEPR and LPL, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0
558	Circulating leptin was negatively correlated with mRNA expression of adiponectin, LEPR and LPL, whereas @COMPOUND$ was positively correlated with levels of @PROTEIN$.	1
559	Circulating leptin was negatively correlated with mRNA expression of adiponectin, @PROTEIN$ and LPL, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0
560	In the absence of exogenous Ca(2+) and Mg(2+) and in the presence of EGTA, which favours the release of endogenous Ca(2+), the polyamine @COMPOUND$ is able to stimulate the activity of pyruvate dehydrogenase complex (@PROTEIN$) of energized rat liver mitochondria (RLM).	1
561	In the absence of exogenous @COMPOUND$+) and Mg(2+) and in the presence of EGTA, which favours the release of endogenous Ca(2+), the polyamine spermine is able to stimulate the activity of pyruvate dehydrogenase complex (@PROTEIN$) of energized rat liver mitochondria (RLM).	0
562	In the absence of exogenous Ca(2+) and Mg(2+) and in the presence of @COMPOUND$, which favours the release of endogenous Ca(2+), the polyamine spermine is able to stimulate the activity of pyruvate dehydrogenase complex (@PROTEIN$) of energized rat liver mitochondria (RLM).	0
563	At concentrations higher than 0.5 mM, @COMPOUND$ still stimulates @PROTEIN$, when compared with the control, but shows a slight dose-dependent decrease.	1
564	Changes in @PROTEIN$ stimulation are very close to the phosphorylation level of the E(1alpha) subunit of PDC, which regulates the activity of the complex, but it is also the target of @COMPOUND$.	1
565	These results provide the first evidence that, when transported in RLM, @COMPOUND$ can interact in various ways with @PROTEIN$, showing dose-dependent behaviour.	1
566	This study assessed relationships between @PROTEIN$ levels and @COMPOUND$ uptake and cytotoxicity in cultures of human renal proximal tubule cells (hRPTCs) that produce multiple transporter types.	0
567	From the known regulatory mechanisms of Arc expression, HFD reduced N-methyl-D-aspartate receptor (NMDAR) activity, as seen by decreases in @COMPOUND$ phosphorylation of @PROTEIN$ and levels of NMDAR1.	1
568	From the known regulatory mechanisms of Arc expression, HFD reduced @PROTEIN$ (NMDAR) activity, as seen by decreases in @COMPOUND$ phosphorylation of NMDAR2A and levels of NMDAR1.	1
569	From the known regulatory mechanisms of Arc expression, HFD reduced N-methyl-D-aspartate receptor (NMDAR) activity, as seen by decreases in @COMPOUND$ phosphorylation of NMDAR2A and levels of @PROTEIN$.	0
570	Additionally, we demonstrated that 27-hydroxy@COMPOUND$, a cholesterol metabolite that enters the brain from the blood, decreases Arc levels as well as NMDAR and @PROTEIN$ kinase activities in rat primary hippocampal neurons.	1
571	Additionally, we demonstrated that @COMPOUND$, a cholesterol metabolite that enters the brain from the blood, decreases Arc levels as well as NMDAR and @PROTEIN$ kinase activities in rat primary hippocampal neurons.	1
572	@PROTEIN$, an inducible enzyme important in inflammation, catalyzes the production of prostanoids from @COMPOUND$.	1
573	cDNA probes have been developed for subsequent use in monitoring the @COMPOUND$ exposure of the clam Ruditapes decussatus and the cockle Cerastoderma glaucum using @PROTEIN$ (MT) gene expression in different tissues of these species.	0
574	Pharmacological (@COMPOUND$) and molecular (shRNA) transcription inhibitor were used to impede formation of @PROTEIN$ transcripts.	1
575	Effect of small interference RNA targeting @PROTEIN$ mediated by rAAV combined @COMPOUND$ on pancreatic tumors in athymic mice.	0
576	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or @COMPOUND$.	1
577	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with @COMPOUND$, escitalopram, or venlafaxine.	1
578	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, @COMPOUND$, or venlafaxine.	1
579	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with sertraline, escitalopram, or @COMPOUND$ and 20 healthy controls.	1
580	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with @COMPOUND$, escitalopram, or venlafaxine and 20 healthy controls.	1
581	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with sertraline, @COMPOUND$, or venlafaxine and 20 healthy controls.	1
582	@COMPOUND$ increased @PROTEIN$ levels after 5 weeks and 6 months of treatment.	1
583	@COMPOUND$ increased @PROTEIN$ levels only after 6 months.	1
584	@COMPOUND$ did not affect @PROTEIN$ levels at either time point.	0
585	However, TXA(2) formation remains elevated in patients with cardiovascular disease on doses of @COMPOUND$ that fully suppress platelet @PROTEIN$, suggesting other tissue sources for TXA(2) formation.	1
586	However, @COMPOUND$) formation remains elevated in patients with cardiovascular disease on doses of aspirin that fully suppress platelet @PROTEIN$, suggesting other tissue sources for TXA(2) formation.	0
587	) production increased; metallothionein (MT) and @COMPOUND$ levels increased in most cases, and acetylcholinesterase (@PROTEIN$) activity decreased in summer.	0
588	) production increased; metallothionein (MT) and @COMPOUND$ levels increased in most cases, and @PROTEIN$ (AChE) activity decreased in summer.	0
589	Using DBA/2OlaHsd mice, we investigated the effects of chronic social defeat and concomitant treatment with @COMPOUND$/NBI 30775 on 1) the behavioural profile in the modified hole board test and 2) in-situ hybridization analysis-based expression of arginine vasopressin (AVP) and @PROTEIN$ mRNA in both the hypothalamic paraventricular nucleus and supraoptic nucleus.	0
590	Using DBA/2OlaHsd mice, we investigated the effects of chronic social defeat and concomitant treatment with @COMPOUND$/NBI 30775 on 1) the behavioural profile in the modified hole board test and 2) in-situ hybridization analysis-based expression of arginine vasopressin (@PROTEIN$) and CRH mRNA in both the hypothalamic paraventricular nucleus and supraoptic nucleus.	0
591	@COMPOUND$ also enhanced @PROTEIN$ release from VSMC.	1
592	@PROTEIN$ release by @COMPOUND$, although significant, was not as remarkable as that induced by TNF-alpha.	1
593	IL-6 release by @COMPOUND$, although significant, was not as remarkable as that induced by @PROTEIN$.	0
594	These data suggest that @COMPOUND$ upregulates @PROTEIN$ via mechanisms distinct from TNF-alpha and contributes to the intra- and extracellular IL-6 deposits within the vasculature.	1
595	These data suggest that @COMPOUND$ upregulates IL-6 via mechanisms distinct from @PROTEIN$ and contributes to the intra- and extracellular IL-6 deposits within the vasculature.	0
596	@COMPOUND$ upregulates @PROTEIN$ via mechanisms that are distinct from those of tumor necrosis factor-alpha, in vascular smooth muscle cells.	1
597	@COMPOUND$ upregulates interleukin-6 via mechanisms that are distinct from those of @PROTEIN$-alpha, in vascular smooth muscle cells.	0
598	Among the 7 IL examined, only @PROTEIN$ transcript was increased by @COMPOUND$ treatment in human aorta smooth muscle cells.	1
599	@PROTEIN$ transcripts increased up to 24 h after treatment with @COMPOUND$, and this effect was profoundly repressed by treatment with p38 MAPK inhibitors and to a lesser extent JNK inhibitors.	1
600	@COMPOUND$, 27-hydroxycholesterol or cholesterol, however, did not induce @PROTEIN$ expression.	0
601	7alpha-Hydroxy@COMPOUND$, 27-hydroxycholesterol or cholesterol, however, did not induce @PROTEIN$ expression.	0
602	7alpha-Hydroxycholesterol, @COMPOUND$ or cholesterol, however, did not induce @PROTEIN$ expression.	0
603	Mechanisms of @PROTEIN$ induction by @COMPOUND$ were investigated in comparison with tumor necrosis factor (TNF)-alpha.	1
604	Mechanisms of IL-6 induction by @COMPOUND$ were investigated in comparison with tumor necrosis factor (@PROTEIN$)-alpha.	0
605	Mechanisms of IL-6 induction by @COMPOUND$ were investigated in comparison with @PROTEIN$ (TNF)-alpha.	0
606	Whereas @PROTEIN$ activated IL-6 promoter, which was impaired by p38 MAPK inhibitors or by mutation in the NF-kappaB-binding site within the promoter region, @COMPOUND$ did not affect IL-6 promoter activity.	0
607	Whereas TNF-alpha activated @PROTEIN$ promoter, which was impaired by p38 MAPK inhibitors or by mutation in the NF-kappaB-binding site within the promoter region, @COMPOUND$ did not affect IL-6 promoter activity.	0
608	@COMPOUND$ significantly increased the amount of intracellular @PROTEIN$ protein in the presence of brefeldin A.	1
609	7-ketocholesterol significantly increased the amount of intracellular @PROTEIN$ protein in the presence of @COMPOUND$.	1
610	@COMPOUND$ is a novel, phenolic antioxidant, and vascular protectant which dose-dependently inhibits @PROTEIN$ biomarkers in vitro.	1
611	Lastly, we found that the downstream metabolite of @COMPOUND$, 5alpha- androstane-3beta,17beta-diol (3betaAdiol), is estrogenic in breast cancer cells, and induces growth and ER-signaling via activation of @PROTEIN$.	1
612	Here we demonstrate that an AR ligand, @COMPOUND$ (DHT), inhibits MCF-7 breast cancer cell growth induced by insulin like growth factor 1 (@PROTEIN$).	1
613	Here we demonstrate that an AR ligand, 5-alpha-dihydrotestosterone (@COMPOUND$), inhibits MCF-7 breast cancer cell growth induced by insulin like growth factor 1 (@PROTEIN$).	1
614	Here, we constructed variants to test whether any of these motifs may explain why @PROTEIN$-DeltaN does not respond to stimulation with either ADP ribose or @COMPOUND$.	0
615	We found that @COMPOUND$ induced the activation of JNK, @PROTEIN$, and p38 MAPKs.	1
616	We found that @COMPOUND$ induced the activation of JNK, ERK, and @PROTEIN$.	1
617	We found that @COMPOUND$ induced the activation of @PROTEIN$, ERK, and p38 MAPKs.	1
618	@COMPOUND$-induced JNK activation was associated with the induction of apoptosis through the mitochondrial pathways as a result of increased phosphorylation (inactivation) of the anti-apoptotic @PROTEIN$ and Bcl-xL proteins.	1
619	@COMPOUND$-induced @PROTEIN$ activation was associated with the induction of apoptosis through the mitochondrial pathways as a result of increased phosphorylation (inactivation) of the anti-apoptotic Bcl-2 and Bcl-xL proteins.	1
620	In comparison, @COMPOUND$-induced activation of @PROTEIN$ and p38 in these cells was found to have a protective effect against 2-MeO-E(2)-induced apoptosis.	1
621	In comparison, @COMPOUND$-induced activation of ERK and @PROTEIN$ in these cells was found to have a protective effect against 2-MeO-E(2)-induced apoptosis.	1
622	Mechanistically, inhibition of @PROTEIN$ and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
623	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic @PROTEIN$ and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
624	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and @PROTEIN$ cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
625	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and @PROTEIN$, thereby preventing them from degradation during @COMPOUND$ treatment.	0
626	Mechanistically, inhibition of ERK and @PROTEIN$ activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
627	Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of @COMPOUND$ (DA) and the regulation of @PROTEIN$, which is a target of methamphetamine (METH).	0
628	Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of @PROTEIN$, which is a target of @COMPOUND$ (METH).	1
629	Accumulating evidence suggests that @COMPOUND$ (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of @PROTEIN$, which is a target of methamphetamine (METH).	1
630	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (GSH) and @COMPOUND$ (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (@PROTEIN$) were evaluated.	0
631	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of @COMPOUND$ (GSH) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (@PROTEIN$) were evaluated.	0
632	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of @PROTEIN$ (GR) and contents of @COMPOUND$ (GSH) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (TNF-alpha) were evaluated.	0
633	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (@COMPOUND$) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (@PROTEIN$) were evaluated.	0
634	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of @COMPOUND$ (GSH) and hydroxyproline (Hpr) in the lung as well as serum level of @PROTEIN$-alpha (TNF-alpha) were evaluated.	0
635	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of @PROTEIN$ (GR) and contents of reduced glutathione (@COMPOUND$) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (TNF-alpha) were evaluated.	0
636	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (GSH) and @COMPOUND$ (Hpr) in the lung as well as serum level of @PROTEIN$-alpha (TNF-alpha) were evaluated.	0
637	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of @PROTEIN$ (GR) and contents of reduced glutathione (GSH) and @COMPOUND$ (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (TNF-alpha) were evaluated.	0
638	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (@COMPOUND$) and hydroxyproline (Hpr) in the lung as well as serum level of @PROTEIN$-alpha (TNF-alpha) were evaluated.	0
639	The obtained data revealed that BCNU induced pathological changes and markedly increased lung collagen and level of @PROTEIN$ but decreased @COMPOUND$ content and GR activity and increased serum TNF-alpha compared to both control and MT-administered rats.	0
640	The obtained data revealed that @COMPOUND$ induced pathological changes and markedly increased lung collagen and level of @PROTEIN$ but decreased GSH content and GR activity and increased serum TNF-alpha compared to both control and MT-administered rats.	1
641	The obtained data revealed that @COMPOUND$ induced pathological changes and markedly increased lung collagen and level of Hpr but decreased GSH content and GR activity and increased serum @PROTEIN$ compared to both control and MT-administered rats.	1
642	The obtained data revealed that BCNU induced pathological changes and markedly increased lung collagen and level of Hpr but decreased @COMPOUND$ content and GR activity and increased serum @PROTEIN$ compared to both control and MT-administered rats.	0
643	Collectively, @PROTEIN$ supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, GLP-2R, and eNOS genes, and net portal absorption of AA.	1
644	Collectively, HMB supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, @PROTEIN$, and eNOS genes, and net portal absorption of AA.	0
645	Collectively, HMB supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, GLP-2R, and @PROTEIN$ genes, and net portal absorption of AA.	0
646	No significant differences were observed in plasma concentrations of @COMPOUND$, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease beta hydroxybutyrate postpartum compared to CTL cows.	0
647	No significant differences were observed in plasma concentrations of glucose, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease @COMPOUND$ postpartum compared to CTL cows.	0
648	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and IL-4 as well as cell proliferation but suppressed specific IgG2a and @PROTEIN$ levels.	1
649	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and @PROTEIN$ as well as cell proliferation but suppressed specific IgG2a and IFN-gamma levels.	1
650	injection of @PROTEIN$ provoked a significant increase in plasma @COMPOUND$ level.	1
651	In 17 adults on a fixed metabolic diet, an 11-day course of @COMPOUND$ increased serum @PROTEIN$ and basal gastric acid output, but not maximal gastric acid output, compared with a placebo.	1
652	Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on esterases, @PROTEIN$, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0
653	Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on @PROTEIN$, phenol sulfotransferases, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0
654	We showed that after treatment of HCT116 cells with a low dose of @COMPOUND$ most of them stopped proliferation as documented by SA-@PROTEIN$ activity and the lack of Ki67 expression.	1
655	@COMPOUND$ can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in CYP2C9 and @PROTEIN$.	1
656	Gliclazide can change the conformation of the active sites and decrease obviously the affinities between @COMPOUND$ in the active site and enzymes when it is docked in the second active sites in @PROTEIN$ and CYP2C19.	1
657	@COMPOUND$ can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in @PROTEIN$ and CYP2C19.	1
658	Gliclazide can change the conformation of the active sites and decrease obviously the affinities between @COMPOUND$ in the active site and enzymes when it is docked in the second active sites in CYP2C9 and @PROTEIN$.	1
659	Suppressing the activity of @PROTEIN$ in 3T3-L1 adipocytes reduces mitochondrial biogenesis but enhances glycolysis and basal @COMPOUND$ uptake.	1
660	Therefore, @PROTEIN$ stands at the crossroad of glucose and fatty acid utilization and acts as a homeostatic switch to regulate the flux of TCA cycle, mitochondrial membrane potential and glycolysis to maintain a steady level of @COMPOUND$ production, particularly, when mitochondrial biogenesis is reduced.	1
661	Therefore, @PROTEIN$ stands at the crossroad of @COMPOUND$ and fatty acid utilization and acts as a homeostatic switch to regulate the flux of TCA cycle, mitochondrial membrane potential and glycolysis to maintain a steady level of ATP production, particularly, when mitochondrial biogenesis is reduced.	1
662	A significant decrease in mean total nitric oxide (NOx), nitrite, and @COMPOUND$ levels was also found after @PROTEIN$ plus dexamethasone administration.	1
663	A significant decrease in mean total nitric oxide (NOx), nitrite, and nitrate levels was also found after @PROTEIN$ plus @COMPOUND$ administration.	0
664	A significant decrease in mean total @COMPOUND$ (NOx), nitrite, and nitrate levels was also found after @PROTEIN$ plus dexamethasone administration.	1
665	Even if partially compensated with u-PA and @PROTEIN$, increased FVIII and vWF activity, and decreased nitric oxide levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus @COMPOUND$ administered healthy granulocyte donors.	0
666	Even if partially compensated with u-PA and protein C, increased FVIII and @PROTEIN$ activity, and decreased @COMPOUND$ levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus dexamethasone administered healthy granulocyte donors.	0
667	Even if partially compensated with u-PA and protein C, increased FVIII and @PROTEIN$ activity, and decreased nitric oxide levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus @COMPOUND$ administered healthy granulocyte donors.	0
668	Even if partially compensated with u-PA and @PROTEIN$, increased FVIII and vWF activity, and decreased @COMPOUND$ levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus dexamethasone administered healthy granulocyte donors.	0
669	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), @COMPOUND$ (vitamin B(1)) and riboflavin (vitamin B(2)).	1
670	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, @COMPOUND$, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
671	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, @COMPOUND$ (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
672	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, @COMPOUND$, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
673	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, @COMPOUND$, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
674	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), @COMPOUND$ (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
675	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (@COMPOUND$), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
676	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, @COMPOUND$, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
677	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of @COMPOUND$, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
678	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), @COMPOUND$ (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
679	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and @COMPOUND$ (vitamin B(2)).	1
680	@COMPOUND$ impairs @PROTEIN$-dependent gene expression in porcine kidney tubulus cells.	1
681	Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor @PROTEIN$ as well as mRNA levels of Nrf2 target genes including glutathione-S-transferase and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0
682	Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor Nrf2 as well as mRNA levels of Nrf2 target genes including @PROTEIN$ and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0
683	@PROTEIN$ was induced by @COMPOUND$, a well-known activator of this transcription factor.	1
684	@COMPOUND$ significantly decreased gamma-glutamylcysteinyl synthetase and @PROTEIN$ mRNA levels in LLC-PK1 cells.	1
685	Furthermore, @COMPOUND$ also lowered @PROTEIN$ mRNA levels.	1
686	Current data indicate that @COMPOUND$ nephrotoxicity may be, at least partly, mediated by an @PROTEIN$-dependent signal transduction pathway.	1
687	The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0
688	The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0
689	The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0
690	The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0
691	Increased incorporation of dietary plant sterols and @COMPOUND$ correlates with decreased expression of hepatic and intestinal Abcg5 and @PROTEIN$ in diabetic BB rats.	1
692	Increased incorporation of dietary plant sterols and @COMPOUND$ correlates with decreased expression of hepatic and intestinal @PROTEIN$ and Abcg8 in diabetic BB rats.	1
693	This increase in @COMPOUND$ and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal Abcg5 (ATP-binding cassette transporter G5) and @PROTEIN$ (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.	1
694	This increase in @COMPOUND$ and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal @PROTEIN$ (ATP-binding cassette transporter G5) and Abcg8 (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.	1
695	Therefore, lower expression levels of Abcg5/@PROTEIN$ in diabetic rats may account for the increased accumulation of plant sterols and @COMPOUND$ in these rats.	1
696	Therefore, lower expression levels of @PROTEIN$/Abcg8 in diabetic rats may account for the increased accumulation of plant sterols and @COMPOUND$ in these rats.	1
697	These effects of @COMPOUND$ during the differentiation period were associated with down-regulation of @PROTEIN$ and ERbeta expression.	1
698	These effects of @COMPOUND$ during the differentiation period were associated with down-regulation of ERalpha and @PROTEIN$ expression.	1
699	@COMPOUND$ (SU) treatment restores insulin secretion in patients with @PROTEIN$ mutations.	0
700	@COMPOUND$ (SU) treatment restores @PROTEIN$ secretion in patients with KCNJ11 mutations.	1
701	@PROTEIN$-alpha inhibition protects against @COMPOUND$-induced endothelial glycocalyx perturbation.	1
702	In the present study, we investigated whether @COMPOUND$-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether @PROTEIN$-alpha (TNFalpha) plays a role in this process.	0
703	In the present study, we investigated whether @COMPOUND$-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether tumor necrosis factor-alpha (@PROTEIN$) plays a role in this process.	0
704	The amino acid sequence deduced from the coding sequence encodes for @PROTEIN$ of 73 amino acids containing 21 @COMPOUND$ residues.	1
705	Ultrastructural analysis in the macaque mediodorsal nucleus revealed that thalamic interneurons are a main postsynaptic target of @PROTEIN$-ir axons ; this suggests that the marked expansion of the @COMPOUND$ innervation in the primate in comparison to the rodent thalamus may be related to the presence of a sizable interneuron population in primates.	0
706	@PROTEIN$-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-actin polymerization with @COMPOUND$ in hippocampal slices.	1
707	Synapsin-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-@PROTEIN$ polymerization with @COMPOUND$ in hippocampal slices.	1
708	Transformation was achieved using a vector that targets genes to the rrn16/rps12 intergenic region of the sugar beet plastome, employing the @PROTEIN$ gene as a selectable marker against @COMPOUND$ and the gfp gene for visual screening of plastid transformants.	1
709	Transformation was achieved using a vector that targets genes to the rrn16/@PROTEIN$ intergenic region of the sugar beet plastome, employing the aadA gene as a selectable marker against @COMPOUND$ and the gfp gene for visual screening of plastid transformants.	0
710	This article investigated the effect of sulfite on total antioxidant capacity (TAC), total oxidant status, lipid @COMPOUND$ (LOOH), and total free sulfydryl groups (-SH) levels in normal and @PROTEIN$-deficient male albino rat plasma.	0
711	@PROTEIN$ deficiency was established by feeding rats a low molybdenum diet and adding to their drinking water 200 ppm @COMPOUND$.	1
712	@PROTEIN$ deficiency was established by feeding rats a low @COMPOUND$ diet and adding to their drinking water 200 ppm tungsten.	1
713	To test the hypothesis that @COMPOUND$S production from DHEA occurs in hepatic cells and that this production is augmented by the presence of sex steroids or @PROTEIN$.	0
714	To test the hypothesis that @COMPOUND$ production from DHEA occurs in hepatic cells and that this production is augmented by the presence of sex steroids or @PROTEIN$.	0
715	Changes in @PROTEIN$ (TNF) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
716	Changes in tumor necrosis factor (@PROTEIN$) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
717	Changes in @PROTEIN$ (TNF) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
718	Changes in tumor necrosis factor (@PROTEIN$) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
719	The differences in tissue distribution and protein levels of @PROTEIN$-B1 during the programmed cell death indicate that the receptor plays a major role in the modulation and function of @COMPOUND$ activity in Bombyx anterior silk glands.	1
720	@COMPOUND$, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases @PROTEIN$ expression.	1
721	Methylthioadenosine phosphorylase (@PROTEIN$) is involved in the metabolism of purines and converts methylthioadenosine (MTA) to @COMPOUND$.	1
722	Methylation-specific primers were used to analyze methylation of the @PROTEIN$ promoter, using DNA treated with @COMPOUND$.	0
723	@COMPOUND$ is released from human monocyte-derived macrophages upon stimulation with @PROTEIN$ and is a sensitive indicator for cellular immune activation.	1
724	Both activity and expression of @PROTEIN$ and APS reductase in plants are modulated by the @COMPOUND$ status of the plant.	1
725	@PROTEIN$ deficiency is a novel cause of secretory diarrhea and may act via disrupting the supply of @COMPOUND$ (ATP) needed for the maintenance of ion gradients across membranes.	1
726	@PROTEIN$ deficiency is a novel cause of secretory diarrhea and may act via disrupting the supply of adenosine triphosphate (@COMPOUND$) needed for the maintenance of ion gradients across membranes.	1
727	This prospective cross-sectional study was performed to investigate the influence of GH excess on @PROTEIN$ and ghrelin levels at baseline and after @COMPOUND$ load in a large group of acromegalic patients.	0
728	This prospective cross-sectional study was performed to investigate the influence of GH excess on leptin and @PROTEIN$ levels at baseline and after @COMPOUND$ load in a large group of acromegalic patients.	0
729	DNA array studies have revealed that @PROTEIN$ is strongly up-regulated by nitroso-glutathione (@COMPOUND$) and also displays a 12-fold increase in expression during biofilm growth of E. coli 83972 and VR50 in human urine.	1
730	We found that the third @COMPOUND$ in @PROTEIN$, Cys122, is oxidized to a sulfenic acid.	0
731	We found that the third cysteine in @PROTEIN$, Cys122, is oxidized to a @COMPOUND$.	0
732	E. coli thioredoxin reductase and @COMPOUND$ produced ROS and caused oxidation and oligomerization of reduced @PROTEIN$.	1
733	E. coli @PROTEIN$ and @COMPOUND$ produced ROS and caused oxidation and oligomerization of reduced YhaK.	0
734	Patients under clozapine-@COMPOUND$ therapy developed a rise of serum @PROTEIN$ levels.	1
735	Patients under @COMPOUND$-risperidone therapy developed a rise of serum @PROTEIN$ levels.	1
736	@COMPOUND$ treatment significantly increased the number of peripheral blood CD34+ CD133+ cells, and serum concentration of vascular endothelial growth factor (@PROTEIN$) and AKT was markedly increased in vivo.	1
737	In cultured EPC, @COMPOUND$ increased the concentrations of @PROTEIN$, AKT and eNOS.	1
738	In cultured EPC, @COMPOUND$ increased the concentrations of VEGF, AKT and @PROTEIN$.	1
739	Western blots analysis showed that simvastatin increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1
740	Western blots analysis showed that simvastatin increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1
741	Western blots analysis showed that @COMPOUND$ increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1
742	Western blots analysis showed that @COMPOUND$ increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1
743	In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of FKHRL1 through the @PROTEIN$/AKT signaling pathway.	1
744	In in vitro study, @COMPOUND$ increases the phosphorylation of @PROTEIN$ and of FKHRL1 through the PI3K/AKT signaling pathway.	1
745	In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of @PROTEIN$ through the PI3K/AKT signaling pathway.	1
746	Only the intracellular @PROTEIN$ response in the lower tertile of IL-2 production was improved with @COMPOUND$ indicating a small influence.	1
747	The elevation of @COMPOUND$ plasma levels by a perioperative intravenous infusion of L-alanyl-L-glutamine influenced the intracellular expression of @PROTEIN$ in the lower tertile only slightly.	1
748	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and @PROTEIN$ while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
749	With supplementation of @COMPOUND$ in diet, lower expression of @PROTEIN$ and VEGF while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
750	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of GLAST, GS and @PROTEIN$ in retina of diabetic rats were determinated by RT-PCR 0.05).	1
751	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of @PROTEIN$, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
752	@PROTEIN$, VEGF, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
753	GFAP, VEGF, @PROTEIN$, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
754	GFAP, VEGF, GLAST, GS and @PROTEIN$ expressions in normal controls were not altered by @COMPOUND$ treatment.	0
755	GFAP, @PROTEIN$, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
756	@PROTEIN$ (GPX1) is a ubiquitously expressed selenium-dependent enzyme that protects cells against oxidative damage by reducing @COMPOUND$ and a wide range of organic peroxides.	1
757	Glutathione peroxidase 1 (@PROTEIN$) is a ubiquitously expressed selenium-dependent enzyme that protects cells against oxidative damage by reducing @COMPOUND$ and a wide range of organic peroxides.	1
758	In conclusion, @COMPOUND$-A has sufficient bonding strength and comparatively low toxicity in clinical use of 0.3 mmol or less of TAD and 0.8 mL of 44 w/w % @PROTEIN$ solution.	0
759	Long intercalated defects in canine ribs can be repaired successfully using porous @COMPOUND$ (beta-TCP) cylinders, infused with a biodegradable polymer (poly D,L-lactic acid-polyethylene block copolymer) containing recombinant human bone @PROTEIN$-2 (rhBMP-2).	0
760	We also explored the effect of @PROTEIN$ released by @COMPOUND$ because this neuropeptide is known to affect the microvasculature environment.	0
761	We also explored the effect of substance P released by @COMPOUND$ because this @PROTEIN$ is known to affect the microvasculature environment.	0
762	@COMPOUND$ release and gene expressions of @PROTEIN$ and MCP-1 in porcine alveolar epithelial type II cells.	0
763	@COMPOUND$ release and gene expressions of IL-8 and @PROTEIN$ in porcine alveolar epithelial type II cells.	0
764	These findings suggest that AEC IIs play an important role in initial inflammatory reactions of the lung by releasing @COMPOUND$, and that they also modulate later inflammatory reactions, evidenced by consistent elevation of @PROTEIN$ gene expression after and during exogenous challenge in pigs.	0
765	Whereas their toxicity is due to @PROTEIN$ inhibition, their secondary toxic effects have been related to free @COMPOUND$ radicals.	0
766	@COMPOUND$ diminished the plasma @PROTEIN$ activity on day 1 post-treatment, although testosterone levels remained unaffected.	1
767	Diazinon diminished the plasma @PROTEIN$ activity on day 1 post-treatment, although @COMPOUND$ levels remained unaffected.	0
768	Melatonin pretreatment prevented every alteration induced by @COMPOUND$, except the diminution of @PROTEIN$ plasmatic activity.	1
769	@COMPOUND$ pretreatment prevented every alteration induced by diazinon, except the diminution of @PROTEIN$ plasmatic activity.	0
770	Ran GTPase guanine nucleotide exchange factor @PROTEIN$ is phosphorylated on @COMPOUND$ 11 by cdc2 kinase in vitro.	0
771	Ran GTPase guanine nucleotide exchange factor RCC1 is phosphorylated on @COMPOUND$ 11 by @PROTEIN$ kinase in vitro.	1
772	An RCC1 mutant in which all N-terminal serine and @COMPOUND$ residues were substituted with glutamate residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, @PROTEIN$, compared with wild type RCC1.	0
773	An RCC1 mutant in which all N-terminal @COMPOUND$ and threonine residues were substituted with glutamate residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, @PROTEIN$, compared with wild type RCC1.	0
774	An RCC1 mutant in which all N-terminal serine and threonine residues were substituted with @COMPOUND$ residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, @PROTEIN$, compared with wild type RCC1.	0
775	@COMPOUND$, acting on P2X (7) receptors, stimulates changes in intracellular calcium concentrations, maturation, and release of interleukin-1beta (@PROTEIN$), and following prolonged agonist exposure, cell death.	1
776	@COMPOUND$, acting on @PROTEIN$ (7) receptors, stimulates changes in intracellular calcium concentrations, maturation, and release of interleukin-1beta (IL-1beta), and following prolonged agonist exposure, cell death.	1
777	While the total @PROTEIN$ released during a 1 h @COMPOUND$ stimulation period was the same from islets in each sample, increasing hydrogel crosslinking density contributed to delays in insulin release from hydrogel samples within the 1 h stimulation period.	1
778	Ischaemia and @PROTEIN$, but not ischaemia and contraction, act synergistically in stimulating muscle @COMPOUND$ uptake in vivo in humans.	1
779	In summary, ischaemia and @PROTEIN$ independently stimulate skeletal muscle @COMPOUND$ uptake in vivo in humans, whereas ischaemia and contraction do not.	1
780	A comparison of the inhibitory effect of @COMPOUND$ on soluble and immobilized @PROTEIN$ showed that immobilization increased the linearity of the inhibition plot particularly in the range 0.1 nM-0.1 microM.	1
781	@COMPOUND$ perfusion marginally increased @PROTEIN$ levels to 7.3 fg/microg/ml on average in the upper arm and control axilla.	1
782	In contrast, perfusion of the inflamed axilla with @COMPOUND$ significantly enhanced the release of both @PROTEIN$ and BDNF.	1
783	In contrast, perfusion of the inflamed axilla with @COMPOUND$ significantly enhanced the release of both NGF and @PROTEIN$.	1
784	@COMPOUND$ induces PON1 expression through p44/42 mitogen-activated @PROTEIN$ signaling cascade in Huh7 cells.	1
785	@COMPOUND$ induces PON1 expression through @PROTEIN$/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1
786	@COMPOUND$ induces @PROTEIN$ expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1
787	Both @PROTEIN$ gene promoter activity and PON1 protein expression were elevated by @COMPOUND$ stimulation.	1
788	@COMPOUND$ phosphorylated @PROTEIN$/42 MAP kinase.	1
789	@COMPOUND$ increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by PD98059.	1
790	Pitavastatin increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by @COMPOUND$.	1
791	Pitavastatin increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by @COMPOUND$.	1
792	@COMPOUND$ increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by PD98059.	1
793	These observations suggest that @COMPOUND$ phosphorylates @PROTEIN$/42 MAP kinase and then activates the transcription of PON1 gene and increases the PON1 protein expression in Huh7 cells.	1
794	These observations suggest that @COMPOUND$ phosphorylates p44/42 MAP kinase and then activates the transcription of @PROTEIN$ gene and increases the PON1 protein expression in Huh7 cells.	1
795	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to PON1 DNA through the activation of @PROTEIN$/42 MAP kinase signaling cascade.	1
796	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of @PROTEIN$ and the Sp1 binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	0
797	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the @PROTEIN$ binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	1
798	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to @PROTEIN$ DNA through the activation of p44/42 MAP kinase signaling cascade.	1
799	Inhibition of cyclooxygenase 2 expression by @COMPOUND$ on joint inflammation induced by urate crystal and @PROTEIN$.	0
800	Inhibition of @PROTEIN$ expression by @COMPOUND$ on joint inflammation induced by urate crystal and IL-1beta.	1
801	Investigation of the effects of @COMPOUND$ (DAS), a garlic sulfur compound, on joint tissue inflammatory responses induced by monosodium urate (MSU) crystals and interleukin-1beta (@PROTEIN$).	0
802	Investigation of the effects of diallyl sulfide (DAS), a garlic sulfur compound, on joint tissue inflammatory responses induced by @COMPOUND$ (MSU) crystals and interleukin-1beta (@PROTEIN$).	0
803	This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced @COMPOUND$ phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (@PROTEIN$, Akt).	0
804	This reduction was associated with the storage of decreased TAG and increased @COMPOUND$, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (PKB, @PROTEIN$).	0
805	This reduction was associated with the storage of decreased TAG and increased @COMPOUND$, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of @PROTEIN$ (PKB, Akt).	1
806	This reduction was associated with the storage of decreased TAG and increased @COMPOUND$, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (@PROTEIN$, Akt).	1
807	This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced @COMPOUND$ phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (PKB, @PROTEIN$).	0
808	This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced @COMPOUND$ phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of @PROTEIN$ (PKB, Akt).	0
809	Improved hepatic @PROTEIN$ signalling led to decreased phosphoenolpyruvate carboxykinase expression and reduced hepatic @COMPOUND$ output accordingly.	1
810	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of @PROTEIN$/iNOS mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1
811	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of COX-2/@PROTEIN$ mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1
812	Pre-synaptic @PROTEIN$s inhibit neurotransmitter release, suggesting that CB1R activation during extinction may decrease CCK peptide release as well as @COMPOUND$ release.	1
813	Pre-synaptic CB1Rs inhibit neurotransmitter release, suggesting that CB1R activation during extinction may decrease @PROTEIN$ peptide release as well as @COMPOUND$ release.	0
814	Pre-synaptic @PROTEIN$ inhibit neurotransmitter release, suggesting that CB1R activation during extinction may decrease CCK peptide release as well as @COMPOUND$ release.	1
815	Acute @COMPOUND$, through D(2) dopamine receptors, induced a dose-response increase in @PROTEIN$ in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).	1
816	Acute @COMPOUND$, through @PROTEIN$, induced a dose-response increase in FADD protein in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).	1
817	@PROTEIN$ was increased by @COMPOUND$ in cytosol (approximately 142%), membranes (approximately 23%) and nucleus (approximately 54%).	1
818	In a second experiment, possible @PROTEIN$ differences were investigated in rats selectively bred for differential responsiveness to novelty, propensity for drug-seeking and @COMPOUND$ sensitization.	0
819	@PROTEIN$ have the unique ability to catalyze oxidative cleavage of C-C bonds and @COMPOUND$ (C-O-C) bonds in non-phenolic aromatic substrates of high redox potential.	1
820	Manganese @PROTEIN$ oxidize Mn(II) to @COMPOUND$), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.	1
821	Manganese @PROTEIN$ oxidize @COMPOUND$) to Mn(III), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.	1
822	@PROTEIN$ are multi-@COMPOUND$-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular oxygen to water.	1
823	@PROTEIN$ are multi-copper-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular @COMPOUND$ to water.	1
824	The co-expression of @PROTEIN$ with M6B results in a significant decrease in SERT-mediated @COMPOUND$ uptake caused by a down-regulation of SERT surface expression.	1
825	The co-expression of SERT with @PROTEIN$ results in a significant decrease in SERT-mediated @COMPOUND$ uptake caused by a down-regulation of SERT surface expression.	1
826	@COMPOUND$ levels and hormones (Peptide YY(3-36), @PROTEIN$ (GLP-1), leptin, ghrelin, insulin) that regulate EI were measured.	0
827	@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (GLP-1), leptin, ghrelin, @PROTEIN$) that regulate EI were measured.	0
828	@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (GLP-1), leptin, @PROTEIN$, insulin) that regulate EI were measured.	0
829	@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (GLP-1), @PROTEIN$, ghrelin, insulin) that regulate EI were measured.	0
830	@COMPOUND$ levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (@PROTEIN$), leptin, ghrelin, insulin) that regulate EI were measured.	0
831	@COMPOUND$ levels and hormones (@PROTEIN$, glucagon-like peptide-1 (GLP-1), leptin, ghrelin, insulin) that regulate EI were measured.	0
832	@PROTEIN$ catalyze a calcium-dependent transamidation reaction that produces covalent cross-linking of available substrate @COMPOUND$ residues and modifies the extracellular matrix.	1
833	We fed rats @COMPOUND$ or valine deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, @PROTEIN$) and serine/threonine degrading enzymes (serine dehydratase, SDS) in the liver.	0
834	We fed rats lysine or @COMPOUND$ deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, @PROTEIN$) and serine/threonine degrading enzymes (serine dehydratase, SDS) in the liver.	0
835	We fed rats lysine or @COMPOUND$ deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, PHGDH) and serine/threonine degrading enzymes (serine dehydratase, @PROTEIN$) in the liver.	0
836	We fed rats @COMPOUND$ or valine deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, PHGDH) and serine/threonine degrading enzymes (serine dehydratase, @PROTEIN$) in the liver.	0
837	Dietary deficiency induced marked elevation of hepatic serine and @COMPOUND$ levels associated with enhancement of @PROTEIN$ mRNA expression and repression of SDS mRNA expression.	0
838	Dietary deficiency induced marked elevation of hepatic @COMPOUND$ and threonine levels associated with enhancement of @PROTEIN$ mRNA expression and repression of SDS mRNA expression.	0
839	Dietary deficiency induced marked elevation of hepatic serine and @COMPOUND$ levels associated with enhancement of PHGDH mRNA expression and repression of @PROTEIN$ mRNA expression.	0
840	Dietary deficiency induced marked elevation of hepatic @COMPOUND$ and threonine levels associated with enhancement of PHGDH mRNA expression and repression of @PROTEIN$ mRNA expression.	0
841	In conclusion, our results indicate that chronic @COMPOUND$ modulates the expression and subcellular localization of proteins implicated in @PROTEIN$ signaling, calcium-buffering potential, and trafficking.	1
842	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor @COMPOUND$ (CHE), capsaicin (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (5HD).	0
843	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor chelerythrine (CHE), capsaicin (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (@COMPOUND$).	0
844	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor chelerythrine (CHE), @COMPOUND$ (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (5HD).	1
845	The anti-convulsant @COMPOUND$ acts directly on the @PROTEIN$ as a positive allosteric modulator.	1
846	Di-@COMPOUND$ phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (@PROTEIN$) enzymatic and biological activities: in vitro and in vivo studies.	1
847	With the exception of specific genetic defects in purine metabolism, increased @COMPOUND$ is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, @PROTEIN$ resistance, the metabolic syndrome and renal failure.	1
848	With the exception of specific genetic defects in @COMPOUND$ metabolism, increased uric acid is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, @PROTEIN$ resistance, the metabolic syndrome and renal failure.	0
849	The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different @COMPOUND$ (FITC) conjugated @PROTEIN$.	0
850	The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different fluorescein isothiocyanate (@COMPOUND$) conjugated @PROTEIN$.	0
851	In Experiment 2, @PROTEIN$ (10 mg/mL) combined with @COMPOUND$ (62.5 microg/mL) inhibited up to 100,200 PFU/mL of virus in cell culture.	0
852	The anti-hyperlipemia effect of EPS and intracellular polysaccharide (IPS) extracted from mycelia were observed that both EPS and IPS can obviously reduce the serum triglyceride (TG), the blood @COMPOUND$ (TC) and serum low density lipoprotein (LDL) level, and increase the @PROTEIN$ (HDL) level of the hyperlipemia mice.	0
853	On a molar basis, @COMPOUND$ yields a signal that is approximately 0.67 times that of @PROTEIN$.	0
854	In patients with hypertension and diabetes, @COMPOUND$, ACEi and diuretic treatment increased @PROTEIN$ activation only during the first week.	1
855	A 23.5-fold increase in @COMPOUND$ O-deethylation activity suggested that metabolic resistance through elevated levels of @PROTEIN$ dependent monooxygenase-activity is a possible resistance mechanism.However, synergism studies with different metabolic inhibitors revealed some contrasting resistance mechanisms between the METI-acaricides.	1
856	The activities of Rho GTPases are predominantly controlled by guanine nucleotide exchange factors (@PROTEIN$), which activate GTPases by catalyzing the exchange of bound @COMPOUND$ for GTP.	1
857	11beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) enzyme catalyzes interconversion of inactive cortisone to active @COMPOUND$.	1
858	11beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) enzyme catalyzes interconversion of inactive @COMPOUND$ to active cortisol.	1
859	Rebinding experiments with Lys-Gly-Asp, an analogue of Arg-Gly-Asp, and other different peptides, such as @PROTEIN$ C-terminal tri- and pentapeptide and @COMPOUND$, further indicated the selectivity of methacrylic acid-trimethylpropane trimethacrylate copolymer for Arg-Gly-Asp giving specific selectivity factor values 1.27, 1.98, 1.31 and 1.67, respectively.	0
860	Parents (N = 19) of children with autism spectrum disorders (ASD) and adult controls (N = 17) underwent positron emission tomography (PET) using ((18)F) @COMPOUND$ to image cortical serotonin type-2 (@PROTEIN$) receptors.	1
861	Vesicle mobilization requires @COMPOUND$+)-induced Ca2+ release by presynaptic endoplasmic reticulum (ER) ryanodine receptors (@PROTEIN$) that in turn stimulates Ca2+/calmodulin-dependent kinase II (CamKII).	1
862	Expression of @PROTEIN$ reduced the intracellular @COMPOUND$ concentration from 140 to 11 mM and resulted in maximal excretion rates of 11.2 nmol min(-1) mg(-1) as compared to 2.3 nmol min(-1) mg(-1) obtained without rhtC expression.	1
863	In combination with an @PROTEIN$ mutation generated and introduced into the chromosome, an accumulation of up to 54 mM @COMPOUND$ was achieved as compared to 21 mM obtained with the ancestor strain.	1
864	This additive effect was not observed when glioma cells were pre-treated with @COMPOUND$, which was unable to increase @PROTEIN$ expression in tumor.	0
865	Furthermore, the CD3(+) T cells co-cultured with @COMPOUND$ treated U-87 and autologous GBM tumor cells showed a significant increase in expression in @PROTEIN$, a key cytokine produced by activated T cells, and accordingly enhanced tumor cytotoxicity.	1
866	Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ 2 up-regulation and increased in situ transglutaminase activity.	1
867	Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ up-regulation and increased in situ transglutaminase activity.	1
868	@COMPOUND$ also induced NF-kappaB activation that seemed associated with @PROTEIN$ 2 up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce transglutaminase expression and activity levels.	1
869	@COMPOUND$ also induced NF-kappaB activation that seemed associated with @PROTEIN$ up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce transglutaminase expression and activity levels.	1
870	There was no correlation between the presence of significant heart-valve regurgitation and @COMPOUND$ cumulative dose, duration of cabergoline treatment, prior use of bromocriptine, age, adenoma size, or @PROTEIN$ levels.	0
871	There was no correlation between the presence of significant heart-valve regurgitation and cabergoline cumulative dose, duration of cabergoline treatment, prior use of @COMPOUND$, age, adenoma size, or @PROTEIN$ levels.	0
872	@PROTEIN$ elevates @COMPOUND$ levels in the hemolymph by stimulating glycogenolysis in target tissues.	1
873	Here, we assessed the regulation of pancreatic @PROTEIN$ release by @COMPOUND$+), mitochondrial membrane potential (Delta Psi m), and reactive oxygen species (ROS), the signals involved in acute pancreatitis.	1
874	Furthermore, it is demonstrated that this strain has @PROTEIN$ activity, and the activity can be optimized under suitable growing conditions where wheat bran and @COMPOUND$ are the primary sources of carbon and nitrogen.	0
875	Furthermore, it is demonstrated that this strain has @PROTEIN$ activity, and the activity can be optimized under suitable growing conditions where wheat bran and urea are the primary sources of carbon and @COMPOUND$.	0
876	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent @PROTEIN$ phosphorylation.	1
877	@COMPOUND$ inhibits @PROTEIN$-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	0
878	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through @PROTEIN$-dependent AMPK phosphorylation.	1
879	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, @PROTEIN$ degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
880	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and @PROTEIN$ production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
881	@COMPOUND$ inhibits TNF-alpha-induced @PROTEIN$ phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
882	@COMPOUND$ phosphorylated p38 and @PROTEIN$ kinases, and blocking of these kinases with specific inhibitors diminished the palmitate-induced cytokine secretion.	0
883	Palmitate phosphorylated @PROTEIN$ and JNK kinases, and blocking of these kinases with specific inhibitors diminished the @COMPOUND$-induced cytokine secretion.	0
884	@COMPOUND$ phosphorylated @PROTEIN$ and JNK kinases, and blocking of these kinases with specific inhibitors diminished the palmitate-induced cytokine secretion.	1
885	Palmitate phosphorylated p38 and @PROTEIN$ kinases, and blocking of these kinases with specific inhibitors diminished the @COMPOUND$-induced cytokine secretion.	1
886	@COMPOUND$ also activated the @PROTEIN$ (c-Jun) transcription factor.	1
887	@PROTEIN$-antagonistic effects of hormones, cytokines and excess metabolic substrates such as @COMPOUND$ and fatty acids may be exerted via common mechanisms involving for example reactive oxygen species (ROS) accumulation and associated inflammatory responses.	1
888	Glycine release was potentiated by the activation of @PROTEIN$ and diminished by increasing cyclic guanosine monophosphate levels with a phosphodiesterase inhibitor, @COMPOUND$.	0
889	Glycine release was potentiated by the activation of @PROTEIN$ and diminished by increasing @COMPOUND$ levels with a phosphodiesterase inhibitor, zaprinast.	0
890	@COMPOUND$ release was potentiated by the activation of @PROTEIN$ and diminished by increasing cyclic guanosine monophosphate levels with a phosphodiesterase inhibitor, zaprinast.	1
891	Our study demonstrates that @COMPOUND$ causes evident damage to acinar cells, impairing both calcium homeostasis and secretory response to @PROTEIN$.	1
892	Enteric neuronal dopamine (DA) inhibits @COMPOUND$ release and gastric motility; this has been thought to be mediated via neuronal dopamine-2 receptor (@PROTEIN$).	1
893	The second enzyme of @COMPOUND$ synthesis, GSH synthase (GS) is also regulated in a coordinated manner as @PROTEIN$ subunits and its up-regulation can further enhance the capacity of the cell to synthesize GSH.	1
894	Consumption of the trichothecene mycotoxin @COMPOUND$ (DON) induces @PROTEIN$ (IL-6)-dependent IgA nephropathy (IgAN) in mice.	1
895	Consumption of the trichothecene mycotoxin @COMPOUND$ (DON) induces interleukin-6 (@PROTEIN$)-dependent IgA nephropathy (IgAN) in mice.	1
896	The purpose of this study was to identify the signal transduction pathways by which DON up-regulates @PROTEIN$ in the peritoneal macrophage and how consumption of fish oil enriched with the n-3 PUFA @COMPOUND$ (DHA) suppresses these processes.	1
897	The aim of the present study was to determine the effects of niacin and @COMPOUND$ on HDL formation by investigating the changes in @PROTEIN$ and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).	0
898	The aim of the present study was to determine the effects of @COMPOUND$ and chromium on HDL formation by investigating the changes in @PROTEIN$ and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).	0
899	Niacin and @COMPOUND$ cotreatment significantly induced the expression of @PROTEIN$ (PPARalpha) mRNA by approximately 1.3-1.8-fold.	1
900	Niacin and @COMPOUND$ cotreatment significantly induced the expression of peroxisome proliferator-activated receptor-alpha (@PROTEIN$) mRNA by approximately 1.3-1.8-fold.	1
901	@COMPOUND$ and chromium cotreatment significantly induced the expression of @PROTEIN$ (PPARalpha) mRNA by approximately 1.3-1.8-fold.	1
902	@COMPOUND$ and chromium cotreatment significantly induced the expression of peroxisome proliferator-activated receptor-alpha (@PROTEIN$) mRNA by approximately 1.3-1.8-fold.	1
903	A combination of @COMPOUND$ and chromium chloride did not significantly increase (3+1 mM) but instead reduced (1+3 mM) @PROTEIN$ gene expression.	1
904	A combination of niacin and @COMPOUND$ did not significantly increase (3+1 mM) but instead reduced (1+3 mM) @PROTEIN$ gene expression.	1
905	We hypothesize that the stimulation of @PROTEIN$ gene expression causes an enhanced @COMPOUND$ efflux, perhaps mediated by PPARalpha pathway(s).	1
906	We hypothesize that the stimulation of ABCA1 gene expression causes an enhanced @COMPOUND$ efflux, perhaps mediated by @PROTEIN$ pathway(s).	1
907	@COMPOUND$ inhibited cell proliferation with IC(50) values at 24 and 48 h of 12.5 and 7.5 muM doses, respectively, and decreased @PROTEIN$ protein expression at concentrations between 2.5 and 30 muM.	1
908	30 muM, the SUL-induced suppression of @PROTEIN$ protein was reversed by preincubation with the proteasome inhibitor @COMPOUND$ and was accompanied by an increase in protein levels of the 20S catalytic core subunit PSMB5.	1
909	30 muM, the SUL-induced suppression of ERalpha protein was reversed by preincubation with the proteasome inhibitor @COMPOUND$ and was accompanied by an increase in protein levels of the 20S catalytic core subunit @PROTEIN$.	0
910	@PROTEIN$ involvement in the discriminative stimulus effects in rats of LSD, but not the @COMPOUND$ hallucinogen DOI.	0
911	@PROTEIN$ involvement in the discriminative stimulus effects in rats of @COMPOUND$, but not the phenethylamine hallucinogen DOI.	1
912	@PROTEIN$ involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen @COMPOUND$.	0
913	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the Ah receptor (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as @PROTEIN$ and CAR, activated by drugs such as rifampicin, carbamazepin and @COMPOUND$.	1
914	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the @PROTEIN$ (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as PXR and CAR, activated by drugs such as @COMPOUND$, carbamazepin and phenytoin.	0
915	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the Ah receptor (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as @PROTEIN$ and CAR, activated by drugs such as @COMPOUND$, carbamazepin and phenytoin.	1
916	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the Ah receptor (activated by aryl hydrocarbons and drugs such as @COMPOUND$) and type 2 steroid receptors such as @PROTEIN$ and CAR, activated by drugs such as rifampicin, carbamazepin and phenytoin.	0
917	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the @PROTEIN$ (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as PXR and CAR, activated by drugs such as rifampicin, carbamazepin and @COMPOUND$.	0
918	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the @PROTEIN$ (activated by aryl hydrocarbons and drugs such as @COMPOUND$) and type 2 steroid receptors such as PXR and CAR, activated by drugs such as rifampicin, carbamazepin and phenytoin.	1
919	The structure-activity relationship between @COMPOUND$ derivatives showing inhibitory effects on @PROTEIN$ in mouse macrophage RAW264.7 cells.	1
920	We have investigated the structure-activity relationship between 63 natural @COMPOUND$ derivatives and their effects on the expression of inducible-nitric oxide synthase (@PROTEIN$) induced by lipopolysaccharide.	0
921	We have investigated the structure-activity relationship between 63 natural oxycoumarin derivatives and their effects on the expression of inducible-nitric oxide synthase (@PROTEIN$) induced by @COMPOUND$.	1
922	We have investigated the structure-activity relationship between 63 natural oxycoumarin derivatives and their effects on the expression of inducible-@PROTEIN$ (iNOS) induced by @COMPOUND$.	1
923	We have investigated the structure-activity relationship between 63 natural @COMPOUND$ derivatives and their effects on the expression of inducible-@PROTEIN$ (iNOS) induced by lipopolysaccharide.	0
924	To determine whether a regimen of @COMPOUND$ pretreatment, bivalirudin during the procedure and clopidogrel (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and platelet activating factor (10 nM).	0
925	To determine whether a regimen of aspirin pretreatment, bivalirudin during the procedure and clopidogrel (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and @COMPOUND$ (10 nM).	0
926	To determine whether a regimen of aspirin pretreatment, bivalirudin during the procedure and @COMPOUND$ (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and platelet activating factor (10 nM).	0
927	To determine whether a regimen of aspirin pretreatment, @COMPOUND$ during the procedure and clopidogrel (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and platelet activating factor (10 nM).	0
928	The enzyme deoxyuridine 5'-triphosphate nucleotidohydrolase (@PROTEIN$) catalyses the hydrolysis of dUTP to dUMP and PPi thus controlling the incorporation of @COMPOUND$ into DNA genomes.	1
929	The enzyme @PROTEIN$ (dUTPase) catalyses the hydrolysis of dUTP to dUMP and PPi thus controlling the incorporation of @COMPOUND$ into DNA genomes.	1
930	In the present study we perform a kinetic analysis of Campylobacter @PROTEIN$ using the continuous spectrophotometric method and show that the enzyme is highly specific for @COMPOUND$ nucleotides.	1
931	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from L-tryptophan pyruvate, @COMPOUND$ and indole.	1
932	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from @COMPOUND$ pyruvate, ammonia and indole.	1
933	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from L-tryptophan @COMPOUND$, ammonia and indole.	1
934	Although incubation with prolactin (PRL) and/or adrenocorticotrophic hormone (@PROTEIN$) resulted in a dose-dependent increase of @COMPOUND$ and progesterone release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
935	Although incubation with @PROTEIN$ (PRL) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of @COMPOUND$ and progesterone release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
936	Although incubation with prolactin (PRL) and/or adrenocorticotrophic hormone (@PROTEIN$) resulted in a dose-dependent increase of corticosterone and @COMPOUND$ release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
937	Although incubation with prolactin (@PROTEIN$) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of @COMPOUND$ and progesterone release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
938	Although incubation with prolactin (@PROTEIN$) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of corticosterone and @COMPOUND$ release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
939	Although incubation with @PROTEIN$ (PRL) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of corticosterone and @COMPOUND$ release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	1
940	@COMPOUND$, a SSRI, is mainly metabolized by cytochrome P450 (@PROTEIN$) 2D6 and 1A2.	1
941	@COMPOUND$, a SSRI, is mainly metabolized by @PROTEIN$ (CYP) 2D6 and 1A2.	1
942	Type I @PROTEIN$ (TG1), an enzyme that catalyzes the formation of epsilon-(gamma-glutamyl) @COMPOUND$ bonds, is the key protein responsible for generation of the crosslinks.	1
943	@PROTEIN$-oncogene inactivating effect by @COMPOUND$ rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.	1
944	Caspase inhibition with z-@COMPOUND$ was unable to prevent @PROTEIN$ localization to the nucleus and subsequently unable to prevent cell death.	0
945	We measured the ability to increase GABA in eight healthy subjects by comparing the binding of ((11)C) @COMPOUND$, a positron emission tomography (PET) radiotracer specific for the benzodiazepine (BDZ) site, at baseline and in the presence of an acute elevation in GABA levels through the blockade of the GABA membrane transporter (@PROTEIN$).	0
946	@PROTEIN$ blockade resulted in significant increases in mean (+/-SD) ((11)C) @COMPOUND$-binding potential (BP(ND)) over baseline in brain regions representing the major functional domains of the cerebral cortex: association cortex+15.2+/-20.2% (p=0.05), sensory cortex+13.5+/-15.5% (p=0.03) and limbic (medial temporal lobe, MTL)+16.4+/-20.2% (p=0.03).	1
947	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds @COMPOUND$ (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
948	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a @COMPOUND$ with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
949	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/@COMPOUND$), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
950	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than @COMPOUND$ (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
951	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than @COMPOUND$ (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
952	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/@COMPOUND$) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
953	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/@COMPOUND$), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
954	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/@COMPOUND$) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
955	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/@COMPOUND$) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
956	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds @COMPOUND$ (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
957	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a @COMPOUND$ with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
958	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/@COMPOUND$), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
959	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds @COMPOUND$ (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
960	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a @COMPOUND$ with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
961	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than @COMPOUND$ (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
962	We investigated whether several different inflammatory markers including C-reactive protein (@PROTEIN$) and fibrinogen and white blood cells (WBCs) count, are associated with maximal @COMPOUND$ consumption (VO(2 max)) in women with polycystic ovary syndrome (PCOS).	0
963	We investigated whether several different inflammatory markers including C-reactive protein (CRP) and @PROTEIN$ and white blood cells (WBCs) count, are associated with maximal @COMPOUND$ consumption (VO(2 max)) in women with polycystic ovary syndrome (PCOS).	0
964	CSE activated the MMP-1 promoter, and this induction was prevented by @COMPOUND$ blockade of @PROTEIN$/2 phosphorylation.	1
965	CSE activated the @PROTEIN$ promoter, and this induction was prevented by @COMPOUND$ blockade of ERK1/2 phosphorylation.	1
966	Cotransfection, @COMPOUND$, and electrophoretic mobility shift assay studies identified activating and repressive roles for @PROTEIN$ and PEA3 transcription factors, respectively.	0
967	We have previously demonstrated that @COMPOUND$, a stable prostacyclin (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	1
968	We have previously demonstrated that iloprost, a stable @COMPOUND$ (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	0
969	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and @PROTEIN$ upregulation are modulated by peroxisome proliferator-activated receptor-alpha (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
970	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and VEGF upregulation are modulated by peroxisome proliferator-activated receptor-alpha (@PROTEIN$), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
971	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and VEGF upregulation are modulated by @PROTEIN$ (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
972	In contrast, @COMPOUND$ induces a robust angiogenic response in wild-type mice, along with local upregulation of @PROTEIN$.	1
973	Importantly, mice lacking the PPARalpha gene exhibit a normal angiogenic response to @PROTEIN$, indicating that the absence of PPARalpha does not result in a general impairment of angiogenesis, but specifically affects the ability of @COMPOUND$ to induce angiogenesis.	1
974	The proportion of @PROTEIN$ molecules that are directed to the novel cleavage pathway is regulated by the ratio of free @COMPOUND$ and cholesteryl esters in cells.	1
975	In the hormone receptor-positive breast cancer cell line T47-D expression of @PROTEIN$ and its soluble isoforms was increased by treatment with estradiol and @COMPOUND$.	1
976	In the hormone receptor-positive breast cancer cell line T47-D expression of @PROTEIN$ and its soluble isoforms was increased by treatment with @COMPOUND$ and tamoxifen.	1
977	These findings suggest that multiple variations in the @PROTEIN$ gene are associated with remission in white non-Hispanic depressed adults treated with @COMPOUND$.	1
978	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to @PROTEIN$ with decreased affinity and binding enthalpy compared with RyR1.	0
979	At 0.15 microM @COMPOUND$+), ((35)S) @PROTEIN$ bound to RyR2 with decreased affinity and binding enthalpy compared with RyR1.	0
980	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to RyR2 with decreased affinity and binding enthalpy compared with @PROTEIN$.	0
981	The rates of ((35)S) CaM dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from @PROTEIN$ was little affected.	0
982	The rates of ((35)S) CaM dissociation from @PROTEIN$ increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
983	The rates of ((35)S) @PROTEIN$ dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
984	In rats, infusion of angiotensin II increases @PROTEIN$ levels and arterial thickness which are reversed by treatment with the iron chelator @COMPOUND$.	1
985	Furthermore, @COMPOUND$ regulated endogenous survival signaling by up-regulating phosphorylated @PROTEIN$ that returned to its basal level later.	1
986	Furthermore, @COMPOUND$ induced nucleus translocalization of p53 and @PROTEIN$ and recruitment of autophagosomes.	1
987	Furthermore, @COMPOUND$ induced nucleus translocalization of @PROTEIN$ and Akt and recruitment of autophagosomes.	1
988	The ubiquitous enzyme dUTP nucleotidohydrolase (@PROTEIN$) catalyses the hydrolysis of dUTP to dUMP and can be considered as the first line of defence against incorporation of @COMPOUND$ into DNA.	0
989	Recent findings indicate that the polypyrimidine tract-binding protein (@PROTEIN$), also named hnRNP I, by binding to the 3'-UTR (untranslated region) of the preproinsulin mRNA molecule, stabilizes the messenger, thereby participating in the @COMPOUND$-induced increase in preproinsulin mRNA.	1
990	Recent findings indicate that the polypyrimidine tract-binding protein (PTB), also named @PROTEIN$, by binding to the 3'-UTR (untranslated region) of the preproinsulin mRNA molecule, stabilizes the messenger, thereby participating in the @COMPOUND$-induced increase in preproinsulin mRNA.	1
991	Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (p38MAPK) significantly decreased @PROTEIN$-induced @COMPOUND$ anion release from macrophages in vivo.	1
992	Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (@PROTEIN$) significantly decreased CRP-induced @COMPOUND$ anion release from macrophages in vivo.	0
993	The free radicals produced are thought to be generated during the production of @COMPOUND$, a reaction catalyzed by @PROTEIN$.	1
994	This study was performed to investigate the effect of combined treatment with @COMPOUND$ and chromium on vascular endothelial dysfunction, with the aim of gaining insight to the mechanisms by detecting the expression levels of ox-LDL and @PROTEIN$.	0
995	This study was performed to investigate the effect of combined treatment with niacin and @COMPOUND$ on vascular endothelial dysfunction, with the aim of gaining insight to the mechanisms by detecting the expression levels of ox-LDL and @PROTEIN$.	0
996	In HF group, the serum levels of total @COMPOUND$ (TC), low-density lipoprotein (LDL), oxidized low-density lipoprotein (ox-LDL) and endothelin (ET) were higher, whereas the levels of @PROTEIN$ (HDL), serum NO were lower than those in CG group.	0
997	These findings indicated that combined treatment with niacin and @COMPOUND$ has potential therapeutic protection of endothelial function by down-regulating ox-LDL/@PROTEIN$ signaling pathway.	1
998	These findings indicated that combined treatment with @COMPOUND$ and chromium has potential therapeutic protection of endothelial function by down-regulating ox-LDL/@PROTEIN$ signaling pathway.	1
999	@PROTEIN$ kinases can be activated by trans-phosphorylation of a @COMPOUND$ located in the central activation loop of the catalytic domain.	1
1000	However, because the required exposure of this @COMPOUND$ is not observed in the down-regulated X-ray structures of @PROTEIN$ kinases, transient partial opening of the activation loop appears to be necessary for such processes.	0
1001	The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and @PROTEIN$ (SOD) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0
1002	The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and superoxide dismutase (@PROTEIN$) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0
1003	The experiment also indicated that catalase (@PROTEIN$) activity was not significantly influenced by @COMPOUND$ for both the two tested aquatic plants.	0
1004	The experiment also indicated that @PROTEIN$ (CAT) activity was not significantly influenced by @COMPOUND$ for both the two tested aquatic plants.	0
1005	The purpose of this study was to investigate the solid-state properties of lyophilized formulations of protein (@PROTEIN$) containing @COMPOUND$ or trehalose across a wide range of compositions, both in the presence or absence of hydroxyethylstarch (HES).	0
1006	The purpose of this study was to investigate the solid-state properties of lyophilized formulations of protein (@PROTEIN$) containing sucrose or @COMPOUND$ across a wide range of compositions, both in the presence or absence of hydroxyethylstarch (HES).	0
1007	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on @PROTEIN$ secretion are mediated via TLR-4.	1
1008	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on MCP-1 secretion are mediated via @PROTEIN$-4.	1
1009	@COMPOUND$ increased the levels of CD95 (@PROTEIN$), CD95-ligand and Fas-associated death domain.	1
1010	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
1011	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
1012	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
1013	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
1014	On the other hand, @COMPOUND$ increased the expression of @PROTEIN$, involved in the regulation of proliferation.	1
1015	We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of cdc2 and, in the case of @COMPOUND$, @PROTEIN$ expression, which induced apoptosis in a caspase-independent manner.	1
1016	We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of @PROTEIN$ and, in the case of @COMPOUND$, SIRT2 expression, which induced apoptosis in a caspase-independent manner.	0
1017	Reduction of intracellular @COMPOUND$+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator BAPTA or inhibition of NAD(P)H oxidase (with apocynin) or inhibition of calpain (calpain 1-specific siRNA).	1
1018	Reduction of intracellular Ca(2+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator @COMPOUND$ or inhibition of NAD(P)H oxidase (with apocynin) or inhibition of calpain (calpain 1-specific siRNA).	1
1019	Reduction of intracellular Ca(2+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator BAPTA or inhibition of NAD(P)H oxidase (with @COMPOUND$) or inhibition of calpain (calpain 1-specific siRNA).	0
1020	In addition to transporting @COMPOUND$, @PROTEIN$ plays other roles in regulating GABA synthesis, reducing oxidative stress in neurons, and is important in supporting neuron viability.	1
1021	In addition to transporting glutamate, @PROTEIN$ plays other roles in regulating @COMPOUND$ synthesis, reducing oxidative stress in neurons, and is important in supporting neuron viability.	1
1022	Whereas both peptides @COMPOUND$ (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of @PROTEIN$ chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic gentamicin.	0
1023	Whereas both peptides lactoferricin (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of @PROTEIN$ chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic @COMPOUND$.	0
1024	We have recently shown that the antidepressant @COMPOUND$ enhances T cell proliferation and T(H)1 cytokine production in vivo, without changes on @PROTEIN$/CD8 subsets.	0
1025	We found that @COMPOUND$ restored T cell proliferation and interleukin-2, @PROTEIN$ and tumor necrosis factor-alpha production by compensatory mechanisms.	1
1026	We found that @COMPOUND$ restored T cell proliferation and interleukin-2, interferon-gamma and @PROTEIN$-alpha production by compensatory mechanisms.	1
1027	The @PROTEIN$ activity was increased by Mn(2+), @COMPOUND$+), and Mg(2+), while strongly inhibited by Fe(2+) and Ba(2+).	1
1028	The @PROTEIN$ activity was increased by @COMPOUND$+), Cu(2+), and Mg(2+), while strongly inhibited by Fe(2+) and Ba(2+).	1
1029	The @PROTEIN$ activity was increased by Mn(2+), Cu(2+), and Mg(2+), while strongly inhibited by Fe(2+) and @COMPOUND$+).	1
1030	The @PROTEIN$ activity was increased by Mn(2+), Cu(2+), and Mg(2+), while strongly inhibited by @COMPOUND$+) and Ba(2+).	1
1031	Meanwhile, SDS, ethyleneglycoltetraacetic acid, urea, and @COMPOUND$ were found to have significantly inhibitory effect on @PROTEIN$ activity.	1
1032	Meanwhile, SDS, ethyleneglycoltetraacetic acid, @COMPOUND$, and ethylenediaminetetraacetic acid were found to have significantly inhibitory effect on @PROTEIN$ activity.	1
1033	In the present study, we screened the inhibitory effect of the extract from 50 Thai medicinal plants on an inducible-nitric oxide synthase (@PROTEIN$) expression induced by @COMPOUND$ (LPS) in mouse macrophages RAW 264.7.	1
1034	In the present study, we screened the inhibitory effect of the extract from 50 Thai medicinal plants on an inducible-@PROTEIN$ (iNOS) expression induced by @COMPOUND$ (LPS) in mouse macrophages RAW 264.7.	1
1035	Following thermal denaturation, rabbit reticulocyte lysate and @COMPOUND$ were added and @PROTEIN$ activity measured.	0
1036	These results are in contrast to postmortem findings in schizophrenia and suggest that reduced @PROTEIN$ protein levels in schizophrenia patients' postmortem brain do not result from perinatal @COMPOUND$ deprivation.	0
1037	We found that the acetylated @PROTEIN$ at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
1038	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (@PROTEIN$) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
1039	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and @PROTEIN$ (HDAC) 11 expression.	0
1040	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the @PROTEIN$ (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
1041	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (@PROTEIN$) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
1042	Although the current studies associating particular genes and their variants with seizure control or adverse events have inherent weaknesses and have not provided unifying conclusions, several results, for example that Asian patients with a particular HLA allele, @PROTEIN$ *1502, are at a higher risk for Stevens-Johnson syndrome when using @COMPOUND$, are helpful to increase our knowledge how genetic variation affects the treatment of epilepsy.	1
1043	Concentrations of @COMPOUND$ 1000 and Na2SO4 were selected as independent variables to evaluate their impact on parameters of partitioning in aqueous two-phase system--the partition coefficient of @PROTEIN$, purification factor and pectinase yield.	0
1044	Concentrations of polyethylene glycol 1000 and @COMPOUND$ were selected as independent variables to evaluate their impact on parameters of partitioning in aqueous two-phase system--the partition coefficient of @PROTEIN$, purification factor and pectinase yield.	0
1045	@COMPOUND$, an inhibitor of glial metabolism, inhibits the up-regulation of @PROTEIN$ expression, activity and NO production in the spinal cord induced by formalin test in rats.	1
1046	In order to explore the involvement of glia in the NO-mediated nociceptive transmission, the present study was undertaken to investigate the effect of @COMPOUND$ (FC), an inhibitor of glial metabolism, on @PROTEIN$ expression and activity and NO production in the spinal cord during the process of peripheral inflammatory pain and hyperalgesia induced by formalin test in rats.	0
1047	Here we show that @PROTEIN$ selectively increases the power of @COMPOUND$-induced, but not carbachol-induced, gamma oscillations in acute hippocampal slices.	1
1048	Here we show that @PROTEIN$ selectively increases the power of kainate-induced, but not @COMPOUND$-induced, gamma oscillations in acute hippocampal slices.	0
1049	These effects of @PROTEIN$beta are blocked by @COMPOUND$, a pan-specific antagonist of ErbB receptors, and are mediated specifically via ErbB4 receptors, because mice harboring a targeted mutation of ErbB4 do not respond to NRG-1.	1
1050	We have generated two novel chimeric @PROTEIN$-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of Flt-1 fused either to a human IgG1 Fc or solely to the CH3 domain of IgG1 Fc through a @COMPOUND$ linker 9Gly.	0
1051	We have generated two novel chimeric VEGF-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of @PROTEIN$ fused either to a human IgG1 Fc or solely to the CH3 domain of IgG1 Fc through a @COMPOUND$ linker 9Gly.	1
1052	By contrast, treatment of N2a cells with 1-10 microM @COMPOUND$ resulted in marked reductions in the expression of the axon growth-associated protein @PROTEIN$-43.	1
1053	@COMPOUND$-treated cells also showed an increased expression of the heat shock protein @PROTEIN$ compared to controls.	1
1054	Mean plasma levels of folic acid, @COMPOUND$, and vitamin B12 did not change, but there was a significant decrease of @PROTEIN$ at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.	0
1055	Mean plasma levels of @COMPOUND$, homocysteine, and vitamin B12 did not change, but there was a significant decrease of @PROTEIN$ at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.	0
1056	Chondrocytes grown in monolayer were treated with interleukin-1alpha (@PROTEIN$), insulin-like growth factor-I (IGF-I), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
1057	Chondrocytes grown in monolayer were treated with interleukin-1alpha (IL-1alpha), @PROTEIN$-like growth factor-I (IGF-I), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
1058	Chondrocytes grown in monolayer were treated with interleukin-1alpha (IL-1alpha), insulin-like growth factor-I (@PROTEIN$), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
1059	Affinity assays were performed to measure endogenous @COMPOUND$-bound @PROTEIN$, and confocal microscopy was used to assess changes in organization of the actin cytoskeleton.	1
1060	Affinity assays were performed to measure endogenous @COMPOUND$-bound Rho, and confocal microscopy was used to assess changes in organization of the @PROTEIN$ cytoskeleton.	0
1061	IL-1alpha and RhoG14V increased cytoplasmic @PROTEIN$ stress fiber formation, which was blocked by C3 Transferase, and @COMPOUND$.	1
1062	@PROTEIN$ and RhoG14V increased cytoplasmic actin stress fiber formation, which was blocked by C3 Transferase, and @COMPOUND$.	1
1063	Expression of RhoQ63L or RhoG14V resulted in increased MMP-13 expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit @PROTEIN$-induced MMP-13 expression.	0
1064	Expression of @PROTEIN$Q63L or RhoG14V resulted in increased MMP-13 expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit IL-1alpha-induced MMP-13 expression.	1
1065	Expression of RhoQ63L or RhoG14V resulted in increased @PROTEIN$ expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit IL-1alpha-induced MMP-13 expression.	0
1066	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1067	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1068	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1069	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1070	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1071	Plasma total @COMPOUND$, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1072	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1073	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1074	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1075	The increase of mature @PROTEIN$ by macrophages was inhibited by @COMPOUND$ : caspase-1 is known to cleave the proform of IL-18 to produce active mature IL-18.	1
1076	In absence of stretch, we could activate @PROTEIN$ and deactivate GK1 by 1-oleoyl-2-acetyl-sn-glycerol (@COMPOUND$) and other amphipaths.	1
1077	In absence of stretch, we could activate @PROTEIN$ and deactivate GK1 by @COMPOUND$ (OAG) and other amphipaths.	1
1078	In absence of stretch, we could activate Gns and deactivate @PROTEIN$ by @COMPOUND$ (OAG) and other amphipaths.	1
1079	In absence of stretch, we could activate Gns and deactivate @PROTEIN$ by 1-oleoyl-2-acetyl-sn-glycerol (@COMPOUND$) and other amphipaths.	1
1080	Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of @PROTEIN$ and TNF-alpha.	1
1081	Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of IL-6 and @PROTEIN$.	1
1082	The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of @PROTEIN$ and PARP, and inhibition of bcl-2.	0
1083	The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of bax and PARP, and inhibition of @PROTEIN$.	0
1084	The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of bax and @PROTEIN$, and inhibition of bcl-2.	0
1085	@COMPOUND$ is a chemical carcinogen found in tobacco smoke that causes activating mutations in @PROTEIN$ and induces lung tumors in mice.	1
1086	Heparin (H), @COMPOUND$ (A), anti@PROTEIN$ III (ATIII), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
1087	Heparin (H), @COMPOUND$ (A), antithrombin III (ATIII), and recombinant human activated @PROTEIN$ (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
1088	Heparin (H), @COMPOUND$ (A), antithrombin III (@PROTEIN$), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
1089	Heparin (H), @COMPOUND$ (A), @PROTEIN$ (ATIII), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
1090	@COMPOUND$ (H2S) is a novel gaseous mediator produced by @PROTEIN$ and cystathionine-gamma-lyase in the cardiovascular system, including the heart.	1
1091	Hydrogen sulfide (@COMPOUND$) is a novel gaseous mediator produced by @PROTEIN$ and cystathionine-gamma-lyase in the cardiovascular system, including the heart.	1
1092	@COMPOUND$ (H2S) is a novel gaseous mediator produced by cystathionine-beta-synthase and @PROTEIN$ in the cardiovascular system, including the heart.	1
1093	Hydrogen sulfide (@COMPOUND$) is a novel gaseous mediator produced by cystathionine-beta-synthase and @PROTEIN$ in the cardiovascular system, including the heart.	1
1094	Chemotaxis, @PROTEIN$ release and @COMPOUND$ anion production have been measured.	0
1095	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), @COMPOUND$ (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1096	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and @COMPOUND$ (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1097	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles @COMPOUND$ (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1098	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), @COMPOUND$ (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1099	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by @COMPOUND$ (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1100	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by @COMPOUND$ (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1101	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles @COMPOUND$ (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1102	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and @COMPOUND$ (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1103	Cell viability and reactive oxygen species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of @COMPOUND$.	0
1104	Cell viability and reactive @COMPOUND$ species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of reduced glutathione.	0
1105	Results showed that MENT treatments increased @PROTEIN$ secretion and proliferation rate with a potency ranged between T and @COMPOUND$.	1
1106	Results showed that @COMPOUND$ treatments increased @PROTEIN$ secretion and proliferation rate with a potency ranged between T and DHT.	1
1107	The studies with @COMPOUND$ showed that in BPH and CaP cells, the conversion of T into DHT significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of MENT to the 5-AR.	0
1108	The studies with finasteride showed that in BPH and CaP cells, the conversion of T into DHT significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of @COMPOUND$ to the 5-AR.	0
1109	The studies with finasteride showed that in BPH and CaP cells, the conversion of T into @COMPOUND$ significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of MENT to the 5-AR.	1
1110	@COMPOUND$-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the cholesterol biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	0
1111	Nitrogen-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the @COMPOUND$ biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	1
1112	In this study we have investigated a long-term pattern of expression and production of spinal COX-1 and @PROTEIN$ in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0
1113	In this study we have investigated a long-term pattern of expression and production of spinal @PROTEIN$ and COX-2 in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0
1114	Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
1115	Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
1116	Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
1117	Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
1118	Peripheral administration of the acetylcholinesterase inhibitor @COMPOUND$ significantly reduced serum @PROTEIN$ levels through vagus nerve signaling, and protected against lethality during murine endotoxemia.	1
1119	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of TNF by @COMPOUND$, indicating that suppressing @PROTEIN$ activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1
1120	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of @PROTEIN$ by @COMPOUND$, indicating that suppressing acetylcholinesterase activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1
1121	Administration of @COMPOUND$ to alpha7nAChR knockout mice failed to suppress @PROTEIN$ levels, indicating that the alpha7nAChR-mediated cholinergic anti-inflammatory pathway is required for the anti-inflammatory effect of galantamine.	0
1122	The involvement of @COMPOUND$ and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
1123	The involvement of superoxide and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (@COMPOUND$ and PTIO, respectively).	1
1124	The involvement of superoxide and @COMPOUND$ was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
1125	Accordingly, @PROTEIN$ were blocked by the peroxynitrite scavenger @COMPOUND$ and could be mimicked by application of exogenous peroxynitrite.	1
1126	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (oleic acid, @COMPOUND$).	1
1127	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (@COMPOUND$, Triton X-100).	1
1128	In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by @COMPOUND$ (MTT), @PROTEIN$-FITC/propidium iodide (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0
1129	In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), @PROTEIN$-FITC/@COMPOUND$ (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0
1130	In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), @PROTEIN$-@COMPOUND$/propidium iodide (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0
1131	Meanwhile, both the enhanced expression of @PROTEIN$ and increased activation of NF-kappaB induced by CRH in aortas of LDLr-/-mice were also largely suppressed by @COMPOUND$, whereas these inhibitory effects were not observed in anti-Svg-30 group.	1
1132	Meanwhile, both the enhanced expression of VCAM-1 and increased activation of NF-kappaB induced by @PROTEIN$ in aortas of LDLr-/-mice were also largely suppressed by @COMPOUND$, whereas these inhibitory effects were not observed in anti-Svg-30 group.	0
1133	@COMPOUND$, a potent orally active angiogenesis inhibitor capable of inhibiting all known isoforms of Vascular Endothelial Growth Factor (@PROTEIN$) receptor, belongs to the class of aminophthalazines.	1
1134	Recent evidence for toxic @COMPOUND$ (O(2)(-)) production by marine microalgae is afforded particular attention given that release of O(2)(-) anions can be exacerbated by the binding of @PROTEIN$ to the microalgal cell wall ; a novel model for grazing-activated chemical defence is proposed.	1
1135	@COMPOUND$ in anionic DSPG liposomes stimulated murine @PROTEIN$ production in RAW 264 cells at concentrations 25-to 30-fold lower than free drug.	1
1136	To elucidate the mechanism by which @COMPOUND$ regulates adipose triglyceride @PROTEIN$ (ATGL).	1
1137	@PROTEIN$ is one of the members of the G protein-coupled receptor family that can catalyze a GDP-@COMPOUND$ exchange reaction on the retinal G protein transducin (Gt) upon photon absorption.	1
1138	Rhodopsin is one of the members of the G protein-coupled receptor family that can catalyze a @COMPOUND$-GTP exchange reaction on the retinal G protein @PROTEIN$ (Gt) upon photon absorption.	1
1139	Rhodopsin is one of the members of the G protein-coupled receptor family that can catalyze a GDP-@COMPOUND$ exchange reaction on the retinal G protein @PROTEIN$ (Gt) upon photon absorption.	1
1140	@PROTEIN$ is one of the members of the G protein-coupled receptor family that can catalyze a @COMPOUND$-GTP exchange reaction on the retinal G protein transducin (Gt) upon photon absorption.	1
1141	@COMPOUND$ was associated with a lower frequency of extrapyramidal symptoms than other antipsychotics, fewer @PROTEIN$-related adverse events than risperidone and other atypical antipsychotics, but greater weight gain than typicals and risperidone.	1
1142	In our earlier method, glutathione disulfide (@COMPOUND$) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of NADPH.	1
1143	In our earlier method, @COMPOUND$ (GSSG) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of NADPH.	1
1144	In our earlier method, glutathione disulfide (GSSG) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of @COMPOUND$.	1
1145	In our earlier method, glutathione disulfide (GSSG) was measured by first reducing it to @COMPOUND$ with @PROTEIN$ (GR) in the presence of NADPH.	1
1146	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, GST, GPx, @PROTEIN$, and CAT activities.	1
1147	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, @PROTEIN$, GPx, SOD, and CAT activities.	1
1148	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, GST, GPx, SOD, and @PROTEIN$ activities.	1
1149	The p-hydroxyphenylpyruvate produced by the Escherichia coli host was converted to @COMPOUND$ through the oxidation reaction of introduced @PROTEIN$.	1
1150	The @COMPOUND$ produced by the Escherichia coli host was converted to HGA through the oxidation reaction of introduced @PROTEIN$.	1
1151	Methylation of these @COMPOUND$ sites may lead to reduced @PROTEIN$ expression in the lymphocytes of these former heroin addicts.	1
1152	Two infants with elevated serum @PROTEIN$ had a decreased serum @COMPOUND$.	1
1153	None of the compounds altered @PROTEIN$ gene expression, indicating that 3-@COMPOUND$ inhibits CYP11B1 activity on the protein level.	0
1154	None of the compounds altered Cyp11b1 gene expression, indicating that 3-@COMPOUND$ inhibits @PROTEIN$ activity on the protein level.	1
1155	Functional analysis demonstrated that elkj encoded a @PROTEIN$-elongase that mediated the elongation of EPA into @COMPOUND$ (22:5n-3), confirming the two-step conversion from EPA to DHA in marine microalga.	1
1156	ANP (atrial natriuretic peptide) exerts its biological effects by binding to GC (guanylate @PROTEIN$)-A/NPR (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1
1157	@PROTEIN$ (atrial natriuretic peptide) exerts its biological effects by binding to GC (guanylate cyclase)-A/NPR (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1
1158	ANP (atrial natriuretic peptide) exerts its biological effects by binding to GC (guanylate cyclase)-A/@PROTEIN$ (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1
1159	ANP (atrial @PROTEIN$) exerts its biological effects by binding to GC (guanylate cyclase)-A/NPR (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1
1160	ANP (@PROTEIN$) exerts its biological effects by binding to GC (guanylate cyclase)-A/NPR (natriuretic peptide receptor)-A, which generates the second messenger @COMPOUND$.	1
1161	Overexpression of Ets-1 enhanced significantly @PROTEIN$ mRNA levels, protein expression, GC activity and ANP-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	0
1162	Overexpression of Ets-1 enhanced significantly Npr1 mRNA levels, protein expression, GC activity and @PROTEIN$-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	1
1163	Overexpression of @PROTEIN$ enhanced significantly Npr1 mRNA levels, protein expression, GC activity and ANP-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	1
1164	"In the current study, these cells were cultured with three different media: "" @PROTEIN$-plus"" medium containing @COMPOUND$ and 100 ng/mL of rhBMP-2, ""odontogenic"" medium containing dexamethasone, and ""control"" medium without supplements."	0
1165	The allatostatins (@PROTEIN$), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are neuropeptides that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	1
1166	The @PROTEIN$ (ASTs), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are neuropeptides that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	1
1167	The allatostatins (ASTs), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are @PROTEIN$ that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	0
1168	As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-REIC treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to @COMPOUND$ and of the P-@PROTEIN$ expression.	0
1169	As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-@PROTEIN$ treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to @COMPOUND$ and of the P-glycoprotein expression.	0
1170	Ad-REIC treatment in MCF7/ADR cells also downregulated P-glycoprotein expresssion through @PROTEIN$ activation, and sensitized its drug resistance against @COMPOUND$.	0
1171	Ad-REIC treatment in MCF7/ADR cells also downregulated P-@PROTEIN$ expresssion through JNK activation, and sensitized its drug resistance against @COMPOUND$.	0
1172	Ad-@PROTEIN$ treatment in MCF7/ADR cells also downregulated P-glycoprotein expresssion through JNK activation, and sensitized its drug resistance against @COMPOUND$.	1
1173	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (@COMPOUND$), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
1174	L-Kynurenine (@COMPOUND$), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
1175	L-@COMPOUND$ (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
1176	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to @COMPOUND$ (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
1177	L-Kynurenine (KYN), a @COMPOUND$ metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	0
1178	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by @COMPOUND$ aminotransferase (@PROTEIN$) I and KAT II.	1
1179	Exposure to @COMPOUND$ (BaP) by intraperitoneal injection increased biliary BaP metabolites and liver @PROTEIN$ gene expression.	1
1180	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1181	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1182	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1183	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
1184	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1185	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1186	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1187	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1188	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1189	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1190	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
1191	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1192	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1193	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1194	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1195	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1196	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1197	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
1198	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
1199	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1200	Erythrocytes were incubated under various treatment conditions (@COMPOUND$ alone, vitamins alone, or malathion plus vitamin) at 37 degrees C for 60 min, and the levels of MDA, and SOD, @PROTEIN$ and GPx activities, were determined.	1
1201	Erythrocytes were incubated under various treatment conditions (@COMPOUND$ alone, vitamins alone, or malathion plus vitamin) at 37 degrees C for 60 min, and the levels of MDA, and @PROTEIN$, CAT and GPx activities, were determined.	0
1202	Treatment with @COMPOUND$ alone increased the levels of MDA and decreased SOD, @PROTEIN$ 0.05).	1
1203	Treatment with @COMPOUND$ alone increased the levels of MDA and decreased @PROTEIN$, CAT 0.05).	1
1204	@PROTEIN$ reduces antioxidant defense system and enhances kidney tissue damage in @COMPOUND$ and lead exposed rats.	1
1205	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
1206	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
1207	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
1208	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
1209	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
1210	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
1211	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
1212	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
1213	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
1214	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
1215	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for morphine, @COMPOUND$ or food.	1
1216	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for @COMPOUND$, cocaine or food.	1
1217	Recent studies showed that LH orexin neurons that project to ventral tegmental area (VTA) have greater @PROTEIN$ induction in association with elevated @COMPOUND$ preference during protracted withdrawal than non-VTA-projecting orexin neurons, indicating that the VTA is an important site of action for orexin's role in reward processing.	0
1218	@PROTEIN$ are metalloproteins that function in electron transfer reactions and contain a @COMPOUND$ moiety covalently attached via thioether linkages between the co-factor and a CXXCH motif in the protein.	1
1219	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1220	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1221	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1222	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1223	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1224	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1225	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1226	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1227	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1228	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1229	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1230	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1231	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1232	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1233	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1234	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1235	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1236	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1237	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1238	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1239	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
1240	MPc also increased @PROTEIN$ activity in all tissues with a concurrent decrease in @COMPOUND$ levels.	0
1241	@COMPOUND$ reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit @PROTEIN$-enzymes.	1
1242	@COMPOUND$ reverses @PROTEIN$-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes.	1
1243	Pretreatment with the MEK-ERK inhibitor (@COMPOUND$) appreciably reversed the mitogenic effects of @PROTEIN$.	1
1244	On the other hand, pretreatment with the polyphenolic @COMPOUND$ resveratrol (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	0
1245	On the other hand, pretreatment with the polyphenolic stilbene @COMPOUND$ (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	1
1246	Further, pretreatment with the specific cGMP-phosphodiesterase inhibitor, @COMPOUND$ (10 microM) appreciably augmented RSVL-evoked cGMP formation, @PROTEIN$ inhibition, and cytostatic response.	1
1247	Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, KT-5823 (10 microM; 69%), but not by the kinase-A inhibitor (@COMPOUND$).	0
1248	Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, @COMPOUND$ (10 microM; 69%), but not by the kinase-A inhibitor (KT-5720).	1
1249	Adding @COMPOUND$ to the diet of the mice during the period of irradiation suppressed the activity and expression of @PROTEIN$ as well as the wrinkling and sagging formation.	1
1250	Dietary @COMPOUND$ prevents the expression of @PROTEIN$, at least partly, by inhibiting photodynamic action involved in the formation of Chol-OOHs.	1
1251	@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (Cip1) and @PROTEIN$ and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
1252	@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (Cip1) and Cdc2 and activates @PROTEIN$-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
1253	@COMPOUND$ causes G(2)/M arrest associated with the modulation of @PROTEIN$ (Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
1254	@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (@PROTEIN$) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
1255	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1
1256	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0
1257	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0
1258	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1
1259	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0
1260	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0
1261	In addition, the @COMPOUND$-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in CDK1 together with @PROTEIN$ and cyclin B.	1
1262	In addition, the @COMPOUND$-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in @PROTEIN$ together with cyclin A and cyclin B.	1
1263	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of @PROTEIN$ (Cip1), with no change in p27 (Kip1).	1
1264	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of p21 (@PROTEIN$), with no change in p27 (Kip1).	1
1265	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of p21 (Cip1), with no change in @PROTEIN$ (Kip1).	0
1266	In an additional study, @COMPOUND$ also increased the accumulation of @PROTEIN$ and further enhanced the level of p21 (Cip1), with no change in p27 (Kip1).	1
1267	The expression of Bax and @PROTEIN$ of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
1268	The expression of Bax and cytochrome c of @PROTEIN$ downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
1269	The expression of @PROTEIN$ and cytochrome c of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
1270	@COMPOUND$ strongly decreased the expression of @PROTEIN$ 0.01).	1
1271	In contrast, the administration of @COMPOUND$ significantly attenuated the immobilization stress-induced decrease in @PROTEIN$ 0.01).	1
1272	@COMPOUND$ exhibited differential effects on @PROTEIN$ mRNA expression in the rat hippocampus and neocortex.	1
1273	These results suggest that @COMPOUND$ might have a neuroprotective effect by recovering stress-induced decreases in @PROTEIN$ mRNA expression.	1
1274	Leptin and soluble @PROTEIN$ receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
1275	@PROTEIN$ and soluble leptin receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
1276	Leptin and soluble @PROTEIN$ receptor (SLR) were compared with evolution of @COMPOUND$ and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).	0
1277	@PROTEIN$ and soluble leptin receptor (SLR) were compared with evolution of @COMPOUND$ and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).	0
1278	Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of @PROTEIN$, and evaluated the effects of tight metabolic control (insulin, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0
1279	Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of CAV-1, and evaluated the effects of tight metabolic control (@PROTEIN$, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0
1280	Androgenic action correlates inversely with a polymorphic CAG repeat region in the AR gene encoding for glutamine residues the length of which appears to influence @PROTEIN$ (HDL) @COMPOUND$ levels.	1
1281	Androgenic action correlates inversely with a polymorphic CAG repeat region in the AR gene encoding for @COMPOUND$ residues the length of which appears to influence @PROTEIN$ (HDL) cholesterol levels.	1
1282	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/@PROTEIN$ (IKK) and mitogen-activated protein kinases (MAPKs) by reducing oxidative stress in aged rats.	1
1283	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/IkappaB kinase (IKK) and @PROTEIN$ (MAPKs) by reducing oxidative stress in aged rats.	1
1284	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/IkappaB kinase (IKK) and mitogen-activated protein kinases (@PROTEIN$) by reducing oxidative stress in aged rats.	1
1285	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (@PROTEIN$)/IkappaB kinase (IKK) and mitogen-activated protein kinases (MAPKs) by reducing oxidative stress in aged rats.	1
1286	Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory @PROTEIN$, iNOS, VCAM-1 and ICAM-1.	1
1287	Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory COX-2, iNOS, @PROTEIN$ and ICAM-1.	1
1288	Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory COX-2, @PROTEIN$, VCAM-1 and ICAM-1.	1
1289	Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory COX-2, iNOS, VCAM-1 and @PROTEIN$.	1
1290	The molecular modulation of NF-kappaB by @COMPOUND$ was further revealed in endothelial YPEN-1 cells through ferulate's ability to suppress the activation of @PROTEIN$/IKK and MAPKs.	1
1291	The molecular modulation of NF-kappaB by @COMPOUND$ was further revealed in endothelial YPEN-1 cells through ferulate's ability to suppress the activation of NIK/IKK and @PROTEIN$.	1
1292	Based on these results, we conclude that @COMPOUND$'s antioxidative capacity suppressed the age-related increase in NF-kappaB activity through inhibition of @PROTEIN$/IKK and MAPKs in vivo.	1
1293	Based on these results, we conclude that @COMPOUND$'s antioxidative capacity suppressed the age-related increase in NF-kappaB activity through inhibition of NIK/IKK and @PROTEIN$ in vivo.	1
1294	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (@PROTEIN$) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
1295	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (@PROTEIN$).	1
1296	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate @PROTEIN$ (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
1297	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (@PROTEIN$) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
1298	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate epidermal growth factor (@PROTEIN$) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
1299	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate @PROTEIN$ (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
1300	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate epidermal growth factor (@PROTEIN$) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
1301	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (@PROTEIN$).	1
1302	@COMPOUND$ is a free radical molecule synthesized from L-arginine by @PROTEIN$ that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.	1
1303	Nitric oxide is a free radical molecule synthesized from @COMPOUND$ by @PROTEIN$ that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.	1
1304	We demonstrated the increase in the levels of p53, Bax, and @PROTEIN$ and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
1305	We demonstrated the increase in the levels of p53, Bax, and cytochrome c and decrease in the level of @PROTEIN$, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
1306	We demonstrated the increase in the levels of p53, @PROTEIN$, and cytochrome c and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
1307	We demonstrated the increase in the levels of @PROTEIN$, Bax, and cytochrome c and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
1308	GFP-fluorescent cells were slowly cycling, as shown by their long-term retention of @COMPOUND$, and less than 10% expressed the proliferative markers Ki67 and @PROTEIN$.	0
1309	@PROTEIN$ gene polymorphisms and high levels of @COMPOUND$ are associated with a high degree of steatosis and fibrosis, conditions associated with a low sustained virological response (SVR) rate.	0
1310	@COMPOUND$ inhibits expression of ADAMTS4 (@PROTEIN$) in human osteoarthritic chondrocytes.	1
1311	@COMPOUND$ inhibits expression of @PROTEIN$ (aggrecanase-1) in human osteoarthritic chondrocytes.	1
1312	The discovery that a common polymorphism (@COMPOUND$TLPR, short variant) in the human serotonin transporter gene (@PROTEIN$) can influence personality traits and increase the risk for depression in adulthood has led to the hypothesis that a relative increase in the extracellular levels of serotonin (5-HT) during development could be critical for the establishment of brain circuits.	0
1313	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, @PROTEIN$ and tumour necrosis factor.	0
1314	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, calmodulin and tumour necrosis factor.	1
1315	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, @PROTEIN$ and tumour necrosis factor.	0
1316	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, calmodulin and tumour necrosis factor.	1
1317	Prior to the first dose of @COMPOUND$, serum concentrations of studied chemokines correlated with marker of RA activity such as the erythrocyte sedimentation rate and @PROTEIN$ level with DAS.	0
1318	Hypothetically, @PROTEIN$ influences the transport of @COMPOUND$ across the blood-brain barrier.	1
1319	In prolonged OJ with LPS administration, hepatocyte apoptosis depending on @PROTEIN$ expression significantly increased in association with a decrease in @COMPOUND$ contents, thus resulting in liver necrapoptosis.	0
1320	Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of CTLA-4, @PROTEIN$ on Tregs, and IL-10 production after burns.	1
1321	Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of CTLA-4, Foxp3 on Tregs, and @PROTEIN$ production after burns.	1
1322	Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of @PROTEIN$, Foxp3 on Tregs, and IL-10 production after burns.	1
1323	@COMPOUND$ attenuated mast cell recruitment thereby decreased the expressions of @PROTEIN$ and 9 in rat liver carcinogenesis.	1
1324	@COMPOUND$ administered rats showed increased MCD as revealed by toluidine blue staining along with upregulated expressions of MMP-2 and @PROTEIN$.	1
1325	@COMPOUND$ administered rats showed increased MCD as revealed by toluidine blue staining along with upregulated expressions of @PROTEIN$ and MMP-9.	1
1326	@COMPOUND$ treatment inhibited this increase in MCD and downregulated the expressions of @PROTEIN$ and MMP-9 as revealed by Western blotting and immunohistochemistry.	1
1327	@COMPOUND$ treatment inhibited this increase in MCD and downregulated the expressions of MMP-2 and @PROTEIN$ as revealed by Western blotting and immunohistochemistry.	1
1328	In conclusion, @COMPOUND$ exerted beneficial effects on liver carcinogenesis by attenuating the recruitment of mast cells and thereby decreased the expressions of @PROTEIN$ and MMP-9.	1
1329	In conclusion, @COMPOUND$ exerted beneficial effects on liver carcinogenesis by attenuating the recruitment of mast cells and thereby decreased the expressions of MMP-2 and @PROTEIN$.	1
1330	As a result, combined @COMPOUND$ and @PROTEIN$ infusion significantly decreased plasma K+ concentration despite a significant decrease of urinary K+ excretion in sgk1+/+ but not in sgk1-/-mice.	0
1331	Osteogenic differentiation was enhanced after treatment with @COMPOUND$ as confirmed by Alizarin Red S staining, elevated alkaline phosphatase activity and @PROTEIN$ mRNA expression, a greater calcium peak by energy-dispersive xray spectrophotometry, and by immunofluorescence staining against CD44 by flow cytometric analysis.	1
1332	Osteogenic differentiation was enhanced after treatment with @COMPOUND$ as confirmed by Alizarin Red S staining, elevated @PROTEIN$ activity and osteocalcin mRNA expression, a greater calcium peak by energy-dispersive xray spectrophotometry, and by immunofluorescence staining against CD44 by flow cytometric analysis.	1
1333	Osteogenic differentiation was enhanced after treatment with @COMPOUND$ as confirmed by Alizarin Red S staining, elevated alkaline phosphatase activity and osteocalcin mRNA expression, a greater calcium peak by energy-dispersive xray spectrophotometry, and by immunofluorescence staining against @PROTEIN$ by flow cytometric analysis.	1
1334	@PROTEIN$ inhibits contraction and proliferation of human aortic smooth muscle cells by @COMPOUND$/PKA pathway activation.	1
1335	@PROTEIN$ was able to inhibit angiotensin II-induced proliferation and contraction in a dose-response fashion via the @COMPOUND$/PKA pathway.	1
1336	The results indicated that the backbone of @PROTEIN$ was composed of (1--&gt;6)-linked-alpha-D-galactopyranosyl and (1--&gt;2,6)-linked-alpha-D-galactopyranosyl residues, which were terminated with a single terminal (1--&gt;)-@COMPOUND$ residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.	1
1337	The results indicated that the backbone of @PROTEIN$ was composed of (1--&gt;6)-linked-alpha-@COMPOUND$ and (1--&gt;2,6)-linked-alpha-D-galactopyranosyl residues, which were terminated with a single terminal (1--&gt;)-beta-D-glucose residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.	1
1338	Preliminary tests in vitro showed POP is capable of enhancing concanavalin A (@PROTEIN$)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
1339	Preliminary tests in vitro showed @PROTEIN$ is capable of enhancing concanavalin A (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	1
1340	Preliminary tests in vitro showed POP is capable of enhancing @PROTEIN$ (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
1341	Cross-linked hydrogels showed increased resistance to digestion by testicular @PROTEIN$ and hyaluronidase SD with increasing @COMPOUND$ concentration.	1
1342	@COMPOUND$ (CPF), a commonly used organophosphorus insecticide, induces @PROTEIN$ inhibition and cholinergic toxicity.	1
1343	It was observed that administration of the PKC inhibitor @COMPOUND$ (5 mg/kg) suppressed the activation of three exercise-induced PKC isoforms (PKCalpha, @PROTEIN$, and PKCepsilon) and attenuated the exercise-mediated reduction of myocardial infarct size during ischemia-reperfusion injury.	1
1344	It was observed that administration of the PKC inhibitor @COMPOUND$ (5 mg/kg) suppressed the activation of three exercise-induced PKC isoforms (@PROTEIN$, PKCdelta, and PKCepsilon) and attenuated the exercise-mediated reduction of myocardial infarct size during ischemia-reperfusion injury.	1
1345	Cholesteryl ester transfer protein (@PROTEIN$) is a plasma glycoprotein that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of high density lipoprotein @COMPOUND$ (HDL-C).	1
1346	Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of @PROTEIN$ @COMPOUND$ (HDL-C).	1
1347	Cholesteryl ester transfer protein (CETP) is a plasma @PROTEIN$ that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of high density lipoprotein @COMPOUND$ (HDL-C).	1
1348	@PROTEIN$ (CETP) is a plasma glycoprotein that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of high density lipoprotein @COMPOUND$ (HDL-C).	1
1349	These studies frequently showed that erythropoietic stimulating agents (ESA) with oral or IV iron often resulted in improvement in left ventricular systolic and diastolic function, dilation, and hypertrophy, stabilization or improvement in renal function, reduced hospitalizations, diuretic dose, mitral regurgitation, pulmonary artery pressure, plasma volume, heart rate, serum brain natriuretic peptide levels, and the inflammatory markers C reactive protein and @PROTEIN$, and an improvement in New York Heart Association class, exercise capacity, @COMPOUND$ utilization during exercise, sleep apnea, caloric intake, depression, and quality of life.	0
1350	These studies frequently showed that erythropoietic stimulating agents (ESA) with oral or IV iron often resulted in improvement in left ventricular systolic and diastolic function, dilation, and hypertrophy, stabilization or improvement in renal function, reduced hospitalizations, diuretic dose, mitral regurgitation, pulmonary artery pressure, plasma volume, heart rate, serum @PROTEIN$ levels, and the inflammatory markers C reactive protein and Interleukin 6, and an improvement in New York Heart Association class, exercise capacity, @COMPOUND$ utilization during exercise, sleep apnea, caloric intake, depression, and quality of life.	0
1351	DNA sequences of a calmodulin (@PROTEIN$)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
1352	DNA sequences of a calmodulin (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the @PROTEIN$ (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
1353	DNA sequences of a calmodulin (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (@PROTEIN$) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
1354	DNA sequences of a @PROTEIN$ (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
1355	Both expression of tac and @PROTEIN$ were induced by 2% @COMPOUND$.	1
1356	Contaminants of current high use in the LRGV, such as atrazine, and some of the highly persistent organochlorines, such as @COMPOUND$ and DDE, could be potentially associated with modulation of @PROTEIN$ activity in avian tissues.	1
1357	Contaminants of current high use in the LRGV, such as @COMPOUND$, and some of the highly persistent organochlorines, such as toxaphene and DDE, could be potentially associated with modulation of @PROTEIN$ activity in avian tissues.	1
1358	Contaminants of current high use in the LRGV, such as atrazine, and some of the highly persistent organochlorines, such as toxaphene and @COMPOUND$, could be potentially associated with modulation of @PROTEIN$ activity in avian tissues.	1
1359	In this view, this study aimed at the investigating the use of a crude @PROTEIN$ preparation from onion solid by-products for oxidising @COMPOUND$, a widespread o-diphenol, whose various derivatives may occur in food industry wastes, such as olive mill waste waters.	1
1360	@COMPOUND$ exposures that caused a loss of binding function were examined for effects on expression of key NK cell-@PROTEIN$ needed for binding to targets.	0
1361	@PROTEIN$ protein contains high glycine and @COMPOUND$, which concerns regulation and function of the matrix structure fiber.	1
1362	@PROTEIN$ protein contains high @COMPOUND$ and tyrosine, which concerns regulation and function of the matrix structure fiber.	1
1363	@COMPOUND$ inhibited MIH induced Mos expression and its phosphorylation, which in turn reduced @PROTEIN$ phosphorylation and GVBD.	1
1364	@COMPOUND$ inhibited MIH induced @PROTEIN$ expression and its phosphorylation, which in turn reduced Myt1 phosphorylation and GVBD.	1
1365	@COMPOUND$ inhibited @PROTEIN$ induced Mos expression and its phosphorylation, which in turn reduced Myt1 phosphorylation and GVBD.	1
1366	@COMPOUND$-mediated ubiquitination regulates @PROTEIN$.	1
1367	Short-acting @PROTEIN$ analogues, in comparison with regular human insulin (HRI), provide a greater control of postprandial @COMPOUND$, while their superiority on haemoglobin A1c (HbA1c) is controversial.	1
1368	Short-acting insulin analogues, in comparison with regular human insulin (@PROTEIN$), provide a greater control of postprandial @COMPOUND$, while their superiority on haemoglobin A1c (HbA1c) is controversial.	1
1369	Western blotting showed that @COMPOUND$ down-regulated @PROTEIN$ protein expression in the BA, which in the SAH-only group was significantly higher than that of the normal group.	1
1370	Hepatocytes exposed to resistin, but only in the presence of @PROTEIN$, show a decrease in insulin-stimulated @COMPOUND$ content.	1
1371	In addition, AIT induced a more favourable regulation of blood @COMPOUND$ and @PROTEIN$ compared with MTG.	0
1372	Beta1,4-@PROTEIN$-I (B4GALT1), one of seven beta1,4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
1373	Beta1,4-galactosyltransferase-I (@PROTEIN$), one of seven beta1,4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
1374	Beta1,4-galactosyltransferase-I (B4GALT1), one of seven beta1,4-@PROTEIN$, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
1375	When compared to the other mammalian @PROTEIN$ genes, the porcine coding sequence contained a single @COMPOUND$ codon inserted into the region encoding the cytoplasmic domain.	1
1376	@COMPOUND$ inhibited the levels of the anti-apoptotic proteins @PROTEIN$ and Bcl-xl, but promoted the levels of the pro-apoptotic protein Bax.	1
1377	@COMPOUND$ inhibited the levels of the anti-apoptotic proteins Bcl-2 and Bcl-xl, but promoted the levels of the pro-apoptotic @PROTEIN$.	1
1378	In conclusion, Gyp induced ER stress and production of reactive @COMPOUND$ species and Ca(2+), change the ratio of @PROTEIN$ and Bax, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0
1379	In conclusion, Gyp induced ER stress and production of reactive oxygen species and @COMPOUND$+), change the ratio of Bcl-2 and @PROTEIN$, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0
1380	In conclusion, Gyp induced ER stress and production of reactive oxygen species and @COMPOUND$+), change the ratio of @PROTEIN$ and Bax, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0
1381	In conclusion, Gyp induced ER stress and production of reactive @COMPOUND$ species and Ca(2+), change the ratio of Bcl-2 and Bax, followed by the dysfunction of mitochondria, caused @PROTEIN$ release, activation of caspase-3 before leading to apoptosis.	0
1382	In conclusion, @COMPOUND$ induced ER stress and production of reactive oxygen species and Ca(2+), change the ratio of @PROTEIN$ and Bax, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	1
1383	In conclusion, Gyp induced ER stress and production of reactive oxygen species and @COMPOUND$+), change the ratio of Bcl-2 and Bax, followed by the dysfunction of mitochondria, caused @PROTEIN$ release, activation of caspase-3 before leading to apoptosis.	0
1384	In conclusion, @COMPOUND$ induced ER stress and production of reactive oxygen species and Ca(2+), change the ratio of Bcl-2 and Bax, followed by the dysfunction of mitochondria, caused @PROTEIN$ release, activation of caspase-3 before leading to apoptosis.	1
1385	In conclusion, Gyp induced ER stress and production of reactive @COMPOUND$ species and Ca(2+), change the ratio of Bcl-2 and @PROTEIN$, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0
1386	In conclusion, @COMPOUND$ induced ER stress and production of reactive oxygen species and Ca(2+), change the ratio of Bcl-2 and @PROTEIN$, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	1
1387	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (LIF), interleukin-6 (@PROTEIN$), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
1388	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (LIF), @PROTEIN$ (IL-6), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
1389	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (@PROTEIN$), interleukin-6 (IL-6), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
1390	Exposure of erythrocytes to PGNs increased cytosolic Ca(2+) concentration, increased ceramide formation, enhanced the percentage of @PROTEIN$-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular @COMPOUND$ concentration.	0
1391	Exposure of erythrocytes to @PROTEIN$ increased cytosolic Ca(2+) concentration, increased ceramide formation, enhanced the percentage of annexin V-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular @COMPOUND$ concentration.	1
1392	Exposure of erythrocytes to PGNs increased cytosolic @COMPOUND$+) concentration, increased ceramide formation, enhanced the percentage of @PROTEIN$-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular ATP concentration.	0
1393	Exposure of erythrocytes to @PROTEIN$ increased cytosolic @COMPOUND$+) concentration, increased ceramide formation, enhanced the percentage of annexin V-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular ATP concentration.	1
1394	Induction of NY-ESO-1 expression on tumor targets using the demethylating agent 5-aza-2'-deoxycytidine (alone or in combination with the histone deacetylase inhibitor @COMPOUND$) resulted in enhanced @PROTEIN$ secretion by the TCR-transduced PBL on culture with treated targets.	1
1395	Induction of NY-ESO-1 expression on tumor targets using the demethylating agent @COMPOUND$ (alone or in combination with the histone deacetylase inhibitor depsipeptide) resulted in enhanced @PROTEIN$ secretion by the TCR-transduced PBL on culture with treated targets.	1
1396	In the absence of @PROTEIN$, cells lost the ability to reduce soluble or insoluble @COMPOUND$).	1
1397	DNA sequences of upstream regions of coregulated operons in the adapted mutant are divergent, suggesting the presence of recognition sites for different @PROTEIN$ and indicating that adaptation of the omcB mutant to growth on soluble @COMPOUND$) has shifted the relevant expression networks involved to a more diverse molecular basis.	0
1398	Elevated beta1,4-@PROTEIN$-I induced by the intraspinal injection of @COMPOUND$.	1
1399	E-selectin, which ligand was modified by beta1,4-@PROTEIN$-I, was correlated with @COMPOUND$-containing glycans following injecting LPS into spinal cord.	0
1400	@COMPOUND$, an anticonvulsant and mood stabilizer, up-regulates @PROTEIN$, a neurotrophic/neuroprotective protein.	1
1401	In this study, we investigated the molecular mechanism through which @PROTEIN$ is up-regulated by @COMPOUND$ using cultured human neuron-like cells.	1
1402	@COMPOUND$, within therapeutically relevant ranges, induced time- and concentration-dependent up-regulations of both @PROTEIN$ messenger RNA and protein implicating an underlying gene transcriptional-mediated mechanism.	1
1403	@COMPOUND$ increased transcriptional activity of a human @PROTEIN$ promoter-reporter gene construct.	1
1404	ERK and/or PI3K pathway inhibitors and RSK1 small hairpin RNA knockdown reduced, but did not abolish, baseline and @COMPOUND$-induced promoter activities and lowered @PROTEIN$ protein levels.	0
1405	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and @PROTEIN$ cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
1406	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, @PROTEIN$, although other unknown mechanism(s) are likely involved.	1
1407	These data collectively suggest that @COMPOUND$ induces @PROTEIN$ regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
1408	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the @PROTEIN$ and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
1409	Given the known roles of @PROTEIN$ in the central nervous system, the current findings offer a partial yet complex molecular mechanistic explanation for the known neurobiological effects of @COMPOUND$ including neurite growth, neuronal survival, and neurogenesis.	0
1410	As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of @PROTEIN$ and C4H, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1
1411	As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of PAL and @PROTEIN$, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1
1412	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by substance P and @PROTEIN$ in a manner similar to galanin, confirming a non-GalR1-mediated effect.	0
1413	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by substance P and calcitonin gene-related peptide in a manner similar to @PROTEIN$, confirming a non-GalR1-mediated effect.	0
1414	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by @PROTEIN$ and calcitonin gene-related peptide in a manner similar to galanin, confirming a non-GalR1-mediated effect.	0
1415	Inhibition of non-small cell lung cancer cell migration by grape seed @COMPOUND$ is mediated through the inhibition of nitric oxide, guanylate cyclase, and @PROTEIN$/2.	1
1416	Inhibition of non-small cell lung cancer cell migration by grape seed @COMPOUND$ is mediated through the inhibition of nitric oxide, guanylate @PROTEIN$, and ERK1/2.	1
1417	Additionally, UO126 and @COMPOUND$ inhibited the migration restoring effects of L-arginine in L-NAME-treated cells, suggesting the involvement of cGMP and @PROTEIN$ pathways in NO-mediated migration.	1
1418	Additionally, UO126 and ODQ inhibited the migration restoring effects of @COMPOUND$ in L-NAME-treated cells, suggesting the involvement of cGMP and @PROTEIN$ pathways in NO-mediated migration.	1
1419	Additionally, UO126 and ODQ inhibited the migration restoring effects of L-arginine in L-NAME-treated cells, suggesting the involvement of @COMPOUND$ and @PROTEIN$ pathways in NO-mediated migration.	0
1420	GSPs inhibited @COMPOUND$ and 8-Br-cGMP-induced activation of @PROTEIN$/2 in A549 cells.	1
1421	GSPs inhibited L-arginine and @COMPOUND$-induced activation of @PROTEIN$/2 in A549 cells.	1
1422	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (@PROTEIN$), mitogen-activated protein kinases (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
1423	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (CREB), mitogen-activated protein kinases (MAPKp44/42; @PROTEIN$/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
1424	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (CREB), @PROTEIN$ (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
1425	Immunoblot analysis of signaling molecules, including cyclic-@PROTEIN$ response element binding protein (CREB), mitogen-activated protein kinases (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	0
1426	@PROTEIN$ resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus @COMPOUND$.	1
1427	Aim To investigate retrospectively the impact of @PROTEIN$ resistance on treatment response in Chinese genotype 1 CHC patients receiving a 24-week course therapy with peginterferon alpha-2b/@COMPOUND$.	1
1428	In men there is a large interindividual variation of @PROTEIN$ levels and consequently of @COMPOUND$ (T) and E(2) levels.	1
1429	Over-expression of @PROTEIN$ decreased the yield of ethanol and 2,3-butanediol, meanwhile it increased the concentration of @COMPOUND$.	1
1430	Over-expression of @PROTEIN$ decreased the yield of @COMPOUND$ and 2,3-butanediol, meanwhile it increased the concentration of acetic acid.	1
1431	Over-expression of @PROTEIN$ decreased the yield of ethanol and @COMPOUND$, meanwhile it increased the concentration of acetic acid.	1
1432	@COMPOUND$ prevents acute liver damage after massive hepatectomy in rats through suppression of a CXC chemokine @PROTEIN$ and induction of heat shock proteins.	1
1433	The adsorption of ovine @PROTEIN$ onto @COMPOUND$-modified surfaces was reduced relative to unmodified surfaces, and in vitro ovine blood contact through a rocking test revealed marked reductions in platelet deposition and bulk phase platelet activation relative to unmodified TiAl6V4 and polystyrene controls.	1
1434	When the @PROTEIN$ concentration was higher than 15 U/mL, the gelation could be finished within 1 min and yielded a composite with evenly suspended and distributed @COMPOUND$ microspheres.	1
1435	The culture tests using MSCs show that the level of alkaline phosphatase (@PROTEIN$) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1
1436	The culture tests using MSCs show that the level of @PROTEIN$ (ALP) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1
1437	The level was unchanged in MSCs cultured on PV-H. In the case of supplementing Dex and @COMPOUND$ to the medium, the level of @PROTEIN$ activity in MSCs cultured on SPV-H was higher than that on PV-H at all time points during the 21-day culture.	1
1438	The combined treatment strategy not only decreased @PROTEIN$-positive aggregation in striatum, alleviated @COMPOUND$ aggregation formation, and reduced striatal volume, but also extended life span in the R6/2 animal model.	0
1439	@PROTEIN$ inhibits toll-like receptor 3-induced @COMPOUND$ production in Schwann cells and subsequent sensory neuronal cell death in vitro.	1
1440	The @PROTEIN$ and LUC genes were chosen because they can be used as markers for the easy detection of transgenic plants, while @COMPOUND$ tail better enables the isolation of protein expressed in plant tissue.	0
1441	Expression was performed in fusion to @COMPOUND$ binding protein using chemically defined minimal medium, followed by a single-step affinity capture and enzymatic cleavage using tobacco etch virus @PROTEIN$.	0
1442	The aims of this study were: (i) to characterize the basal circadian rhythm of adrenocorticotropin hormone (@PROTEIN$) and cortisol in IBS vs healthy controls; (ii) to compare stimulated ACTH, cortisol and @COMPOUND$ responses to a pelvic visceral stressor (sigmoidoscopy) in IBS and controls; and (iii) to correlate neuroendocrine responses with colonic mucosal cytokine expression and symptoms in IBS.	0
1443	The aims of this study were: (i) to characterize the basal circadian rhythm of adrenocorticotropin hormone (@PROTEIN$) and @COMPOUND$ in IBS vs healthy controls; (ii) to compare stimulated ACTH, cortisol and noradrenaline responses to a pelvic visceral stressor (sigmoidoscopy) in IBS and controls; and (iii) to correlate neuroendocrine responses with colonic mucosal cytokine expression and symptoms in IBS.	0
1444	In Study 1, basal @COMPOUND$ levels were analysed in 41 IBS and 25 controls using 24-h collections of plasma @PROTEIN$ and cortisol (q10 min sampling).	0
1445	Basal @PROTEIN$ 0.05), while basal and stimulated plasma @COMPOUND$ levels were higher in patients.	0
1446	ALK2 (R206H) with @PROTEIN$ or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1
1447	ALK2 (R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by @PROTEIN$ or @COMPOUND$.	0
1448	ALK2 (R206H) with Smad1 or @PROTEIN$ induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1
1449	@PROTEIN$ (R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1
1450	The aim of the present study was to examine whether increased serum Hsp70 levels are related to clinical characteristics and standard laboratory parameters of preeclamptic patients, as well as to markers of inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) or endothelial injury (@PROTEIN$), trophoblast debris (cell-free fetal DNA) and oxidative stress (@COMPOUND$).	0
1451	The aim of the present study was to examine whether increased serum @PROTEIN$ levels are related to clinical characteristics and standard laboratory parameters of preeclamptic patients, as well as to markers of inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) or endothelial injury (fibronectin), trophoblast debris (cell-free fetal DNA) and oxidative stress (@COMPOUND$).	0
1452	Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1453	Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1454	Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1455	Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1456	Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1457	Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1458	Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1459	Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1460	Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1461	Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1462	Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1463	Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1464	Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1465	Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1466	Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1467	Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1468	Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1469	Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1470	Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1471	Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
1472	In preeclamptic patients, serum Hsp70 levels showed significant correlations with serum @PROTEIN$ levels (Spearman R = 0.32, p = 0.010), serum aspartate aminotransferase (R = 0.32, p = 0.008) and LDH (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	0
1473	In preeclamptic patients, serum @PROTEIN$ levels showed significant correlations with serum CRP levels (Spearman R = 0.32, p = 0.010), serum aspartate aminotransferase (R = 0.32, p = 0.008) and LDH (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	1
1474	In preeclamptic patients, serum Hsp70 levels showed significant correlations with serum CRP levels (Spearman R = 0.32, p = 0.010), serum @PROTEIN$ (R = 0.32, p = 0.008) and LDH (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	0
1475	In preeclamptic patients, serum Hsp70 levels showed significant correlations with serum CRP levels (Spearman R = 0.32, p = 0.010), serum aspartate aminotransferase (R = 0.32, p = 0.008) and @PROTEIN$ (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	0
1476	In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, @COMPOUND$, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the @PROTEIN$ receptor, is compared to paclitaxel in combination therapy employing monospecific or bispecific oligos.	1
1477	In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, Rapamycin, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the @PROTEIN$ receptor, is compared to @COMPOUND$ in combination therapy employing monospecific or bispecific oligos.	0
1478	In this study we investigated the superoxide radicals scavenging effect and @PROTEIN$ inhibitory activity by @COMPOUND$, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.	1
1479	In this study we investigated the @COMPOUND$ radicals scavenging effect and @PROTEIN$ inhibitory activity by magnesium lithospermate B, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.	0
1480	Superoxide radicals were generated both in beta-NADH/@COMPOUND$ system and xanthine/@PROTEIN$ system.	0
1481	Superoxide radicals were generated both in @COMPOUND$/PMS system and xanthine/@PROTEIN$ system.	0
1482	Superoxide radicals were generated both in beta-NADH/PMS system and @COMPOUND$/@PROTEIN$ system.	1
1483	@COMPOUND$ radicals were generated both in beta-NADH/PMS system and xanthine/@PROTEIN$ system.	1
1484	Further study suggested that @COMPOUND$ can directly inhibit @PROTEIN$ and exhibits competitive inhibition.	1
1485	In addition, @COMPOUND$ significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the xanthine/@PROTEIN$ reactions.	1
1486	In addition, magnesium lithospermate B significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the @COMPOUND$/@PROTEIN$ reactions.	1
1487	Four different molecules contain galactofuranose in A. fumigatus: (i) the @COMPOUND$ present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted @PROTEIN$ (iii) a GPI-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	0
1488	Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted @PROTEIN$ (iii) a GPI-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an @COMPOUND$.	0
1489	Four different molecules contain galactofuranose in A. fumigatus: (i) the @COMPOUND$ present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted glycoproteins (iii) a @PROTEIN$-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	0
1490	Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O @COMPOUND$ moieties of secreted @PROTEIN$ (iii) a GPI-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	1
1491	Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted glycoproteins (iii) a @PROTEIN$-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an @COMPOUND$.	0
1492	Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O @COMPOUND$ moieties of secreted glycoproteins (iii) a @PROTEIN$-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	0
1493	The estimated @PROTEIN$ level and the IMCL content in these patients were correlated with body mass index, percentage of body fat, other measures of abdominal obesity, serum lipoproteins, fasting and post-oral @COMPOUND$ load serum insulin levels and other surrogate markers of insulin resistance.	0
1494	The estimated CRP level and the IMCL content in these patients were correlated with body mass index, percentage of body fat, other measures of abdominal obesity, serum lipoproteins, fasting and post-oral @COMPOUND$ load serum @PROTEIN$ levels and other surrogate markers of insulin resistance.	1
1495	Studies suggest that @PROTEIN$ activation in osteoblasts is the underlying cause of glucocorticoid- and estrogen deficiency-mediated osteoporosis, and at least partially underlies the teratogenic effects of @COMPOUND$ on limb development.	1
1496	The @PROTEIN$-induced up-regulation of RhoA was inhibited by @COMPOUND$, an inhibitor of signal transducer and activator of transcription 6 (STAT6).	0
1497	The IL-13-induced up-regulation of @PROTEIN$ was inhibited by @COMPOUND$, an inhibitor of signal transducer and activator of transcription 6 (STAT6).	1
1498	The IL-13-induced up-regulation of RhoA was inhibited by @COMPOUND$, an inhibitor of signal transducer and activator of transcription 6 (@PROTEIN$).	1
1499	The goal of this study was to determine the mechanisms by which @COMPOUND$ induces @PROTEIN$ gene expression in airway epithelial cells.	1
1500	Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced @PROTEIN$/2-MAPK activation and MUC5B gene expression.	1
1501	Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced ERK1/2-@PROTEIN$ activation and MUC5B gene expression.	1
1502	Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced ERK1/2-MAPK activation and @PROTEIN$ gene expression.	1
1503	We here show that calumenin in the presence of @COMPOUND$+) binds to @PROTEIN$ with a dissociation constant K (d) around 0.4 muM.	1
1504	However, as opposed to exogenous @COMPOUND$, the continuous use of @PROTEIN$ during in vitro differentiation completely blocked rMSC mineralization.	0
1505	We show that the effects of both @PROTEIN$-2 and @COMPOUND$ are mediated through FGF receptor 1 (FGFR1) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.	0
1506	We show that the effects of both @PROTEIN$ and @COMPOUND$ are mediated through FGF receptor 1 (FGFR1) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.	0
1507	We show that the effects of both FGF-2 and @COMPOUND$ are mediated through FGF receptor 1 (@PROTEIN$) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.	1
1508	Two related polytopic @PROTEIN$ of the major facilitator family, NarK and NarU, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	0
1509	Two related polytopic membrane proteins of the major facilitator family, NarK and @PROTEIN$, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	1
1510	Two related polytopic membrane proteins of the major facilitator family, @PROTEIN$ and NarU, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	1
1511	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
1512	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
1513	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
1514	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
1515	@COMPOUND$ stimulates antioxidant response element-mediated expression of @PROTEIN$ in mouse macrophages.	1
1516	The current study investigated whether @COMPOUND$ induces transcription of @PROTEIN$ (Gcl), via ARE driven gene expression in mouse macrophages.	0
1517	The current study investigated whether @COMPOUND$ induces transcription of glutamate-cysteine ligase (@PROTEIN$), via ARE driven gene expression in mouse macrophages.	0
1518	Treatment of mouse macrophages with d-/l-@COMPOUND$ (50microM) induced depletion of intracellular glutathione and a compensatory increase in @PROTEIN$ activity.	1
1519	Treatment of mouse macrophages with d-/l-homocysteine (50microM) induced depletion of intracellular @COMPOUND$ and a compensatory increase in @PROTEIN$ activity.	0
1520	Real-time RT-PCR revealed increased mRNA-expression of the catalytic subunit of Gcl (Gclc) after treatment with @COMPOUND$, and this occurred via increased transcription as demonstrated with @PROTEIN$ promoter reporter constructs for Gclc.	0
1521	Only EGF activated @PROTEIN$ signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced PSA transcript in A549 cells.	0
1522	Only EGF activated ERK signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced @PROTEIN$ transcript in A549 cells.	0
1523	Only @PROTEIN$ activated ERK signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced PSA transcript in A549 cells.	0
1524	@COMPOUND$ and @PROTEIN$ up-regulated cyclinD1 (CD1) at both mRNA and protein levels in A549 cells, while in LNCaP cells each mitogen increased only CD1 protein expression.	0
1525	@COMPOUND$ and EGF up-regulated cyclinD1 (@PROTEIN$) at both mRNA and protein levels in A549 cells, while in LNCaP cells each mitogen increased only CD1 protein expression.	1
1526	High @COMPOUND$ induced endothelial cell growth inhibition is associated with an increase in @PROTEIN$ secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway.	1
1527	High @COMPOUND$ induced endothelial cell growth inhibition is associated with an increase in TGFbeta1 secretion and inhibition of @PROTEIN$ prenylation via suppression of the mevalonate pathway.	1
1528	The influence of the prenylation status of @PROTEIN$ on the observed changes in endothelial cell growth under high @COMPOUND$ conditions has not previously been examined.	0
1529	Accumulation of @COMPOUND$ in PA was increased by @PROTEIN$ at 10nM and by IGF-I at 1 nM and 10nM.	1
1530	Accumulation of @COMPOUND$ in PA was increased by insulin at 10nM and by @PROTEIN$ at 1 nM and 10nM.	1
1531	It was shown that PAR significantly increased serum ALT, @PROTEIN$, ALP, liver MDA levels and significantly decreased liver @COMPOUND$-Px activity, when compared to the control group (Group 1).	0
1532	It was shown that PAR significantly increased serum ALT, AST, @PROTEIN$, liver MDA levels and significantly decreased liver @COMPOUND$-Px activity, when compared to the control group (Group 1).	0
1533	The activity of guanylyl @PROTEIN$ was determined by the amount of @COMPOUND$ generated in responses to sodium nitroprusside (SNP) or ANP.	1
1534	Immunolocalization of @PROTEIN$ in the boar epididymis: the effect of GnRH agonist @COMPOUND$.	0
1535	E(2) increased the expression of @PROTEIN$ and caveolin-2 mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1
1536	E(2) increased the expression of caveolin-1 and @PROTEIN$ mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1
1537	Phospho-@PROTEIN$ was significantly blocked by @COMPOUND$ or pyrazolopyrimidine 2 (PP2 ; a Src-kinase inhibitor).	1
1538	Phospho-@PROTEIN$ was significantly blocked by ICI 182,780 or @COMPOUND$ 2 (PP2 ; a Src-kinase inhibitor).	1
1539	LY 294002 (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-@COMPOUND$ incorporation.	1
1540	LY 294002 (a PI3K inhibitor) or @COMPOUND$ (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1
1541	@COMPOUND$ (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1
1542	Furthermore, inhibition of caveolin-1 expression using a caveolin-1 siRNA significantly attenuated E(2)-induced up-regulation of proto-oncogenes, @PROTEIN$, ((3)H)-@COMPOUND$ incorporation, overall cell number, and percent of the cell population in S phase, while mediating a concomitant increase in the G0/G1 population.	0
1543	Almost all @PROTEIN$ kinase that translocates to the nucleus shows a marked phosphorylation on @COMPOUND$ 473.	1
1544	During the early response in AR, @COMPOUND$ has been found to be the most abundant mediator and it is associated with many symptoms of this disease mediated through the @PROTEIN$.	1
1545	During the incubation of @COMPOUND$ with para-hydroquinones using @PROTEIN$ as biocatalyst, one or two main products were formed.	1
1546	Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the @COMPOUND$ residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
1547	@COMPOUND$-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
1548	Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of @COMPOUND$ to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
1549	A D-amino acid oxidase gene (dao) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of @PROTEIN$ without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
1550	A D-amino acid oxidase gene (@PROTEIN$) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of DAAO without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
1551	In response to a @COMPOUND$-containing atherogenic diet, C57BL/6J mice significantly increased expression of @PROTEIN$ in the aorta, while mice lacking UCP2, in the absence of any other genetic modification, displayed significant endothelial dysfunction following the atherogenic diet.	1
1552	These data establish that in the vasculature @PROTEIN$ functions as an adaptive antioxidant defense to protect against the development of atherosclerosis in response to a fat and @COMPOUND$ diet.	1
1553	To confirm that mouse @PROTEIN$-PG possesses a single GAG chain attached to Ser (89), we substituted Ser (89) by @COMPOUND$ (89).	1
1554	In analogy to the reduction of @COMPOUND$+) oscillation frequency, the blockers impaired HCEC contraction, NF-kappaB activation, and @PROTEIN$ expression.	1
1555	Cisternal SAH-CSF induces cytosolic @COMPOUND$+) oscillations in HCEC that results in cellular constriction, NF-kappaB activation, and @PROTEIN$ expression.	1
1556	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce @COMPOUND$ from xylose while metabolizing glucose (Cirino et al.	1
1557	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce xylitol from xylose while metabolizing @COMPOUND$ (Cirino et al.	1
1558	Studies in which the expression of CbXR or a @PROTEIN$ was increased suggest that enzyme activity and xylose transport are not limiting @COMPOUND$ production in PC09.	1
1559	For the case of xylose-proton symport, omitting the @PROTEIN$ (glucose-6-phosphate dehydrogenase) or PntAB (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
1560	For the case of xylose-proton symport, omitting the Zwf (glucose-6-phosphate dehydrogenase) or @PROTEIN$ (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
1561	Experimentally, deleting pgi (encoding @PROTEIN$) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1
1562	Experimentally, deleting @PROTEIN$ (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1
1563	Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (@PROTEIN$ and pntA) has no significant effect on the measured yield.	0
1564	Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and @PROTEIN$) has no significant effect on the measured yield.	0
1565	Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1
1566	Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
1567	Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1
1568	Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
1569	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for alkaline phosphatase and @PROTEIN$ polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1570	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for alkaline phosphatase and @PROTEIN$ polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1571	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for @PROTEIN$ and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1572	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for alkaline phosphatase and reverse transcriptase polymerase chain reaction (RT-@PROTEIN$) analysis of pluripotency state markers viz.	0
1573	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for alkaline phosphatase and reverse transcriptase polymerase chain reaction (RT-@PROTEIN$) analysis of pluripotency state markers viz.	0
1574	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for @PROTEIN$ and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1575	Solamargine induces apoptosis and enhances susceptibility to trastuzumab and @COMPOUND$ in breast cancer cells with low or high expression levels of HER2/@PROTEIN$.	0
1576	@COMPOUND$ induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of @PROTEIN$/neu.	0
1577	Solamargine induces apoptosis and enhances susceptibility to trastuzumab and @COMPOUND$ in breast cancer cells with low or high expression levels of @PROTEIN$/neu.	0
1578	@COMPOUND$ induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of HER2/@PROTEIN$.	0
1579	SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0
1580	SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0
1581	SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0
1582	SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0
1583	The effects of @PROTEIN$ were reversed by the mitochondrial KATP blocker, @COMPOUND$, indicating that mitochondrial KATP channels participate in the regulation of astrocyte activation.	1
1584	The aim of this phase 0 study was to investigate whether @COMPOUND$ passes the blood-tumor barrier, and is phosphorylated in the tumor by @PROTEIN$ (dCK) to gemcitabine nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.	1
1585	The aim of this phase 0 study was to investigate whether @COMPOUND$ passes the blood-tumor barrier, and is phosphorylated in the tumor by deoxycytidine kinase (@PROTEIN$) to gemcitabine nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.	1
1586	The @COMPOUND$ mutation at amino acid location 164 significantly reduced the initial hydrolysis of either the @PROTEIN$ in solution or the proteins bound on HAP, which was confirmed by amelogenin oligopeptide assays.	1
1587	In conclusion, dentin mineralization in a corrected @COMPOUND$ and vitamin D environment compensates the adverse effect of @PROTEIN$ mutation.	0
1588	In conclusion, dentin mineralization in a corrected phosphate and @COMPOUND$ environment compensates the adverse effect of @PROTEIN$ mutation.	0
1589	Prolonged L-alanine exposure induces changes in metabolism, @COMPOUND$+) handling and desensitization of @PROTEIN$ secretion in clonal pancreatic beta-cells.	0
1590	Prolonged L-@COMPOUND$ exposure induces changes in metabolism, Ca(2+) handling and desensitization of @PROTEIN$ secretion in clonal pancreatic beta-cells.	1
1591	Collectively, these results illustrate the phenomenon of beta-cell desensitization by amino acids, indicating that prolonged exposure to alanine can induce reversible alterations to metabolic flux, @COMPOUND$+) handling and @PROTEIN$ secretion.	0
1592	Collectively, these results illustrate the phenomenon of beta-cell desensitization by amino acids, indicating that prolonged exposure to @COMPOUND$ can induce reversible alterations to metabolic flux, Ca(2+) handling and @PROTEIN$ secretion.	1
1593	Using a set of experiments aimed at manipulate a putative @COMPOUND$/NMDA/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1
1594	Using a set of experiments aimed at manipulate a putative l-glutamate/@COMPOUND$/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1
1595	Reaction parameters for the production of XOS from corncob using @PROTEIN$ from Aspergillus oryzae MTCC 5154 were optimized and an XOS yield of 10.2+/-0.14 mg ml(-1) corresponding to 81+/-3.9% with 73.5% @COMPOUND$ was obtained.	0
1596	Serum @COMPOUND$ (E2) levels were not altered at any time point after @PROTEIN$, demonstrating that the increased KiSS-1 expression observed was not caused by an elevation in E2.	0
1597	In addition, treatment of primary mouse lung fibroblasts with @COMPOUND$ stimulated @PROTEIN$ activity and collagen formation in vitro.	1
1598	These data support the idea that @COMPOUND$ may play a role in airway diseases, including asthma and pulmonary fibrosis, through NOS inhibition and enhancement of @PROTEIN$ activity.	1
1599	These data support the idea that @COMPOUND$ may play a role in airway diseases, including asthma and pulmonary fibrosis, through @PROTEIN$ inhibition and enhancement of arginase activity.	1
1600	Prostaglandins D2, E2, and F2alpha were increased in the tissues from mouse pups exposed to &gt;95% @COMPOUND$ at 7 d indicating a differential expression of @PROTEIN$ products.	1
1601	@COMPOUND$ replacement to euglycemia causes hypoxia, acidosis, and decreased @PROTEIN$ secretion in fetal sheep with intrauterine growth restriction.	1
1602	@COMPOUND$ stimulated @PROTEIN$ secretion (GSIS) was lower in the Glu group.	1
1603	These data confirm that endogenous miR-34a regulates @PROTEIN$ levels and supports the notion that miR-34a contributes to the effects of @COMPOUND$ and VPA on GRM7.	1
1604	These results confirm the therapeutic potential of @PROTEIN$ blockade on motor symptoms induced by reduced striatal @COMPOUND$ function.	1
1605	Further, they demonstrate that @PROTEIN$ blockade may also have beneficial effects on cognitive deficits induced by @COMPOUND$ depletion.	1
1606	Here, we found that the addition of glucocorticoids, such as dexamethasone and @COMPOUND$, to cultured human keratinocytes increased their @PROTEIN$ gene expression.	1
1607	Here, we found that the addition of glucocorticoids, such as @COMPOUND$ and cortisol, to cultured human keratinocytes increased their @PROTEIN$ gene expression.	1
1608	Gene expression of mitogen-activated protein kinase (@PROTEIN$) phosphatase-1 was also increased by the addition of @COMPOUND$.	1
1609	Achieving CCgR within 12 months and maintaining it without an increase in @PROTEIN$-ABL transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1
1610	Achieving CCgR within 12 months and maintaining it without an increase in BCR-@PROTEIN$ transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1
1611	Rac1 (-/-) platelets displayed defective thrombus formation on collagen under flow conditions which could be fully restored by co-infusion of ADP and the @COMPOUND$) analog U46619, indicating that impaired @PROTEIN$-, but not G-protein signaling, was responsible for the observed defect.	0
1612	@PROTEIN$ (-/-) platelets displayed defective thrombus formation on collagen under flow conditions which could be fully restored by co-infusion of ADP and the @COMPOUND$) analog U46619, indicating that impaired GPVI-, but not G-protein signaling, was responsible for the observed defect.	0
1613	@PROTEIN$ 13910 CC genotype is associated with @COMPOUND$ intolerance, a condition often resulting in reduced milk intake.	1
1614	Use of @PROTEIN$ and fibronectin to influence osteoblast responses to @COMPOUND$ scaffolds.	1
1615	Use of tissue transglutaminase and @PROTEIN$ to influence osteoblast responses to @COMPOUND$ scaffolds.	1
1616	To explore the possibility of controlling cell interaction with biomaterials, @COMPOUND$ scaffolds were modified using the enzyme @PROTEIN$ (tTgase) in conjunction with fibronectin.	1
1617	To explore the possibility of controlling cell interaction with biomaterials, @COMPOUND$ scaffolds were modified using the enzyme tissue transglutaminase (tTgase) in conjunction with @PROTEIN$.	1
1618	@PROTEIN$ (UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase), a three-domain bacterial protein, catalyses a highly specific incorporation of D-glutamate to the cytoplasmic intermediate UDP-N-acetyl-muramoyl-L-alanine (@COMPOUND$) utilizing ATP hydrolysis to ADP and P(i).	1
1619	On the basis of structural studies of @PROTEIN$ complexes, a stepwise catalytic mechanism was proposed that commences with a formation of the acyl-phosphate intermediate, followed by a nucleophilic attack of @COMPOUND$ that, through the formation of a tetrahedral reaction intermediate and subsequent phosphate dissociation, affords the final product, UDP-N-acetyl-muramoyl-L-alanine-D-glutamate (UMAG).	1
1620	Although the overall amino acid identity between @PROTEIN$ and the LeuT(Aa) is only 17%, it increases to above 50% in the first shell of the putative 5-HT binding site, allowing de novo computational docking of @COMPOUND$ derivatives in atomic detail.	0
1621	The antidepressant @COMPOUND$ blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (@PROTEIN$) expression in the hippocampus of rats.	1
1622	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/@COMPOUND$ clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and somatostatin.	0
1623	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/L) @COMPOUND$ clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and somatostatin.	0
1624	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/L) glucose clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and @COMPOUND$.	0
1625	@COMPOUND$+) also induces the release of the pro-apoptotic factors, @PROTEIN$ and AIF.	1
1626	@COMPOUND$+) also induces the release of the pro-apoptotic factors, cytochrome c and @PROTEIN$.	1
1627	Incubation of rat hepatocyte primary cultures with @COMPOUND$+) results in apoptosis induction with caspase activation and increased level of expression of @PROTEIN$.	1
1628	Intravenous @COMPOUND$ enhances @PROTEIN$ activity giving cardioprotection.	1
1629	We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (COX)-2 and heat shock protein (@PROTEIN$) 72, might induce preconditioning.	1
1630	We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (@PROTEIN$)-2 and heat shock protein (HSP) 72, might induce preconditioning.	1
1631	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher @PROTEIN$ content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1632	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, @PROTEIN$, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1633	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and @PROTEIN$ (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1634	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, @PROTEIN$, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1635	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (@PROTEIN$) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1636	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, @PROTEIN$, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1637	Moreover, @COMPOUND$ supplementation significantly increased both basal and @PROTEIN$ stimulated tyrosine phosphorylation of the insulin receptor in skeletal muscle and liver tissues.	0
1638	Moreover, @COMPOUND$ supplementation significantly increased both basal and insulin stimulated tyrosine phosphorylation of the @PROTEIN$ in skeletal muscle and liver tissues.	1
1639	Moreover, taurine supplementation significantly increased both basal and insulin stimulated @COMPOUND$ phosphorylation of the @PROTEIN$ in skeletal muscle and liver tissues.	1
1640	Moreover, taurine supplementation significantly increased both basal and @PROTEIN$ stimulated @COMPOUND$ phosphorylation of the insulin receptor in skeletal muscle and liver tissues.	1
1641	These results indicate that @COMPOUND$ controls glucose homeostasis by regulating the expression of genes required for glucose-stimulated @PROTEIN$ secretion.	1
1642	These results indicate that taurine controls @COMPOUND$ homeostasis by regulating the expression of genes required for glucose-stimulated @PROTEIN$ secretion.	1
1643	In addition, @COMPOUND$ enhances peripheral @PROTEIN$ sensitivity.	1
1644	Amino acids (@COMPOUND$, aspartic acid, glutamic acid) and @PROTEIN$ (GOx) were adsorbed on CNF and the results were compared with those obtained when activated carbon (AC) was used as support.	0
1645	Amino acids (alanine, aspartic acid, glutamic acid) and @PROTEIN$ (GOx) were adsorbed on CNF and the results were compared with those obtained when @COMPOUND$ (AC) was used as support.	0
1646	Amino acids (alanine, @COMPOUND$, glutamic acid) and @PROTEIN$ (GOx) were adsorbed on CNF and the results were compared with those obtained when activated carbon (AC) was used as support.	0
1647	Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of PBR expression may augment HE development.	1
1648	Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of @PROTEIN$ expression may augment HE development.	0
1649	Whereas @COMPOUND$+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0
1650	Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1
1651	Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0
1652	Whereas @COMPOUND$+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1
1653	@COMPOUND$ decreased fasting glucose by 20 % and liver weights by 37 % compared with those in the CLA group; it maintained circulating @PROTEIN$, HOMA1-IR and HOMA1 for beta cell function at levels found in the control group.	1
1654	FSO decreased fasting @COMPOUND$ by 20 % and liver weights by 37 % compared with those in the CLA group; it maintained circulating @PROTEIN$, HOMA1-IR and HOMA1 for beta cell function at levels found in the control group.	0
1655	Animal evidence indicates that green tea may modulate @PROTEIN$ sensitivity, with epigallocatechin-3-gallate (@COMPOUND$) proposed as a likely health-promoting component.	0
1656	Animal evidence indicates that green tea may modulate @PROTEIN$ sensitivity, with @COMPOUND$ (EGCG) proposed as a likely health-promoting component.	0
1657	Animal evidence indicates that @COMPOUND$ may modulate @PROTEIN$ sensitivity, with epigallocatechin-3-gallate (EGCG) proposed as a likely health-promoting component.	0
1658	The purpose of this study was to investigate the effect of dietary supplementation with @COMPOUND$ on @PROTEIN$ resistance and associated metabolic risk factors in man.	1
1659	@COMPOUND$ treatment had no effect on @PROTEIN$ sensitivity, insulin secretion or glucose tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; EGCG-2.68 (se 0.72) mmHg; P = 0.014).	0
1660	EGCG treatment had no effect on @PROTEIN$ sensitivity, insulin secretion or @COMPOUND$ tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; EGCG-2.68 (se 0.72) mmHg; P = 0.014).	0
1661	In conclusion, regular intake of @COMPOUND$ had no effect on @PROTEIN$ resistance but did result in a modest reduction in diastolic blood pressure.	0
1662	Furthermore, @PROTEIN$ overexpression reduced @COMPOUND$ anion generation after H/R, whereas glutathione levels were significantly improved compared with WT controls.	1
1663	Furthermore, @PROTEIN$ overexpression reduced superoxide anion generation after H/R, whereas @COMPOUND$ levels were significantly improved compared with WT controls.	1
1664	We used this model to identify a potent competitive inhibitor, N1,N7-dihexyl-1,7-diamino-4-azaheptane, and to develop an affinity column, 1,16-diamino4,13-diazahexadecane-linked @COMPOUND$, which was useful for the purification of @PROTEIN$.	1
1665	Purification, characterization, and preliminary X-ray diffraction analysis of a @COMPOUND$-specific @PROTEIN$ from Cymbosema roseum seeds.	1
1666	Here, we report the purification, partial primary structure, carbohydrate affinity characterization, crystallization, and preliminary X-ray diffraction analysis of a @COMPOUND$-specific @PROTEIN$ from Cymbosema roseum seeds (CRLII).	1
1667	Associations between the uptake of 111In-@COMPOUND$-trastuzumab, @PROTEIN$ density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.	1
1668	The purpose of the study was to investigate the associations between uptake of (111)In-@COMPOUND$-trastuzumab, tumour @PROTEIN$ density and response to trastuzumab (Herceptin) of human breast cancer (BC) xenografts in athymic mice.	1
1669	The @COMPOUND$ (the final product of ATP hydrolysis by @PROTEIN$), have a recognized neuroprotective actions in the central nervous system (CNS) in pathological conditions.	1
1670	Also, @PROTEIN$ induction and concomitant @COMPOUND$ generation appear to participate in the cytotoxicity of excessive portal pressure after extended hepatectomy.	1
1671	Superoxide dismutase (SOD), @PROTEIN$ (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1672	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), @PROTEIN$ (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1673	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (@PROTEIN$) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1674	Superoxide dismutase (@PROTEIN$), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1675	Superoxide dismutase (SOD), @PROTEIN$ (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1676	@PROTEIN$ (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1677	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (@PROTEIN$) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1678	@PROTEIN$ (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1679	Superoxide dismutase (@PROTEIN$), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1680	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), @PROTEIN$ (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1681	Inhibition of apoptotic signaling and neointimal hyperplasia by @COMPOUND$ and @PROTEIN$ following vascular injury.	1
1682	Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and @PROTEIN$ expression by primary monocytes and macrophage-like THP-1 cell lines.	0
1683	Forced cytoplasmic overexpression of @PROTEIN$ profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1
1684	Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of @PROTEIN$-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1
1685	NO, a gas, is produced from L-@COMPOUND$ by different isoforms of @PROTEIN$ (NOS) and serves many normal physiologic purposes, such as promoting vasodilation of blood vessels and mediating communication between nervous system cells.	1
1686	NO, a gas, is produced from L-@COMPOUND$ by different isoforms of nitric oxide synthase (@PROTEIN$) and serves many normal physiologic purposes, such as promoting vasodilation of blood vessels and mediating communication between nervous system cells.	1
1687	As one of the very few repair systems for oxidized proteins, @PROTEIN$ and MsrB enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive @COMPOUND$ species.	1
1688	As one of the very few repair systems for oxidized proteins, MsrA and @PROTEIN$ enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive @COMPOUND$ species.	1
1689	@PROTEIN$-@COMPOUND$ levels increase with age in American women but not in Hong Kong Chinese women.	1
1690	@PROTEIN$ (HDL) @COMPOUND$ is a powerful cardiovascular risk factor.	1
1691	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of @PROTEIN$, catalase, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0
1692	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and @PROTEIN$, lipid peroxidation along with reduction of superoxide dismutase, catalase, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0
1693	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of superoxide dismutase, @PROTEIN$, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0
1694	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of superoxide dismutase, catalase, @COMPOUND$ content, @PROTEIN$ and succinate dehydrogenase activities.	0
1695	Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, SOD, @PROTEIN$, AcP, AlkP and GRD levels towards near normal.	0
1696	Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, @PROTEIN$, CAT, AcP, AlkP and GRD levels towards near normal.	0
1697	Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, SOD, CAT, @PROTEIN$, AlkP and GRD levels towards near normal.	0
1698	Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, SOD, CAT, AcP, AlkP and @PROTEIN$ levels towards near normal.	0
1699	The interaction of quercetin, which is a @COMPOUND$, with bovine @PROTEIN$ (BSA) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1
1700	The interaction of @COMPOUND$, which is a bioflavonoid, with bovine @PROTEIN$ (BSA) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1
1701	The interaction of quercetin, which is a @COMPOUND$, with bovine serum albumin (@PROTEIN$) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1
1702	The interaction of @COMPOUND$, which is a bioflavonoid, with bovine serum albumin (@PROTEIN$) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1
1703	1x10(-5) mol L(-1)), most of the site marker reacted with the quercetin-@PROTEIN$, but free @COMPOUND$ was present at higher concentrations.	0
1704	Under optimum conditions, the fluorescence intensity of @PROTEIN$-GNPs is linearly proportional to @COMPOUND$ concentration from 6.0x10(-8)mol/L to 8.0x10(-6)mol/L with a detection limit of 1.0x10(-8)mol/L.	1
1705	C18 and C20Gb(3) were, in mixtures without @COMPOUND$ :1Gb(3), dominant negative for @PROTEIN$ vesicle binding.	0
1706	@PROTEIN$/VT1bound C18 and @COMPOUND$ :1Gb(3) mixtures, although neither isoform bound alone.	1
1707	Monolayer surface pressure measurement showed VT1, but not VT2, bound @COMPOUND$) at cellular DRM surface pressures, and confirmed loss of VT1 and @PROTEIN$ (but not VT2) specific C18Gb(3) binding.	0
1708	@PROTEIN$ inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary @COMPOUND$.	0
1709	The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to @COMPOUND$ (CPF) as assessed by measurement of urinary 3,5,6-trichloro-2-pyridinol (TCPy) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1
1710	The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to chlorpyrifos (CPF) as assessed by measurement of urinary 3,5,6-trichloro-2-pyridinol (@COMPOUND$) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1
1711	The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to chlorpyrifos (CPF) as assessed by measurement of urinary @COMPOUND$ (TCPy) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1
1712	A role for @PROTEIN$ in @COMPOUND$-induced fever in Pekin ducks (Anas platyrhynchos): is natriuretic peptide an endogenous antipyretic in birds.	0
1713	We induced fever in Pekin ducks with @COMPOUND$ and, at the same time, treated the animals with @PROTEIN$ antiserum at a dose that effectively inhibited the known renal actions of endogenously secreted natriuretic peptide.	0
1714	The data presented here show that NH4Cl (5 mM) mediates astroglial cell swelling, and that treatment with NH4Cl or @COMPOUND$ (25 mM) causes rearrangements of @PROTEIN$ filaments and reduces astroglial glutamate uptake capacity.	1
1715	Here, we proposed that @PROTEIN$, a vacuolar amino peptidase, is involved in glutathione catabolism under @COMPOUND$ stress.	1
1716	Thus, under cadmium stress, @PROTEIN$ and gamma-glutamyl transferase seem to work together to assure an efficient @COMPOUND$ turnover stored in the vacuole.	1
1717	Thus, under @COMPOUND$ stress, @PROTEIN$ and gamma-glutamyl transferase seem to work together to assure an efficient glutathione turnover stored in the vacuole.	1
1718	In this research, the effects of pH, temperature, and @COMPOUND$ on growth kinetics of a newly isolated strain of Bacillus circulans from the Amazon and their correlations with @PROTEIN$ (TGase) production and cell sporulation were investigated.	1
1719	In this research, the effects of pH, temperature, and @COMPOUND$ on growth kinetics of a newly isolated strain of Bacillus circulans from the Amazon and their correlations with transglutaminase (@PROTEIN$) production and cell sporulation were investigated.	1
1720	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (dopamine-2, @COMPOUND$ type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
1721	No relationships were observed among mercury, @COMPOUND$, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
1722	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (@COMPOUND$-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
1723	No relationships were observed among mercury, @COMPOUND$, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
1724	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (@COMPOUND$-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
1725	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (dopamine-2, @COMPOUND$ type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
1726	No relationships were observed among @COMPOUND$, selenium, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
1727	No relationships were observed among @COMPOUND$, selenium, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
1728	Despite responsive antioxidative defense (increased activities of superoxide dismutase, ascorbate @PROTEIN$, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0
1729	Despite responsive antioxidative defense (increased activities of @PROTEIN$, ascorbate peroxidase, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0
1730	Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of @PROTEIN$ phosphorylation and reactive @COMPOUND$ species generation.	0
1731	In the present study, we showed that selenocystine (SeC), a naturally occurring selenoamino acid, induced caspase-independent apoptosis in MCF-7 breast carcinoma cells, which was accompanied by poly(ADP-ribose) polymerase (@PROTEIN$) cleavage, caspase activation, DNA fragmentation, @COMPOUND$ exposure and nuclear condensation.	0
1732	In the present study, we showed that selenocystine (SeC), a naturally occurring selenoamino acid, induced caspase-independent apoptosis in MCF-7 breast carcinoma cells, which was accompanied by poly(@PROTEIN$-ribose) polymerase (PARP) cleavage, caspase activation, DNA fragmentation, @COMPOUND$ exposure and nuclear condensation.	0
1733	Silencing and attenuating of @PROTEIN$ activation with RNA interference and @COMPOUND$ treatment, respectively, partially suppressed SeC-induced cell apoptosis.	1
1734	Activation of c-@PROTEIN$ N-terminal kinase is essential for oxidative stress-induced Jurkat cell apoptosis by @COMPOUND$.	1
1735	Within 10min of NH(2) Cl treatment, c-Jun N-terminal kinase (@PROTEIN$) activation and elevation of cytosolic @COMPOUND$+) were observed.	0
1736	Within 10min of NH(2) @COMPOUND$ treatment, c-Jun N-terminal kinase (@PROTEIN$) activation and elevation of cytosolic Ca(2+) were observed.	0
1737	Within 10min of NH(2) Cl treatment, c-@PROTEIN$ N-terminal kinase (JNK) activation and elevation of cytosolic @COMPOUND$+) were observed.	0
1738	Within 10min of NH(2) @COMPOUND$ treatment, c-@PROTEIN$ N-terminal kinase (JNK) activation and elevation of cytosolic Ca(2+) were observed.	0
1739	In all cases, the phenotype of SVQ524 was nearly overcome by the addition of @COMPOUND$ or cobalamin to the plant growth media or by the presence of a copy of the @PROTEIN$ gene in cosmid pMUS756.	0
1740	In all cases, the phenotype of SVQ524 was nearly overcome by the addition of methionine or @COMPOUND$ to the plant growth media or by the presence of a copy of the @PROTEIN$ gene in cosmid pMUS756.	0
1741	Inhibition of @PROTEIN$ kinase by @COMPOUND$ : Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.	1
1742	The investigation included simulated docking experiments to fit @COMPOUND$ within the binding pocket of @PROTEIN$ followed by experimental in vitro and in vivo validations.	1
1743	@COMPOUND$ was found to optimally fit within the binding pocket of @PROTEIN$ via several attractive interactions with key amino acids.	1
1744	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1745	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1746	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1747	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1748	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1749	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1750	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1751	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1752	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1753	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1754	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1755	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1756	Studies using 1-@COMPOUND$ (1-MT), the specific inhibitor of IDO, showed that this enzyme is important in @PROTEIN$ (IFN-gamma)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	0
1757	Studies using 1-methyl-tryptophan (@COMPOUND$), the specific inhibitor of IDO, showed that this enzyme is important in interferon-gamma (@PROTEIN$)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
1758	Studies using 1-@COMPOUND$ (1-MT), the specific inhibitor of IDO, showed that this enzyme is important in interferon-gamma (@PROTEIN$)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
1759	Studies using 1-methyl-tryptophan (@COMPOUND$), the specific inhibitor of IDO, showed that this enzyme is important in @PROTEIN$ (IFN-gamma)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
1760	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, Substance P, cannabinoid receptors 1 and 2 (CB(1), CB(2)), and the neuronal activation marker @PROTEIN$ in the least shrew (Cryptotis parva).	0
1761	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, @PROTEIN$, cannabinoid receptors 1 and 2 (CB(1), CB(2)), and the neuronal activation marker Fos in the least shrew (Cryptotis parva).	0
1762	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, Substance P, @PROTEIN$ and 2 (CB(1), CB(2)), and the neuronal activation marker Fos in the least shrew (Cryptotis parva).	0
1763	To observe the inhibitory effects of TSP-1 functional fragments, critical for @PROTEIN$ binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1764	To observe the inhibitory effects of @PROTEIN$ functional fragments, critical for CD36 binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1765	To observe the inhibitory effects of TSP-1 functional fragments, critical for CD36 binding, on the activation of L-@PROTEIN$, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1766	The pERE@PROTEIN$9 vector was delivered to a single MCF-7 using a nanoneedle and the effect of @COMPOUND$, which is an antagonist of estrogen, was observed using the GFP expression level.	0
1767	By @COMPOUND$ treatment, the fluorescence intensity of the @PROTEIN$ was decreased by 30-50% within 24h.	1
1768	Effect of different @PROTEIN$ dosages on cell viability and @COMPOUND$ production by Kluyveromyces marxianus in SSF processes.	1
1769	This study was aimed to study the effect of commercial @PROTEIN$ (Celluclast 1.5 LFG) on Kluyveromyces marxianus CECT 10875 growth and @COMPOUND$ production in SSF processes.	1
1770	Crustacean hyperglycemic hormone (@PROTEIN$) not only plays an important role in the modulation of hemolymph @COMPOUND$ level but also functions in other biological events including molting, reproduction and stress response.	1
1771	@PROTEIN$ (CHH) not only plays an important role in the modulation of hemolymph @COMPOUND$ level but also functions in other biological events including molting, reproduction and stress response.	1
1772	As a proof-of-concept, @PROTEIN$-coated QDs (ConA-QDs) and @COMPOUND$-coated AuNPs (Dex-AuNPs) were used to detect the mannosylated proteins.	0
1773	As a proof-of-concept, Concanavalin A-coated QDs (@PROTEIN$-QDs) and @COMPOUND$-coated AuNPs (Dex-AuNPs) were used to detect the mannosylated proteins.	0
1774	As a result, the PL intensity of QDs was found to be linearly correlated with the concentration and the number of @COMPOUND$ moiety of the @PROTEIN$.	1
1775	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-@COMPOUND$ to l-ornithine and urea.	1
1776	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-arginine to l-ornithine and @COMPOUND$.	1
1777	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-arginine to @COMPOUND$ and urea.	1
1778	To overcome this limitation we turned to the yeast Pichia stipitis, which naturally produces @COMPOUND$, as a source of @PROTEIN$ (Xyl3).	1
1779	We examined the effects of plasmid-based expression of Xyl3 versus @PROTEIN$ on growth and @COMPOUND$ production by engineered E. coli strains.	0
1780	Behavioral and biochemical responses including filtering rates, key phase I, II and antioxidant enzymes and levels of @PROTEIN$, @COMPOUND$, lipid peroxidation and DNA strand breaks were determined in digestive glands of mussels after being exposed to sublethal levels of mercury chloride, methyl mercury, cadmium and Aroclor 1260 during 5 days.	0
1781	If no pretreatment applied, hydrolyses of the textiles by cellulase and @PROTEIN$ for 24 h followed by simultaneous saccharification and fermentation (SSF) in 4 days, resulted in 0.140-0.145 g @COMPOUND$/g textiles, which was 25-26% of the corresponding theoretical yield.	1
1782	If no pretreatment applied, hydrolyses of the textiles by @PROTEIN$ and beta-glucosidase for 24 h followed by simultaneous saccharification and fermentation (SSF) in 4 days, resulted in 0.140-0.145 g @COMPOUND$/g textiles, which was 25-26% of the corresponding theoretical yield.	1
1783	In cystic fibrosis, this equilibrium is disrupted by mutations in the cystic fibrosis transmembrane conductance regulator (@PROTEIN$) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent Cl (-) secretion and predominant @COMPOUND$ (+) absorption.	1
1784	In cystic fibrosis, this equilibrium is disrupted by mutations in the cystic fibrosis transmembrane conductance regulator (@PROTEIN$) gene resulting in the absence of functional CFTR protein, which in turn results in deficient @COMPOUND$-dependent Cl (-) secretion and predominant Na (+) absorption.	1
1785	In cystic fibrosis, this equilibrium is disrupted by mutations in the @PROTEIN$ (CFTR) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent Cl (-) secretion and predominant @COMPOUND$ (+) absorption.	1
1786	In cystic fibrosis, this equilibrium is disrupted by mutations in the @PROTEIN$ (CFTR) gene resulting in the absence of functional CFTR protein, which in turn results in deficient @COMPOUND$-dependent Cl (-) secretion and predominant Na (+) absorption.	1
1787	In cystic fibrosis, this equilibrium is disrupted by mutations in the cystic fibrosis transmembrane conductance regulator (@PROTEIN$) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent @COMPOUND$ (-) secretion and predominant Na (+) absorption.	1
1788	In cystic fibrosis, this equilibrium is disrupted by mutations in the @PROTEIN$ (CFTR) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent @COMPOUND$ (-) secretion and predominant Na (+) absorption.	1
1789	Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the @PROTEIN$, which results in a leucine-to-@COMPOUND$ substitution at codon 173.	1
1790	Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the @PROTEIN$, which results in a @COMPOUND$-to-arginine substitution at codon 173.	1
1791	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood @COMPOUND$ and low @PROTEIN$ cholesterol were not.	0
1792	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood glucose and low @PROTEIN$ @COMPOUND$ were not.	1
1793	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as corticotropin-releasing factor (@PROTEIN$), in the extended amygdala.	1
1794	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as @PROTEIN$ (CRF), in the extended amygdala.	1
1795	Transitions in the @COMPOUND$ microenvironment and secondary structure of two monocot @PROTEIN$ from Sauromatum guttatum and Arisaema tortuosum under different denaturing conditions were studied by steady state and time resolved fluorescence and CD spectroscopy.	0
1796	The @PROTEIN$ exist as tetramers with a single @COMPOUND$ residue estimated per monomer, present in a polar environment.	1
1797	Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M Gdn-@COMPOUND$ or 6 M Urea or at pH 2.0 and below.	1
1798	Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M Gdn-HCl or 6 M @COMPOUND$ or at pH 2.0 and below.	1
1799	Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M @COMPOUND$-HCl or 6 M Urea or at pH 2.0 and below.	1
1800	We examined @COMPOUND$ (1,25(OH)(2)D(3))-induced expression of 25-hydroxyvitamin D(3) 24-hydroxylase (CYP24) and apical calcium channel (@PROTEIN$) mRNA levels in 2-, 9-, and 15-day cultures Caco-2 cells that model proliferating, post-proliferative, and differentiated enterocytes.	1
1801	We examined @COMPOUND$ (1,25(OH)(2)D(3))-induced expression of 25-hydroxyvitamin D(3) 24-hydroxylase (@PROTEIN$) and apical calcium channel (TRPV6) mRNA levels in 2-, 9-, and 15-day cultures Caco-2 cells that model proliferating, post-proliferative, and differentiated enterocytes.	1
1802	Here, we tested the hypothesis that interactions with @PROTEIN$ play a role in the DNA-damaging properties of @COMPOUND$.	0
1803	Next, we selected @COMPOUND$ as the most DNA-damaging Alternaria metabolite for further studies of interactions with @PROTEIN$.	0
1804	Stabilisation of covalent @PROTEIN$ II-DNA intermediates by @COMPOUND$ was also detectable in cell culture, and here, the IIalpha isoform was preferentially targeted.	1
1805	Bone formation and maturation processes were evaluated by double staining for alkaline @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1806	Bone formation and maturation processes were evaluated by double staining for alkaline phosphatase and tartrate-resistant acid phosphatase, immunohistochemistry for bone @PROTEIN$, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1807	Bone formation and maturation processes were evaluated by double staining for @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1808	Phosphorylation of insulin receptor substrate (@PROTEIN$) proteins on @COMPOUND$ residues has emerged as a key step in these control processes under both physiological and pathological conditions.	1
1809	Phosphorylation of @PROTEIN$ substrate (IRS) proteins on @COMPOUND$ residues has emerged as a key step in these control processes under both physiological and pathological conditions.	1
1810	The progressive ankylosis gene (ank) is a @PROTEIN$ that transports intracellular @COMPOUND$ to the extracellular milieu.	1
1811	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to @COMPOUND$-glucose deprivation in murine neonatal organotypic hippocampal slices.	1
1812	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to oxygen-@COMPOUND$ deprivation in murine neonatal organotypic hippocampal slices.	1
1813	The role of tumor necrosis factor (@PROTEIN$) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1
1814	The role of @PROTEIN$ (TNF) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1
1815	Accommodation of @COMPOUND$ and its analogues by @PROTEIN$ is dominated by hydrophobic interactions.	1
1816	The role of the functional architecture of the HuAChE (human @PROTEIN$) in reactivity toward the carbamates pyridostigmine, @COMPOUND$ and several analogues of physostigmine, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	1
1817	The role of the functional architecture of the HuAChE (human @PROTEIN$) in reactivity toward the carbamates pyridostigmine, rivastigmine and several analogues of @COMPOUND$, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	1
1818	The role of the functional architecture of the HuAChE (human @PROTEIN$) in reactivity toward the carbamates @COMPOUND$, rivastigmine and several analogues of physostigmine, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	1
1819	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or @COMPOUND$ red (RuR).	0
1820	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or @COMPOUND$ red (RuR).	0
1821	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or ruthenium red (@COMPOUND$).	0
1822	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), @COMPOUND$ (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (RuR).	0
1823	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (@COMPOUND$).	0
1824	Cells were grown for 24 h with @COMPOUND$ in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or ruthenium red (RuR).	0
1825	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), @COMPOUND$ (L-NAME), @PROTEIN$ (SOD), or ruthenium red (RuR).	0
1826	Cells were grown for 24 h with @COMPOUND$ in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (RuR).	0
1827	Synaptic vesicle-bound @PROTEIN$ can support vesicular @COMPOUND$ uptake.	1
1828	We present evidence that ATP generated by synaptic vesicle-associated @PROTEIN$ is harnessed to transport @COMPOUND$ into synaptic vesicles.	1
1829	However, @COMPOUND$ was equally effective in @PROTEIN$alpha1(-/-) and wild-type animals, suggesting additional AMPK-independent action of phenformin.	0
1830	The relationship between prolactin (@PROTEIN$), leptin, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1831	The relationship between @PROTEIN$ (PRL), leptin, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1832	The relationship between prolactin (PRL), @PROTEIN$, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1833	The aim of this study was to determine the changes in serum @PROTEIN$, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1834	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (@PROTEIN$), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1835	The aim of this study was to determine the changes in serum leptin, @PROTEIN$-alpha (TNF-alpha), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1836	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (@PROTEIN$), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1837	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1838	Differences in the expression of inwardly rectifying potassium channels (Kir4.1), glial fibrillary @PROTEIN$ (GFAP), and @COMPOUND$ levels in cortical astrocytes were detected using immunohistochemical methods.	0
1839	Differences in the expression of inwardly rectifying potassium channels (@PROTEIN$), glial fibrillary acidic protein (GFAP), and @COMPOUND$ levels in cortical astrocytes were detected using immunohistochemical methods.	0
1840	Differences in the expression of inwardly rectifying potassium channels (Kir4.1), glial fibrillary acidic protein (@PROTEIN$), and @COMPOUND$ levels in cortical astrocytes were detected using immunohistochemical methods.	0
1841	Immunohistochemical analysis suggests that the diverse expression of @PROTEIN$ channels and GFAP as well as differences in the accumulation of @COMPOUND$ might contribute to the distinct ability of astrocytes to regulate their volume.	0
1842	Immunohistochemical analysis suggests that the diverse expression of Kir4.1 channels and @PROTEIN$ as well as differences in the accumulation of @COMPOUND$ might contribute to the distinct ability of astrocytes to regulate their volume.	0
1843	Regulation of the phosphoinositide-3 kinase and @PROTEIN$ signaling pathways by @COMPOUND$ and its reduced metabolites in the rat brain.	1
1844	Several growth factors, such as vascular endothelial growth factor, @PROTEIN$, and insulin-like growth factor-I are involved in the actions of @COMPOUND$ in the central nervous system.	1
1845	Several growth factors, such as vascular endothelial growth factor, brain-derived neurotrophic factor, and @PROTEIN$-like growth factor-I are involved in the actions of @COMPOUND$ in the central nervous system.	1
1846	Significant increases in the phosphorylation of @PROTEIN$, in the expression of the catalytic (p110) and the regulatory (p85) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1847	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (@PROTEIN$) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1848	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (@PROTEIN$) and the regulatory (p85) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1849	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (p85) subunits of PI3K and in the phosphorylation of @PROTEIN$ were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1850	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (p85) subunits of @PROTEIN$ and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1851	In addition, we used PET to evaluate the striatal dopamine transporter availability (@PROTEIN$) with ((11)C)d-threo-@COMPOUND$ in the patient group.	1
1852	Associated with the mitochondrial permeabilization, PdC also induced the release of @PROTEIN$, which is sensitive to inhibition by @COMPOUND$.	1
1853	Toll-like receptor 4 (@PROTEIN$-4)/myeloid differentiation protein-2 complex ligation by @COMPOUND$ induces production of pro-inflammatory cytokines and co-stimulatory molecules on antigen presenting cells.	1
1854	Toll-like receptor 4 (TLR-4)/myeloid differentiation @PROTEIN$ complex ligation by @COMPOUND$ induces production of pro-inflammatory cytokines and co-stimulatory molecules on antigen presenting cells.	1
1855	Immunohistochemistry was performed on paraffin-embedded sections, using anti-@COMPOUND$ (5mc) and anti-Acetyl-@PROTEIN$ (Lys 9).	0
1856	Here, the @PROTEIN$-mediated (45)Ca(2+) uptake was compared in @COMPOUND$ (+)-loaded pig coronary artery smooth muscle and endothelial cells.	0
1857	The concept of a linkage between NCX and SERCA in smooth muscle was also confirmed by similar distribution of NCX and @PROTEIN$ proteins when detergent-treated microsomes were fractionated by flotation on @COMPOUND$ density gradients.	0
1858	The concept of a linkage between @PROTEIN$ and SERCA in smooth muscle was also confirmed by similar distribution of NCX and SERCA2 proteins when detergent-treated microsomes were fractionated by flotation on @COMPOUND$ density gradients.	0
1859	The recent approval of sunitinib, sorafenib, @COMPOUND$ and bevacizumab in combination with @PROTEIN$ has revolutionized the management of renal cell carcinoma.	0
1860	The recent approval of sunitinib, @COMPOUND$, temsirolimus and bevacizumab in combination with @PROTEIN$ has revolutionized the management of renal cell carcinoma.	0
1861	The recent approval of @COMPOUND$, sorafenib, temsirolimus and bevacizumab in combination with @PROTEIN$ has revolutionized the management of renal cell carcinoma.	0
1862	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, p300, and @PROTEIN$.	1
1863	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: @PROTEIN$, p300, and CREB-binding protein.	1
1864	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, @PROTEIN$, and CREB-binding protein.	1
1865	@PROTEIN$ was able to perform autopropionylation on @COMPOUND$ residues in cells.	1
1866	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (@PROTEIN$, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1867	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, @PROTEIN$, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1868	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (@PROTEIN$ and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1869	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) @PROTEIN$ in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1870	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and @PROTEIN$) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1871	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (@PROTEIN$) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	0
1872	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon @PROTEIN$ (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	0
1873	In @PROTEIN$-D patients, plasma triglycerides, apolipoprotein B-48 (apoB-48), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0
1874	In CD36-D patients, plasma triglycerides, apolipoprotein B-48 (@PROTEIN$), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0
1875	In CD36-D patients, plasma triglycerides, @PROTEIN$ (apoB-48), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0
1876	Identification of @PROTEIN$ as a candidate gene for regulation of responsiveness to dietary @COMPOUND$ in rats.	1
1877	Here we narrowed Dihc2 to a region including 33 genes and predicted transcripts and identified RGD1309450_predicted, a homologous gene of @PROTEIN$, as a strong candidate for responsiveness to dietary @COMPOUND$.	1
1878	@COMPOUND$ is a strong correlate of @PROTEIN$ levels in men and postmenopausal women.	1
1879	Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% @COMPOUND$ at 140 degrees C for 30 min and enzymatic hydrolysis with cellulase (15 filter per unit (FPU)/g cellulose) and @PROTEIN$ (50 cellobiose units (CBU)/g cellulose).	0
1880	Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% @COMPOUND$ at 140 degrees C for 30 min and enzymatic hydrolysis with @PROTEIN$ (15 filter per unit (FPU)/g cellulose) and beta-glucosidase (50 cellobiose units (CBU)/g cellulose).	0
1881	@COMPOUND$ (GSH), catalase (@PROTEIN$), and malondialdehyde (MDA) activities in blood were measured.	0
1882	Glutathione (@COMPOUND$), catalase (@PROTEIN$), and malondialdehyde (MDA) activities in blood were measured.	0
1883	Glutathione (GSH), catalase (@PROTEIN$), and @COMPOUND$ (MDA) activities in blood were measured.	0
1884	Glutathione (@COMPOUND$), @PROTEIN$ (CAT), and malondialdehyde (MDA) activities in blood were measured.	0
1885	Glutathione (GSH), @PROTEIN$ (CAT), and @COMPOUND$ (MDA) activities in blood were measured.	0
1886	@COMPOUND$ (GSH), @PROTEIN$ (CAT), and malondialdehyde (MDA) activities in blood were measured.	0
1887	Catalase, myeloperoxidase (@PROTEIN$), glutathione peroxidase (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
1888	Catalase, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), @PROTEIN$ (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
1889	@PROTEIN$, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
1890	Catalase, myeloperoxidase (MPO), @PROTEIN$ (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
1891	Catalase, myeloperoxidase (MPO), @PROTEIN$ (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
1892	@PROTEIN$, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
1893	Catalase, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), @PROTEIN$ (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
1894	Catalase, myeloperoxidase (@PROTEIN$), glutathione peroxidase (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
1895	In this study we examined the possible antigenotoxic effect of selenium (Se) in rats chronically exposed to low levels of @COMPOUND$ (MeHg) and the association between @PROTEIN$ (GSH-Px) activity and DNA lesions (via comet assay) in the same exposed animals.	0
1896	In this study we examined the possible antigenotoxic effect of selenium (Se) in rats chronically exposed to low levels of methylmercury (@COMPOUND$) and the association between @PROTEIN$ (GSH-Px) activity and DNA lesions (via comet assay) in the same exposed animals.	0
1897	H2S can be produced from @COMPOUND$ by enzymes such as @PROTEIN$.	1
1898	The influence of carbon sources on rhGH (recombinant human @PROTEIN$) production by two Pichia pastoris strains having different @COMPOUND$ utilization phenotypes (P. pastoris-hGH-Mut (+) and P. pastoris-hGH-Mut (s)) was investigated using batch bioreactors.	0
1899	Insulin-like growth factor-I (@PROTEIN$) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1
1900	@PROTEIN$-like growth factor-I (IGF-I) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1
1901	These data indicate that @PROTEIN$ may be a potential treatment for some of @COMPOUND$'s damaging effects, a finding that has important implications for children of women who drink alcohol during pregnancy.	1
1902	This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of @PROTEIN$ (COX-2) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
1903	This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of cyclooxygenase-2 (@PROTEIN$) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
1904	This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (@PROTEIN$) in cultured murine macrophage cell line RAW 264.7.	1
1905	This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible @PROTEIN$ (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
1906	This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of cyclooxygenase-2 (@PROTEIN$) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
1907	This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (@PROTEIN$) in cultured murine macrophage cell line RAW 264.7.	1
1908	This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible @PROTEIN$ (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
1909	This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of @PROTEIN$ (COX-2) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
1910	SWCNT coatings were thus functionalized with poly(@COMPOUND$-pyrrole) and applied to the anchoring of glucose oxidase (@PROTEIN$), modified with beta-cyclodextrin.	1
1911	SWCNT coatings were thus functionalized with poly(@COMPOUND$-pyrrole) and applied to the anchoring of @PROTEIN$ (GOX), modified with beta-cyclodextrin.	1
1912	This allows the immobilization of @COMPOUND$-tagged @PROTEIN$.	1
1913	@COMPOUND$-induced bone @PROTEIN$ (BMP) 2 expression during bone regeneration: an immunohistochemical study.	1
1914	@COMPOUND$-induced bone morphogenetic protein (@PROTEIN$) 2 expression during bone regeneration: an immunohistochemical study.	1
1915	The purpose of this study was to investigate bone morphogenetic protein (BMP) 2 expression after implantation of a @COMPOUND$ and recombinant human @PROTEIN$ (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1916	The purpose of this study was to investigate bone @PROTEIN$ (BMP) 2 expression after implantation of a @COMPOUND$ and recombinant human BMP-2 (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1917	The purpose of this study was to investigate bone morphogenetic protein (@PROTEIN$) 2 expression after implantation of a @COMPOUND$ and recombinant human BMP-2 (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1918	Although we reported that 8-Cl-cAMP induces growth inhibition via p38 mitogen-activated protein kinase (@PROTEIN$) and a metabolite of 8-Cl-cAMP, 8-Cl-@COMPOUND$ mediates this process, the action mechanism of 8-Cl-cAMP is still uncertain.	1
1919	Certain non-steroidal anti-inflammatory drugs, e.g., the @PROTEIN$-specific nonsteroidal anti-inflammatory drugs, @COMPOUND$, raise Abeta(42) levels.	1
1920	@COMPOUND$, @PROTEIN$ and CRP as markers of silent brain infarction.	0
1921	@COMPOUND$, IL-6 and @PROTEIN$ as markers of silent brain infarction.	0
1922	We found previously that increased levels of polyamine oxidase (PAO) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (@PROTEIN$)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
1923	We found previously that increased levels of polyamine oxidase (@PROTEIN$) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
1924	We found previously that increased levels of @PROTEIN$ (PAO) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
1925	We found previously that increased levels of polyamine oxidase (PAO) (acetylpolyamine oxidase (AcPAO) plus @PROTEIN$ (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
1926	We then investigated whether silent brain infarction (SBI) can be detected by measuring @COMPOUND$, @PROTEIN$, or other biomarkers.	0
1927	It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), @PROTEIN$ (IL-6) and C-reactive protein (CRP) were significantly higher in SBI than in normal subjects.	0
1928	It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), interleukin-6 (@PROTEIN$) and C-reactive protein (CRP) were significantly higher in SBI than in normal subjects.	0
1929	It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), interleukin-6 (IL-6) and C-reactive protein (@PROTEIN$) were significantly higher in SBI than in normal subjects.	0
1930	Human skin keratinocytes HaCat attacked by Staphylococcus aureus @PROTEIN$ showed a transient drop of cellular @COMPOUND$ levels whereas in toxin-perforated bovine mammary epithelial cells (BMEC), the ATP levels dropped more slowly.	1
1931	The characterization for the binding of calcium and @COMPOUND$ to Euplotes octocarinatus @PROTEIN$.	1
1932	Alkaline phosphatase activity and @PROTEIN$ expression of the osteoblasts cultured on the @COMPOUND$ scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	0
1933	@PROTEIN$ activity and osteonectin expression of the osteoblasts cultured on the @COMPOUND$ scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	0
1934	The @PROTEIN$ activity of osteoblasts cultured on @COMPOUND$ scaffolds is comparable with that from two commercially-available scaffolds-OPLA and collagen scaffolds (Becton-Dickinson (BD) Inc., Franklin Lakes, NJ, USA).	0
1935	@PROTEIN$ and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to rapamycin and @COMPOUND$.	1
1936	P27 and @PROTEIN$ play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to @COMPOUND$ and paclitaxel.	1
1937	@PROTEIN$ and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to @COMPOUND$ and paclitaxel.	1
1938	P27 and @PROTEIN$ play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to rapamycin and @COMPOUND$.	1
1939	Involvement of @PROTEIN$ in TPA-potentiated apoptosis induction during @COMPOUND$-mediated erythroid differentiation in K562 cells.	0
1940	To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied the effects of @PROTEIN$ pathway with an activator of the protein kinase C, 12-O-tetradecanoylphorbol-13-acetate (TPA), during @COMPOUND$-induced erythroid differentiation of K562 erythroleukemia cells.	0
1941	To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied the effects of @PROTEIN$ pathway with an activator of the protein kinase C, @COMPOUND$ (TPA), during hemin-induced erythroid differentiation of K562 erythroleukemia cells.	1
1942	Taken together, our results suggested the involvement of @PROTEIN$ in TPA-potentiated apoptosis induction during @COMPOUND$-mediated erythroid differentiation in K562 cells.	0
1943	At glutamatergic synapses, increased binding to the @COMPOUND$-B site located in the @PROTEIN$ (NMDAR) can enhance neurotransmission via NMDARs.	1
1944	The most common adverse events were mild and transient gastrointestinal disturbances, skin rash, nonprogressive transient increases in serum @COMPOUND$ and urine @PROTEIN$, and a temporary reduction of the creatinine clearance.	0
1945	Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-@COMPOUND$) structures and their characterization for @PROTEIN$-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces.	1
1946	Chemo-enzymatic synthesis of @COMPOUND$ (poly-LacNAc) structures and their characterization for CGL2-@PROTEIN$-mediated binding of ECM glycoproteins to biomaterial surfaces.	1
1947	Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-@COMPOUND$) structures and their characterization for CGL2-@PROTEIN$-mediated binding of ECM glycoproteins to biomaterial surfaces.	1
1948	Chemo-enzymatic synthesis of @COMPOUND$ (poly-LacNAc) structures and their characterization for @PROTEIN$-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces.	1
1949	Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-@COMPOUND$) structures and their characterization for CGL2-galectin-mediated binding of ECM @PROTEIN$ to biomaterial surfaces.	1
1950	Chemo-enzymatic synthesis of @COMPOUND$ (poly-LacNAc) structures and their characterization for CGL2-galectin-mediated binding of ECM @PROTEIN$ to biomaterial surfaces.	1
1951	@COMPOUND$ (poly-LacNAc) structures have been identified as important ligands for @PROTEIN$-mediated cell adhesion to extra-cellular matrix (ECM) proteins.	1
1952	Poly-N-acetyllactosamine (poly-@COMPOUND$) structures have been identified as important ligands for @PROTEIN$-mediated cell adhesion to extra-cellular matrix (ECM) proteins.	1
1953	We here present the biofunctionalization of surfaces with poly-@COMPOUND$ structures and subsequent binding of ECM @PROTEIN$.	1
1954	A mixture of poly-@COMPOUND$-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model galectin His(6) @PROTEIN$.	1
1955	A mixture of poly-@COMPOUND$-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model @PROTEIN$ His(6) CGL2.	1
1956	We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further @PROTEIN$-mediated binding of the ECM glycoproteins laminin and fibronectin.	1
1957	We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further galectin-mediated binding of the ECM glycoproteins laminin and @PROTEIN$.	1
1958	We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further galectin-mediated binding of the ECM @PROTEIN$ laminin and fibronectin.	1
1959	We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further galectin-mediated binding of the @PROTEIN$ glycoproteins laminin and fibronectin.	1
1960	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1961	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1962	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1963	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1964	These transcripts were predicted to synthesis of @PROTEIN$ proteins truncated of the binding site for @COMPOUND$, an essential cofactor, therefore cannot function as a decarboxylase.	1
1965	Loss-of-expression of @PROTEIN$ in tumor tissues has been suggested to correlate with tumor progression and to the relatively poorer outcomes of @COMPOUND$ analog treatment in some clinical trials.	1
1966	@COMPOUND$ (CVF) is a structural and functional analog of @PROTEIN$ isolated from cobra venom.	1
1967	Activities of malate- and succinate-dehydrogenases (MDH, @PROTEIN$) and NADH- and succinate-cytochrome c reductases (NCCR, SCCR) were rapidly inhibited, while cytochrome c oxidase (CCO) was unaltered by @COMPOUND$ treatment.	1
1968	Activities of malate- and succinate-dehydrogenases (@PROTEIN$, SDH) and NADH- and succinate-cytochrome c reductases (NCCR, SCCR) were rapidly inhibited, while cytochrome c oxidase (CCO) was unaltered by @COMPOUND$ treatment.	1
1969	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, @PROTEIN$ (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1970	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (@PROTEIN$, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1971	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (@PROTEIN$), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1972	This paper investigates the effect of sterilisation by gamma irradiation (dose 2.5Mrad) on the following properties of @COMPOUND$ (PCL): (1) degradation rate (catalysed by @PROTEIN$), (2) mechanical properties, (3) the ability of cells to attach and subsequently grow on its surface.	1
1973	Specifically, animals were exposed to one of five dipsetic stimuli: (1) 24-h water deprivation, (2) replacement of drinking water with 2.5% @COMPOUND$, (3) peripheral administration of hypertonic saline, (4) ICV injection of angiotensin II (@PROTEIN$), or (5) the combination of peripheral hypertonic saline and central AngII.	0
1974	Specifically, animals were exposed to one of five dipsetic stimuli: (1) 24-h water deprivation, (2) replacement of drinking water with 2.5% @COMPOUND$, (3) peripheral administration of hypertonic saline, (4) ICV injection of @PROTEIN$ (AngII), or (5) the combination of peripheral hypertonic saline and central AngII.	0
1975	We therefore propose @COMPOUND$-dependent homodimerization to be an essential step in the regulation of @PROTEIN$-dependent transcription.	1
1976	In order to investigate the role of spinal @PROTEIN$ in the phenomenon of @COMPOUND$-precipitated withdrawal we examined the effect of herpes simplex virus vector-mediated overexpression of proenkephalin in lumbar dorsal root ganglia in rats with neuropathic pain treated with morphine.	1
1977	The @PROTEIN$ were isolated by @COMPOUND$ treatment of crude extracts followed by chromatography on chitin.	1
1978	The @PROTEIN$-deficient mouse, which develops atherosclerotic lesions rapidly when fed @COMPOUND$, was used to determine the ability of dried plums to reduce atherosclerosis.	0
1979	Urinary @COMPOUND$-reactive substances (TBARS) excretion and serum amyloid P-component (@PROTEIN$) were measured as indicators of oxidative stress and inflammation, respectively.	0
1980	Urinary @COMPOUND$-reactive substances (TBARS) excretion and @PROTEIN$ (SAP) were measured as indicators of oxidative stress and inflammation, respectively.	0
1981	Inhibition in the brain is dominated by the neurotransmitter @COMPOUND$ (GABA); operating through @PROTEIN$.	1
1982	Inhibition in the brain is dominated by the neurotransmitter gamma-aminobutyric acid (@COMPOUND$); operating through @PROTEIN$.	1
1983	Thus, in keeping with the ability of neurosteroids to potentiate @COMPOUND$ currents via a broad variety of @PROTEIN$ isoforms in neurons, the potentiation site is structurally highly conserved on this important neurotransmitter receptor family.	1
1984	The 5-HT2AR response dominated the @PROTEIN$ signaling pathway when co-expressed with 5-HT1AR, and diminution of the response by the 5-HT2AR antagonist @COMPOUND$ could not be rescued by the 5-HT1AR agonist.	1
1985	The inhibitors include mitogen-inducible gene-6 (@PROTEIN$)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1986	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (@PROTEIN$).	0
1987	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/@PROTEIN$/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1988	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/@PROTEIN$, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1989	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, @PROTEIN$ (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1990	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (@PROTEIN$)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1991	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/@PROTEIN$, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1992	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/@PROTEIN$ (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1993	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (@PROTEIN$)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1994	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (@PROTEIN$)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1995	Novel homo- and hetero-nuclear @COMPOUND$ (II) complexes of tetradentate Schiff bases: synthesis, characterization, solvent-extraction and @PROTEIN$-like activity studies.	1
1996	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the hemoglobin A (1c), non-fasting plasma @PROTEIN$, fasting blood @COMPOUND$ levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total cholesterol) with neutral effect on body weight.	0
1997	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the @PROTEIN$ (1c), non-fasting plasma insulin, fasting blood @COMPOUND$ levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total cholesterol) with neutral effect on body weight.	0
1998	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the @PROTEIN$ (1c), non-fasting plasma insulin, fasting blood glucose levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total @COMPOUND$) with neutral effect on body weight.	0
1999	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the hemoglobin A (1c), non-fasting plasma @PROTEIN$, fasting blood glucose levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total @COMPOUND$) with neutral effect on body weight.	0
2000	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, PO4 4.4+/-1.3 mg/dL, alkaline phosphatase (@PROTEIN$) 1,341+/-823, @COMPOUND$ (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0
2001	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, PO4 4.4+/-1.3 mg/dL, @PROTEIN$ (ALP) 1,341+/-823, @COMPOUND$ (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0
2002	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, @COMPOUND$ 4.4+/-1.3 mg/dL, alkaline phosphatase (@PROTEIN$) 1,341+/-823, 25-hydroxyvitamin D (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0
2003	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, @COMPOUND$ 4.4+/-1.3 mg/dL, @PROTEIN$ (ALP) 1,341+/-823, 25-hydroxyvitamin D (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0
2004	There are no controlled trials comparing @PROTEIN$ and @COMPOUND$ efficacy and therapeutic mechanisms in psoriasis.	0
2005	Inhibition of human poly(A)-specific @PROTEIN$ (PARN) by @COMPOUND$ nucleotides: kinetic analysis.	1
2006	Inhibition of human poly(A)-specific ribonuclease (@PROTEIN$) by @COMPOUND$ nucleotides: kinetic analysis.	1
2007	The aqueous extract was found to be more effective than @COMPOUND$, a classical anticarcinogenic drug, with respect to its action on antioxidant enzymes and @PROTEIN$ in the liver of mice with developing lymphomas.	1
2008	The picture of signalling mechanisms underlying the wound-regulated FAD7 expression, and potential roles of @PROTEIN$ proteins as attenuators of wound-induced @COMPOUND$ biosynthesis, are discussed.	0
2009	The picture of signalling mechanisms underlying the wound-regulated @PROTEIN$ expression, and potential roles of CPL proteins as attenuators of wound-induced @COMPOUND$ biosynthesis, are discussed.	0
2010	KiSS-1 mRNA was significantly increased by seizure activity in rats and when neuronal activity in organotypic hippocampal slice cultures was enhanced by kainate or @COMPOUND$, while mRNA for @PROTEIN$ remained essentially unchanged.	0
2011	KiSS-1 mRNA was significantly increased by seizure activity in rats and when neuronal activity in organotypic hippocampal slice cultures was enhanced by @COMPOUND$ or picrotoxin, while mRNA for @PROTEIN$ remained essentially unchanged.	0
2012	The dominant positive regulator of mTORC1 is the @COMPOUND$-charged form of the @PROTEIN$-like GTPase Rheb.	1
2013	The dominant positive regulator of mTORC1 is the @COMPOUND$-charged form of the ras-like GTPase @PROTEIN$.	1
2014	In contrast, amino acids, especially leucine, regulate mTORC1 by controlling the ability of @PROTEIN$-@COMPOUND$ to activate mTORC1.	1
2015	@COMPOUND$, hematocrit, blood urea nitrogen, total protein, albumin, @PROTEIN$ 0.05) after transport regardless of space allowance.	0
2016	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-@PROTEIN$) positive and annexin V negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0
2017	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-AAD) positive and @PROTEIN$ negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0
2018	Methylene@COMPOUND$ dehydrogenase) @PROTEIN$) formyltetrahydrofolate synthetase (MTHFD1) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1
2019	Methylene@COMPOUND$ dehydrogenase) methenyltetrahydrofolate cyclohydrolase) formyltetrahydrofolate synthetase (@PROTEIN$) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1
2020	Methylene@COMPOUND$ dehydrogenase) methenyltetrahydrofolate cyclohydrolase) @PROTEIN$ (MTHFD1) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1
2021	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and @PROTEIN$ genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
2022	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, @PROTEIN$, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
2023	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of @PROTEIN$ and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	1
2024	An oncogenetic tree model was built using data on mutations of TP53, @PROTEIN$, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
2025	An oncogenetic tree model was built using data on mutations of @PROTEIN$, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
2026	We characterized this selenoprotein @PROTEIN$ which had a single Sec residue at the catalytic site but no @COMPOUND$ (Cys) residues in the protein sequence.	0
2027	Zn2+-linked dimerization of @PROTEIN$ from Helicobacter pylori, a chaperone involved in @COMPOUND$ trafficking and urease activation.	1
2028	Zn2+-linked dimerization of UreG from Helicobacter pylori, a chaperone involved in @COMPOUND$ trafficking and @PROTEIN$ activation.	0
2029	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a @COMPOUND$-carbamate functional group concomitantly with the delivery of two Ni(2+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1
2030	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a lysine-carbamate functional group concomitantly with the delivery of two @COMPOUND$+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1
2031	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a lysine-@COMPOUND$ functional group concomitantly with the delivery of two Ni(2+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1
2032	Residue-wise conformational stability of @PROTEIN$ dimer from native-state @COMPOUND$ exchange.	1
2033	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and @PROTEIN$ did not change significantly.	0
2034	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, @PROTEIN$ saturation and ferritin did not change significantly.	0
2035	Total antioxidant capacity, @PROTEIN$, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and ferritin did not change significantly.	0
2036	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, @PROTEIN$, transferrin saturation and ferritin did not change significantly.	0
2037	LH, FSH, 17 @COMPOUND$, progesterone, aldosterone and @PROTEIN$ were assayed at the seventh, fourteenth, twenty-first and twenty-eighth days of the cycle after 30 min of recumbency.	0
2038	LH, FSH, 17 beta-estradiol, @COMPOUND$, aldosterone and @PROTEIN$ were assayed at the seventh, fourteenth, twenty-first and twenty-eighth days of the cycle after 30 min of recumbency.	0
2039	Aldosterone was positively related to @PROTEIN$ and @COMPOUND$.	0
2040	Quinone formation is closely linked to other representative hypotheses such as mitochondrial dysfunction, inflammation, oxidative stress, and dysfunction of the @PROTEIN$-proteasome system, in the pathogenesis of neurodegenerative diseases such as Parkinson's disease and @COMPOUND$-induced neurotoxicity.	0
2041	The effect of @COMPOUND$ exposure on birds was examined by measuring aerobic metabolism, blood hemoglobin content, plasma @PROTEIN$, and body weight for up to 21 d postdose.	1
2042	The effect of @COMPOUND$ exposure on birds was examined by measuring aerobic metabolism, blood @PROTEIN$ content, plasma cholinesterases, and body weight for up to 21 d postdose.	1
2043	These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of @COMPOUND$-dependent @PROTEIN$ secretion, suppression of glucagon secretion, slowing of gastric emptying, and reduction of food intake.	1
2044	These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of @COMPOUND$-dependent insulin secretion, suppression of @PROTEIN$ secretion, slowing of gastric emptying, and reduction of food intake.	0
2045	Induction of the spliced form of @PROTEIN$ as well as total XBP1 by @COMPOUND$ was significantly attenuated in patients with BD.	1
2046	Induction of @PROTEIN$ by @COMPOUND$ was also decreased in the BD group.	1
2047	Efforts in the field of synthetic vaccine carriers are focussing on decorating the particle surface with ligands for DC receptors such as heparan @COMPOUND$ glycosaminoglycan structures, integrins, Siglecs, ga@PROTEIN$, C-type lectins and toll-like receptors.	0
2048	Efforts in the field of synthetic vaccine carriers are focussing on decorating the particle surface with ligands for DC receptors such as heparan @COMPOUND$ glycosaminoglycan structures, integrins, Siglecs, @PROTEIN$, C-type lectins and toll-like receptors.	0
2049	Reversal of the inhibitory effect of @COMPOUND$ on @PROTEIN$ generation by rFVIIa, aPCC and PCC.	1
2050	Reversal of the inhibitory effect of fondaparinux on @PROTEIN$ generation by rFVIIa, a@COMPOUND$ and PCC.	1
2051	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	1
2052	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2053	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2054	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
2055	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1
2056	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2057	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
2058	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2059	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1
2060	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
2061	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2062	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2063	These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to @PROTEIN$ activation, which is regulated, in part, by PKC-delta and AR.	1
2064	These results indicate that @COMPOUND$-induced @PROTEIN$ shedding could be attributed to TACE activation, which is regulated, in part, by PKC-delta and AR.	1
2065	These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to TACE activation, which is regulated, in part, by @PROTEIN$ and AR.	0
2066	We conclude that gastrocnemius, heart, and liver mitochondria of streptozotocin diabetic rats are not irrevocably altered toward excess @COMPOUND$ production either by @PROTEIN$ or complex III.	1
2067	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA @PROTEIN$ (MGMT).	1
2068	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA methyltransferase (@PROTEIN$).	1
2069	Radioisotopic localization of (90) @COMPOUND$-ibritumomab tiuxetan in patients with @PROTEIN$+ non-Hodgkin's lymphoma.	1
2070	Effect of obestatin on insulin, @PROTEIN$ and @COMPOUND$ secretion in the perfused rat pancreas.	0
2071	Effect of @PROTEIN$ on insulin, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	1
2072	Effect of obestatin on @PROTEIN$, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	0
2073	The potentiated effect of obestatin on @COMPOUND$-induced @PROTEIN$ output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
2074	The potentiated effect of @PROTEIN$ on @COMPOUND$-induced insulin output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
2075	The potentiated effect of obestatin on glucose-induced @PROTEIN$ output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
2076	The potentiated effect of @PROTEIN$ on glucose-induced insulin output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
2077	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (@COMPOUND$ (+), K(+), Cl (-)) contents, immunostained for albumin and glial fibrillary @PROTEIN$ (GFAP), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
2078	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (@COMPOUND$ (+), K(+), Cl (-)) contents, immunostained for albumin and glial fibrillary acidic protein (@PROTEIN$), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
2079	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (Na (+), K(+), @COMPOUND$ (-)) contents, immunostained for albumin and glial fibrillary acidic protein (@PROTEIN$), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
2080	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (Na (+), K(+), @COMPOUND$ (-)) contents, immunostained for albumin and glial fibrillary @PROTEIN$ (GFAP), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
2081	The Arg105 in @PROTEIN$ is highly conserved across species and its replacement with @COMPOUND$ is predicted to be pathogenic.	1
2082	0.05 vs. aortic IR) plasma levels of @COMPOUND$, P-selectin, intercellular adhesion molecule-1 (ICAM-I), and tissue levels of malondialdehyde and @PROTEIN$.	0
2083	Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of @PROTEIN$ or NPC2 proteins, leading to an accumulation of unesterified @COMPOUND$ and glycosphingolipids (GSLs) in the lysosomes.	1
2084	Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of NPC1 or @PROTEIN$ proteins, leading to an accumulation of unesterified @COMPOUND$ and glycosphingolipids (GSLs) in the lysosomes.	1
2085	The relative gene expression of @PROTEIN$ 0.05) in-@COMPOUND$ calves compared with+ Cu or-Cu+Mn calves.	1
2086	Effects of a flaxseed-derived @COMPOUND$ supplement on C-reactive protein, @PROTEIN$ and retinol-binding protein 4 in type 2 diabetic patients.	1
2087	Effects of a flaxseed-derived @COMPOUND$ supplement on C-reactive protein, IL-6 and retinol-binding @PROTEIN$ in type 2 diabetic patients.	1
2088	The present study explored the effects of flaxseed-derived @COMPOUND$ on inflammatory factors and @PROTEIN$ concentrations in type 2 diabetics, who have higher levels of these biomarkers.	1
2089	No between-treatment differences were found with regard to IL-6 or @PROTEIN$ ; though IL-6 0.001 following @COMPOUND$ and placebo treatments, respectively).	0
2090	No between-treatment differences were found with regard to @PROTEIN$ or RBP4 ; though IL-6 0.001 following @COMPOUND$ and placebo treatments, respectively).	0
2091	Polymorphism in the @PROTEIN$ gene, plasma lipoprotein(a), cardiovascular disease, and low-dose @COMPOUND$ therapy.	0
2092	We investigated whether this allele was associated with elevated @PROTEIN$ and cardiovascular risk in the Women's Health Study, a randomized trial of low-dose @COMPOUND$, and whether aspirin reduced cardiovascular risk in minor allele carriers.	0
2093	Serum @COMPOUND$ (25-OHD), calcium, @PROTEIN$ and phosphorus were measured.	0
2094	Serum 25-hydroxyvitamin D (25-OHD), calcium, @PROTEIN$ and @COMPOUND$ were measured.	0
2095	In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated @COMPOUND$ (DEX)-induced @PROTEIN$ (GCR)-alpha nuclear translocation in both CD4 (+) and CD8(+) T cells.	1
2096	In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated @COMPOUND$ (DEX)-induced glucocorticoid receptor (GCR)-alpha nuclear translocation in both @PROTEIN$ (+) and CD8(+) T cells.	1
2097	Linear regression analyses showed that @COMPOUND$ and phospholipid efflux and cellular apoA-I binding correlated significantly with the ability of @PROTEIN$ to form cell surface lipid domains.	1
2098	Linear regression analyses showed that @COMPOUND$ and phospholipid efflux and cellular @PROTEIN$ binding correlated significantly with the ability of ABCA1 to form cell surface lipid domains.	0
2099	Wheat germ @PROTEIN$ had a high activity and enantioselectivity only in n-hexane with a high initial water activity (alpha(w) = 0.97), especially with @COMPOUND$ (C 32%, E &gt; 200).	1
2100	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2101	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2102	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2103	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2104	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2105	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2106	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2107	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2108	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2109	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2110	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2111	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2112	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2113	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
2114	The results suggest that modulation of matrix @PROTEIN$, oxidants, cytokines, and NOSs with omapatrilat and @COMPOUND$ contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	1
2115	The results suggest that modulation of matrix @PROTEIN$, oxidants, cytokines, and NOSs with @COMPOUND$ and candesartan contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	1
2116	We recently reported @COMPOUND$ (Hcy)-induced @PROTEIN$-phosphorylation was suppressed by pertussis toxin (PTX), which suggested the involvement of GPCRs in initiating signal transduction.	1
2117	Association between @COMPOUND$ (247) polymorphism of @PROTEIN$ and cerebral infarction in a Chinese population.	1
2118	The purpose of this study was to identify associations between the @COMPOUND$ (247) polymorphism of @PROTEIN$ gene and CI in a Chinese cohort.	1
2119	We have discovered multiple genetic and biochemical differences between humans and these other hominids, in relation to @COMPOUND$ and in Siglecs (Sia-recognizing Ig superfamily @PROTEIN$).	0
2120	Possible binding site for the substrate, prostaglandin H(2) (@COMPOUND$)), was identified by systematically probing the refined molecular structure of @PROTEIN$.	1
2121	We cloned the zGCAP4 gene, purified non-myristoylated and myristoylated forms of the protein after heterologous expression in Escherichia coli and studied its properties: zGCAP4 was a strong activator of membrane-bound guanylate @PROTEIN$ from bovine and zebrafish retina, showing half-maximal activation at 520-570 nM free @COMPOUND$+) concentration.	0
2122	Thus, expression and biochemical properties of zGCAP4 are in agreement with its function as an efficient @COMPOUND$+)-sensitive regulator of guanylate @PROTEIN$ activity in cone vision.	0
2123	Anti-P mAb promoted @PROTEIN$ overproduction in a dose- and time-dependent manner in both @COMPOUND$ (LPS)-activated RAW 264.7 cells and primary human macrophages.	0
2124	Increased secretion of hyperimmune antibodies following @COMPOUND$ stimulation of @PROTEIN$-activated human B cells in vitro.	1
2125	We have investigated the pre-receptor metabolism of @COMPOUND$ in primary hOSE cells and an immortalised hOSE cell line, OSE-C2, focusing on transcriptional regulation of 3beta-hydroxysteroid dehydrogenase (@PROTEIN$) by inflammatory, anti-inflammatory and apoptotic factors.	0
2126	We have investigated the pre-receptor metabolism of @COMPOUND$ in primary hOSE cells and an immortalised hOSE cell line, OSE-C2, focusing on transcriptional regulation of @PROTEIN$ (3beta-HSD) by inflammatory, anti-inflammatory and apoptotic factors.	0
2127	Coexpression with H6PDH potentiated @PROTEIN$ reductase activity at high @COMPOUND$.	1
2128	@PROTEIN$ dehydrogenase activity was observed in H4IIE cells only at subphysiological @COMPOUND$ levels, indicating a highly efficient supply of substrate for H6PDH and NADPH generation in the ER-lumen.	1
2129	There are data to suggest that psychological intervention can influence neuroendocrine (e.g., @COMPOUND$) and immune function indicators, especially lymphocyte proliferation and @PROTEIN$ cytokine production.	0
2130	In the present study, we investigated whether CD147/basigin is involved, via its association with @PROTEIN$ and 4 to transport @COMPOUND$, in glycolysis and then contributes to the progression of A375 melanoma cells.	1
2131	In the present study, we investigated whether CD147/@PROTEIN$ is involved, via its association with MCT1 and 4 to transport @COMPOUND$, in glycolysis and then contributes to the progression of A375 melanoma cells.	1
2132	TCblR belongs to the @PROTEIN$ family, with 2 low-density lipoprotein receptor type A domains separated by a complement-like @COMPOUND$-rich region.	1
2133	TCblR belongs to the low-density lipoprotein receptor family, with 2 low-density lipoprotein receptor @PROTEIN$ domains separated by a complement-like @COMPOUND$-rich region.	1
2134	Variability of AChE, BChE, and @PROTEIN$ genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with @COMPOUND$ and Rivastigmine.	1
2135	Variability of AChE, BChE, and @PROTEIN$ genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and @COMPOUND$.	1
2136	Variability of @PROTEIN$, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and @COMPOUND$.	1
2137	Variability of @PROTEIN$, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with @COMPOUND$ and Rivastigmine.	1
2138	Extended-release PEG-@COMPOUND$ allows for long-term imaging of firefly @PROTEIN$ activity in vivo.	1
2139	Spectrofluorimetric determination of vitamin B(1) using horseradish @PROTEIN$ as catalyst in the presence of @COMPOUND$.	1
2140	In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish peroxidase (@PROTEIN$) in the presence of hydrogen peroxide (@COMPOUND$), has been developed.	1
2141	In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish @PROTEIN$ (HRP) in the presence of hydrogen peroxide (@COMPOUND$), has been developed.	1
2142	In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish peroxidase (@PROTEIN$) in the presence of @COMPOUND$ (H2O2), has been developed.	1
2143	In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish @PROTEIN$ (HRP) in the presence of @COMPOUND$ (H2O2), has been developed.	1
2144	Electrospun polyglyconate (@COMPOUND$) and its blends with proteins such as gelatin and @PROTEIN$, with a spatially designed layer structure, were prepared as potential scaffolds for vascular tissue engineering.	1
2145	Electrospun @COMPOUND$ (Maxon) and its blends with proteins such as gelatin and @PROTEIN$, with a spatially designed layer structure, were prepared as potential scaffolds for vascular tissue engineering.	1
2146	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: @PROTEIN$, lpa2 and lpa3.	1
2147	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, @PROTEIN$ and lpa3.	1
2148	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, lpa2 and @PROTEIN$.	1
2149	The low content of sphingomyelin, sulfatide and @COMPOUND$ is consistent with the immunohistochemical results showing that in the grey-lethal brain significant depletion and disorganization of the myelinated fibres is present, thus supporting the hypothesis that loss of function of the @PROTEIN$ causes neuronal impairment and myelin deficit.	0
2150	PCFT/@PROTEIN$ could therefore play a physiological role in Fe nutrition and the data highlight the potential for the interaction of @COMPOUND$ and haem at the level of intestinal absorption.	1
2151	Association between serum retinol-binding @PROTEIN$ and small dense low-density lipoprotein @COMPOUND$ levels in young adult women.	1
2152	Role of @PROTEIN$ and Nox2 in hyperoxia-induced reactive @COMPOUND$ species generation and migration of human lung endothelial cells.	1
2153	Downregulation of @PROTEIN$, or pretreatment with @COMPOUND$, attenuated hyperoxia-induced cell migration and capillary tube formation, suggesting that ROS generated by Nox4 regulate endothelial cell motility.	0
2154	Using newly designed degenerate primers targeting the @PROTEIN$ gene we analysed the potential for @COMPOUND$ utilization in DNA and cDNA libraries constructed from a phytoplankton bloom in the Western English Channel during July 2006.	1
2155	Finally, we show that Vcx1 helps return cytosolic @COMPOUND$+) toward resting levels after shock with high extracellular Ca(2+) much more effectively than @PROTEIN$ and that calcineurin, a protein phosphatase regulator of Vcx1 and Pmc1, had no detectable effects on these factors within the first few minutes of its activation.	0
2156	Long-term blinded placebo-controlled study of SNT-MC17/@COMPOUND$ in the @PROTEIN$ deficient mdx mouse: cardiac protection and improved exercise performance.	1
2157	Long-term blinded placebo-controlled study of @COMPOUND$/idebenone in the @PROTEIN$ deficient mdx mouse: cardiac protection and improved exercise performance.	1
2158	@PROTEIN$ blockade normalizes hippocampal alterations and cognitive impairment in @COMPOUND$-induced type 1 diabetes mice.	1
2159	Transgene optimization significantly improves SIN vector titers, @PROTEIN$ expression and reconstitution of @COMPOUND$ production in X-CGD cells.	0
2160	Quantitative evaluation of @PROTEIN$ contribution to oral absorption of @COMPOUND$ in rats.	1
2161	@COMPOUND$ concentration in the liver and in plasma alanine aminotransferase (ALT) and aspartate transaminase (@PROTEIN$) activities were determined.	1
2162	In brain tissue, Cu concentration, superoxide dismutase (@PROTEIN$) activities, @COMPOUND$ (MDA) levels and glutathione (GSH) concentrations were determined.	0
2163	In brain tissue, Cu concentration, @PROTEIN$ (SOD) activities, @COMPOUND$ (MDA) levels and glutathione (GSH) concentrations were determined.	0
2164	In brain tissue, @COMPOUND$ concentration, @PROTEIN$ (SOD) activities, malondialdehyde (MDA) levels and glutathione (GSH) concentrations were determined.	0
2165	In brain tissue, @COMPOUND$ concentration, superoxide dismutase (@PROTEIN$) activities, malondialdehyde (MDA) levels and glutathione (GSH) concentrations were determined.	0
2166	We previously reported that inhibition of @PROTEIN$-kinase (ROCK) by hydroxyl @COMPOUND$ improves cognitive deficit and neuronal damage in rats with chronic cerebral ischemia (Huang et al., Cell Mol Neurobiol 28:757-768, 2008).	1
2167	Finally, in the presence of OGD and @COMPOUND$ mesylate, superoxide dismutase (@PROTEIN$) activity was increased by 50% for cortex and by 58% for hippocampus, compared to OGD only group.	1
2168	Finally, in the presence of OGD and @COMPOUND$ mesylate, @PROTEIN$ (SOD) activity was increased by 50% for cortex and by 58% for hippocampus, compared to OGD only group.	1
2169	Na+/H+ exchanger isoform 3 (@PROTEIN$) is responsible for net uptake of @COMPOUND$ and water from the gastrointestinal (GI) tract.	1
2170	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and nitric oxide (NO).	1
2171	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and @COMPOUND$ (NO).	0
2172	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0
2173	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0
2174	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and nitric oxide (NO).	1
2175	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and nitric oxide (NO).	1
2176	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and @COMPOUND$ (NO).	0
2177	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and nitric oxide (NO).	1
2178	Silencing of @PROTEIN$, the key entry-point enzyme for @COMPOUND$ biosynthesis led to flavonoid-deficient roots.	1
2179	@PROTEIN$ enzymes have been characterised in plants, bacteria and fungi and are thought to be important in detoxification of nitriles, utilisation of @COMPOUND$ and synthesis of plant hormones.	1
2180	In plants cyanide is converted to beta-cyano-L-alanine, which is subsequently detoxified to aspartic acid and @COMPOUND$ by @PROTEIN$.	1
2181	In plants cyanide is converted to beta-cyano-L-alanine, which is subsequently detoxified to @COMPOUND$ and ammonia by @PROTEIN$.	1
2182	The mitochondrial membrane potential (Delta psi (mit)) was also tested with @COMPOUND$ 30 min after SI challenge, and was shown to have collapsed in the incompatible pollen tubes after exposure to @PROTEIN$.	1
2183	In conclusion, female rats undernourished in utero had normophagic obesity as adults but had an absence of @COMPOUND$-induced hypophagia and low hypothalamic levels of the @PROTEIN$ receptor.	0
2184	Compensatory adaptations for the functional serotonergic impairment were evidenced, such as an enhanced release of @COMPOUND$ in response to a meal allied to up-regulated hypothalamic @PROTEIN$ and transporter expression.	1
2185	They potentiate @COMPOUND$-induced @PROTEIN$ secretion and may be responsible for up to 70% of postprandial insulin secretion.	1
2186	However, in supraphysiological doses, @PROTEIN$ administration may completely normalize beta as well as alpha cell sensitivity to @COMPOUND$.	1
2187	Interaction of @COMPOUND$ with bovine @PROTEIN$ : determination of the binding mechanism and binding site by spectroscopic methods.	1
2188	The interaction between @COMPOUND$ (MG) and bovine @PROTEIN$ (BSA) under simulative physiological conditions was investigated by the methods of fluorescence spectroscopy, UV-vis absorption and circular dichroism (CD) spectroscopy.	1
2189	The interaction between @COMPOUND$ (MG) and bovine serum albumin (@PROTEIN$) under simulative physiological conditions was investigated by the methods of fluorescence spectroscopy, UV-vis absorption and circular dichroism (CD) spectroscopy.	1
2190	The binding distance (r) between MG and the @COMPOUND$ residue of @PROTEIN$ was obtained to be 4.79 nm according to Förster theory of non-radioactive energy transfer.	1
2191	Unlike @COMPOUND$, Cystatin C (@PROTEIN$) is believed to be independent of body composition in both adults and children.	0
2192	Unlike @COMPOUND$, @PROTEIN$ C (CysC) is believed to be independent of body composition in both adults and children.	0
2193	Thereafter we determined that hCG effect could be partially blocked by pharmacologic inhibition of @PROTEIN$ pathway with 50 microM @COMPOUND$ but not by the inhibition of the phosphatidylinositol 3-kinase pathway with 0.1 microm wortmannin.	1
2194	Thereafter we determined that hCG effect could be partially blocked by pharmacologic inhibition of @PROTEIN$ pathway with 50 microM PD98059 but not by the inhibition of the phosphatidylinositol 3-kinase pathway with 0.1 microm @COMPOUND$.	0
2195	Lung injury was assessed by measuring vascular permeability (via @COMPOUND$), edema, neutrophil infiltration (via myeloperoxidase (@PROTEIN$), and expression of proinflammatory cytokines.	0
2196	Cholesterol efflux from ((3)H) @COMPOUND$-acetyl-LDL-loaded monocyte-derived macrophages to standard apolipoprotein A-I (@PROTEIN$), HDL(2), and serum was measured.	1
2197	@COMPOUND$ efflux from ((3)H) cholesterol-oleate-acetyl-LDL-loaded monocyte-derived macrophages to standard apolipoprotein A-I (@PROTEIN$), HDL(2), and serum was measured.	1
2198	Cholesterol efflux from ((3)H) @COMPOUND$-acetyl-LDL-loaded monocyte-derived macrophages to standard @PROTEIN$ (apoA-I), HDL(2), and serum was measured.	1
2199	@COMPOUND$ efflux from ((3)H) cholesterol-oleate-acetyl-LDL-loaded monocyte-derived macrophages to standard @PROTEIN$ (apoA-I), HDL(2), and serum was measured.	1
2200	@COMPOUND$ efflux to @PROTEIN$, HDL(2), and serum from macrophage foam cells derived from low- and high-HDL subjects was similar.	0
2201	@COMPOUND$ efflux from THP-1 macrophages to serum from study subjects correlated with serum apoB (P = 0.033), @PROTEIN$ (P = 0.004), apoA-II 0.0001), and the percentage of apoA-I present in the form of prebeta-HDL (P = 0.0001).	1
2202	@COMPOUND$ efflux from THP-1 macrophages to serum from study subjects correlated with serum apoB (P = 0.033), apoA-I (P = 0.004), @PROTEIN$ 0.0001), and the percentage of apoA-I present in the form of prebeta-HDL (P = 0.0001).	1
2203	In this study, the degradation of @PROTEIN$- and R-@COMPOUND$ under anaerobic conditions was studied.	0
2204	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the @PROTEIN$ (NDRG1-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1
2205	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the n-myc downstream-regulated gene 1 protein (@PROTEIN$-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1
2206	Although G (Na) is negligible in hormone-deprived cells, these cells displayed basal @PROTEIN$ activity that was sensitive to @COMPOUND$, an inhibitor of 3-phosphatidylinositol phosphate kinase (PI3K).	1
2207	@PROTEIN$ expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with @COMPOUND$-based chemotherapy.	1
2208	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as @PROTEIN$ and catalase, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, @COMPOUND$ and selenium, incorporated in conventional treatment regimen.	0
2209	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as superoxide dismutase and @PROTEIN$, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, @COMPOUND$ and selenium, incorporated in conventional treatment regimen.	0
2210	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as @PROTEIN$ and catalase, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, vitamin E and @COMPOUND$, incorporated in conventional treatment regimen.	0
2211	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as superoxide dismutase and @PROTEIN$, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, vitamin E and @COMPOUND$, incorporated in conventional treatment regimen.	0
2212	This study was designed to determine the effect of molsidomine (MO), a precursor of @COMPOUND$ (NO) donor, on hypoxia inducible factor alpha (@PROTEIN$) and Sonic hedgehog (Shh) levels considered to be involved in the development of testes ischemia/reperfusion (I-R) injury.	1
2213	This study was designed to determine the effect of @COMPOUND$ (MO), a precursor of nitric oxide (NO) donor, on hypoxia inducible factor alpha (@PROTEIN$) and Sonic hedgehog (Shh) levels considered to be involved in the development of testes ischemia/reperfusion (I-R) injury.	1
2214	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (@COMPOUND$, fluconazole and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute.	0
2215	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (amphotericin B, @COMPOUND$ and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute.	0
2216	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (amphotericin B, fluconazole and @COMPOUND$) by the reference method of the Clinical and Laboratory Standards Institute.	0
2217	To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S((@COMPOUND$))KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine serum albumin (@PROTEIN$) as a control.	0
2218	To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S((@COMPOUND$))KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine @PROTEIN$ (BSA) as a control.	0
2219	The @COMPOUND$/@PROTEIN$ (PKA) signaling cascade is crucial for synaptic plasticity in a wide variety of species.	1
2220	Epigenetic reprogramming of breast cancer cells by @COMPOUND$ occurs regardless of @PROTEIN$ status.	0
2221	In the present study, we have investigated the effect of @PROTEIN$ on ABCA1 expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	1
2222	In the present study, we have investigated the effect of IFN-gamma on @PROTEIN$ expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	0
2223	As such, the aim of the present study was to investigate whether @PROTEIN$-inhibition with @COMPOUND$, a molecule distinctly different from torcetrapib, impacts on vascular function, a well-established surrogate of atherosclerotic vascular disease, as well as markers of inflammation and oxidative stress in patients with type II hyperlipidemia.	1
2224	Pathways involved in the hydrolysis of nitrile pollutants (aliphatic nitriles, @COMPOUND$ analogues) and the corresponding enzymes (@PROTEIN$, nitrile hydratase) are described in detail.	1
2225	Since stellate cells have been found to express the beta but not the alpha isoform of the @PROTEIN$, it can be predicted that nutritional intakes of the soy isoflavone @COMPOUND$-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	0
2226	Since stellate cells have been found to express the beta but not the alpha isoform of the @PROTEIN$, it can be predicted that nutritional intakes of the soy @COMPOUND$ genistein-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	1
2227	Aqueous extract of cumin was tested for its antiglycating ability against @COMPOUND$-induced glycation of goat lens total soluble protein (TSP), alpha-crystallin from goat lens and a nonlenticular protein bovine @PROTEIN$ (BSA).	1
2228	Aqueous extract of cumin was tested for its antiglycating ability against @COMPOUND$-induced glycation of goat lens total soluble protein (@PROTEIN$), alpha-crystallin from goat lens and a nonlenticular protein bovine serum albumin (BSA).	1
2229	Aqueous extract of cumin was tested for its antiglycating ability against @COMPOUND$-induced glycation of goat lens total soluble protein (TSP), alpha-crystallin from goat lens and a nonlenticular protein bovine serum albumin (@PROTEIN$).	1
2230	To investigate the effects of selenium on mRNA expressions of proinflammatory cytokines and inducible nitric oxide synthase (@PROTEIN$) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a @COMPOUND$-treated diabetes mellitus group.	0
2231	To investigate the effects of selenium on mRNA expressions of proinflammatory cytokines and inducible @PROTEIN$ (iNOS) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a @COMPOUND$-treated diabetes mellitus group.	0
2232	To investigate the effects of @COMPOUND$ on mRNA expressions of proinflammatory cytokines and inducible @PROTEIN$ (iNOS) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a selenite-treated diabetes mellitus group.	1
2233	To investigate the effects of @COMPOUND$ on mRNA expressions of proinflammatory cytokines and inducible nitric oxide synthase (@PROTEIN$) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a selenite-treated diabetes mellitus group.	1
2234	The results showed that pancreatic @COMPOUND$ content and @PROTEIN$.05), respectively, in selenite-treated diabetes mellitus group compared with untreated diabetes mellitus group.	0
2235	The results showed that pancreatic selenium content and @PROTEIN$.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	0
2236	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, @PROTEIN$-alpha and interferon-gamma ; mRNA expression and activity of iNOS.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
2237	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, tumor necrosis factor-alpha and interferon-gamma ; mRNA expression and activity of @PROTEIN$.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
2238	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, tumor necrosis factor-alpha and @PROTEIN$ ; mRNA expression and activity of iNOS.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
2239	Decreases in PNNs, aggrecan and @COMPOUND$ were observed only in the terminal stages and correlated with the distribution of @PROTEIN$ (BSE) and activated glial cells.	1
2240	This study suggests that the loss of PNNs, aggrecan and @COMPOUND$ is a consequence of @PROTEIN$ (BSE) accumulation.	0
2241	This study suggests that the loss of @PROTEIN$, aggrecan and @COMPOUND$ is a consequence of PrP (BSE) accumulation.	0
2242	In hypersensitive alpha4L9'A mice, injections of a low dose of @COMPOUND$ (0.1 mg/kg) led to strong c-@PROTEIN$ expression in only the ventrolateral region of the MHb, but not in the MHb of wild-type (WT) mice.	1
2243	"Participating in a significant fraction of the fundamental paths connecting the ligands to the phenotypes, cofactor @COMPOUND$ and complex Gbeta/Ggamma were identified as ""housekeeping"" molecules, through which all pathways of @PROTEIN$ network are cross-talking."	1
2244	This study confirmed QTL previously identified for pH except those on @PROTEIN$, 11, 12, and X, and found 11 new 5% genome-wise significant QTL for @COMPOUND$-related traits.	0
2245	The objective of this study was to examine the effect of level and duration of feeding of an n-3 PUFA-enriched fish oil (@COMPOUND$) supplement in combination with soybean oil (SO) on the transcriptional regulation of @PROTEIN$ gene expression in bovine muscle.	1
2246	Whole blood and plasma were analyzed for total Se, @PROTEIN$ activity in whole blood (GPX-1) and plasma, and thyroid hormones (thyroxine and @COMPOUND$) in plasma.	0
2247	Whole blood and plasma were analyzed for total Se, @PROTEIN$ activity in whole blood (GPX-1) and plasma, and thyroid hormones (@COMPOUND$ and triiodothyronine) in plasma.	0
2248	Whole blood and plasma were analyzed for total Se, glutathione peroxidase activity in whole blood (@PROTEIN$) and plasma, and thyroid hormones (thyroxine and @COMPOUND$) in plasma.	0
2249	Whole blood and plasma were analyzed for total Se, glutathione peroxidase activity in whole blood (@PROTEIN$) and plasma, and thyroid hormones (@COMPOUND$ and triiodothyronine) in plasma.	0
2250	Studies have shown that administration of @COMPOUND$ (estrogen) after trauma-hemorrhage normalized cardiac @PROTEIN$ levels and restored cardiac functions under those conditions.	1
2251	Each of the developed consortium has a phosphate solubilizer, @COMPOUND$ fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
2252	Each of the developed consortium has a @COMPOUND$ solubilizer, nitrogen fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
2253	Using cannabinoid receptor antagonists and cannabinoid receptor gene deficient mice (CB(1) (-/-) and CB(2) (-/-)), we showed that both CB(1) and CB(2) receptors were involved in the @COMPOUND$-induced attenuation of serum IL-12 and @PROTEIN$.	0
2254	In vivo administration of a synthetic phospholipid, named hereafter phospho-ceramide analogue-1 (PCERA-1), was previously found to suppress @COMPOUND$ (LPS)-induced @PROTEIN$ blood levels.	1
2255	In conclusion, the anti-inflammatory activity of PCERA-1 seems to be mediated by a cell membrane receptor, upstream of @COMPOUND$ production, and eventually TNF-alpha suppression and @PROTEIN$ induction.	0
2256	In conclusion, the anti-inflammatory activity of PCERA-1 seems to be mediated by a cell membrane receptor, upstream of @COMPOUND$ production, and eventually @PROTEIN$ suppression and IL-10 induction.	0
2257	Acylated ghrelin and TNF α, @PROTEIN$ γ, IL-1β and IL-6 were measured with @COMPOUND$.	0
2258	Acylated ghrelin and @PROTEIN$ α, IFN γ, IL-1β and IL-6 were measured with @COMPOUND$.	0
2259	Acylated @PROTEIN$ and TNF α, IFN γ, IL-1β and IL-6 were measured with @COMPOUND$.	0
2260	Acylated ghrelin and TNF α, IFN γ, IL-1β and @PROTEIN$ were measured with @COMPOUND$.	0
2261	Pre-gravid physical activity and reduced risk of @COMPOUND$ intolerance in pregnancy : the role of @PROTEIN$ sensitivity.	1
2262	Thus, we sought to study the relationships between types of pre-gravid physical activity and metabolic parameters in pregnancy, including @COMPOUND$ tolerance, @PROTEIN$ sensitivity and beta-cell function.	0
2263	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of @PROTEIN$-II, Beclin-1, BAG-1 and cardioprotection.	1
2264	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, Beclin-1, @PROTEIN$ and cardioprotection.	1
2265	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, @PROTEIN$, BAG-1 and cardioprotection.	1
2266	When myosin molecules work as an aggregate, the sliding movement of a myosin filament driven by the power strokes of some myosin heads makes other myosin heads that have completed their power strokes detach from the @PROTEIN$ without consuming @COMPOUND$.	0
2267	A critical requirement for this mechanism is that @COMPOUND$ must preferentially facilitate the detachment of myosins that have completed their power strokes, but are still strongly attached to the @PROTEIN$.	0
2268	Efficacy, safety and patient-reported outcomes of combination @PROTEIN$ and @COMPOUND$ versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study.	0
2269	To determine the efficacy and safety of @PROTEIN$ and etanercept plus @COMPOUND$ versus sulfasalazine in patients with rheumatoid arthritis (RA) despite sulfasalazine therapy.	0
2270	Aberrant methylation of the @PROTEIN$ (O6-methylguanine-DNA methyltransferase) DNA-repair gene is a predictive marker for the response to chemotherapy with alkylating agents (e.g., @COMPOUND$) in malignant gliomas.	1
2271	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on @COMPOUND$ plus fumarate significantly, although the specific activities of @PROTEIN$ and especially formate dehydrogenase were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
2272	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on @COMPOUND$ plus fumarate significantly, although the specific activities of hydrogenase and especially @PROTEIN$ were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
2273	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on propionate plus @COMPOUND$ significantly, although the specific activities of @PROTEIN$ and especially formate dehydrogenase were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
2274	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on propionate plus @COMPOUND$ significantly, although the specific activities of hydrogenase and especially @PROTEIN$ were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
2275	Our results suggest a more prominent role for H2 as electron carrier in the syntrophic conversion of @COMPOUND$, when the essential trace metals W and Mo for the functioning of @PROTEIN$ are depleted.	1
2276	Previous studies have demonstrated an association between genetic polymorphisms of the mu opioid receptor gene (@PROTEIN$) and response to @COMPOUND$ treatment.	1
2277	Wet-wrap treatment using dilutions of @COMPOUND$ ointment and fluticasone propionate cream in human @PROTEIN$ (+/+) mice with atopic dermatitis.	0
2278	Wet-wrap treatment using dilutions of tacrolimus ointment and @COMPOUND$ cream in human @PROTEIN$ (+/+) mice with atopic dermatitis.	0
2279	The use of low-dose COCs is preferable in PCOS, especially among patients with @COMPOUND$ intolerance, @PROTEIN$ resistance and uncomplicated diabetes mellitus.	0
2280	Due to its faculty to protect @PROTEIN$ (ChE) activity against irreversible inactivation by OP, @COMPOUND$ (PB) was used as a prophylaxis treatment during the first Persian Gulf War.	1
2281	Mice lacking Niemann-Pick C1-Like 1 (@PROTEIN$) (NPC1L1 (-/-)mice) exhibit a defect in intestinal absorption of cholesterol and @COMPOUND$.	1
2282	In this study, we examined the role of @PROTEIN$ in @COMPOUND$ and cholesterol trafficking in mice lacking ATP-binding cassette (ABC) transporters G5 and G8 (G5/G8(-/-) mice).	0
2283	We found that mice lacking ABCG5/G8 and @PROTEIN$ (triple knockout (TKO) mice) did not accumulate @COMPOUND$ in plasma and the liver.	0
2284	We found that mice lacking @PROTEIN$/G8 and NPC1L1 (triple knockout (TKO) mice) did not accumulate @COMPOUND$ in plasma and the liver.	0
2285	In conclusion, @PROTEIN$ is essential for @COMPOUND$ to enter the body in mice.	1
2286	Effects of nonspecific targeting of @PROTEIN$ were evaluated with addition of imatinib (@COMPOUND$) to cell cultures.	0
2287	In the pericentral necrotic zone after @COMPOUND$-treatment, no induction of @PROTEIN$ was found.	0
2288	Sixty-one percent of the isolates were @PROTEIN$ producers, which explains the poor activity of @COMPOUND$.	1
2289	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific @PROTEIN$ (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II ribosome-inactivating protein (Type-II RIPs, SNA-V), found in the same species.	1
2290	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific lectin (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II @PROTEIN$ (Type-II RIPs, SNA-V), found in the same species.	0
2291	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific lectin (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II ribosome-inactivating protein (Type-II @PROTEIN$, SNA-V), found in the same species.	0
2292	Infusion of each receptor antagonist alone similarly reduced basal unstressed volume and blood flow in @PROTEIN$-treated CHF patients, but not in healthy volunteers or @COMPOUND$-treated CHF patients.	0
2293	In @COMPOUND$-treated heart failure, venous responses to @PROTEIN$ are preserved but arterial responses are reduced compared with healthy controls.	0
2294	Effects of @COMPOUND$ on breast cancer cell migration and invasion through the @PROTEIN$ cytoskeleton.	1
2295	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/@PROTEIN$ signalling.	0
2296	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of @PROTEIN$/STAT3 signalling.	0
2297	High @COMPOUND$ attenuates @PROTEIN$ expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling.	1
2298	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
2299	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
2300	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
2301	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
2302	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
2303	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
2304	Hepatic stellate cell activation in focal nodular hyperplasia with a central scar was accompanied by the expression of @COMPOUND$ and inducible @PROTEIN$ in the liver.	0
2305	Expression of @COMPOUND$ and inducible @PROTEIN$ was rarely seen in focal nodular hyperplasia without a central scar, focal nodular hyperplasia-like nodules, or nodular regenerative hyperplasia.	0
2306	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
2307	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
2308	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
2309	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
2310	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
2311	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
2312	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
2313	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
2314	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
2315	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
2316	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
2317	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
2318	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and @PROTEIN$ were detected, while those secreting glucagon and insulin were not.	0
2319	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and PYY were detected, while those secreting glucagon and @PROTEIN$ were not.	0
2320	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and PYY were detected, while those secreting @PROTEIN$ and insulin were not.	0
2321	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and PYY were detected, while those secreting @PROTEIN$ and insulin were not.	0
2322	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and @PROTEIN$ were detected, while those secreting glucagon and insulin were not.	0
2323	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and PYY were detected, while those secreting glucagon and @PROTEIN$ were not.	0
2324	In the final part of the gizzard, endocrine cells secreting @COMPOUND$ were more frequent, and cells secreting somatostatin and @PROTEIN$ were not detected.	0
2325	In the final part of the gizzard, endocrine cells secreting 5-HT were more frequent, and cells secreting @COMPOUND$ and @PROTEIN$ were not detected.	0
2326	Sorbitol can fuel mouse sperm motility and protein @COMPOUND$ phosphorylation via @PROTEIN$.	0
2327	@COMPOUND$ can fuel mouse sperm motility and protein tyrosine phosphorylation via @PROTEIN$.	1
2328	Here we characterize @PROTEIN$ mRNA and SORD expression during mouse spermatogenesis and examine the ability of @COMPOUND$ to support epididymal sperm motility and tyrosine phosphorylation.	0
2329	Here we characterize Sord mRNA and @PROTEIN$ expression during mouse spermatogenesis and examine the ability of @COMPOUND$ to support epididymal sperm motility and tyrosine phosphorylation.	0
2330	Here we characterize Sord mRNA and @PROTEIN$ expression during mouse spermatogenesis and examine the ability of sorbitol to support epididymal sperm motility and @COMPOUND$ phosphorylation.	0
2331	Here we characterize @PROTEIN$ mRNA and SORD expression during mouse spermatogenesis and examine the ability of sorbitol to support epididymal sperm motility and @COMPOUND$ phosphorylation.	0
2332	The present study was designed to evaluate the impact of zinc status before burn on the recovery of injury with focus on plasma @PROTEIN$ and @COMPOUND$ levels.	0
2333	Blood and tissue samples were collected 3, 6, and 24 h after injury in order to study biochemical parameters and the @COMPOUND$/@PROTEIN$ response in relation with the zinc status.	0
2334	In addition, the burn-induced insulin resistance, leading to protein catabolism, was emphasized, with higher plasma insulin, @COMPOUND$, and @PROTEIN$ levels in zinc-deficient animals versus normal-fed rats.	0
2335	In addition, the burn-induced @PROTEIN$ resistance, leading to protein catabolism, was emphasized, with higher plasma insulin, @COMPOUND$, and leptin levels in zinc-deficient animals versus normal-fed rats.	0
2336	@COMPOUND$ has a three-fold higher binding affinity for ERalpha than for @PROTEIN$.	1
2337	@COMPOUND$ has a three-fold higher binding affinity for @PROTEIN$ than for ERbeta.	1
2338	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
2339	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
2340	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
2341	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
2342	This was achieved by (1) direct comparison of the sensitivity of ASIC1, ASIC2, @PROTEIN$ and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
2343	This was achieved by (1) direct comparison of the sensitivity of ASIC1, @PROTEIN$, ASIC3 and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
2344	This was achieved by (1) direct comparison of the sensitivity of @PROTEIN$, ASIC2, ASIC3 and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
2345	This was achieved by (1) direct comparison of the sensitivity of ASIC1, ASIC2, ASIC3 and @PROTEIN$ knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
2346	Following @COMPOUND$ injection, ASIC1 (-/-) and ASIC2 (-/-), but not @PROTEIN$ (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	0
2347	Following @COMPOUND$ injection, ASIC1 (-/-) and @PROTEIN$ (-/-), but not ASIC3 (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	1
2348	Following @COMPOUND$ injection, ASIC1 (-/-) and ASIC2 (-/-), but not ASIC3 (-/-) or @PROTEIN$ (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	0
2349	Following @COMPOUND$ injection, @PROTEIN$ (-/-) and ASIC2 (-/-), but not ASIC3 (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	1
2350	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total @COMPOUND$ (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2351	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, @COMPOUND$, sodium, and potassium.	0
2352	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total @COMPOUND$ (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2353	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, @COMPOUND$, sodium, and potassium.	0
2354	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), @COMPOUND$ (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2355	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), @COMPOUND$, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2356	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), @COMPOUND$ (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2357	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), @COMPOUND$, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2358	The @PROTEIN$ isolated from the youngest group had the highest capacity to form @COMPOUND$ and AGEs under glycation in vitro.	1
2359	The patterns of nerves immunoreactive (IR) to antibodies towards serotonin (@COMPOUND$) and the invertebrate @PROTEIN$ FMRFamide are described in relation to the musculature.	0
2360	The patterns of nerves immunoreactive (IR) to antibodies towards @COMPOUND$ (5-HT) and the invertebrate neuropeptide @PROTEIN$ are described in relation to the musculature.	0
2361	The patterns of nerves immunoreactive (IR) to antibodies towards @COMPOUND$ (5-HT) and the invertebrate @PROTEIN$ FMRFamide are described in relation to the musculature.	0
2362	The patterns of nerves immunoreactive (IR) to antibodies towards serotonin (@COMPOUND$) and the invertebrate neuropeptide @PROTEIN$ are described in relation to the musculature.	0
2363	Based on these results we analyzed the expression of either M1 receptors or @PROTEIN$ following @COMPOUND$ treatment of retinal cell cultures.	0
2364	Immunotoxicity of perfluorooctanoic acid and perfluorooctane @COMPOUND$ and the role of @PROTEIN$.	0
2365	@COMPOUND$) was injected into pregnant mice 3 hr after the @PROTEIN$ administration to label the neural progenitor cells.	0
2366	A vitreous fraction showing @PROTEIN$ 1000 Da, consistent with @COMPOUND$.	0
2367	In particular, a Cimicifuga heracleifolia extract (CHE) was reported to inhibit the formation of @COMPOUND$ and the @PROTEIN$ activity in cultured rat islet.	0
2368	No differences in estradiol, @COMPOUND$, or @PROTEIN$ plasma concentrations were observed in exposed males or females compared to controls.	0
2369	No differences in @COMPOUND$, testosterone, or @PROTEIN$ plasma concentrations were observed in exposed males or females compared to controls.	0
2370	Macrophages located in the media differentiate into giant cells and/or produce reactive oxygen species, @COMPOUND$ and matrix metallo-@PROTEIN$.	0
2371	Macrophages located in the media differentiate into giant cells and/or produce reactive @COMPOUND$ species, nitric oxide and matrix metallo-@PROTEIN$.	0
2372	@COMPOUND$ is a potent glucocorticoid with high affinity for the @PROTEIN$, which is now used for the treatment of inflammatory bowel diseases.	1
2373	Studies on the antioxidant effect and interaction of @COMPOUND$ and dicholesteroyl diselenide with hepatic @PROTEIN$ and isoforms of lactate dehydrogenase.	0
2374	Studies on the interaction of dicholesteroyl diselenide (DCDS) and @COMPOUND$ (DPDS) with hepatic @PROTEIN$ (ALA-D) and different isoforms of lactate dehydrogenase (LDH) from different tissues were investigated.	0
2375	Studies on the interaction of dicholesteroyl diselenide (DCDS) and @COMPOUND$ (DPDS) with hepatic delta-aminolevulinic acid dehydratase (ALA-D) and different isoforms of lactate dehydrogenase (@PROTEIN$) from different tissues were investigated.	0
2376	A single @COMPOUND$ insertion/deletion (4G/5G) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
2377	A single guanosine insertion/deletion (4G/@COMPOUND$) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
2378	@COMPOUND$ is an effective chemo-sensitizer via @PROTEIN$ inhibition.	1
2379	@COMPOUND$ also recovered the depletion of I-kappaBalpha via @PROTEIN$ 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	1
2380	@COMPOUND$ also recovered the depletion of @PROTEIN$ via TGase 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	1
2381	Signaling involving @COMPOUND$ is organized in subcellular compartments and a distinct cAMP compartment might be required for proper @PROTEIN$ mobility and function.	1
2382	Differential effects of @PROTEIN$ receptor activation by WAY 161503 on @COMPOUND$-induced place conditioning and locomotor activity in rats.	0
2383	Control @COMPOUND$-loaded @PROTEIN$ nanoparticles with IgG2a antibodies yielded only marginal effects.	1
2384	Engineered @COMPOUND$-containing glutaredoxin displays strong @PROTEIN$ activity rivaling natural enzyme.	0
2385	Engineered @COMPOUND$-containing @PROTEIN$ displays strong glutathione peroxidase activity rivaling natural enzyme.	1
2386	The use of a common thioredoxin fold with a high affinity for @COMPOUND$ in glutaredoxin (Grx) and @PROTEIN$ (GPx) suggests a possibility of engineering Grx into GPx and vice versa.	1
2387	The use of a common thioredoxin fold with a high affinity for @COMPOUND$ in @PROTEIN$ (Grx) and glutathione peroxidase (GPx) suggests a possibility of engineering Grx into GPx and vice versa.	1
2388	The potassium channels blockade by either @COMPOUND$ or @PROTEIN$ also resulted in a potent inhibition of HEDS-induced aortic relaxation, whereas apamine only slightly reduced it.	0
2389	The potassium channels blockade by either tetraethylammonium or @PROTEIN$ also resulted in a potent inhibition of HEDS-induced aortic relaxation, whereas @COMPOUND$ only slightly reduced it.	0
2390	ROS activated almost immediately in a time- and concentration-dependent manner the MAPK pathways p38, ERK and @PROTEIN$ (their activation was abrogated by the antioxidant @COMPOUND$).	1
2391	ROS activated almost immediately in a time- and concentration-dependent manner the MAPK pathways p38, @PROTEIN$ and JNK (their activation was abrogated by the antioxidant @COMPOUND$).	1
2392	ROS activated almost immediately in a time- and concentration-dependent manner the @PROTEIN$ pathways p38, ERK and JNK (their activation was abrogated by the antioxidant @COMPOUND$).	1
2393	ROS activated almost immediately in a time- and concentration-dependent manner the MAPK pathways @PROTEIN$, ERK and JNK (their activation was abrogated by the antioxidant @COMPOUND$).	1
2394	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2395	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2396	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2397	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2398	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2399	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2400	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2401	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2402	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2403	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2404	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2405	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2406	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2407	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2408	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2409	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2410	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, interleukin-6 (@PROTEIN$) expression and caspase-3 activity.	0
2411	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, @PROTEIN$ (IL-6) expression and caspase-3 activity.	0
2412	Elevation of antioxidative capacity, as evidenced by decreased MDA level and increased @PROTEIN$ activity and @COMPOUND$ level, was detected only in the chronic daily-administration group.	0
2413	@PROTEIN$ secretion is highly sensitive to desorption of plasma membrane @COMPOUND$.	1
2414	Suppression of retinal @PROTEIN$ in experimental diabetes and @COMPOUND$-induced retinopathy: role of NADPH oxidase.	0
2415	TKTL 1 was highest expressed in cell lines derived from more invasive tumors but the expression level was not strongly correlated to proliferation rate, to @PROTEIN$ expression or to the response to @COMPOUND$.	0
2416	The increase of @COMPOUND$ availability caused the induction of the antioxidant enzyme @PROTEIN$, which indicates that the defensive mechanisms of the cells against oxidative stress were effective and cells could cope with increased pressure.	1
2417	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
2418	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
2419	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
2420	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
2421	Approximately 68% depletion of the parent compound and 98% depletion of its related acute aquatic toxicity are achieved in 6 h. Because no PFOA removal is observed in the absence of cosubstrate and/or following consumption thereof, we conclude that radical intermediate species generated during reaction between @PROTEIN$ and @COMPOUND$ mediate nonspecific depletion of PFOA and that these intermediates may be sufficiently reactive to sever the extremely stable C-F bonds of PFOA.	1
2422	In the present study, the mRNA expression and promoter @COMPOUND$ methylation of @PROTEIN$ isoforms (i.e.	0
2423	The present study is the first report that demonstrates selective inactivation of @PROTEIN$ isoforms through the promoter @COMPOUND$ methylation pathway in leukaemias.	1
2424	@PROTEIN$ monogalactosyldiacylglycerol synthases are involved in @COMPOUND$ starvation-induced lipid remodeling, and are crucial for low-phosphate adaptation.	1
2425	Recently, we reported stimulatory effect of ghrelin alone and in combination with growth hormone (GH) on @COMPOUND$ secretion, @PROTEIN$ activity in parallel with inhibitory effect on cell apoptosis.	0
2426	Recently, we reported stimulatory effect of ghrelin alone and in combination with @PROTEIN$ (GH) on @COMPOUND$ secretion, aromatase activity in parallel with inhibitory effect on cell apoptosis.	1
2427	Recently, we reported stimulatory effect of @PROTEIN$ alone and in combination with growth hormone (GH) on @COMPOUND$ secretion, aromatase activity in parallel with inhibitory effect on cell apoptosis.	1
2428	In cultures treated together ghrelin and (D-Lys-3)-GHRP-6, @COMPOUND$ secretion, @PROTEIN$ activity and cell proliferation returned to control levels.	0
2429	In cultures treated together @PROTEIN$ and (D-Lys-3)-GHRP-6, @COMPOUND$ secretion, aromatase activity and cell proliferation returned to control levels.	1
2430	Nevertheless, certain clinical cases manifest themselves with the onset of acute renal failure bought upon by the administration of blockers of the rennin-@PROTEIN$-@COMPOUND$ system, or by some other causes responsible for a sudden drop in renal plasma flow (e.g., thrombosis of the renal artery).	1
2431	Effect of polyols on the solubility of bovine serum albumin (@PROTEIN$) in the presence of @COMPOUND$ glycols (PEGs) was investigated in order to strengthen the understanding of the observed effects of polyols and PEGs on protein properties in solution.	0
2432	Effect of polyols on the solubility of bovine @PROTEIN$ (BSA) in the presence of @COMPOUND$ glycols (PEGs) was investigated in order to strengthen the understanding of the observed effects of polyols and PEGs on protein properties in solution.	0
2433	After 2 and 6 weeks of treatment, parotid gland was removed and total protein and @COMPOUND$ (free and total) concentration and amylase and @PROTEIN$ activities were determined.	0
2434	At week 2 of the study, parotid gland of diabetic rats presented a reduction of total protein concentration (55%) and an increase of amylase (120%) and @PROTEIN$ (160%) activities, free (150%) and total (170%) @COMPOUND$ concentration.	0
2435	To investigate the change pattern of @PROTEIN$ (SP) and @COMPOUND$ (NO) in the portal vein during the recto-anal inhibitory reflex (RAIR), and its physiological significance; the influence of external splanchnic nerve (ESN) of rectum and anus to the RAIR.	0
2436	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, DAT) and @PROTEIN$ A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
2437	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, DAT) and monoamine oxidase A (@PROTEIN$) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
2438	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (@PROTEIN$, DAT) and monoamine oxidase A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
2439	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, @PROTEIN$) and monoamine oxidase A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
2440	A @PROTEIN$ (F2) and lipase-like materials (F1) were purified from the culture supernatant of P. monteilii TKU009 with soybean powder as the sole carbon/@COMPOUND$ source.	0
2441	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2442	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2443	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2444	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2445	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2446	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2447	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2448	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2449	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2450	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2451	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2452	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2453	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2454	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2455	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2456	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2457	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2458	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2459	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2460	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2461	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2462	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2463	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2464	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2465	The enzyme responsible for D-@COMPOUND$ biosynthesis, @PROTEIN$ (SR), is therefore a promising target for treatment of neuropathologies related to glutamate receptor excitotoxicity, such as stroke or Alzheimer's disease.	1
2466	Hepatocyte apoptosis was estimated morphologically using @PROTEIN$ combined with @COMPOUND$, or toluidine blue staining.	0
2467	Hepatocyte apoptosis was estimated morphologically using @PROTEIN$ combined with propidium iodide, or @COMPOUND$ staining.	0
2468	To investigate the metabolism of @COMPOUND$ through the @PROTEIN$ (CYP450) metabolic pathway, we studied the in vitro rat liver microsomal production of hydroxylated metabolites and their activity at recombinant human TRPV(1) receptors.	1
2469	The FFA fractions elicited pro-inflammatory responses inducing @PROTEIN$ and intracellular adhesion molecule expression and reactive @COMPOUND$ species (ROS) production in human aortic endothelial cells (HAECs).	0
2470	@PROTEIN$ single nucleotide polymorphism G2677T/A and haplotype are correlated with response to @COMPOUND$-cisplatin chemotherapy in patients with non-small-cell lung cancer.	1
2471	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
2472	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human @PROTEIN$ (HSA) using various biophysical methods.	1
2473	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human @PROTEIN$ (HSA) using various biophysical methods.	1
2474	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
2475	The observed fluorescence quenching of @PROTEIN$ by @COMPOUND$ is due to a complex formation by a static quenching process with a quenching constant of the order of 10(5) M(-1).	1
2476	From the observed Förster-type fluorescence resonance energy transfer (FRET), the donor (Trp 214 in @PROTEIN$) to acceptor (@COMPOUND$) distance is calculated to be 3.2 nm.	1
2477	The preferred binding site of IOC was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and @COMPOUND$-bound @PROTEIN$.	1
2478	The preferred binding site of IOC was analyzed by ligand displacement experiments with @COMPOUND$ (ANS) and warfarin-bound @PROTEIN$.	1
2479	The preferred binding site of @COMPOUND$ was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and warfarin-bound @PROTEIN$.	1
2480	We here demonstrate that @PROTEIN$ confers a sensitivity towards near ultraviolet (UVA) light, which rapidly causes @COMPOUND$+) entry.	1
2481	In the presence of the photosensitising agents @COMPOUND$ (100 nM) or hypericin (10 nM), the sensitivity of light-induced @PROTEIN$ activation was increased and extended towards the visible spectrum.	1
2482	In the presence of the photosensitising agents acridine orange (100 nM) or @COMPOUND$ (10 nM), the sensitivity of light-induced @PROTEIN$ activation was increased and extended towards the visible spectrum.	1
2483	A new biosensor for trehalose determination has been realized by means of a flow system, based on a reactor in which the trehalase enzyme catalyses its hydrolysis into two @COMPOUND$ molecules, and a GOD (@PROTEIN$) amperometric biosensor is employed for the glucose determination.	0
2484	A new biosensor for trehalose determination has been realized by means of a flow system, based on a reactor in which the trehalase enzyme catalyses its hydrolysis into two @COMPOUND$ molecules, and a @PROTEIN$ (glucose oxidase) amperometric biosensor is employed for the glucose determination.	1
2485	The angiogenic potential of vascular endothelial growth factor (@PROTEIN$) and its @COMPOUND$ pressure-dependent regulation suggest a strong connection between this growth factor and the 'delay phenomenon'.	1
2486	Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated @PROTEIN$ activation in response to @COMPOUND$.	1
2487	@COMPOUND$ toxicity and @PROTEIN$-dependent detoxification in astrocytes.	1
2488	After serum @COMPOUND$ reached a stable nadir in the transplant recipients, @PROTEIN$ and its hemodynamic determinants were evaluated and the whole allograft K(f) was computed.	0
2489	Furthermore, constitutive expression of an @COMPOUND$-insensitive, active form of @PROTEIN$ protein mimicked the effects of low oxygen, inhibiting the differentiation of trophoblast giant cells.	0
2490	Effect of the inoculum size on carbapenem susceptibilities of @PROTEIN$-negative, @COMPOUND$-resistant Haemophilus influenzae.	0
2491	However, the effect of inoculum size of @PROTEIN$-negative, @COMPOUND$-resistant H. influenzae (BLNAR) on MICs for carbapenems has not been investigated.	0
2492	It has been proposed that there is improvement in @COMPOUND$ and @PROTEIN$ metabolism after weight loss in patients who underwent diet restriction and bariatric surgery.	0
2493	@COMPOUND$ deficiency due to the methylenetetrahydrofolate reductase (@PROTEIN$) and methionine synthase (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	1
2494	@COMPOUND$ deficiency due to the methylenetetrahydrofolate reductase (MTHFR) and @PROTEIN$ (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	1
2495	@COMPOUND$ deficiency due to the @PROTEIN$ (MTHFR) and methionine synthase (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	1
2496	@COMPOUND$ has been the mainstay of endocrine therapy for @PROTEIN$-positive breast cancer.	1
2497	The bifunctional enzyme @PROTEIN$/N-acetylmannosamine kinase (GNE) is the key enzyme for the biosynthesis of @COMPOUND$, terminal components of glycoconjugates associated with a variety of physiological and pathological processes.	1
2498	The bifunctional enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (@PROTEIN$) is the key enzyme for the biosynthesis of @COMPOUND$, terminal components of glycoconjugates associated with a variety of physiological and pathological processes.	1
2499	A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal @PROTEIN$ and glial Cx43 hemichannel activity, favoring @COMPOUND$ release and generation of preconditioning.	1
2500	A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal Cx36 and glial @PROTEIN$ hemichannel activity, favoring @COMPOUND$ release and generation of preconditioning.	1
2501	A study of rituximab and ifosfamide, carboplatin, and @COMPOUND$ chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1
2502	A study of rituximab and ifosfamide, @COMPOUND$, and etoposide chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1
2503	A study of rituximab and @COMPOUND$, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1
2504	4) PKA regulates neurotransmission without @PROTEIN$ involvement because, after @COMPOUND$ or CaC modulation of the PKC activity, coupling to the ACh release of PKA can normally be stimulated with Sp-8-BrcAMP or inhibited with H-89.	0
2505	5) After PKA inhibition with H-89, @PROTEIN$ stimulation with @COMPOUND$ (or inhibition with CaC) does not lead to any change in evoked ACh release.	1
2506	In contrast, PKA inhibition prevent @PROTEIN$ stimulation (with the @COMPOUND$) and coupling to ACh output.	1
2507	The inhibition of female rabbit sexual behavior by @COMPOUND$ : @PROTEIN$-dependent and-independent effects.	1
2508	The influence of @COMPOUND$, atorvastatin and high-cholesterol diet on @PROTEIN$ activity, amyloid beta and cholesterol synthesis in rat brain.	0
2509	The influence of simvastatin, @COMPOUND$ and high-cholesterol diet on @PROTEIN$ activity, amyloid beta and cholesterol synthesis in rat brain.	0
2510	The expressions of serotonin receptors (5-hydroxytryptamine receptor), corticotropin-releasing hormone (@PROTEIN$) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
2511	The expressions of serotonin receptors (5-hydroxytryptamine receptor), @PROTEIN$ (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
2512	The expressions of serotonin receptors (@PROTEIN$), corticotropin-releasing hormone (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
2513	The expressions of @PROTEIN$ (5-hydroxytryptamine receptor), corticotropin-releasing hormone (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
2514	After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, estrone (E1) and @COMPOUND$ (E2), detected suggesting that the pathway of @PROTEIN$ is not important in these cell lines.	0
2515	After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, @COMPOUND$ (E1) and estradiol (E2), detected suggesting that the pathway of @PROTEIN$ is not important in these cell lines.	0
2516	The aim of this study was to investigate the effects of acute and chronic exercise on @COMPOUND$ reactive substances, as an indicator of lipid peroxidation, in the hippocampus, which has a high concentration of @PROTEIN$, and prefrontal cortex and striatum, which have high dopamine content.	0
2517	The aim of this study was to investigate the effects of acute and chronic exercise on thiobarbituric acid reactive substances, as an indicator of lipid peroxidation, in the hippocampus, which has a high concentration of @PROTEIN$, and prefrontal cortex and striatum, which have high @COMPOUND$ content.	0
2518	Additionally we examined antioxidant enzyme activities, @PROTEIN$ and glutathione peroxidase and nitrite-@COMPOUND$ levels to assess the effects of reactive oxygen and nitrogen species.	0
2519	Additionally we examined antioxidant enzyme activities, superoxide dismutase and @PROTEIN$ and nitrite-@COMPOUND$ levels to assess the effects of reactive oxygen and nitrogen species.	0
2520	Oral administration of (PhSe)(2) in rats did not change plasma alanine and @PROTEIN$ activities (AST and ALT) as well as @COMPOUND$ and creatinine levels.	0
2521	Oral administration of (PhSe)(2) in rats did not change plasma alanine and aspartate aminotransferase activities (@PROTEIN$ and ALT) as well as @COMPOUND$ and creatinine levels.	0
2522	Oral administration of (PhSe)(2) in rats did not change plasma alanine and @PROTEIN$ activities (AST and ALT) as well as urea and @COMPOUND$ levels.	0
2523	Oral administration of (PhSe)(2) in rats did not change plasma alanine and aspartate aminotransferase activities (@PROTEIN$ and ALT) as well as urea and @COMPOUND$ levels.	0
2524	Total plasma @COMPOUND$ level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma folate and cobalamin levels were determined.	0
2525	Total plasma homocysteine level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma folate and @COMPOUND$ levels were determined.	0
2526	Total plasma homocysteine level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma @COMPOUND$ and cobalamin levels were determined.	0
2527	Immunohistochemical colabeling for nesfatin-1 and @PROTEIN$, histidine decarboxylase, or @COMPOUND$ revealed two subtypes of nesfatin-1-positive endocrine cells.	0
2528	Immunohistochemical colabeling for nesfatin-1 and ghrelin, @PROTEIN$, or @COMPOUND$ revealed two subtypes of nesfatin-1-positive endocrine cells.	0
2529	Cells in the midportion of the glands coexpressed nesfatin-1 and @PROTEIN$, whereas few cells in the glandular base coexpressed nesfatin-1 and @COMPOUND$ or histidine decarboxylase.	0
2530	Cells in the midportion of the glands coexpressed nesfatin-1 and ghrelin, whereas few cells in the glandular base coexpressed nesfatin-1 and @COMPOUND$ or @PROTEIN$.	0
2531	The role of @COMPOUND$ in the treatment of obesity through @PROTEIN$ antagonism.	1
2532	In conclusion, the enhanced H(2)O(2) contraction in resistance arteries from SHRs seems to be mediated by increased TXA(2) release from @PROTEIN$ followed by elevations in vascular smooth muscle (@COMPOUND$+))(i) levels and O(2)(.	0
2533	The @PROTEIN$ proto-oncogene and microRNA-@COMPOUND$ comprise an active autoregulatory feedback loop in human hematopoietic cells.	1
2534	Herein we show that @PROTEIN$ expression is subject to posttranscriptional regulation by microRNA (miRNA)-@COMPOUND$.	1
2535	Exogenous expression of @PROTEIN$ mRNA lacking the 3'-UTR partially rescued the miR-@COMPOUND$ induced cell-cycle block.	1
2536	Occupancy of one canonical @PROTEIN$ binding site was demonstrated by chromatin immunoprecipitation analysis and shown to be required for miR-@COMPOUND$ expression in K562 cells.	1
2537	In aggregate, these findings suggest the presence of a @PROTEIN$-miR-@COMPOUND$ autoregulatory feedback loop of potential importance in human hematopoiesis.	1
2538	The central homeostasis is characterized by increased cerebrocortical synaptosomal T(3) content, deiodinase type II (@PROTEIN$) activity, and @COMPOUND$ content.	0
2539	This review provides an introduction to epigenetic concepts for renal investigators and an overview of our work detailing an epigenetic pathway for @COMPOUND$ signaling and the control of epithelial @PROTEIN$-alpha (ENaCalpha) subunit gene expression in the collecting duct.	0
2540	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the @PROTEIN$ (CEA) promoter.	1
2541	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1
2542	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1
2543	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the @PROTEIN$ (CEA) promoter.	1
2544	Cytopathic effects of AxdAdB-3 plus AxCEAprTK (an adenovirus expressing HSVtk directed by CEA promoter) or AxCAHSVtk (an adenovirus expressing HSVtk directed by a nonspecific @PROTEIN$ promoter) with @COMPOUND$ administration were examined in several GBC lines and normal cells.	0
2545	This mutation in the @PROTEIN$ gene replaces a @COMPOUND$ encoding codon with a stop signal.	1
2546	Cyclophilin A (CypA), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (@PROTEIN$) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	0
2547	Cyclophilin A (@PROTEIN$), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (PPIase) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	1
2548	@PROTEIN$ (CypA), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (PPIase) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	1
2549	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2550	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (@PROTEIN$).	0
2551	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2552	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and @PROTEIN$ (GST).	0
2553	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of @PROTEIN$ (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2554	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2555	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), @PROTEIN$ (GPx) and glutathione S-transferase (GST).	0
2556	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2557	@PROTEIN$ alpha is a proximal mediator of synergistic hepatotoxicity from @COMPOUND$/lipopolysaccharide coexposure.	1
2558	A small cytoplasmic protein, @PROTEIN$, has been identified in human hepatic tissue, but its role in @COMPOUND$ metabolism is unknown.	0
2559	As with @PROTEIN$, they are involved in making @COMPOUND$ available to apo-enzymes inside the cell.	1
2560	BrdU proliferation assays showed that in vivo proliferation of CD8+ T cells was reduced in @COMPOUND$-fed mice, and @PROTEIN$-dependent in vitro proliferation of naive CD8+ T cells was also reduced.	0
2561	Regulation of T-type @PROTEIN$.1 channels expression by synthetic glucocorticoid @COMPOUND$ in neonatal cardiac myocytes.	1
2562	Role of @PROTEIN$ as a biomarker for predicting resistance to @COMPOUND$ in breast cancer.	1
2563	Acute regulation is mediated by the @PROTEIN$ (StAR), which facilitates the rapid influx of @COMPOUND$ into mitochondria, where P450scc resides.	1
2564	Acute regulation is mediated by the steroidogenic acute regulatory protein (@PROTEIN$), which facilitates the rapid influx of @COMPOUND$ into mitochondria, where P450scc resides.	1
2565	In the absence of @PROTEIN$ in the zona glomerulosa, C21 deoxy steroids are produced, leading to the mineralocorticoid, @COMPOUND$.	0
2566	In the presence of the 17alpha-hydroxylase but not the 17,20 lyase activity of @PROTEIN$ in the zona fasciculata, C21, 17-hydroxy steroids are produced, leading to the glucocorticoid, @COMPOUND$.	0
2567	When both the 17alpha-hydroxylase and 17,20 lyase activities of @PROTEIN$ are present in the zona reticularis, the androgen precursor @COMPOUND$ is produced.	1
2568	In the adrenal zona reticularis, the abundant expression of P450 oxidoreductase and cytochrome b5, and the low expression of @PROTEIN$ (HSD3B2) result in the production of the large amounts of @COMPOUND$ that characterize adrenarche.	1
2569	In the adrenal zona reticularis, the abundant expression of P450 oxidoreductase and @PROTEIN$, and the low expression of 3beta-hydroxysteroid dehydrogenase (HSD3B2) result in the production of the large amounts of @COMPOUND$ that characterize adrenarche.	1
2570	In the adrenal zona reticularis, the abundant expression of P450 oxidoreductase and cytochrome b5, and the low expression of 3beta-hydroxysteroid dehydrogenase (@PROTEIN$) result in the production of the large amounts of @COMPOUND$ that characterize adrenarche.	1
2571	These were mutated in onion @PROTEIN$ (acINV) according to the residue in festuca @COMPOUND$ : sucrose 1-fructosyltransferase (saSST) and vice versa.	0
2572	These were mutated in onion vacuolar invertase (acINV) according to the residue in festuca @COMPOUND$ : @PROTEIN$-fructosyltransferase (saSST) and vice versa.	0
2573	Furthermore, the effect of @COMPOUND$ on @PROTEIN$ has not been reported previously.	1
2574	In the present study, we investigated the cellular and molecular mechanisms of @PROTEIN$ regulation by @COMPOUND$ in VSMCs (vascular SMCs).	1
2575	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
2576	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
2577	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
2578	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
2579	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
2580	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
2581	Inhibition of @PROTEIN$ by @COMPOUND$ analogues: Implications for anticancer activity.	1
2582	An isocratic fluorescence HPLC assay for the monitoring of @PROTEIN$ activity and l-@COMPOUND$ depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.	0
2583	Anti-gastric cancer effects of @COMPOUND$, a selective COX-2 inhibitor, through inhibition of @PROTEIN$ signaling.	1
2584	Among the R-Nx strains, a substitution of @COMPOUND$ to Cys at position 81 (Gly81à Cys) of the @PROTEIN$ gene in 10 strains isolated from wild birds and ovine foetuses, and of Asp to Tyr at position 87 (Asp87à Tyr) in one strain isolated from ewe faeces, were revealed by sequencing the gene.	1
2585	Expansion of the first @COMPOUND$ tract of the @PROTEIN$ gene in a boy presenting with generalized dystonia in the absence of infantile spasms.	1
2586	Gene sequencing detected an additional seven GCG repeats in the first @COMPOUND$ tract of the @PROTEIN$ gene, a mutation which leads to an expansion of the normal 16 alanine residues to 23.	1
2587	Emerging evidence that both @PROTEIN$ (BDNF) and @COMPOUND$ suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	0
2588	Emerging evidence that both brain-derived neurotrophic factor (@PROTEIN$) and @COMPOUND$ suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	0
2589	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2590	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2591	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2592	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2593	We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2594	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2595	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2596	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2597	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2598	We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2599	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2600	ESRD patients showed a significant increase in Cu/Zn @PROTEIN$, total @COMPOUND$ and hs CRP levels between controls and all patients group.	0
2601	ESRD patients showed a significant increase in Cu/Zn SOD, total @COMPOUND$ and hs @PROTEIN$ levels between controls and all patients group.	0
2602	Diabetes is characterized by elevated fasting blood @COMPOUND$ (FBG) resulting from improper @PROTEIN$ regulation and/or insulin resistance.	1
2603	THII significantly diminished these changes in @COMPOUND$ and @PROTEIN$.	0
2604	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
2605	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
2606	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
2607	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
2608	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
2609	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
2610	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
2611	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
2612	An extensive kinetic profile towards a plethora of purines and mutational analyses have established models on how @PROTEIN$ recognizes the @COMPOUND$ and revealed specific amino acid residues involved in proper folding, topogenesis, function and specificity.	1
2613	The present work describes for the first time the purification of the @PROTEIN$ transporter of A. nidulans through overexpression via the strong, @COMPOUND$-inducible, glucose-repressible, alcA promoter.	1
2614	The present work describes for the first time the purification of the @PROTEIN$ transporter of A. nidulans through overexpression via the strong, ethanol-inducible, @COMPOUND$-repressible, alcA promoter.	1
2615	The present work describes for the first time the purification of the UapA transporter of A. nidulans through overexpression via the strong, @COMPOUND$-inducible, glucose-repressible, @PROTEIN$ promoter.	1
2616	The present work describes for the first time the purification of the UapA transporter of A. nidulans through overexpression via the strong, ethanol-inducible, @COMPOUND$-repressible, @PROTEIN$ promoter.	1
2617	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
2618	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
2619	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
2620	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
2621	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
2622	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
2623	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
2624	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
2625	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
2626	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
2627	Synthesis of GDP-@COMPOUND$ from exogenous mannose requires @PROTEIN$ or phosphotransferase enzymes together with PMM and GMPP.	1
2628	Synthesis of GDP-@COMPOUND$ from exogenous mannose requires hexokinase or phosphotransferase enzymes together with @PROTEIN$ and GMPP.	1
2629	Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1
2630	Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0
2631	Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1
2632	Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0
2633	@PROTEIN$, vascular endothelial growth factor, and @COMPOUND$ increased EC permeability, disrupted cell junctions, and induced stress fiber formation.	0
2634	Clarified glycomic and protemic information combined with publicly available microarray data sets allowed us to identify @PROTEIN$ as a receptor of @COMPOUND$ epitope.	1
2635	Also, our previous studies implicated the SphK1/@PROTEIN$ pathway in the induction of the @COMPOUND$ cascade, a major inflammatory pathway involved in colon carcinogenesis.	1
2636	In the azoxymethane (@COMPOUND$) murine model of colon cancer, SphK1 and @PROTEIN$ were significantly elevated in colon cancer tissues compared to normal mucosa.	1
2637	In the @COMPOUND$ (AOM) murine model of colon cancer, SphK1 and @PROTEIN$ were significantly elevated in colon cancer tissues compared to normal mucosa.	1
2638	Uptake of @COMPOUND$, losartan, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
2639	Uptake of valsartan, @COMPOUND$, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
2640	Uptake of valsartan, losartan, and @COMPOUND$ was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
2641	In contrast to cefadroxil, no @PROTEIN$-specific uptake of @COMPOUND$ and losartan was found.	0
2642	In contrast to cefadroxil, no @PROTEIN$-specific uptake of valsartan and @COMPOUND$ was found.	0
2643	In contrast to @COMPOUND$, no @PROTEIN$-specific uptake of valsartan and losartan was found.	1
2644	Hormone-sensitive lipase (@PROTEIN$) is a key regulator of @COMPOUND$ esters metabolism.	1
2645	@PROTEIN$ (HSL) is a key regulator of @COMPOUND$ esters metabolism.	1
2646	Much interest has been directed to the study of the @PROTEIN$, because @COMPOUND$ has been instrumental in discovering the unique role of a subset of primary sensory neurons in causing nociceptive responses, in activating reflex pathways including cough, and in producing neurogenic inflammation.	0
2647	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of @COMPOUND$, 2b and 3a, were studied.	0
2648	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) @COMPOUND$ (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
2649	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, @COMPOUND$-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
2650	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and @COMPOUND$-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
2651	Among them, @COMPOUND$ and 5 had significant @PROTEIN$ inhibitory activities.	1
2652	Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the @PROTEIN$ model, as GSTs were found to be affected by tea catechins.	1
2653	Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the GST P1-1 model, as @PROTEIN$ were found to be affected by tea catechins.	1
2654	The protein glycation inhibitory activity of ethanolic extract of Lawsonia inermis (henna) plant tissues was evaluated in vitro using the model system of bovine @PROTEIN$ and @COMPOUND$.	0
2655	In vitro effects of @COMPOUND$ treatment on fish liver @PROTEIN$ activity.	1
2656	The effect of @COMPOUND$ (PN), a highly toxic agent, on @PROTEIN$ (CAT) activity in fish liver microsomal homogenates was determined.	1
2657	The effect of @COMPOUND$ (PN), a highly toxic agent, on catalase (@PROTEIN$) activity in fish liver microsomal homogenates was determined.	1
2658	NMR-derived @COMPOUND$-bound structure of @PROTEIN$ from the halophile Haloferax volcanii.	1
2659	@COMPOUND$-regulated activity of @PROTEIN$.	1
2660	The biological roles of the @COMPOUND$-regulated conformational equilibrium of @PROTEIN$ are discussed in terms of the self and non-self discrimination mechanism.	1
2661	The Iowa Gambling Task (IGT) was used to examine (i) social decision-making in women with borderline personality disorder (BPD), and (ii) the relationship between impaired decision-making and the tryptophan hydroxylase-1 (@PROTEIN$) gene, involved in @COMPOUND$ synthesis.	1
2662	These results underscore the differential regulation of GPX expression in response to cadmium, aluminium and @COMPOUND$, and strongly support a role for @PROTEIN$ and possibly other GPX genes in stress and/or metabolic signalling.	1
2663	These results underscore the differential regulation of @PROTEIN$ expression in response to cadmium, @COMPOUND$ and nitric oxide, and strongly support a role for GPX6 and possibly other GPX genes in stress and/or metabolic signalling.	1
2664	These results underscore the differential regulation of GPX expression in response to cadmium, @COMPOUND$ and nitric oxide, and strongly support a role for @PROTEIN$ and possibly other GPX genes in stress and/or metabolic signalling.	1
2665	These results underscore the differential regulation of @PROTEIN$ expression in response to cadmium, aluminium and @COMPOUND$, and strongly support a role for GPX6 and possibly other GPX genes in stress and/or metabolic signalling.	1
2666	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (@COMPOUND$ reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2667	Systemic, hepatosplanchnic, and renal hemodynamics; @COMPOUND$ exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2668	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (@COMPOUND$ reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2669	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/@COMPOUND$ and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2670	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (@COMPOUND$/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2671	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/@COMPOUND$ and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2672	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/@COMPOUND$ and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2673	Systemic, hepatosplanchnic, and renal hemodynamics; @COMPOUND$ exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2674	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (@COMPOUND$ reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2675	Systemic, hepatosplanchnic, and renal hemodynamics; @COMPOUND$ exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2676	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (@COMPOUND$, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2677	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (@COMPOUND$/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2678	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (@COMPOUND$/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2679	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (@COMPOUND$, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2680	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (@COMPOUND$, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2681	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (@COMPOUND$ reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, @PROTEIN$, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2682	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (@COMPOUND$, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2683	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (@COMPOUND$/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, @PROTEIN$); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2684	Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/@COMPOUND$ and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (@PROTEIN$, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2685	Systemic, hepatosplanchnic, and renal hemodynamics; @COMPOUND$ exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, @PROTEIN$-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	0
2686	The purpose of this retrospective study was to compare the effects of @PROTEIN$ and @COMPOUND$ in the management of HIT.	0
2687	The outer membrane @PROTEIN$ is involved in @COMPOUND$ tolerance and overproduction in Escherichia coli.	1
2688	Gene expression analysis revealed that the @PROTEIN$ gene encoding the outer membrane channel is essential for @COMPOUND$ tolerance in E. coli cells.	1
2689	Bacterial strains differed in their ability to synthesize @COMPOUND$ and hydrogen cyanide compounds, as well as in their @PROTEIN$ activity.	0
2690	Bacterial strains differed in their ability to synthesize auxin and @COMPOUND$ compounds, as well as in their @PROTEIN$ activity.	0
2691	Toll-like receptor (@PROTEIN$) 4 is a critical receptor and signal transducer for @COMPOUND$ (LPS), a major component of Gram-negative bacteria.	1
2692	Postprandial @COMPOUND$ and @PROTEIN$.05) in HTAG.	0
2693	Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the @COMPOUND$-dependent glutathione peroxidases, @PROTEIN$.	1
2694	Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the @COMPOUND$-dependent @PROTEIN$, GPx2.	1
2695	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), @COMPOUND$ (NO) and dopamine (DA) in aged mice.	0
2696	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), nitric oxide (NO) and @COMPOUND$ (DA) in aged mice.	0
2697	The purpose of this study was to investigate whether or not the role of @COMPOUND$ (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), nitric oxide (NO) and dopamine (DA) in aged mice.	0
2698	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), @COMPOUND$ (NO) and dopamine (DA) in aged mice.	0
2699	The purpose of this study was to investigate whether or not the role of @COMPOUND$ (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), nitric oxide (NO) and dopamine (DA) in aged mice.	1
2700	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), nitric oxide (NO) and @COMPOUND$ (DA) in aged mice.	0
2701	Model analysis of local @COMPOUND$ delivery with liposome-encapsulated @PROTEIN$.	1
2702	Liposome-encapsulated @PROTEIN$ (LHs) are comparable to red blood cells (RBCs) in terms of @COMPOUND$ (O(2))-carrying capacity.	1
2703	Moreover, both lung and plasma concentrations of the pro-inflammatory cytokines tumour necrosis factor-alpha and @PROTEIN$ were higher in @COMPOUND$-treated animals at this time-point.	1
2704	Increased intrahepatic vascular tone in cirrhosis has been attributed to a decrease of hepatic @COMPOUND$ (NO) secondary to disturbances in the post-translational regulation of the enzyme @PROTEIN$.	0
2705	The profile of global DNA and @PROTEIN$ (ER)-alpha gene methylation during cancer development was determined by analysis of @COMPOUND$ (5-MeC) using immunohistochemical (IHC) staining, dot blot analysis or a quantitative gene methylation assay (QGMA).	0
2706	The profile of global DNA and @PROTEIN$ (ER)-alpha gene methylation during cancer development was determined by analysis of 5-methylcytosine (5-@COMPOUND$) using immunohistochemical (IHC) staining, dot blot analysis or a quantitative gene methylation assay (QGMA).	0
2707	Zebularine suppresses the apoptotic potential of @COMPOUND$ via cAMP/PKA/@PROTEIN$ pathway against human oral squamous cell carcinoma cells.	1
2708	Zebularine suppresses the apoptotic potential of 5-fluorouracil via @COMPOUND$/PKA/@PROTEIN$ pathway against human oral squamous cell carcinoma cells.	0
2709	Complex modulation of L-type @COMPOUND$+) current inactivation by @PROTEIN$ in isolated rabbit cardiomyocytes.	1
2710	Donor testicular cells were prepared from heterozygous chicken beta actin (CAG)/enhanced @PROTEIN$ (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
2711	Donor testicular cells were prepared from heterozygous chicken beta actin (@PROTEIN$)/enhanced green fluorescent protein (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
2712	Donor testicular cells were prepared from heterozygous chicken @PROTEIN$ (CAG)/enhanced green fluorescent protein (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
2713	In the present work, the activity of the enzymes xylose reductase (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (@PROTEIN$) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
2714	In the present work, the activity of the enzymes @PROTEIN$ (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (G6PD) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
2715	Inhibition of human @PROTEIN$ by @COMPOUND$ and irreversible formation of advanced glycation end products.	1
2716	The affinity of @PROTEIN$ for gluconeogenic substrate @COMPOUND$ altered after preincubation with MG in the same manner, but less intensively.	1
2717	Inhibitory effects of Cefazolin and @COMPOUND$ on the activity of mushroom @PROTEIN$.	1
2718	Inhibitory effects of @COMPOUND$ and Cefodizime on the activity of mushroom @PROTEIN$.	1
2719	The order of the cytotoxicity of the compounds was; IV &gt; III &gt; II &gt; I &gt; V. @COMPOUND$, had the highest Hammett and log P values (0.23 and 4.21, respectively) and exerted both highest cytotoxicity and strongest @PROTEIN$ inhibition.	1
2720	Heme oxygenase-1 (@PROTEIN$) and @COMPOUND$ (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	0
2721	@PROTEIN$ (HO-1) and @COMPOUND$ (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	0
2722	A shift toward proinflammatory microglial activation is indicated by the release of interleukin-6, @PROTEIN$-alpha, and @COMPOUND$ and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide.	0
2723	A shift toward proinflammatory microglial activation is indicated by the release of @PROTEIN$, tumor necrosis factor-alpha, and @COMPOUND$ and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide.	0
2724	The human AU @PROTEIN$/enoyl-Coenzyme A hydratase (AUH) is a 3-hydroxy-3-methylglutaconyl-CoA dehydratase in the @COMPOUND$ degradation pathway.	1
2725	The human AU RNA binding protein/enoyl-Coenzyme A hydratase (@PROTEIN$) is a 3-hydroxy-3-methylglutaconyl-CoA dehydratase in the @COMPOUND$ degradation pathway.	1
2726	@PROTEIN$ is responsible for the sulfation and inactivation of @COMPOUND$ (E2) at physiological concentrations.	1
2727	The main mechanism of resistance to @COMPOUND$ was extra-chromosomal amplification of the @PROTEIN$ gene.	1
2728	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) @COMPOUND$ (3) binding and @PROTEIN$ protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	0
2729	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by @COMPOUND$ (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and @PROTEIN$ protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	0
2730	Here, PCA is applied to three problems in @PROTEIN$ research: (i) distinguishing origins of heparin preparations, (ii) structural analysis of heparin derivatives, and (iii) classification of @COMPOUND$ (CS).	1
2731	The CL(int) was obtained using either individual or combined cofactors for cytochrome P450 (P450) and UGT enzymes with @COMPOUND$ activation and in the presence and absence of 2% bovine serum albumin (@PROTEIN$).	0
2732	The CL(int) was obtained using either individual or combined cofactors for cytochrome P450 (P450) and UGT enzymes with @COMPOUND$ activation and in the presence and absence of 2% bovine @PROTEIN$ (BSA).	0
2733	By using purified bovine @PROTEIN$, the reduction was observed in the presence of @COMPOUND$ (P)H. These results suggest that FLU-1 N-OH is involved in flutamide-induced hepatotoxicity and that cytosolic reduction of FLU-1 N-OH plays a major role in protection against flutamide-induced hepatotoxicity.	1
2734	An acute increase in @COMPOUND$ tension led to Smad activation within 30 minutes, even in the absence of exogenous @PROTEIN$ treatment.	0
2735	Recognition of @COMPOUND$ components of pectin by @PROTEIN$.	1
2736	By using a combination of fluorescence microscopy, flow cytometry, and force spectroscopy, it has been possible to demonstrate, for the first time, specific binding of a pectin @COMPOUND$ to the recombinant form of human @PROTEIN$.	1
2737	@PROTEIN$ has been identified as an endoplasmic reticulum (ER)-resident @COMPOUND$+) sensor that regulates store-operated calcium entry (SOCE) in immune cells and platelets, but the identity of the platelet SOC channel has remained elusive.	1
2738	A sensitive and specific ELISA detects @COMPOUND$-containing @PROTEIN$ in HDL.	1
2739	A wide range of reactive intermediates oxidizes methionine residues to @COMPOUND$ (MetO) in @PROTEIN$ (apoA-I), the major HDL protein.	1
2740	A wide range of reactive intermediates oxidizes methionine residues to @COMPOUND$ (MetO) in apolipoprotein A-I (@PROTEIN$), the major HDL protein.	1
2741	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between @COMPOUND$-clavulanate and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
2742	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, @COMPOUND$ and aztreonam.	1
2743	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and @COMPOUND$, ceftriaxone, ceftazidime and aztreonam.	1
2744	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, @COMPOUND$, ceftazidime and aztreonam.	1
2745	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, ceftazidime and @COMPOUND$.	1
2746	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-@COMPOUND$ and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
2747	@COMPOUND$ (NO) and interlukin-6 (@PROTEIN$) are highly reactive mediators that have been shown to play different roles in a variety of different biological process.	0
2748	Mitochondrial @PROTEIN$ (ALDH-2)--maker of and marker for nitrate tolerance in response to @COMPOUND$ treatment.	1
2749	Mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)--maker of and marker for nitrate tolerance in response to @COMPOUND$ treatment.	1
2750	Mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)--maker of and marker for @COMPOUND$ tolerance in response to nitroglycerin treatment.	1
2751	Mitochondrial @PROTEIN$ (ALDH-2)--maker of and marker for @COMPOUND$ tolerance in response to nitroglycerin treatment.	1
2752	According to the oxidative stress concept, increased vascular @COMPOUND$ and peroxynitrite production as well as an increased sensitivity to vasoconstrictors secondary to activation of @PROTEIN$ as well as vascular NADPH oxidases contribute to the development of tolerance.	0
2753	According to the oxidative stress concept, increased vascular superoxide and @COMPOUND$ production as well as an increased sensitivity to vasoconstrictors secondary to activation of @PROTEIN$ as well as vascular NADPH oxidases contribute to the development of tolerance.	0
2754	mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)) and mitochondria as potential sources of reactive @COMPOUND$ species (ROS).	0
2755	mitochondrial @PROTEIN$ (ALDH-2)) and mitochondria as potential sources of reactive @COMPOUND$ species (ROS).	0
2756	Finally, we will address the question whether @PROTEIN$-2 inactivation by nitroglycerin could be a useful marker for clinical nitrate tolerance and discuss the redox-regulation of this enzyme by oxidative stress and @COMPOUND$.	0
2757	Finally, we will address the question whether @PROTEIN$-2 inactivation by @COMPOUND$ could be a useful marker for clinical nitrate tolerance and discuss the redox-regulation of this enzyme by oxidative stress and dihydrolipoic acid.	0
2758	Finally, we will address the question whether @PROTEIN$-2 inactivation by nitroglycerin could be a useful marker for clinical @COMPOUND$ tolerance and discuss the redox-regulation of this enzyme by oxidative stress and dihydrolipoic acid.	0
2759	Sex steroids enhance @PROTEIN$ and @COMPOUND$ oxidation in Chang liver cells.	0
2760	The present study was designed to assess the effect of sex steroids (testosterone and 17beta-estradiol) on @PROTEIN$ receptor expression, insulin binding and @COMPOUND$ oxidation in human liver cell line.	0
2761	The present study was designed to assess the effect of sex steroids (@COMPOUND$ and 17beta-estradiol) on @PROTEIN$ receptor expression, insulin binding and glucose oxidation in human liver cell line.	1
2762	The present study was designed to assess the effect of sex steroids (testosterone and @COMPOUND$) on @PROTEIN$ receptor expression, insulin binding and glucose oxidation in human liver cell line.	1
2763	The present study was designed to assess the effect of sex steroids (@COMPOUND$ and 17beta-estradiol) on @PROTEIN$ expression, insulin binding and glucose oxidation in human liver cell line.	1
2764	The present study was designed to assess the effect of sex steroids (testosterone and 17beta-estradiol) on @PROTEIN$ expression, insulin binding and @COMPOUND$ oxidation in human liver cell line.	0
2765	The present study was designed to assess the effect of sex steroids (testosterone and @COMPOUND$) on @PROTEIN$ expression, insulin binding and glucose oxidation in human liver cell line.	1
2766	In order to suppress the emergence of such resistant variants, we introduced charged and hydrophilic amino acids, @COMPOUND$ (E) and lysine (K), at the solvent accessible site of @PROTEIN$.	1
2767	In order to suppress the emergence of such resistant variants, we introduced charged and hydrophilic amino acids, glutamic acid (E) and @COMPOUND$ (K), at the solvent accessible site of @PROTEIN$.	1
2768	Cloning, expression, and characterization of @COMPOUND$-induced @PROTEIN$ from the earthworms Metaphire posthuma and Polypheretima elongata.	1
2769	In this study we report the sequences of @PROTEIN$ cDNA from two species of Megascoleidae earthworms, Metaphire posthuma and Polypheretima elongata, by mRNA differential display after exposure of the organisms to @COMPOUND$.	1
2770	Complementary (c)DNA was verified as the @PROTEIN$ gene by the characteristics of its predicted translation product, namely a high @COMPOUND$ content, conserved CXC motifs, and a molecular weight of around 8 kDa.	1
2771	These earthworms could be used to evaluate heavy-metal pollution in soil due to the inducible @PROTEIN$ by @COMPOUND$ exposure.	1
2772	The culture medium was analyzed for pH value, concentration of free calcium and @COMPOUND$ and @PROTEIN$.	0
2773	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl oxygen in uracil or @COMPOUND$, cause substantial reductions in XDG and @PROTEIN$ activities.	0
2774	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl @COMPOUND$ in uracil or xanthine, cause substantial reductions in XDG and @PROTEIN$ activities.	0
2775	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl oxygen in @COMPOUND$ or xanthine, cause substantial reductions in XDG and @PROTEIN$ activities.	0
2776	Most interestingly, a proline substitution at the G63 position switches the Gme SMUG1 enzyme to an exclusive @PROTEIN$ as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
2777	Most interestingly, a proline substitution at the G63 position switches the Gme @PROTEIN$ enzyme to an exclusive UDG as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
2778	Most interestingly, a @COMPOUND$ substitution at the G63 position switches the Gme @PROTEIN$ enzyme to an exclusive UDG as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
2779	Most interestingly, a proline substitution at the G63 position switches the @PROTEIN$ SMUG1 enzyme to an exclusive UDG as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
2780	Most interestingly, a @COMPOUND$ substitution at the G63 position switches the Gme SMUG1 enzyme to an exclusive @PROTEIN$ as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
2781	Most interestingly, a @COMPOUND$ substitution at the G63 position switches the @PROTEIN$ SMUG1 enzyme to an exclusive UDG as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
2782	Furthermore, increased production of high inducible nitric oxide synthase (iNOS) and @PROTEIN$ (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
2783	Furthermore, increased production of high inducible @PROTEIN$ (iNOS) and cyclooxygenase 2 (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
2784	Furthermore, increased production of high inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (@PROTEIN$) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
2785	Furthermore, increased production of high inducible nitric oxide synthase (@PROTEIN$) and cyclooxygenase 2 (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
2786	We report herein some novel phenomena between hemin-H(2)O(2)-NO(2)(-) and @COMPOUND$ (SIN-1)-mediated oxidation and nitration reactions of glutamate dehydrogenase (@PROTEIN$).	1
2787	We report herein some novel phenomena between hemin-H(2)O(2)-NO(2)(-) and @COMPOUND$ (SIN-1)-mediated oxidation and nitration reactions of @PROTEIN$ (GDH).	1
2788	@COMPOUND$ was the most potent regulator of @PROTEIN$ affinity, with concentrations of 5 mmol L(-1) causing an increase in p(50) from 5 to 19 mm Hg at pH 7.5, while the order of potency of the other phosphates was IHP&gt;ATP&gt;BPG.	1
2789	No main effect of group assignment on TSST responses was found for @PROTEIN$, @COMPOUND$ or POMS scores.	0
2790	The objective of this study was to determine: (i) the prevalence of resistance in current clinical isolates of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis and Klebsiella pneumoniae; (ii) the prevalence of production of extended-spectrum @PROTEIN$ (ESBLs) and @COMPOUND$ resistance in S. aureus; and (iii) regional differences in the prevalence of ESBL production and clonality of K. pneumoniae isolates.	1
2791	@COMPOUND$-induced expression of the orphan nuclear receptor @PROTEIN$ in MA-10 Leydig cells involves a CaMKI pathway.	1
2792	@COMPOUND$-induced expression of the orphan nuclear receptor Nur77 in MA-10 Leydig cells involves a @PROTEIN$ pathway.	1
2793	In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the @PROTEIN$/@COMPOUND$ (cAMP) signaling pathway.	1
2794	In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the @PROTEIN$/cyclic adenosine monophosphate (@COMPOUND$) signaling pathway.	1
2795	Here, we report that @COMPOUND$-mediated induction of @PROTEIN$ expression at the protein, mRNA, and promoter levels in MA-10 cells involves different mechanisms.	1
2796	In addition, our detailed analysis of the @PROTEIN$ promoter in MA-10 cells revealed that distinct regulatory elements are involved in basal and @COMPOUND$-induced Nur77 transcription.	1
2797	Expression of @PROTEIN$ during germ cell apoptosis in testis of cynomolgus monkey after @COMPOUND$ and heat treatment.	0
2798	Comparing expression of @COMPOUND$ and @PROTEIN$ in testicular tissue from men with obstructive and nonobstructive azoospermia.	0
2799	Based on fasting @PROTEIN$ and @COMPOUND$, several indices of insulin sensitivity have been developed in adults.	0
2800	LDL from all subjects stimulated both the basal and @PROTEIN$-induced @COMPOUND$ and cortisol release from adrenocortical cells.	1
2801	LDL from all subjects stimulated both the basal and @PROTEIN$-induced aldosterone and @COMPOUND$ release from adrenocortical cells.	1
2802	@PROTEIN$/KC was detected as early as 6 hours after @COMPOUND$ instillation and returned to basal levels after Day 8.	1
2803	DF2162 treatment reduced @COMPOUND$-induced expression of @PROTEIN$, a marker of angiogenesis, in the lung.	1
2804	Therapeutic strategy to rescue mutation-induced exon skipping in @PROTEIN$ by adaptation of @COMPOUND$ snRNA.	1
2805	As a therapeutic strategy, @COMPOUND$ snRNAs were adapted to the novel @PROTEIN$ mutation and tested for its potential to reverse missplicing.	1
2806	Urinary concentrations of @COMPOUND$, dihydrogenistein, O-desmethylangolensin, and equol exceeded @PROTEIN$ aglycone equivalents.	0
2807	Urinary concentrations of dihydrodaidzein, dihydrogenistein, O-desmethylangolensin, and @COMPOUND$ exceeded @PROTEIN$ aglycone equivalents.	0
2808	Urinary concentrations of dihydrodaidzein, dihydrogenistein, @COMPOUND$, and equol exceeded @PROTEIN$ aglycone equivalents.	0
2809	Urinary concentrations of dihydrodaidzein, @COMPOUND$, O-desmethylangolensin, and equol exceeded @PROTEIN$ aglycone equivalents.	0
2810	Concentrations of @COMPOUND$, @PROTEIN$, C-peptide, nonesterified fatty acids, triacylglycerol, total and exogenous glucose kinetics were assessed for 6 h postprandially.	0
2811	After 120 min, @COMPOUND$ and @PROTEIN$ responses declined, but remained higher after the Pol 0.05) in parallel to the inhibition of lipolysis.	0
2812	It controls the expression of a total of 11 genes, the @PROTEIN$ regulon, in a @COMPOUND$-dependent manner.	1
2813	An enzymatic reaction between @COMPOUND$ and @PROTEIN$ produced oxygen bubbles and thus many internal pores within microsphere were naturally developed.	1
2814	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0
2815	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0
2816	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0
2817	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0
2818	We present a robust and simple method for the direct detection of multiple point mutations in the Mycobacterium tuberculosis @PROTEIN$ gene during the development of @COMPOUND$ (RIF) resistance using an electrochemical genosensor.	1
2819	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the @PROTEIN$ (CD39) and the ecto-5'-nucleotidase (CD73).	1
2820	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (@PROTEIN$) and the ecto-5'-nucleotidase (CD73).	1
2821	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (CD39) and the @PROTEIN$ (CD73).	1
2822	Critical role of @PROTEIN$ in prostacyclin production by human endothelial cells under modification of @COMPOUND$ tone.	0
2823	Critical role of @PROTEIN$ in @COMPOUND$ production by human endothelial cells under modification of hydroperoxide tone.	1
2824	We aimed at evaluating the relative contribution of cyclooxygenase (@PROTEIN$)-1 and COX-2 to the synthesis of prostacyclin in endothelial cells under static conditions in the presence or absence of exogenous @COMPOUND$ and/or altered intracellular redox balance.	0
2825	We aimed at evaluating the relative contribution of cyclooxygenase (COX)-1 and @PROTEIN$ to the synthesis of prostacyclin in endothelial cells under static conditions in the presence or absence of exogenous @COMPOUND$ and/or altered intracellular redox balance.	0
2826	We aimed at evaluating the relative contribution of cyclooxygenase (COX)-1 and @PROTEIN$ to the synthesis of @COMPOUND$ in endothelial cells under static conditions in the presence or absence of exogenous arachidonic acid and/or altered intracellular redox balance.	1
2827	We aimed at evaluating the relative contribution of cyclooxygenase (@PROTEIN$)-1 and COX-2 to the synthesis of @COMPOUND$ in endothelial cells under static conditions in the presence or absence of exogenous arachidonic acid and/or altered intracellular redox balance.	1
2828	In contrast, @PROTEIN$.24, CYP2D6.26, and CYP2D6.27 allelic isoforms all showed active drug-metabolizing activities toward both codeine and @COMPOUND$ O-demethylation.	1
2829	In contrast, @PROTEIN$.24, CYP2D6.26, and CYP2D6.27 allelic isoforms all showed active drug-metabolizing activities toward both @COMPOUND$ and dextromethorphan O-demethylation.	1
2830	Mechanism-based inactivation of @PROTEIN$ by tienilic acid and (+/-)-@COMPOUND$ : a comparison of kinetics and probe substrate selection.	1
2831	Mechanism-based inactivation of @PROTEIN$ by @COMPOUND$ and (+/-)-suprofen : a comparison of kinetics and probe substrate selection.	1
2832	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by @COMPOUND$ and (+/-)-suprofen using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1
2833	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by tienilic acid and (+/-)-@COMPOUND$ using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1
2834	Effects of chronic inflammation and @COMPOUND$ tolerance on the expression of phospho-ERK 1/2 and phospho-@PROTEIN$ in the injured tissue.	1
2835	Effects of chronic inflammation and @COMPOUND$ tolerance on the expression of phospho-@PROTEIN$/2 and phospho-P38 in the injured tissue.	1
2836	The results of the present study show that @PROTEIN$ phosphorylation is unaltered by inflammation or @COMPOUND$ tolerance, each one individually, in the plantar tissue.	0
2837	In contrast, no significant differences in phospho-@PROTEIN$ expression were observed between naïve and tolerant animals acutely injected with saline or @COMPOUND$ in presence of CFA inflammation.	0
2838	These results suggest that @PROTEIN$ but not p38 could be implicated in the development of @COMPOUND$ tolerance during peripheral inflammation.	1
2839	In addition to @COMPOUND$ and hyperforin, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	0
2840	In addition to rifampicin and @COMPOUND$, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	0
2841	In addition to rifampicin and hyperforin, the anticancer drug @COMPOUND$ has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	1
2842	In addition to rifampicin and @COMPOUND$, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	0
2843	In addition to @COMPOUND$ and hyperforin, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	0
2844	In addition to rifampicin and hyperforin, the anticancer drug @COMPOUND$ has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	1
2845	A comprehensive literature review of clinical studies in children evaluating s-@PROTEIN$ or CysC-based formulas and plasma @COMPOUND$ or creatinine-based formulas against an exogenous reference method using receiver operating characteristics (ROC) curves or Bland-Altman plots is presented.	0
2846	The comparison of s-@PROTEIN$ with plasma @COMPOUND$ indicated that s-CysC was superior to plasma creatinine in five of 13 studies; four studies showed no difference, and, in four studies, no statistical comparison was made.	0
2847	S-@PROTEIN$ is most likely superior to plasma @COMPOUND$ and at least equal to creatinine-based formulas.	0
2848	@PROTEIN$-based prediction equations are at least as good as @COMPOUND$-based formulas but cannot replace exogenous methods.	0
2849	We examined the relationship between @PROTEIN$ and serum calcium, @COMPOUND$, 1,25(OH)(2)D(3), and PTH levels in haemodialysis patients.	0
2850	@PROTEIN$ was immunostained with mouse anti-FLAG primary antibody and @COMPOUND$-conjugated goat anti-mouse IgG secondary antibody.	1
2851	Intramuscular triacylglycerol does not appear to be a ubiquitous marker of @PROTEIN$ resistance, although specific IMCL intermediates such as long-chain fatty acyl-CoAs, ceramide, and @COMPOUND$ may inhibit insulin signal transduction.	1
2852	Light stimulates @COMPOUND$ hydrolysis via the G-protein @PROTEIN$, which directly binds to and activates phosphodiesterase.	1
2853	Inhibition of gamma-glutamyl transferase (@PROTEIN$, EC 2.3.2.2)-catalyzed extracellular GSH degradation with @COMPOUND$ significantly blocked GSH efflux, suggesting that GSH breakdown is a driving force for GSH export.	0
2854	We injected females with human chorionic gonadotropin (@PROTEIN$), estradiol, estradiol plus progesterone, saline, or HCG plus @COMPOUND$ (an aromatase blocker) and tested their responses to mating calls.	0
2855	We injected females with human chorionic gonadotropin (@PROTEIN$), @COMPOUND$, estradiol plus progesterone, saline, or HCG plus fadrozole (an aromatase blocker) and tested their responses to mating calls.	0
2856	We injected females with human chorionic gonadotropin (@PROTEIN$), estradiol, estradiol plus @COMPOUND$, saline, or HCG plus fadrozole (an aromatase blocker) and tested their responses to mating calls.	0
2857	Here we use an array of flow cytometric analyses to characterize silkworm hemocytes with various molecular probes, such as @COMPOUND$, green fluorescence protein, monoclonal antibodies, and fluorescent @PROTEIN$.	0
2858	Amino acid 1092 (AA1092) in @PROTEIN$ 1 of coxsackievirus B3 (CVB3) is located in close vicinity to the central @COMPOUND$ group of capsid binders (i.e.	1
2859	In vivo assays confirmed that the three resulting genotypes differed in their ability to produce @COMPOUND$ in response to intravenous insulin injection implicating @PROTEIN$ as the primary cause of the observed hypocortisolism.	1
2860	In vivo assays confirmed that the three resulting genotypes differed in their ability to produce @COMPOUND$ in response to intravenous @PROTEIN$ injection implicating CYP17 as the primary cause of the observed hypocortisolism.	1
2861	In addition, @PROTEIN$ facilitates bi-directional flux of @COMPOUND$ by modifying the phospholipid content of the plasma membrane.	1
2862	Overall, @PROTEIN$ is the cell surface receptor responsible for selective uptake of lipoprotein @COMPOUND$ and its ultimate delivery to sites of hormone synthesis in steroidogenic tissues.	1
2863	Susceptibility to esophageal cancer may be modified by functional polymorphisms in genes along the @COMPOUND$ metabolic pathway, such as methylenetetrahydrofolate reductase (@PROTEIN$).	1
2864	Susceptibility to esophageal cancer may be modified by functional polymorphisms in genes along the @COMPOUND$ metabolic pathway, such as @PROTEIN$ (MTHFR).	1
2865	We looked at the toxicity of non-drug-containing liposomes on (3)H-@COMPOUND$ incorporation by @PROTEIN$ (Con A)-stimulated human lymphocytes, splenocytes and Epstein-Barr virus (EBV)-transformed human B-cell lymphoblastoid cell line (LCL).	1
2866	We looked at the toxicity of non-drug-containing liposomes on (3)H-@COMPOUND$ incorporation by concanavalin A (@PROTEIN$)-stimulated human lymphocytes, splenocytes and Epstein-Barr virus (EBV)-transformed human B-cell lymphoblastoid cell line (LCL).	1
2867	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), @PROTEIN$ (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2868	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on @PROTEIN$ (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	1
2869	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (@PROTEIN$) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2870	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), tumor necrosis factor (@PROTEIN$), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2871	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (@PROTEIN$), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2872	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), @PROTEIN$ (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2873	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on @PROTEIN$ (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2874	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (@PROTEIN$) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2875	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), tumor necrosis factor (@PROTEIN$), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2876	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (@PROTEIN$), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2877	We previously determined that @PROTEIN$ Tyr51 is a canonical and Trp150 an anti-canonical TEM-1-contact residue, where canonical refers to the @COMPOUND$ substitution resulting in a matched change in the hydrophobicity of binding free energy.	1
2878	We previously determined that BLIP Tyr51 is a canonical and Trp150 an anti-canonical @PROTEIN$-contact residue, where canonical refers to the @COMPOUND$ substitution resulting in a matched change in the hydrophobicity of binding free energy.	1
2879	This explains the anti-canonical nature of the Trp150 to @COMPOUND$ substitution, and also reveals a strong long distance coupling between Trp150 and Asp49 of @PROTEIN$, because these two residues are more than 25 angstroms apart.	1
2880	Because both TCDD and HFD are associated with increased breast cancer risk, we examined their effects on metabolic syndrome-associated phenotypes in three mouse models of breast cancer: 7,12-dimethylbenz(a) @COMPOUND$ (DMBA), Tg(MMTV-Neu)202Mul/J (@PROTEIN$), and TgN(MMTV-PyMT)634Mul/J (PyMT), all on an FVB/N genetic background.	0
2881	Because both TCDD and HFD are associated with increased breast cancer risk, we examined their effects on metabolic syndrome-associated phenotypes in three mouse models of breast cancer: 7,12-dimethylbenz(a) anthracene (@COMPOUND$), Tg(MMTV-Neu)202Mul/J (@PROTEIN$), and TgN(MMTV-PyMT)634Mul/J (PyMT), all on an FVB/N genetic background.	0
2882	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (@PROTEIN$) concentration, pancreatic hormone levels, and glucose metabolism.	0
2883	This study investigated the acute effects of treatment with @COMPOUND$ on @PROTEIN$ (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
2884	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, @PROTEIN$ levels, and glucose metabolism.	0
2885	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, @PROTEIN$ (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
2886	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (@PROTEIN$-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
2887	The primary aims were to determine the effects of @PROTEIN$-4 inhibition on GLP-1 clearance and on hepatic @COMPOUND$ uptake.	0
2888	The primary aims were to determine the effects of DPP-4 inhibition on @PROTEIN$ clearance and on hepatic @COMPOUND$ uptake.	0
2889	In the present study we determined the effect of @PROTEIN$ on the secretome by comparing incorporation rates of (13)C-labeled @COMPOUND$ in the presence and absence of insulin.	0
2890	@PROTEIN$ as an alternative to @COMPOUND$ in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.	0
2891	@PROTEIN$ cytokine profile may be related to the risk of the vaginal erosions following placement of @COMPOUND$ meshes.	1
2892	The oxidative stress in the mollusk was observed at the U site during spring and at the R site during summer and autumn according to the differences in Mn-superoxide dismutase and @PROTEIN$ activities, O (2) (*-) production, lipid peroxidation, and @COMPOUND$ levels.	0
2893	The oxidative stress in the mollusk was observed at the U site during spring and at the R site during summer and autumn according to the differences in Mn-@PROTEIN$ and catalase activities, O (2) (*-) production, lipid peroxidation, and @COMPOUND$ levels.	0
2894	These results suggest that @COMPOUND$ by activation of ERK1/2 and @PROTEIN$/Akt signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1
2895	These results suggest that @COMPOUND$ by activation of @PROTEIN$/2 and PI3K/Akt signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1
2896	These results suggest that @COMPOUND$ by activation of ERK1/2 and PI3K/@PROTEIN$ signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1
2897	This decrease was not modified by @PROTEIN$ or @COMPOUND$, demonstrating that ONOO (-) was responsible for the effect.	0
2898	This decrease was not modified by @PROTEIN$ or Trolox, demonstrating that @COMPOUND$ (-) was responsible for the effect.	0
2899	Cell viability (MTT colorimetric determination) and transmembrane mitochondrial potential (J-C1 fluorescence) were concentration-dependently reduced 24 h after NaN (3); neither nuclear fragmentation by @COMPOUND$, nor @PROTEIN$ positivity by flow cytometry were detected, ruling out the occurrence of apoptosis.	0
2900	Plasma @COMPOUND$ and @PROTEIN$ in Huntington's disease.	0
2901	We assessed plasma @COMPOUND$ (pHVA) and plasma @PROTEIN$ (pPRL), two correlates of dopaminergic activity, in 116 subjects with CAG repeats expansion in the HD gene, 26 presymptomatic (18 females) and 90 with overt symptomatology (43 females).	0
2902	A hydrogel was fabricated by chemically crosslinking alpha-@PROTEIN$ with @COMPOUND$ at high pressure CO(2).	1
2903	We evaluated whether inhibition of @PROTEIN$ (hsp90) function by @COMPOUND$ derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	1
2904	We evaluated whether inhibition of heat shock protein 90 (@PROTEIN$) function by @COMPOUND$ derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	1
2905	The cancer cells could find an alternate pathway to make this protein that does not require @COMPOUND$ secretion, or the cancer cells may actually utilize progesterone and thus make @PROTEIN$ in a similar fashion to normal pregnancy.	0
2906	The different mechanisms might be explained by the different sensitivity of @PROTEIN$ isoforms to Ca2+, @COMPOUND$+, and Ba2+.	1
2907	Each residue was modified with one to three @COMPOUND$ units, and the most dominant @PROTEIN$ glycoform was modified with nine hexose units.	1
2908	The transcription factors @PROTEIN$ and retinoid X receptors participate in @COMPOUND$-induced locomotor activities.	1
2909	We now show that treatment of cells with phosphomimic @PROTEIN$ (uPA138E/303E, @COMPOUND$ 138 and 303 substituted with glutamic acid) strongly inhibits matrix-induced cell migration.	1
2910	We further demonstrate that loss of @PROTEIN$ stress fibers is due to a @COMPOUND$, protein kinase A-mediated pathway that results in Rho inhibition.	1
2911	We further demonstrate that loss of actin stress fibers is due to a @COMPOUND$, @PROTEIN$-mediated pathway that results in Rho inhibition.	1
2912	We further demonstrate that loss of actin stress fibers is due to a @COMPOUND$, protein kinase A-mediated pathway that results in @PROTEIN$ inhibition.	1
2913	The nuclear NF-kappaB @PROTEIN$ expression after treatment with the SFN-@COMPOUND$ combination was also evaluated by western blot analysis.	0
2914	Treatment ACCs cells with SFN and @COMPOUND$ in combination, led to synergistic inhibition on cell growth and a decreased expression in nuclear NF-kappaB @PROTEIN$ protein.	1
2915	Our results demonstrate synergism between SFN and @COMPOUND$ at higher doses against the ACC-M and ACC-2 cells, which was associated with the decreased expression of nuclear NF-kappaB @PROTEIN$ protein.	1
2916	In order to further analyse the protective mode of action, the superoxide anion scavenging activity of two extracts was evaluated in a @COMPOUND$/@PROTEIN$ system.	1
2917	In order to further analyse the protective mode of action, the @COMPOUND$ anion scavenging activity of two extracts was evaluated in a xanthine/@PROTEIN$ system.	0
2918	Human genetic diseases that affect N-glycosylation result from the defective synthesis of the N-linked sugar moiety (@COMPOUND$) of @PROTEIN$.	1
2919	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (@PROTEIN$, catalase, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
2920	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and @COMPOUND$).	0
2921	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
2922	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, @PROTEIN$, glutathione-S-transferase and @COMPOUND$).	0
2923	Antiobesity effect of @COMPOUND$ involves the @PROTEIN$ and PPAR-gamma signal pathways.	1
2924	Antiobesity effect of @COMPOUND$ involves the AMPK and @PROTEIN$ signal pathways.	1
2925	This inhibitory effect of @COMPOUND$ on adipocyte differentiation was accompanied by @PROTEIN$ inhibition in rosiglitazone-treated cells.	1
2926	Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, @COMPOUND$, involves the @PROTEIN$ signaling pathway and PPAR-gamma inhibition.	1
2927	Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, @COMPOUND$, involves the AMPK signaling pathway and @PROTEIN$ inhibition.	1
2928	Selenocystine is taken up well by the b(0,+) rBAT system, while @COMPOUND$ is a low-affinity substrate only for @PROTEIN$ and PAT1.	1
2929	Selenocystine is taken up well by the b(0,+) rBAT system, while @COMPOUND$ is a low-affinity substrate only for SIT1 and @PROTEIN$.	1
2930	Experiments using a classical inhibitor of phosphotyrosine @PROTEIN$, @COMPOUND$, also showed that the ecto-phosphatase activity was inhibited in a dose-dependent manner.	1
2931	Our data suggest a developmental role of PBRs in erythropoiesis in chickens, possibly via the regulation of @COMPOUND$ availability for the assembly of functional @PROTEIN$.	1
2932	Our data suggest a developmental role of @PROTEIN$ in erythropoiesis in chickens, possibly via the regulation of @COMPOUND$ availability for the assembly of functional hemoglobins.	1
2933	Circulating @COMPOUND$, adiponectin, leptin, @PROTEIN$, hsCRP and insulin levels were determined both at baseline and after TLC intervention and statin treatment.	0
2934	Circulating @COMPOUND$, adiponectin, leptin, TNF-alpha, hsCRP and @PROTEIN$ levels were determined both at baseline and after TLC intervention and statin treatment.	0
2935	Circulating @COMPOUND$, adiponectin, @PROTEIN$, TNF-alpha, hsCRP and insulin levels were determined both at baseline and after TLC intervention and statin treatment.	0
2936	VEGF, @PROTEIN$ and @COMPOUND$ levels in exhaled breath condensate and serum of patients with lung cancer.	0
2937	@PROTEIN$, TNF-alpha and @COMPOUND$ levels in exhaled breath condensate and serum of patients with lung cancer.	0
2938	The aim of the present study was to evaluate the levels of VEGF, @COMPOUND$ and @PROTEIN$ in EBC and serum of patients with primary lung cancer prior to the initiation of any treatment, in order to evaluate their possible diagnostic role.	0
2939	The aim of the present study was to evaluate the levels of @PROTEIN$, @COMPOUND$ and TNF-alpha in EBC and serum of patients with primary lung cancer prior to the initiation of any treatment, in order to evaluate their possible diagnostic role.	0
2940	Furthermore, associations between VEGF, @COMPOUND$ and @PROTEIN$ levels in EBC and serum with clinicopathologic factors were investigated.	0
2941	Furthermore, associations between @PROTEIN$, @COMPOUND$ and TNF-alpha levels in EBC and serum with clinicopathologic factors were investigated.	0
2942	@PROTEIN$, VEGF and @COMPOUND$ levels in EBC and serum were analyzed by an immunoenzymatic method (ELISA).	0
2943	TNF-alpha, @PROTEIN$ and @COMPOUND$ levels in EBC and serum were analyzed by an immunoenzymatic method (ELISA).	0
2944	The addition of a protein kinase C (PKC) activator, @COMPOUND$, rescued PhIP-inhibited @PROTEIN$ expression in LTA-stimulated cells.	1
2945	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, @PROTEIN$, IFN-gamma, IL-17, and iNOS in pancreatic lymph nodes.	0
2946	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, @PROTEIN$ content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, IL-17, and iNOS in pancreatic lymph nodes.	0
2947	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, @PROTEIN$, and iNOS in pancreatic lymph nodes.	0
2948	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, IL-17, and @PROTEIN$ in pancreatic lymph nodes.	0
2949	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, @PROTEIN$, IL-17, and iNOS in pancreatic lymph nodes.	0
2950	They secreted @PROTEIN$ in response to @COMPOUND$ and could correct hyperglycemia in vivo when cotransplanted with vascular cells.	1
2951	A functional @PROTEIN$ system is essential for @COMPOUND$ antiobesity action.	1
2952	Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates @COMPOUND$-stimulated @PROTEIN$ release in female mice.	1
2953	Collectively, these studies identify a novel role for @COMPOUND$ (3) and the @PROTEIN$ in the control of adipocyte metabolism and lipid storage in vivo.	0
2954	Because many drug-drug interactions may occur at the level of drug transporting proteins, we studied interactions of @COMPOUND$ with apical ATP-binding cassette (ABC) @PROTEIN$.	1
2955	Furthermore, in Sf9-@PROTEIN$ membrane vesicles @COMPOUND$ inhibited transport of methotrexate in a concentration-dependent manner.	0
2956	To test this hypothesis, we measured the effect of @PROTEIN$ on RyR2 channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator @COMPOUND$ acetoxymethyl ester.	0
2957	To test this hypothesis, we measured the effect of AMT on @PROTEIN$ channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator @COMPOUND$ acetoxymethyl ester.	0
2958	To test this hypothesis, we measured the effect of @PROTEIN$ on RyR2 channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator Fura-2 @COMPOUND$ ester.	0
2959	To test this hypothesis, we measured the effect of AMT on @PROTEIN$ channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator Fura-2 @COMPOUND$ ester.	0
2960	Most cells contain @COMPOUND$ sulfoxide reductases, which catalyze a @PROTEIN$-dependent reduction of methionine sulfoxide back to methionine.	1
2961	The intracellular free methionine and @COMPOUND$ pools were not altered, nor was the specific activity of the key enzyme, @PROTEIN$.	0
2962	The intracellular free @COMPOUND$ and S-adenosylmethionine pools were not altered, nor was the specific activity of the key enzyme, @PROTEIN$.	0
2963	Activity of muscle citrate synthase and @PROTEIN$, as well as maximal @COMPOUND$ uptake and 10-km performance time, remained unaltered in both groups.	0
2964	Activity of muscle @PROTEIN$ and 3-hydroxyacyl-CoA dehydrogenase, as well as maximal @COMPOUND$ uptake and 10-km performance time, remained unaltered in both groups.	0
2965	@PROTEIN$ (MTs) are @COMPOUND$-rich, metal-binding proteins that are useful biomarkers for monitoring pollution by heavy metals.	1
2966	The deduced amino acid sequence has 18 @COMPOUND$ residues, implying that S. henanense @PROTEIN$ binds six equivalents of bivalent metal ions (Cd) as opposed to the seven in its mammalian counterparts.	1
2967	Treatment of Platelet Rich Plasma (PRP) with the dialyzed supernatant from the leucocyte suspension incubated with 80 microM @COMPOUND$ resulted in parallel syntheses of NO and @PROTEIN$ as determined by methemoglobin assay and enzyme linked immunosorbent assay respectively.	1
2968	Muscular oxidative stress and inflammation induced by @COMPOUND$ or MS were assessed by measurements of isoprostanes and @PROTEIN$ levels.	1
2969	In control rats, @COMPOUND$, @PROTEIN$ and MS significantly enhanced the HFV response.	0
2970	Pre-treatment with @PROTEIN$ abolished the post-MS-enhanced HFV response whereas diclofenac lowered the peak HFV response to MS and @COMPOUND$.	0
2971	Pre-treatment with @PROTEIN$ abolished the post-MS-enhanced HFV response whereas @COMPOUND$ lowered the peak HFV response to MS and H2O2.	0
2972	@COMPOUND$ injection and MS elicited significant and similar increases in isoprostanes and @PROTEIN$.	1
2973	The decreased level of GSH as well as @PROTEIN$ and GSH-Px activities in @COMPOUND$-treated mice were significantly increased by NTA pretreatment.	1
2974	Association between @PROTEIN$ resistance, @COMPOUND$ intolerance, and hypertension in pregnancy.	0
2975	These results suggest that @PROTEIN$ resistance and relative @COMPOUND$ intolerance are associated with an increased risk of new-onset hypertension in pregnancy, particularly preeclampsia, and support the hypothesis that insulin resistance may play a role in the pathogenesis of this disorder.	0
2976	@PROTEIN$ and II form a ubiquitous @COMPOUND$-dependent pathway for the detoxification of reactive and mutagenic ketoaldehydes.	1
2977	@PROTEIN$ (17beta-HSD1) is responsible for the catalytic reduction of the weak estrogen estrone (E1) into the highly potent @COMPOUND$ (E2).	1
2978	17beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) is responsible for the catalytic reduction of the weak estrogen estrone (E1) into the highly potent @COMPOUND$ (E2).	1
2979	The combination of @COMPOUND$-rich repeat (LRR) and immunoglobulin-like (Ig) domains is found in the domain architecture of the @PROTEIN$ neurotrophin receptor protein.	1
2980	Given the significant biological roles of @PROTEIN$ and such newly identified proteins, we have searched the public database for human proteins with LRR and Ig domains (collectively termed the @COMPOUND$-rich repeat and Ig domain-containing protein, LRRIG protein, in this study), and have analyzed the mRNA expression pattern of mouse orthologs of obtained human LRRIG proteins at embryonic day 10.	0
2981	Pretreatment with oligonol diminished the levels of proliferating cell nuclear antigen and expression of @PROTEIN$ in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1
2982	Pretreatment with oligonol diminished the levels of @PROTEIN$ and expression of COX-2 in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1
2983	TnBP (@COMPOUND$) and polysorbate 20 during the manufacture of the factor VIII/@PROTEIN$ concentrate Optivate has been investigated.	0
2984	2-Deoxyglucose decreased @COMPOUND$H/NAD (+) and NADPH/NADP(+) ratios by 59 and 50%, respectively, and intact cell @PROTEIN$ activity by 74%; lactate restored NADH/NAD (+), but not NADPH/NADP(+) or NQO1 activity.	0
2985	We propose that the coordinated regulation of @PROTEIN$ cytoskeletal reorganization and macropinocytosis-mediated retrograde membrane trafficking may contribute to @COMPOUND$+)-induced axon growth inhibition.	1
2986	Cocaine stimulated @PROTEIN$, @COMPOUND$, and LH, whereas cocaine+nalbuphine in combination produced a smaller increase in ACTH, and decreased cortisol and LH.	0
2987	Thus it appears that nalbuphine attenuated cocaine's effects on @PROTEIN$, @COMPOUND$, and LH.	0
2988	Membrane inlet mass spectrometry was used to observe @COMPOUND$ in the well-studied reaction of nitrite with @PROTEIN$.	1
2989	Diminished levels of L-arginine and endothelial @PROTEIN$ (eNOS) uncoupling through deficiency of @COMPOUND$ (BH(4)) may contribute to endothelial dysfunction.	1
2990	Diminished levels of L-@COMPOUND$ and endothelial nitric oxide synthase (@PROTEIN$) uncoupling through deficiency of tetrahydrobiopterin (BH(4)) may contribute to endothelial dysfunction.	0
2991	Diminished levels of L-arginine and endothelial nitric oxide synthase (@PROTEIN$) uncoupling through deficiency of @COMPOUND$ (BH(4)) may contribute to endothelial dysfunction.	1
2992	Diminished levels of L-@COMPOUND$ and endothelial @PROTEIN$ (eNOS) uncoupling through deficiency of tetrahydrobiopterin (BH(4)) may contribute to endothelial dysfunction.	0
2993	Serum testosterone, estradiol, sex hormone binding globulin (@PROTEIN$), and @COMPOUND$ levels were measured in 1947 postmenopausal women aged 45-84 years (30% White, 14% Chinese-American, 31% Black, and 25% Hispanic) and not on hormone therapy.	0
2994	Serum testosterone, @COMPOUND$, sex hormone binding globulin (@PROTEIN$), and dehydroepiandrosterone levels were measured in 1947 postmenopausal women aged 45-84 years (30% White, 14% Chinese-American, 31% Black, and 25% Hispanic) and not on hormone therapy.	0
2995	Total and bioavailable testosterone were positively associated with common cIMT independent of age, BMI, hypertension, smoking, HDL-@COMPOUND$, LDL-cholesterol and @PROTEIN$ sensitivity (p=0.009 and p=0.002, respectively).	0
2996	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
2997	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
2998	In addition to lipid peroxidation, the activities of antioxidant enzymes such as @PROTEIN$, catalase, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
2999	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and @PROTEIN$ and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3000	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3001	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3002	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, @PROTEIN$, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3003	In addition to lipid peroxidation, the activities of antioxidant enzymes such as @PROTEIN$, catalase, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3004	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, @PROTEIN$, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3005	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and @PROTEIN$ and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
3006	This study shows that changes in lipid peroxidation, @PROTEIN$, catalase, glutathione reductase, glutathione S-transferase and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0
3007	This study shows that changes in lipid peroxidation, superoxide dismutase, @PROTEIN$, glutathione reductase, glutathione S-transferase and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0
3008	This study shows that changes in lipid peroxidation, superoxide dismutase, catalase, @PROTEIN$, glutathione S-transferase and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0
3009	This study shows that changes in lipid peroxidation, superoxide dismutase, catalase, glutathione reductase, @PROTEIN$ and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0
3010	At the same time, both types of conduits were permeable to three compounds tested including @COMPOUND$, lysozyme and bovine @PROTEIN$, indicating the suitability of the conduits for free exchanges of nutrients.	0
3011	At the same time, both types of conduits were permeable to three compounds tested including @COMPOUND$, @PROTEIN$ and bovine serum albumin, indicating the suitability of the conduits for free exchanges of nutrients.	0
3012	The inhibitory effect of @COMPOUND$ on the migration of ES-2 ovarian carcinoma cells involves a @PROTEIN$-dependent pathway.	1
3013	This inhibitory effect is possibly mediated by a @COMPOUND$-dependent activation of the small GTPase @PROTEIN$ via Epac.	1
3014	This inhibitory effect is possibly mediated by a @COMPOUND$-dependent activation of the small GTPase Rap1 via @PROTEIN$.	1
3015	Gender differences in corticotropin and @COMPOUND$ secretion and @PROTEIN$ mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats.	0
3016	Gender differences in @PROTEIN$ and @COMPOUND$ secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats.	0
3017	Although females in both proestrus and diestrus showed significant increases in plasma @PROTEIN$ and @COMPOUND$ and CRF mRNA expression in the PVN in response to PS, no significant responses of the HPA axis to PS were found in males.	0
3018	Although females in both proestrus and diestrus showed significant increases in plasma ACTH and @COMPOUND$ and @PROTEIN$ mRNA expression in the PVN in response to PS, no significant responses of the HPA axis to PS were found in males.	0
3019	In vitro and in vivo models simulating the bee sting have been developed using live honeybees and, as the envenomation sites, pig ears and rat legs; MALDI MSI has been used to map, over time, the diffusion and distribution of three venom allergens (@COMPOUND$ m 1, Api m 4, and Api m 6) and two venom toxins (apamine and @PROTEIN$).	0
3020	Despite widespread expression of @PROTEIN$ (EGF) receptors (EGFRs) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0
3021	Despite widespread expression of epidermal growth factor (EGF) receptors (@PROTEIN$) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0
3022	It is noteworthy that FGF2 and FGF9 as well as @PROTEIN$ IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
3023	It is noteworthy that @PROTEIN$ and FGF9 as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
3024	It is noteworthy that FGF2 and @PROTEIN$ as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
3025	It is noteworthy that FGF2 and FGF9 as well as FGFR1 IIIc and/or @PROTEIN$ IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
3026	Effects of gram-negative bacterial @COMPOUND$ (LPS) and supplemental dietary Met on N balance, serum hormones and @PROTEIN$, and plasma urea-N and AA were evaluated in 20 Angus-cross steers (BW = 262+/-6.3 kg).	0
3027	Effects of gram-negative bacterial lipopolysaccharide (LPS) and supplemental dietary Met on N balance, serum hormones and @PROTEIN$, and plasma @COMPOUND$-N and AA were evaluated in 20 Angus-cross steers (BW = 262+/-6.3 kg).	0
3028	Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of @COMPOUND$, prolactin, tumor necrosis factor-alpha, and @PROTEIN$ 0.01).	0
3029	Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of @COMPOUND$, prolactin, @PROTEIN$-alpha, and haptoglobin 0.01).	0
3030	Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of @COMPOUND$, @PROTEIN$, tumor necrosis factor-alpha, and haptoglobin 0.01).	0
3031	Plasma @COMPOUND$-N was greater for+LPS than-LPS steers (LPS; P = 0.03), and serum @PROTEIN$ was not affected (P &gt; or = 0.26) by LPS or Met.	0
3032	Using neighborhood approaches, we were able to assign seven novel functional partners in @PROTEIN$ synthesis, @COMPOUND$ metabolism, and quorum sensing to BLUF domain-containing proteins (involved in light sensing).	0
3033	Chondroitin lyases (or @PROTEIN$) are a family of enzymes that depolymerize @COMPOUND$ (CS) and dermatan sulfate (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology.	1
3034	This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) and cytosine methylation inhibitor @COMPOUND$ (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in @PROTEIN$ silencing by hypoxia.	1
3035	This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor @COMPOUND$ (TSA) and cytosine methylation inhibitor 5-aza-2-deoxycytidine (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in @PROTEIN$ silencing by hypoxia.	1
3036	@COMPOUND$-@PROTEIN$ conjugate selectively overcomes multidrug resistance in leukaemia cells.	1
3037	The purpose of this study was to examine the distribution and action of @COMPOUND$-@PROTEIN$ conjugate (DOXTRF) in a leukaemia cell line (HL60), a multidrug-resistant leukaemia cell line (HL60ADR) and a normal tissue cell line (human fibroblasts).	1
3038	All strains tested positive for @PROTEIN$ activity while none where capable of @COMPOUND$ degradation.	0
3039	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3040	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3041	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3042	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3043	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3044	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST) and @PROTEIN$ (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3045	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
3046	Addition of SOD (@PROTEIN$) doubled the amount of @COMPOUND$ detected.	1
3047	Addition of @PROTEIN$ (superoxide dismutase) doubled the amount of @COMPOUND$ detected.	1
3048	At 1 min before the exposure rats were treated with one of the following: intravenous @PROTEIN$, 4.4 mg/kg; intraperitoneal (ip) @COMPOUND$, 25mg/kg; or ip trolox, 500 microg/kg.	0
3049	At 1 min before the exposure rats were treated with one of the following: intravenous @PROTEIN$, 4.4 mg/kg; intraperitoneal (ip) ilomastat, 25mg/kg; or ip @COMPOUND$, 500 microg/kg.	0
3050	Treatment with @PROTEIN$ or @COMPOUND$ eliminated these PF changes, yielding results comparable with controls for each of these parameters.	0
3051	While @PROTEIN$ and @COMPOUND$ both alleviated the PF perturbations, surprisingly only aprotinin reduced the observed pathology, both grossly and histologically.	0
3052	These early results indicate that treatment with @PROTEIN$ and to a lesser extent @COMPOUND$ reduces some of the direct inflammatory response and damage associated with SM-induced lung injury.	0
3053	Pretreatment with DEX abrogated @PROTEIN$ inhibition by sst (2)-preferring analogue @COMPOUND$ in TT.	1
3054	@COMPOUND$ enhances the activity of nuclear factor-kappaB pathway through @PROTEIN$ and BLT2 receptors in atherosclerosis.	1
3055	@PROTEIN$ activity and total nitrite and @COMPOUND$ concentrations in serum: novel biochemical markers for type 2 diabetes.	0
3056	The aim of this study was to evaluate the activity of semicarbazide-sensitive amine oxidase (@PROTEIN$) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
3057	The aim of this study was to evaluate the activity of @PROTEIN$ (SSAO) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
3058	Serum lipid, creatinine, @COMPOUND$, @PROTEIN$, HbA(1C) and urinary albumin concentration were measured.	0
3059	Serum lipid, @COMPOUND$, uric acid, @PROTEIN$, HbA(1C) and urinary albumin concentration were measured.	0
3060	@COMPOUND$ activity showed highest correlations to @PROTEIN$ II and microtubule targeting drugs.	1
3061	Ulcerated tissues were processed to assess ulcer area, @COMPOUND$, @PROTEIN$ (PCNA) and cleaved caspase-3.	0
3062	Ulcerated tissues were processed to assess ulcer area, @COMPOUND$, proliferating cell nuclear antigen (@PROTEIN$) and cleaved caspase-3.	0
3063	Serum NO, @PROTEIN$ and @COMPOUND$ were measured.	0
3064	Serum @COMPOUND$ and @PROTEIN$ levels were significantly lower in FM patients than controls.	0
3065	This article discusses the physiology of proximal @COMPOUND$ (+)/H(+) exchange, the multiple mechanisms of @PROTEIN$ regulation, and the reciprocal relationship between NHE3 and NHE8 at the lumen of the proximal tubule.	0
3066	This article discusses the physiology of proximal @COMPOUND$ (+)/H(+) exchange, the multiple mechanisms of NHE3 regulation, and the reciprocal relationship between NHE3 and @PROTEIN$ at the lumen of the proximal tubule.	0
3067	@COMPOUND$ and DHEA-sulfate response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0
3068	Cortisol and @COMPOUND$ response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0
3069	Cortisol and @COMPOUND$ response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0
3070	@COMPOUND$ and DHEA-sulfate response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0
3071	Streptokinase (SK), @PROTEIN$ (GOx) and @COMPOUND$ (PC) were immobilized onto PGLD to obtain a blood compatible bioconjugate with glucose sensing properties.	0
3072	Treatment of RPE cells with high @COMPOUND$-induced a significant increased of @PROTEIN$, accompanied by an increase in cell damage, NO and nitrotyrosine levels.	1
3073	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of @PROTEIN$ expression that requires the activation of p38MAPK and ERK.	1
3074	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of iNOS expression that requires the activation of p38MAPK and @PROTEIN$.	0
3075	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of iNOS expression that requires the activation of @PROTEIN$ and ERK.	0
3076	Our data suggest that @PROTEIN$ translocates to the contractile system and anchors to TnI in a @COMPOUND$+)-dependent manner in the human heart, contributing to the maintenance of contractile force.	1
3077	Our data suggest that PKCalpha translocates to the contractile system and anchors to @PROTEIN$ in a @COMPOUND$+)-dependent manner in the human heart, contributing to the maintenance of contractile force.	1
3078	Prediction of the effect of erythromycin, @COMPOUND$, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
3079	Prediction of the effect of @COMPOUND$, diltiazem, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
3080	Previous studies have suggested a regulatory relationship between serum @COMPOUND$, vitamin D, and fibroblast growth factor 23 (@PROTEIN$), a hormone that promotes renal excretion of phosphate.	1
3081	Previous studies have suggested a regulatory relationship between serum phosphorus, @COMPOUND$, and fibroblast growth factor 23 (@PROTEIN$), a hormone that promotes renal excretion of phosphate.	1
3082	This condition is caused by mutations in the PTH/@PROTEIN$ receptor that result in ligand-independent @COMPOUND$ accumulation, thus rendering the receptor constitutively active.	1
3083	This condition is caused by mutations in the @PROTEIN$/PTHrP receptor that result in ligand-independent @COMPOUND$ accumulation, thus rendering the receptor constitutively active.	1
3084	Adiponectin, an adipokine secreted by the white adipose tissue, plays an important role in regulating @COMPOUND$ and lipid metabolism and controlling energy homeostasis in @PROTEIN$-sensitive tissues.	0
3085	@PROTEIN$ is involved in @COMPOUND$-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.	1
3086	Both @PROTEIN$ and PKA are effectors of the second messenger @COMPOUND$.	1
3087	Since a polypeptide lacking the @COMPOUND$-rich region (P-region) of @PROTEIN$ (103Q) cannot form aggresomes, this domain serves as an aggresome-targeting signal.	1
3088	Expression of @COMPOUND$ : @PROTEIN$ in gastric mucosa, intestinal metaplasia, and gastric carcinoma.	0
3089	@COMPOUND$ : @PROTEIN$ (ppGalNAc-T6) is one of the enzymes responsible for the initial step in O-glycosylation.	1
3090	In addition, SAH caused large increases in markers of inflammation, including @PROTEIN$ and NFkappaB, and markers of cell injury or cell death, including IgG endocytosis and caspase-3 activation, with @COMPOUND$ significantly reducing these effects.	1
3091	We conclude that block of @PROTEIN$ by @COMPOUND$ may ameliorate several pathologic effects associated with inflammation that lead to cortical dysfunction after SAH.	1
3092	Intrinsic fluorescence of @COMPOUND$-214 in @PROTEIN$ was monitored upon addition of the chemicals.	1
3093	CYP719A subfamily of @PROTEIN$ oxygenases and @COMPOUND$ alkaloid biosynthesis in Eschscholzia californica.	0
3094	Radical scavenging activity of lipophilized products from @PROTEIN$-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids.	1
3095	Lipase-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids using an immobilized @PROTEIN$ from Candida antarctica (E.C.	1
3096	@PROTEIN$-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids using an immobilized lipase from Candida antarctica (E.C.	1
3097	Validation of a food frequency questionnaire measurement of dietary acrylamide intake using @PROTEIN$ adducts of acrylamide and @COMPOUND$.	1
3098	The study established that SPZ attenuated myocardial I/R injury through overexpression of @PROTEIN$, leading to enhancement of @COMPOUND$ bioavailability and tissue oxygenation.	1
3099	The study established that @COMPOUND$ attenuated myocardial I/R injury through overexpression of @PROTEIN$, leading to enhancement of nitric oxide bioavailability and tissue oxygenation.	1
3100	The purpose of this study was to propose a new preparation method to fabricate @PROTEIN$-loaded poly(lactic-coglycolic acid) (@COMPOUND$) microparticles satisfying protein loading, release profiles, burst release, and particularly stability of the encapsulated protein.	1
3101	This injury induces central sensitization leading to tactile allodynia and is mediated by activation of @COMPOUND$+) permeable AMPA/kainate receptors through @PROTEIN$ and PKA.	1
3102	Transport properties of PIs by the drug efflux transporters P-gp and @PROTEIN$ (MRP1) were assessed by measuring the cellular uptake of (3)H-@COMPOUND$ or (3)H-ritonavir in P-gp and MRP1 overexpressing cells as well as hCMEC/D3.	1
3103	Transport properties of PIs by the drug efflux transporters P-gp and @PROTEIN$ (MRP1) were assessed by measuring the cellular uptake of (3)H-atazanavir or (3)H-@COMPOUND$ in P-gp and MRP1 overexpressing cells as well as hCMEC/D3.	1
3104	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood @COMPOUND$, or plasma concentrations of catecholamines, @PROTEIN$, and cortisol.	0
3105	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood glucose, or plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
3106	During hypoxemia, treatment with acidified saline increased the magnitude of the fetal bradycardia and femoral vasoconstriction and concomitantly increased chemoreflex function and enhanced the increments in plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
3107	In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of HA synthases (HAS: @PROTEIN$, HAS2, and HAS3) during atresia in pig ovaries.	0
3108	In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of @PROTEIN$ (HAS: HAS1, HAS2, and HAS3) during atresia in pig ovaries.	0
3109	In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of HA synthases (HAS: HAS1, HAS2, and @PROTEIN$) during atresia in pig ovaries.	0
3110	In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of HA synthases (HAS: HAS1, @PROTEIN$, and HAS3) during atresia in pig ovaries.	0
3111	Although no significant change in the apparent K(m) was revealed in animals that exhibited an escalation in the rate of cocaine intake, an increased @COMPOUND$ uptake rate was found suggesting an upregulation of @PROTEIN$ number in response to a history of high cocaine intake.	1
3112	Previous work has shown that repeated @COMPOUND$ treatment causes downregulation of the norepinephrine transporter (@PROTEIN$) and persistent antidepressant-like effects on behavior, ie effects observed 2 days after discontinuation of drug treatment when acute effects are minimized.	1
3113	Previous work has shown that repeated @COMPOUND$ treatment causes downregulation of the @PROTEIN$ (NET) and persistent antidepressant-like effects on behavior, ie effects observed 2 days after discontinuation of drug treatment when acute effects are minimized.	1
3114	Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the @PROTEIN$ and SERT, or 10 mg/kg per day @COMPOUND$, a monoamine oxidase inhibitor, produced antidepressant-like effects on behavior without altering NET or SERT expression.	0
3115	Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the NET and @PROTEIN$, or 10 mg/kg per day @COMPOUND$, a monoamine oxidase inhibitor, produced antidepressant-like effects on behavior without altering NET or SERT expression.	0
3116	However, detection of @COMPOUND$ and Zn in @PROTEIN$ after PAGE-LA-ICP-MS depends on the conditions of the PAGE method because possible metal losses can occur (either with SDS-PAGE or with native PAGE).	1
3117	Recent studies have suggested that a decrease in the specific activity of the 2-@PROTEIN$ complex (ODHC) is important for @COMPOUND$ overproduction by Corynebacterium glutamicum.	1
3118	Anticancer effect of @COMPOUND$ via @PROTEIN$ dependent and independent mechanisms in human gastric cancers cells.	1
3119	Real-time polymerase chain reaction analysis of hypoxic, NO-@COMPOUND$ treated PC-3 cells showed downregulation of lysyl oxidase and @PROTEIN$ mRNA expression.	1
3120	Real-time polymerase chain reaction analysis of hypoxic, NO-@COMPOUND$ treated PC-3 cells showed downregulation of @PROTEIN$ and carbonic anhydrase IX mRNA expression.	1
3121	Established risk cardiovascular factors like hypertension, atherogenic dyslipidaemia, and @COMPOUND$ intolerance occur in the setting of @PROTEIN$ resistance and central adiposity, with genetic and environmental influences modulating the ultimate risk.	1
3122	Despite this lack of oxidative and cytotoxic action, exposure of hepatoma cells to @COMPOUND$+) resulted in a significant activation of @PROTEIN$ that was abrogated by inhibitors of PI3K.	1
3123	Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood glucose and @COMPOUND$ determination.	0
3124	Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood @COMPOUND$ and lactate determination.	0
3125	Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood glucose and @COMPOUND$ determination.	0
3126	Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood @COMPOUND$ and lactate determination.	0
3127	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by nickel ions and @COMPOUND$, characteristics of @PROTEIN$ not of PP1.	1
3128	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by @COMPOUND$ and chlorogenic acid, characteristics of @PROTEIN$ not of PP1.	1
3129	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by @COMPOUND$ and chlorogenic acid, characteristics of PP2B not of @PROTEIN$.	0
3130	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by nickel ions and @COMPOUND$, characteristics of PP2B not of @PROTEIN$.	0
3131	Plasma levels of @COMPOUND$, cortisol, and @PROTEIN$ were measured.	0
3132	Plasma levels of citalopram, @COMPOUND$, and @PROTEIN$ were measured.	0
3133	An increase in @COMPOUND$ and @PROTEIN$ concentrations was observed from the EOI until 60 min after the EOI.	0
3134	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from genipin-crosslinked gelatin within @COMPOUND$ (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
3135	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from @COMPOUND$-crosslinked gelatin within polycaprolactone (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
3136	In this study, 10% (w/v) gelatin was mixed with @PROTEIN$, crosslinked with 0%, 0.1%, 0.5%, and 1% (w/v) @COMPOUND$, and then sucked into the wall of PCL conduits.	0
3137	The majority of patients with acute depression shows an exaggerated plasma corticotrophin (@PROTEIN$) and @COMPOUND$ response to this test that normalizes gradually during successful antidepressant therapy.	0
3138	We examined plasma @PROTEIN$ and @COMPOUND$ responses to the dex/CRH test in acutely depressed inpatients treated either with mirtazapine (n=55) or a monoamine reuptake inhibitor (n=105) according to doctor's choice and compared the test results with healthy controls (n=40).	0
3139	Both extracts increased AMP-kinase phosphorylation and @PROTEIN$ phosphorylation by 2.5-to 4-fold, but with different time courses: maximal phosphorylation with @COMPOUND$ was evident within 30 min of treatment, whereas with black tea phosphorylation was slower to develop, with maximal phosphorylation occurring &gt; or =3 hours after treatment.	1
3140	However, the ethyl ester of commipheric acid (150 mg/kg, twice daily) lowered fasting blood @COMPOUND$ and plasma @PROTEIN$, and plasma triglycerides without affecting food intake or body weight.	0
3141	This finding led the authors to propose that @PROTEIN$ may be involved in the pathogenesis of psoriasis through its potential role in @COMPOUND$ biosynthesis and stimulation of keratinocyte proliferation.	1
3142	In this study, we began the characterization of @PROTEIN$ protein in order to determine whether it might play a role in @COMPOUND$ biosynthesis.	0
3143	The preference for NAD(+) suggests that @PROTEIN$ is likely to function in the oxidative direction in vivo, further supporting its potential role in the oxidation of retinol to retinaldehyde for @COMPOUND$ biosynthesis in human keratinocytes.	1
3144	Identification of Aldh1a, @PROTEIN$ and RAR orthologs in protostomes pushes back the @COMPOUND$ genetic machinery in evolutionary time to the bilaterian ancestor.	1
3145	As release of @COMPOUND$ can be a rate-limiting step for @PROTEIN$ activity, NADH binding was evaluated for R166wt and R166H enzymes.	1
3146	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by glutathione-S-transferases (@PROTEIN$) and glutathione peroxidases (GPx).	1
3147	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by glutathione-S-transferases (GST) and @PROTEIN$ (GPx).	1
3148	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by @PROTEIN$ (GST) and glutathione peroxidases (GPx).	1
3149	Peripheral @PROTEIN$ gastroprotection against @COMPOUND$ : the role of exendin, NO, CGRP, prostaglandins and blood flow.	0
3150	Peripheral GLP-1 gastroprotection against @COMPOUND$ : the role of exendin, NO, @PROTEIN$, prostaglandins and blood flow.	0
3151	@COMPOUND$ was administered through an orogastric cannula right after the injection of @PROTEIN$ (1, 10, 100, 1000 or 10,000 ng/kg; i.p.).	0
3152	It inhibited Trypanosoma brucei @PROTEIN$ with an IC(50) value of 240 microM and has been shown to be a competitive reversible inhibitor (Ki=200+/-10 microM) of this enzyme with respect to its cofactor @COMPOUND$ (+).	1
3153	It is suggested that in this animal model, characterized by TSH elevation and low-grade inflammation, an increased expression and function of @PROTEIN$, resulting in @COMPOUND$ generation, accounts for an impaired NO availability.	1
3154	Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates @PROTEIN$ resistance and @COMPOUND$ intolerance in obese mice.	0
3155	These changes were associated with an alleviation of hyperglycemia, @COMPOUND$ intolerance, and @PROTEIN$ resistance.	0
3156	Vernakalant was metabolized rapidly via 4-O-demethylation by @PROTEIN$ (CYP)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive @COMPOUND$ conjugate.	0
3157	Vernakalant was metabolized rapidly via 4-O-demethylation by cytochrome P450 (@PROTEIN$)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive @COMPOUND$ conjugate.	0
3158	To examine the relationship of functional expression of @PROTEIN$ to prognosis in AML, we studied marrow samples from 175 adult AML patients who underwent induction chemotherapy with anthracycline and @COMPOUND$ on Southwest Oncology Group trials.	0
3159	The capacity for osmotic adjustment, superoxide dismutase (@PROTEIN$) and ascorbate peroxidase (APX) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
3160	The capacity for osmotic adjustment, superoxide dismutase (SOD) and ascorbate peroxidase (@PROTEIN$) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
3161	The capacity for osmotic adjustment, @PROTEIN$ (SOD) and ascorbate peroxidase (APX) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
3162	A naturally occurring glycine to @COMPOUND$ mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1
3163	A naturally occurring @COMPOUND$ to aspartic acid mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1
3164	Serum free @COMPOUND$ in association with @PROTEIN$ as a diagnostic marker of acute myocardial infarction.	1
3165	The aim of this study was to monitor the level of serum free @COMPOUND$ in combination with @PROTEIN$ (Myo) and creatine kinase (total activity and CK-MB level) for usefulness as a predictor of AMI in ICU patients.	0
3166	L-@COMPOUND$ was the most effective promoter of @PROTEIN$ absorption compared with others CPPs.	1
3167	A dose-dependent relationship of L-@COMPOUND$ and @PROTEIN$ bioavailability was statically significant.	1
3168	There was no significant difference in the release of @PROTEIN$ in nasal lavage fluid and the integrity of nasal respiratory epithelium when L-@COMPOUND$ was present.	0
3169	With the exception of significantly elevated serum @PROTEIN$ after @COMPOUND$, no effects in the secondary outcome measures were detected.	1
3170	The cellular response to dsRNA or its synthetic analog @COMPOUND$ (poly I:C) results in IRF-3-, @PROTEIN$- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
3171	The cellular response to dsRNA or its synthetic analog polyinosinic-polycytidylic acid (@COMPOUND$) results in @PROTEIN$-, IRF-7- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
3172	The cellular response to dsRNA or its synthetic analog @COMPOUND$ (poly I:C) results in @PROTEIN$-, IRF-7- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
3173	The cellular response to dsRNA or its synthetic analog polyinosinic-polycytidylic acid (@COMPOUND$) results in IRF-3-, @PROTEIN$- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
3174	Fluoroimmunoassay based on the fluorescent property of quantum dot was used along with immunoassay to detect 2,4-D. CdTe capped with mercaptopropionic acid, was conjugated using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and a coupling reagent like @COMPOUND$ (NHS) to alkaline phosphatase (@PROTEIN$) which was in turn conjugated to 2,4-D molecule.	1
3175	Fluoroimmunoassay based on the fluorescent property of quantum dot was used along with immunoassay to detect 2,4-D. CdTe capped with mercaptopropionic acid, was conjugated using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and a coupling reagent like @COMPOUND$ (NHS) to @PROTEIN$ (ALP) which was in turn conjugated to 2,4-D molecule.	1
3176	The SoxN protein is proposed to harbor the heme b of lower reduction potential and the @COMPOUND$ (s), and @PROTEIN$ the other heme b.	0
3177	Seleno-L-methionine (SeMet) can be oxidized to L-methionine selenoxide (MetSeO) by flavin-containing monooxygenase 3 (@PROTEIN$) and rat liver microsomes in the presence of @COMPOUND$.	1
3178	The ethidium bromide (EB) demyelinating model was associated with vitamin E (Vit E) and @COMPOUND$ (Ebs) treatment to evaluate @PROTEIN$ (AChE) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0
3179	The ethidium bromide (EB) demyelinating model was associated with vitamin E (Vit E) and @COMPOUND$ (Ebs) treatment to evaluate acetylcholinesterase (@PROTEIN$) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0
3180	The ethidium bromide (EB) demyelinating model was associated with @COMPOUND$ (Vit E) and ebselen (Ebs) treatment to evaluate @PROTEIN$ (AChE) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0
3181	The ethidium bromide (EB) demyelinating model was associated with @COMPOUND$ (Vit E) and ebselen (Ebs) treatment to evaluate acetylcholinesterase (@PROTEIN$) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	0
3182	A search of publicly available microarray data reveals that expression of mitochondrial manganese superoxide dismutase (@PROTEIN$), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1
3183	A search of publicly available microarray data reveals that expression of mitochondrial manganese @PROTEIN$ (Sod2), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1
3184	It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to thioredoxin (@PROTEIN$), via the cofactor FAD.	1
3185	It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to @PROTEIN$ (Trx), via the cofactor FAD.	1
3186	@PROTEIN$ (HIF-1alpha) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
3187	Hypoxia-inducible factor-1alpha (@PROTEIN$) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
3188	However, @PROTEIN$, a protein with no active site @COMPOUND$, was covalently modified in vitro by 0.5mM 10-fluoroethoxyphosphinyl-N-biotinamido pentyldecanamide, chlorpyrifos oxon, diisopropylfluorophosphate, dichlorvos, sarin, and soman.	0
3189	The mechanism of lysoPAF-mediated inhibition of neutrophils involves an elevation in the intracellular @COMPOUND$ level, and pharmacological blockade of @PROTEIN$ completely reverses the inhibitory effect of lysoPAF.	1
3190	DnaB (BA) demonstrated a strong DNA @PROTEIN$ activity that required ATP or @COMPOUND$.	1
3191	@PROTEIN$ (BA) demonstrated a strong DNA helicase activity that required ATP or @COMPOUND$.	1
3192	@PROTEIN$ (BA) demonstrated a strong DNA helicase activity that required @COMPOUND$ or dATP.	1
3193	DnaB (BA) demonstrated a strong DNA @PROTEIN$ activity that required @COMPOUND$ or dATP.	1
3194	MerH was found to transport mercuric ions in Escherichia coli via a pair of essential @COMPOUND$ residues but only when coexpressed with the @PROTEIN$.	0
3195	HmuY and @PROTEIN$ are @COMPOUND$ binding proteins required for P. gingivalis growth.	1
3196	Liver @COMPOUND$ DNA adducts and acrylamide and glycidamide N-terminal valine @PROTEIN$ adducts were also determined.	0
3197	Liver glycidamide DNA adducts and acrylamide and glycidamide N-terminal @COMPOUND$ @PROTEIN$ adducts were also determined.	1
3198	Liver glycidamide DNA adducts and @COMPOUND$ and glycidamide N-terminal valine @PROTEIN$ adducts were also determined.	0
3199	Tests of the blood samples obtained at the ED revealed leucocytosis (11 070.6+/-4302.5/microl), increased blood @COMPOUND$, @PROTEIN$, CK and CK-MB levels.	0
3200	Molecular and biochemical characterization of a distinct @PROTEIN$ involved in @COMPOUND$ production from Aeromonas media.	1
3201	TyrA had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other @PROTEIN$.	0
3202	TyrA had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other @PROTEIN$.	0
3203	@PROTEIN$ had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other tyrosinases.	0
3204	TyrA had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other @PROTEIN$.	0
3205	@PROTEIN$ had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other tyrosinases.	1
3206	@PROTEIN$ had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other tyrosinases.	1
3207	EDTA or glutathione notably inhibited the enzymatic activities of @PROTEIN$, whereas @COMPOUND$ and SDS activated them.	1
3208	These results suggest that @PROTEIN$ is the first reported distinct tyrosinase involved in @COMPOUND$ production in the genus Aeromonas.	1
3209	These results suggest that TyrA is the first reported distinct @PROTEIN$ involved in @COMPOUND$ production in the genus Aeromonas.	1
3210	@PROTEIN$ from goldfish white muscle: regulatory properties and redistribution under exposure to high environmental @COMPOUND$ level.	1
3211	Both sodium and potassium ions activated goldfish @PROTEIN$ at low concentrations, with maximal activation at about 80 mM of each @COMPOUND$ salt, whereas higher concentrations became inhibitory.	0
3212	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did phosphate and @COMPOUND$ ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
3213	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did @COMPOUND$ and fluoride ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
3214	An efficient electrocatalytic biosensor for sulfite detection was developed by co-immobilizing sulfite oxidase and @PROTEIN$ with polyaniline @COMPOUND$ in a layer-by-layer assembly.	0
3215	An efficient electrocatalytic biosensor for sulfite detection was developed by co-immobilizing @PROTEIN$ and cytochrome c with polyaniline @COMPOUND$ in a layer-by-layer assembly.	0
3216	After 10 days of treatment, otomicroscopic evaluation of tympanic membranes and measurement of anti-inflammatory mediators such as @PROTEIN$, nitrite/nitrate, glutathione peroxidase and @COMPOUND$ were performed.	0
3217	After 10 days of treatment, otomicroscopic evaluation of tympanic membranes and measurement of anti-inflammatory mediators such as superoxide dismutase, nitrite/nitrate, @PROTEIN$ and @COMPOUND$ were performed.	0
3218	The levels of @COMPOUND$ and @PROTEIN$ were lower in ginkgo groups but not significantly.	0
3219	These results indicate that cloned embryos have aberrant DNA methylation in the @COMPOUND$ sites of the PE region of @PROTEIN$, and this may contribute directly to abnormal expression of this gene in cloned embryos.	1
3220	Xenopus follicle-enclosed oocytes are endowed with @PROTEIN$ located in the follicular cell membrane ; their stimulation by @COMPOUND$ elicits an electrical response that includes generation of a fast inward current (F(Cl)) carried by Cl(-).	1
3221	Moreover, the dopaminergic and glutamatergic regulation of @PROTEIN$ gene activation by @COMPOUND$ was investigated.	1
3222	The acute @COMPOUND$-mediated activation of @PROTEIN$ gene was regulated by D1 but not D2 dopamine receptors.	1
3223	Activation of @PROTEIN$ gene may contribute to the @COMPOUND$-mediated synaptic and behavioral plasticity.	1
3224	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, @PROTEIN$ and oxytocin transcripts was reduced.	1
3225	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of @PROTEIN$, HSD3B1, CYP19A1 and oxytocin transcripts was reduced.	1
3226	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, @PROTEIN$, CYP19A1 and oxytocin transcripts was reduced.	1
3227	In granulosa-lutein cells, STAR transcript abundance was not affected by @PROTEIN$, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, CYP19A1 and oxytocin transcripts was reduced.	1
3228	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, CYP19A1 and @PROTEIN$ transcripts was reduced.	1
3229	In both cell types, follistatin attenuated the suppressive effect of activin A and @PROTEIN$ on @COMPOUND$-induced P4 secretion but had no effect alone.	1
3230	@COMPOUND$ (1-ABT) is generally considered to be a nonselective mechanism-based inactivator of both human and non-human @PROTEIN$ (P450) enzymes.	1
3231	@COMPOUND$ is present in lipid deposits in the primate retina: potential implication in the induction of @PROTEIN$ and CNV formation.	1
3232	ETEC infection also caused a drastic inhibition of host @PROTEIN$ activity, as measured by @COMPOUND$ fluorescence.	0
3233	@COMPOUND$ is a nonnucleoside inhibitor of the hepatitis C virus (HCV) nonstructural protein 5B (@PROTEIN$) polymerase, and boceprevir is an inhibitor of the NS3 serine protease.	1
3234	Mutations known to confer resistance to @COMPOUND$ (@PROTEIN$ C316Y) and boceprevir (NS3 V170A) were present in the combination-resistant replicons.	1
3235	Mutations known to confer resistance to @COMPOUND$ (NS5B C316Y) and boceprevir (@PROTEIN$ V170A) were present in the combination-resistant replicons.	0
3236	A role for @COMPOUND$ and @PROTEIN$ combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.	0
3237	Genetic type 2 diabetic Goto-Kakizaki rats were fed with a high-fat diet to test hepatic effects of type 2 diabetes with hyperlipidemia and the effect of @COMPOUND$ and @PROTEIN$, individually and in combination, in systemic and hepatic inflammatory and oxidative stress markers.	0
3238	Combination of @PROTEIN$ and @COMPOUND$ further improved glycemic and lipid profiles and decreased circulating C-reactive protein levels and liver inflammatory and oxidative stress markers.	0
3239	@PROTEIN$ and @COMPOUND$ combination leads to better glycaemic and lipid profiles and to better protection against liver inflammation and oxidative stress, giving a superior level of liver protection in type 2 diabetic with hyperlipidemia.	0
3240	The-417- and-593 bp promoter regions were sufficient for @PROTEIN$ gene activation by ethylene and @COMPOUND$ treatments, respectively.	1
3241	The-417- and-593 bp promoter regions were sufficient for @PROTEIN$ gene activation by @COMPOUND$ and methyl jasmonate treatments, respectively.	1
3242	Reversible two-step unfolding of @COMPOUND$-human @PROTEIN$ : a (1)H-NMR relaxometric and circular dichroism study.	1
3243	Human serum albumin (@PROTEIN$) participates in @COMPOUND$ scavenging, the bound heme turning out to be a reactivity center and a powerful spectroscopic probe.	1
3244	Human @PROTEIN$ (HSA) participates in @COMPOUND$ scavenging, the bound heme turning out to be a reactivity center and a powerful spectroscopic probe.	1
3245	Here, the reversible unfolding of @COMPOUND$-@PROTEIN$ has been investigated by (1)H-NMR relaxometry, circular dichroism, and absorption spectroscopy.	1
3246	The purified enzymes were a monomer with an apparent molecular mass of 32 kDa (Chi32) and 46 kDa (Chi46), respectively, and showed @PROTEIN$ activity bands with 0.01% @COMPOUND$ chitin as a substrate after SDS-PAGE.	0
3247	The interaction of propafenone (@COMPOUND$) enantiomers with human plasma, human @PROTEIN$ (HSA), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
3248	The interaction of propafenone (@COMPOUND$) enantiomers with human plasma, human serum albumin (@PROTEIN$), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
3249	The interaction of @COMPOUND$ (PPF) enantiomers with human plasma, human serum albumin (@PROTEIN$), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
3250	The interaction of @COMPOUND$ (PPF) enantiomers with human plasma, human @PROTEIN$ (HSA), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
3251	@COMPOUND$-Epac2-mediated activation of @PROTEIN$ in developing male germ cells: RA-RhoGAP as a possible direct down-stream effector.	1
3252	@COMPOUND$-@PROTEIN$-mediated activation of Rap1 in developing male germ cells: RA-RhoGAP as a possible direct down-stream effector.	1
3253	Taken together, our results, obtained with endogenously expressed proteins, are consistent with a @COMPOUND$/Epac2/@PROTEIN$-mediated signaling that could exert its action, among others, through RA-RhoGAP to promote the progression of spermatogenesis.	1
3254	Taken together, our results, obtained with endogenously expressed proteins, are consistent with a @COMPOUND$/@PROTEIN$/Rap1-mediated signaling that could exert its action, among others, through RA-RhoGAP to promote the progression of spermatogenesis.	1
3255	0.05) in the overall @COMPOUND$-mediated @PROTEIN$ response.	1
3256	@COMPOUND$-stimulated @PROTEIN$ levels were not significantly different from controls.	1
3257	The inducible form of @PROTEIN$ (NOS2) plays an important role in sepsis incurred as a result of infection with Gram-negative bacteria that elaborate @COMPOUND$.	1
3258	The inducible form of nitric oxide synthase (@PROTEIN$) plays an important role in sepsis incurred as a result of infection with Gram-negative bacteria that elaborate @COMPOUND$.	1
3259	Atypical sialylated N-@COMPOUND$ structures are attached to neuronal @PROTEIN$.	1
3260	@COMPOUND$ linkages were identified for @PROTEIN$, Kv3.1, 3.3, 3.4, 1.1, 1.2 and 1.4, by evaluating their electrophoretic migration patterns in adult rat brain membranes digested with various glycosidases.	1
3261	TP53, BCL-2 and @PROTEIN$ analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0
3262	TP53, @PROTEIN$ and BAX analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0
3263	TP53, BCL-2 and @PROTEIN$ analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0
3264	TP53, @PROTEIN$ and BAX analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0
3265	@PROTEIN$, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0
3266	@PROTEIN$, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0
3267	Exposure of HEK293 cells to BK produced a concentration-dependent rise in intracellular Ca(2+) (EC(50)=36.5+/-8.0 x 10(-9)M), a rapid increase in @COMPOUND$ phosphorylation of @PROTEIN$ (EC(50)=9.8+/-0.4 x 10(-9)M), and elevation in ECAR by approximately 20%.	1
3268	@PROTEIN$ expression coupled with infusion of the IGF binding protein inhibitor @COMPOUND$ significantly prevented corticospinal motor neuron death 0.05), but did not promote corticospinal axon regeneration.	1
3269	We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to c-Src-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor @PROTEIN$.	1
3270	We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to @PROTEIN$-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor AP-2.	1
3271	Interaction of @PROTEIN$ and @COMPOUND$ in endemic dilated cardiomyopathy.	1
3272	We studied the gene-environment interaction in the pathogenesis of KD by assessing the association of low blood @COMPOUND$ and polymorphisms in @PROTEIN$ (GPx-1) gene.	1
3273	We studied the gene-environment interaction in the pathogenesis of KD by assessing the association of low blood @COMPOUND$ and polymorphisms in glutathione peroxidase-1 (@PROTEIN$) gene.	1
3274	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of superoxide dismutase (@PROTEIN$), catalase and glucose-6-phosphate dehydrogenase.	0
3275	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of superoxide dismutase (@PROTEIN$), catalase and glucose-6-phosphate dehydrogenase.	0
3276	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of @PROTEIN$ (SOD), catalase and glucose-6-phosphate dehydrogenase.	0
3277	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of @PROTEIN$ (SOD), catalase and glucose-6-phosphate dehydrogenase.	0
3278	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of superoxide dismutase (SOD), @PROTEIN$ and glucose-6-phosphate dehydrogenase.	0
3279	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of superoxide dismutase (SOD), @PROTEIN$ and glucose-6-phosphate dehydrogenase.	0
3280	This analysis reveals @PROTEIN$ as major and unsuspected gates of @COMPOUND$+) entry that contribute, depending on context, to activation of transcription factors, apoptosis, vascular contractility, platelet activation, and cardiac hypertrophy, as well as to normal and abnormal cell proliferation.	1
3281	A single bout of exercise increases @COMPOUND$ uptake and fatty acid oxidation in skeletal muscle, with a corresponding activation of AMP-activated @PROTEIN$ (AMPK).	1
3282	A single bout of exercise increases @COMPOUND$ uptake and fatty acid oxidation in skeletal muscle, with a corresponding activation of AMP-activated protein kinase (@PROTEIN$).	1
3283	Changes in @COMPOUND$ consumption and the RQ ratio during sedentary and low-intensity exercise were not different between alpha(1)-@PROTEIN$-DN and WT.	0
3284	The electrons released from @COMPOUND$ by @PROTEIN$ were transferred to CTC in the reaction medium, and CTC reduction activity could be assessed spectrophotometrically and spectrofluorometrically.	1
3285	Goldfish scales were incubated either with 20:3n-9 or with @COMPOUND$ at 15 degrees C for 6 and 18 h. Both osteoblastic and osteoclastic activities in the scale were assessed by measuring alkaline phosphatase (@PROTEIN$) and tartrate-resistant acid phosphatase, respectively.	0
3286	Goldfish scales were incubated either with 20:3n-9 or with @COMPOUND$ at 15 degrees C for 6 and 18 h. Both osteoblastic and osteoclastic activities in the scale were assessed by measuring @PROTEIN$ (ALP) and tartrate-resistant acid phosphatase, respectively.	0
3287	MC3T3-E1 cells (an osteoblast cell line derived from the mouse) were incubated with 20:3n-9 or @COMPOUND$ at 37 degrees C for 6 and 18 h. @PROTEIN$ activity in cell lysate was measured.	0
3288	Reactive oxygen species induce phosphorylation of @COMPOUND$ 118 and 167 on @PROTEIN$ alpha.	1
3289	Both kinases have been implicated in the phosphorylation of @COMPOUND$ 118 and serine 167 on @PROTEIN$, respectively.	1
3290	Our data show for the first time that ROS can induce post-translational modifications of @PROTEIN$ at @COMPOUND$ 118 and serine 167, and may lead to ERalpha down-regulation in human breast cancer cells.	1
3291	Expression of the @PROTEIN$-GFP fusion protein was observed exclusively upon @COMPOUND$ induction and was uniformly distributed throughout the intestinal epithelium.	1
3292	A decrease in @PROTEIN$ (7)R expression was observed in cultured OPCs after exposure to oxygen-@COMPOUND$ deprivation (OGD) for 2 h in vitro.	1
3293	Reactivity of @COMPOUND$ with the (4Fe-4S) cluster of @PROTEIN$ from Escherichia coli.	1
3294	The rate constant for the initial reaction between NO and the @PROTEIN$ (@COMPOUND$ is estimated to be (7.0+/-2.0)x10(6) M(-2) x s(-1) at 25 degrees C, which is approx.	1
3295	These results suggest that @PROTEIN$ delivers @COMPOUND$ to mitochondria where regulatory oxysterols are generated.	1
3296	@PROTEIN$ promoter hypermethylation correlates with a survival benefit from @COMPOUND$ in patients with recurrent anaplastic astrocytoma but not glioblastoma.	1
3297	To investigate the correlation between O(6)-methylguanine-DNA-methyltransferase (@PROTEIN$) promoter methylation and benefit from @COMPOUND$ in patients with recurrent high-grade glioma.	1
3298	Adenosine nucleotide translocase (@PROTEIN$) translocates ADP/@COMPOUND$ across the inner mitochondrial membrane.	1
3299	The data provide the first demonstration for the presence of @PROTEIN$ in primary cilia of renal epithelial cells, and a functional @COMPOUND$-signaling pathway, which targets ciliary channel function and may help control the sensory function of the primary cilium.	0
3300	The endothelial (Ca(2+))(@COMPOUND$) response to @PROTEIN$ (100 nM) was significantly attenuated.	1
3301	The endothelial (@COMPOUND$+))(CYT) response to @PROTEIN$ (100 nM) was significantly attenuated.	1
3302	The purpose of this research was to enhance intranasal drug targeting to the CNS by incorporating a vasoconstrictor (phenylephrine (PHE)) into nasal formulations containing therapeutic @PROTEIN$ (hypocretin-1 (HC) or the dipeptide L-Tyr-D-Arg (D-@COMPOUND$)).	0
